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Abstract
Canine atopic dermatitis is a skin condition of an allergic origin which usually 
becomes apparent in dogs between the ages of one and three years. This is a particular 
problem for Guide Dogs for the Blind Association (GDBA) dogs as this is the age that 
dogs are finishing training and beginning their working life. Hence much time and 
money is spent on dogs which may have to be retired early due to this skin condition. 
Therefore, if  dogs likely to go on and develop atopic dermatitis could be identified 
before beginning their training more efficient use of funds and facilities could be 
made by trainers and the society.
A group of dogs passing through the GDBA kennels were studied for a period of three 
years. This involved collecting clinical and serological data, with the aim of 
identifying factors which could be used to isolate dogs likely to develop clinical signs 
of atopic dermatitis. In addition to GDBA dogs, groups of racing greyhounds, 
laboratory beagles and pet dogs were also examined in order to identify factors 
peculiar to the GDBA population.
GDBA dogs provided an ideal opportunity to study a large number of dogs in a 
particular environment with excellent husbandly and recording of clinical histories. 
Both clinical and serological parameters were studied. Examination of clinical 
histories revealed that GDBA dogs demonstrating four or more episodes of atopic 
type skin disease before 15 months of age were at an increased risk of developing 
atopic dermatitis.
Serological studies revealed that serum total IgE concentrations are unrelated to the 
age or parasite status of a dog. Rather there appears to be a range of serum total IgE 
concentrations in the canine population with some dogs showing high levels and other 
low. Although it has been suggested (de Week et al, 1998) that only dogs with high 
serum total IgE concentrations will go on to develop atopic dermatitis this was not
always found to be the case as a number Katopfc dogs was found to have low serum
' -f'-Vv ; :i|
total IgE concentrations.  ^ ■**:'
Unlike serum total IgE, serum total IgGi concentrations were found to be significantly 
higher in dogs affected by atopic dermatitis and/or parasitism. In addition serum total 
IgGi concentrations were found to increase in dogs following hyposensifisation 
therapy and this appeared to he associated with the success of byposensitisation It is 
possible that measurement of serum total IgGi concentrations could be used as an 
indicator of the success of byposensitisation before a  clinical improvement becomes 
apparent.
When comparing intradennal skin test results and serological results in the same dogs, 
results do not often agree, possibly due to the different methodologies involved. 
Allergen exposure appears to influence antibody levels with dogs in different 
environments and at different times of year showing different serological results. 
Although allergen exposure can be assumed to be different in different environments 
an interesting method of identifying exactly which pollens a dog has been exposed to 
was developed. This involved examination of faecal samples for their pollen contents 
and revealed a large variety of pollens. This method could be used in the design of 
intradermal skin tests or serological tests which to date are primarily based on human 
pollen exposures.
Examination of individual allergen responses revealed that atopic dogs appear more 
likely to demonstrate higher serological results against mould allergens than non- 
atopic dogs. This was the case even though very few dogs actually demonstrated 
positive intradermal skin test results against mould allergens.
In summary, this study has disproved a number of hypotheses, including the belief 
that serum total IgE concentrations depend on the parasite status of an animal, and 
that it is not possible to compare different serological tests and expect a good 
correlation.
The author has demonstrated that by examining the number of episodes of skin 
disease in dogs by particular ages, the serological response of individuals to particular 
allergens, especially moulds, and by assessing serum total IgGi concentrations it is 
possible to identify dogs at risk of developing atopic dermatitis.
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Preface
This study is designed to foJJow the progress of dogs passing through the Guide Dogs 
for the Blind Association (GDBA) kennels at Forfar. The main area of interest in the 
study is atopic dermatitis, which usually becomes evident in dogs between the ages of 
one and three years. As guide dogs often begin their working life at two years of age it 
is not uncommon for a dog to go through a year’s training after which clinical signs of 
atopic dermatitis become. Atopic dermatitis interferes with a dog’s ability to work and 
is distressing for an owner. Indeed, in cases where medical management is not 
successful it can lead to the early retirement of a dog, which is obviously costly for 
the GDBA.
Thus, the main aim of the study is to create a predictive model, which will be able to 
identify those dogs likely to develop atopic dermatitis before they begin their training 
at a year old.
A number of areas are incorporated in the study including clinical examinations, 
clinical histories and serological studies. The GDBA population provides a situation 
where a detailed examination of a large number of dogs from a closed population can 
take place. This is advantageous, as these dogs undergo regular clinical examinations 
and highly detailed clinical histories are kept In addition, all dogs undergo a rigorous 
parasite control programme and both endo- and ectoparasites are rare in the GDBA 
population at this particular kennel. Thus factors such as parasitism or even owner 
observation, which may influence results, can be minimised.
For comparative purposes, groups of kennelled beagles, racing greyhounds and pet 
dogs will also be studied, to identify whether or not findings are peculiar to the 
GDBA population. These measures will allow findings to be applied to the canine 
population as a whole.
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Chapter 1 Literature Review
LI History of atopic dermatitis
Atopic dermatitis is a skin condition found in both humans and animals which 
is assumed to have an allergic pathogenesis. A common feature is evidence of 
pruritus usually presenting at a young age.
The term atopy was first introduced in 1923 by Coca & Cook. At that time it 
was restricted to a ‘hypersensitivity reaction of the asthma and hayfever 
group.’ The term atopy was derived from the Greek aroma (atopia) meaning 
strange disease, an apt description to this day. Among the criteria devised by 
Coca and Cook were features such as, the condition was inherited by way of a 
dominant gene; a hypersensitivity reaction against substances such as 
tuberculin was present and that by injecting the active substance the severity 
of clinical signs could be lessened. As will be discussed hater these clinical 
findings have stood tire test of time. However, Coca and Cook also suggested 
that the disease could not be transferred passively to normal individuals via the 
blood of hypersensitive individuals -  a fact later proved false.
The term ‘atopic dermatitis’ was first introduced in human medicine in 1935 
by Hill & Sulzberger to describe a pruritic skin condition often associated with 
hay fever and asthma, hr veterinary medicine atopy was first described hr the 
dog in 1941 by Wittich, and later by Patterson (1960), and Schwartzman & 
Rockey (1967). The first description by Wittich (1941) noted that the main 
clinical features were respiratory signs of a hayfever like condition, associated 
with pruritus and urticaria. In addition this dog demonstrated positive direct 
skin tests.
In later reports of canine atopy, the condition was described as, either a 
pruritic skin condition, or a respiratory problem (Schwartzman & Rockey, 
1967). Criteria for a diagnosis of atopy by Schwartzman & Rockey (1967) 
included die presence of reaginic antibodies in die serum of a hypersensitive 
patient; that these antibodies could be demonstrated by means of a Prausnitz 
Kustner test and that positive skin tests could be obtained for allergens such as
1 _
pollens, house dust or mould. These authors also noted that the clinical signs 
of atopy were seasonal and that the condition appeared to be familial.
The majority of recent work on canine atopic dermatitis has been carried out 
by Willemse. His review of atopic skin disease (1986) defined atopy as a 
hereditary, IgE mediated hypersensitivity to environmental allergens. 
Currently diagnosis of canine atopic dermatitis is based on Willemse’s criteria. 
This will be discussed in some detail later.
L2 Pathogenesis of atopic dermatitis
Atopic dermatitis is a condition where the patient (human or animal) becomes 
sensitised to environmental antigens that in non-atopic animals create no 
disease (Scott et al, 1995). Type 1 hypersensitivity reactions involving the 
production of Immunoglobulin E (IgE) and mast cell degranulation are 
believed to be the major pathogenic process (Scott et a l, 1995), although late 
phase reactions and Type IV hypersensitivity reactions may also be involved. 
Substances such as pollens and house dust mites are believed to come in 
contact with the immune system in the respiratory tract, with initial 
presentation resulting in the formation of antibodies, generally of the IgE 
class, which bind to mast cells. On subsequent exposure to the same substance 
(or allergen), cross linkage of IgE molecules via allergen results in the 
degrahulation of mast cells and release of vaso-active mediators such as 
histamine. These mediators are responsible for the clinical signs such as 
pruritus associated with atopic dermatitis.
Although this is the accepted basis to the pathogenesis of atopic dermatitis 
much controversy exists about this theory and other ideas have been put 
forward by various authors. Szentivanyi (1968) put forward the beta 
adrenergic theory which suggests an abnormal response in the sympathetic 
branch of the autonomic nervous system. Both cyclic adenosine 
monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) are 
involved in the mediation of cell reactions. The beta adrenergic theory 
suggests that reduced cAMP or elevated cGMP levels tend to labilize cells and
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promote the release of inflammatory mediators. This is stimulated by 
substances such as cholinergic drugs, oestrogen or levamisole.
A further theory of atopy is that of the Basenji greyhound model suggested by 
Chan et a l (1985). Again, this is based on studies of cAMP, where increased 
phosphodiesterase activity results in a lowering of cAMP responses and 
resultant airway hypersensitivity.
The route by which allergens come into contact with die immune system is 
currently under examination. The traditional theory of allergen presentation, as 
mentioned above, is via the respiratory tract However, there is some proof 
that percutaneous absorption of allergens may also be involved.
The clinical presentatiorr of atopic dermatitis in both humans and dogs would 
suggest that percutaneous absorption of allergens may take place. In humans, 
the commonly affected sites are the flexural areas of the arms and legs, or 
periacularly where the skin is relatively thin. In the dog, dermatitis is often 
present around the eyes, on the abdomen, flexural areas of the lower legs, and 
between the pads of the feet. These areas are subject to friction and/or have 
poor hair covering allowing easy contact between allergens and the skin.
In addition, increased numbers of Langerhans cells have been demonstrated in 
the skin of atopic humans and dogs compared to non-atopics (de Vries, 1994) 
and from this Olivry et a l (1996) suggested that transepidermal capture of 
allergens is possible.
1.2.1 Cellular components of immune response 
t .Zf. i  Langerhans cells
Langerhans cells were first described in 1868 by Paul Langerhans. These cells 
are derived from the bone marrow, from which they migrate to the suprabasai 
epidermis (Stingl et a l , 1993). The identifying feature is the Birbeck granule 
(Yager, 1998), which is thought to represent internalised ligand receptor 
complexes and is present in the Langerhans cells of humans, cats, mice and 
horses, but is absent in avians and amphibians. In the dog, the presence of 
Birbeck granules is controversial (Yager, 1998).
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Langerhans cells are the chief antigen presenting cell in the skin immune 
system (Stingl et a l , 1989). Surface molecules such as Major
Histocompatability Complex II (MHC II) and receptors for the Fc portion of 
IgE and IgG are present on Langerhans cells and are important in 
hypersensitivity reactions in humans (Bieber et at., 1992).
As mentioned above, increased numbers of Langerhans cells have been 
identified in the skin of human atopies compared with non-atopies (de Vries,
1994) suggesting that the Langerhans cell may be important in the 
pathogenesis of atopic dermatitis.
1,2,1,2 Keratinocytes
The traditional functions of keratinocytes are well known, including the 
production of keratin, surface liprds and intercellular substances (Scott et at.,
1995). Keratinocytes are also capable o f producing cytokines involved in the 
inflammatory response; releasing inflammatory mediators such as histamine 
and carrying out phagocytosis under certain: conditions (Scott et at., 1995). 
Release of preformed interleukin-1 (IL-1) takes place after injury to the 
keratinocyte (Yager, 1998). This cytokine is pro-inflammatory and is involved 
in the T cell response. Keratinocytes can also release histamine following 
exposure to ultraviolet light. (Yager, 1998).
Activated keratinocytes can express the Major Histocompatability Complex 
molecule II (MCH II) on their surface (Reviewed by Chu & Morris, 1997). 
The MHC II molecule is usually expressed on the surface of B lymphocytes 
and macrophages and is required for the presentation of antigenic epitopes to 
T helper cells in order to stimulate an immune response. Theoretically, 
keratinocytes could process and present antigens to T lymphocytes (Stingl et 
al, 1989). If this is the case then percutaneous absorption of allergen could 
take place with the keratinocyte playing a major role. However, although 
activated keratinocytes can express MHC II molecules on their surface they 
have been shown to lack B7-1 (otherwise known as CD80) receptor molecules 
which are required for presentation of antigen to T lymphocytes (Yager, 
1998). It is more probable that keratinocytes have a role to play in antigen
processing but do not contribute to the pathogenesis of atopic dermatitis by 
presenting antigens to T lymphocytes (Yager, 1998). Indeed it has been 
suggested that presentation of antigens by keratinocytes may well result in a 
down regulation of the immune response or the induction of tolerance (Yager, 
1998). From this it can be seen that much work is still required on the role of 
the keratinocyte in the pathogenesis of atopic dermatitis.
1.2.1.3 Monocytes /  macrophages
Monocytes are derived from the bone marrow. These cells enter the blood 
stream and then enter the tissues where they will reside. In these tissues 
monocytes differentiate into macrophages, where their main function is 
phagocytosis of foreign material and presentation of this to B and T 
lymphocytes. In addition to phagocytosis, macrophages can act as secretory 
cells and produce enzymes, proteins in the complement cascade, interferon 
gamma (IFN y), IFN P and IL-1; IL-1 being required to activate T cells 
(Changed/., 1990).
1.2.1.4 Lymphocytes
Lymphocytes are immune system cells which can be divided into three 
groups. These are bone marrow derived cells (B cells), thymus dependent cells 
(T cells) and null cells. Null cells do not demonstrate any of the characteristic 
markers of B and T lymphocytes and will not receive any further mention. T 
cells have received by far the most attention in both canine and human atopic 
dermatitis.
T Lymphocytes
Although produced in the bone marrow T lymphocytes are activated and 
released from the thymus. From here they disperse to the secondary lymphoid 
organs such as the spleen and lymph nodes. T lymphocytes can express a 
number of surface molecules. Groups of surface molecules which can be 
identified by a single monoclonal antibody have been described as Clusters of 
Differentiation (CD) (Cobbold & Metcalfe, 1994) and each monoclonal 
antibody has been given an identifying number.
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All mature T lymphocytes express surface molecules which can be identified 
with the use of CD3 antibodies and surface molecules called T Cell Receptors 
(TCR). Two forms of T cell receptors (TCR) have been described. Firstly the 
a/p TCR which is found on 90% of human cutaneous lymphocytes, and 
secondly the y/5 TCR which is the predominant cutaneous T cell in ruminants. 
T cells expressing a/0 TCR can be further sub-divided into two distinct groups 
depending on whether they express CD4+ or CD8 + markers. Those cells 
which express CD4+ are designated T helper cells (Th) and those that express 
CD8 +, suppressor cells (Ts).
T helper cells are involved in the stimulation of B lymphocytes and these T 
helper cells can be further divided according to the cytokines which they 
produce. Thl cells produce interleukin-2 (IL-2), interferon-y (IFN-y), and 
tumour necrosis factor a (TNF-a) whereas Th2 cells produce EL-4, IL-5 and 
IL-10.
Thl cells preferentially develop against bacterial infection and are important 
in delayed hypersensitivity reactions (Chang et a l, 1990). Th2 cells are 
involved in activation and proliferation of mast cells, eosinophils and 
lymphocytes (Hnilca & Angarano, 1996) via their cytokine production. They 
also promote antibody dependent immunity especially IgE production (Yager,
1993), with reactions predominantly against helminths and environmental 
allergens. As such, Th2 cells are important in the pathogenesis of atopic 
dermatitis (de Vries, 1994).
Defective cell mediated immunity has been demonstrated in both canine and 
human atopic patients (Leung et al., 1993; Nimmo Wilkie, 1990), with a lower 
proportion of CD8 + T suppressor cells present in the circulation of atopies. 
This leads to an increase in the ratio of CD4+.CD8+ cells (Leung et a l, 1993; 
Kapsenberg et al, 1991; van der Heijden et a l, 1991; Stingl et al., 1981). In 
atopic dermatitis this decrease in T suppressor cell numbers may be important 
(Chiorazzi et a l, 1977) as it may allow excessive IgE production by B cells.
In addition to decreased T suppressor cell numbers, atopic patients have been 
shown to have increased concentrations of T helper cells, in particular those
patients suffering from disease (Wiemga et a l, 1990) and much research has 
concentrated on this subset of cells.
van der Hiejden (1991) demonstrated that Th2 cells specific for the house dust 
mite Dermatophagoides pteronyssinus from the skin of atopic people 
produced IL-4. As IL-4 stimulates the production of IgE this would suggest 
that Th2 cells are important in the pathogenesis of raised serum IgE levels in 
atopic patients.
External factors such as drug therapy can augment Th2 cell reactions. 
Glucocorticoids, calcitrol and progesterone (Romagnani, 1994) may enhance 
the differentiation of Th2 cells and thus tend towards the production of IgE 
and the proliferation of mast cells. This would appear to be an anomaly in the 
treatment of atopic dermatitis. However, as glucocorticoids have an obvious 
beneficial effect in the treatment of atopic dermatitis there must be other 
factors involved. Hyposensitisation also appears to influence the activity of 
Th2 cells. Secrist et al. (1993) demonstrated that allergic patients receiving 
hyposensitisation produced lower levels of IL-4 but these authors did not 
provide an explanation for this.
B lymphocytes
B lymphocytes make up between 5 and 15% of the peripheral blood 
lymphocytes and unlike T lymphocytes, B lymphocytes are capable of 
interacting directly with antigens. Antigen presenting cells present antigens to 
B cells in association with T helper cells in the lymph nodes. The resultant 
activated B cells divide and thus generate large numbers of antigen specific 
effector cells. These will develop into plasma cells capable of producing 
antigen specific antibodies and memory cells capable of responding on 
subsequent exposure to the same allergen (reviewed by Day, 1993). Most 
research on atopic dermatitis in both humans and animals has concentrated on 
T lymphocytes rather than B lymphocytes even though B cells are the source 
of IgE, central to the pathogenesis of atopic dermatitis.
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1.2.1.5 Mast cells
Mast cells are one of the most important cells in the pathogenesis of atopic 
dermatitis due to the pathological effects caused by their degranulation. Mast 
cells are derived from the bone marrow and are located mainly in connective 
tissues or near mucosal surfaces. Mast cells contain numerous granules which 
give the cells a distinctive appearance. These granules contain preformed 
mediators such as histamine, heparin and serotonin. Mast cells can also release 
cytokines, IL-1 and TNFa. On the surface of the mast cell are surface 
receptors for the Fc region of IgE and IgG antibodies and complement 
(Aalberse et a l , 1998). Cross linkage of IgE molecules bound to these Fc 
receptors results in the degranulation of mast cells following re-exposure to 
antigen or directly by substance P from irritated cutaneous nerve endings 
(Cooper, 1994).
A heterogeneity of mast cells has been suggested by Becker et a l , (1985, 
1986). These authors observed two populations of mast cells which could be 
differentiated histologically and physiologically. One population of cells was 
observed to take part in the early response to antigens and a different 
population was associated with the late phase reaction. The exact role of this 
finding in the pathogenesis of atopic dermatitis was not explained.
1.2.1.6 Granulocytes
Other cells such as eosinophils, basophils and neutrophils can be involved in 
atopic dermatitis. Eosinophils are generally associated with parasitism and 
hypersensitivity and are often found in association with mast cells. On the 
surface of eosinophils are low affinity receptors for IgE which may be 
involved in atopy. Their characteristic granules contain histaminase and 
peroxidases. Eosinophils are influenced by IL-5 from T cells.
Unlike eosinophils, basophils possess a high affinity receptor for IgE and 
similar to mast cells, activation of basophils takes place via cross linkage of 
IgE molecules on their surface. This results in degranulation and release of 
histamine and other physiologically active substances contained in basophil 
granules -  hence their role in the pathogenesis of atopic dermatitis.
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Neutrophils are involved in inflammation and are capable of phagocytosis and 
enzyme release. They also possess surface receptors for the Fc portion of 
immunoglobulins and complement but little is known about the function of 
these receptors.
1.2.2 Humoral components of immune response
1.2.2.1 immunoglobulins
Immunoglobulins or antibodies are a group of serum proteins produced by 
plasma cells as part of the immune response. The function of these antibodies 
is to bind to the antigen which induced their formation, and then to interact 
with neutrophils, macrophages or complement in order to facilitate destruction 
of that antigen. Immunoglobulins are composed of two identical heavy chains 
(50,000-55,000 Daltons) and two light chains (20,000-25,000D), each of 
which possess a constant region and a variable region of amino acids. Either 
end of the immunoglobulin molecule has a particular function. The variable 
end (N-terminal) deals with binding to antigen and is called the Fab region. 
The constant (carboxyl terminal) end interacts with host cells and complement 
and is called the Fc region.
There are five major classes of antibody, IgM, IgE, IgG, IgA and IgD. The 
class of antibody depends on the amino acid sequence in the constant region of 
the heavy chain. When animals and humans are first exposed to antigens the 
first antibody formed is IgM (Schultz 8l Halliwell, 1985). Due to the influence 
of cytokines and T cells these B cells switch, to produce a different heavy 
chain constant region, which results in the production of a different antibody 
class (Stavnezer, 1996). Interleukin-4 is specifically responsible for the 
induction of switching to IgE production (del Prete et al., 1988).
IgE
The presence of reaginic antibodies has been suggested as a major feature of 
atopy / atopic dermatitis in both humans and animals (Willemse, 1986). IgE is 
the predominant antibody associated with atopy although IgG has also been 
shown to be involved (Willemse et a l , 1985b).
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In humans IgE is present in very Jow concentrations in the serum (300ng/mJ, 
Johansson et a l , 1970) due to its short half life of two days (Tizard, 1987b). 
Increased levels of serum JgE are associated with both parasitism (Bloch et a l, 
1972) and hypersensitivities (Tizard, 1987b).
IgE production is induced by IL-4, and IL-13 but is reduced by IFNy. 
Analogous properties, such as heat instability and the ability to induce passive 
cutaneous anaphylactic reactions have been illustrated for both human and 
canine IgE (Patterson et a l, 1963, Rockey & Schwartzman, 1967, 
Schwartzman etal., 1971).
Increases in serum IgE levels have been demonstrated in human atopic 
subjects, which are significantly higher than in non-atopics, or people 
suffering from contact dermatitis or psoriasis (Gurevitch et a l, 1973; Juhlin et 
a l, 1969; Jones et a l, 1975; Ogawa et a l, 1971; Wittig et a l, 1980). The 
degree of increase in serum IgE concentrations is highest in patients suffering 
from disease at the time of sampling (Jones et al., 1975; Johansson & Juhlin, 
1970). Hence IgE concentrations can be used as a diagnostic parameter for 
atopic dermatitis in human medicine.
The kinetics of serum IgE in the dog reveal a picture different to that painted 
for human serology. Generally canine serum JgE concentrations are much 
higher than that of humans with levels of 350ug/ml standardly recorded 
(Schwartzman & Rockey, 1967). The high levels of parasitism present in the 
canine population has been put forward as the reason for these increased 
serum IgE concentrations (Halliwell, 1990).
In contrast to the findings in humans, non-atopic dogs can demonstrate a wide 
variety of serum IgE concentrations. Initial work on IgE by Katz, (1978) 
demonstrated that there were two populations of mice that could be divided 
into ‘high’ responders with high serum IgE concentrations and ‘low’ 
responders with low concentrations. These responses were genetically 
inherited. Work by de Week et a l (1998) has found similar results in the 
canine population. These authors demonstrated that the phenotype to produce 
high levels of serum IgE was inherited in a dominant fashion and that only
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dogs which demonstrated this trait had the ability to go on to develop atopic 
dermatitis. This is perhaps the most exciting area of serological research in 
canine atopy at the present time.
It has also been shown that both parasitism and viral infection have the ability 
to potentiate the IgE response to other allergens and may have a role in the 
pathogenesis of atopic dermatitis. Frick et a l (1979) demonstrated that young 
children with viral infections had increased levels of serum total IgE; Frick & 
Brooks (1983) demonstrated that following vaccination against distemper 
virus, dogs demonstrated increased levels of pollen allergen specific IgE 
antibodies. Similarly increased levels of serum total IgE were found in people 
and rats with concomitant parasite infestations (Bloch et a l, 1972).
Although the half life of serum IgE in non-atopic humans is only two days, in 
atopic dogs the half life was found to be two months (Frick & Brooks, 1983). 
No reason was given for this difference but prolonged, high serum 
concentrations of IgE may have a role in the pathogenesis of atopic dermatitis. 
The exact relationship between IgE bound to mast cells and that free in the 
serum is not known but it is possible that where there are Ju'gh serum 
concentrations of total IgE, this leads to increased binding of IgE to mast cells 
with an increased potential for degranulation.
Hence it is apparent that the role of IgE in both human and canine atopic 
dermatitis is not as simple as once believed -  there are many arguments for 
and against the part which IgE plays in the pathogenesis of atopic dermatitis.
IgG
Immunoglobulin G (IgG) antibodies are the most abundant antibody class in 
the body and are the major antibodies produced during the secondary phase of 
the immune response. Total IgG is composed of at least four different sub­
groups in the dog, namely IgGj, IgG2, IgG3, and IgG.4. This nomenclature is 
based on their physicochemical properties and follows a similar naming 
system used in human medicine. In addition to these four groups, a further 
subgroup JgG<i has been described in the dog by Willemse et a l (1985a, 
1985b). It has been suggested that IgG<j is equivalent to IgGi (Halliwell,
1990). However, this is disputed by Day et a l (1996) who found that JgG<j 
antibody did not jeact with antiserum to any of the four recognised IgG 
antibody subgroups. Personal communication with Willemse confirms that 
JgG<i is not equivalent to any of the known JgG subgroups.
Normal dogs have been shown to develop IgG antibodies against 
environmental allergens (Wheeler, 1993; Shaw, 1996) but disease, parasites 
and hypersensitivity have all been shown to influence serum IgG levels. Hill et 
a l (1995) demonstrated that serum total IgG levels are higher in atopic and 
parasitised dogs than in healthy dogs. Willemse et a l (1985a) demonstrated 
that dogs suffering from Toxocara canis had elevated levels of serum IgGa. In 
addition Halliwell & Longino (1985) demonstrated that dogs with flea 
hypersensitivity had raised levels of allergen specific IgG. However, these 
authors also found that the levels of allergen specific IgG were higher in dogs 
with flea allergy than in those dogs chronically exposed to fleas which did not 
demonstrate any allergic reaction towards the fleas. This would suggest that an 
increase in allergen specific IgG levels was directed more towards a 
hypersensitivity reaction than parasitism. In contrast however, Hill et a l 
(1995) observed that the profiles of serum total IgG in both atopic and 
parasitised dogs followed similar patterns and therefore there may be a similar 
immunoregulatory mechanism occurring in both of these conditions.
There still appears to be some disagreement as to the circumstances necessary 
for the production of specific IgG subgroups. It has been suggested that in 
humans and animals the genetic background, type of antigen, the route and 
duration of exposure may all affect the subclass of IgG produced in an 
immune response (Day et a l, 1996; Mazza et a l, 1994). However, there has 
not been a study of the functional properties of these IgG subclasses (Day et 
a l, 1996) which would be very helpful in determining their importance in 
disease.
Both humans and dogs with atopic dermatitis have shown variations in 
specific IgG subgroups compared to non-atopies. Djurup & Mailing (1985)
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and McHugh et a l (1990) demonstrated a dominant allergen specific IgGi and 
IgG4 response in human atopies.
In the dog, Day et a l (1996) found that IgGi and IgG4 were the dominant IgG 
subclasses present in atopic individuals. However, the levels of these 
antibodies varied between different causative allergens. IgG4 was the 
dominant subgroup against Dermatophagoides farinae and D. pteronyssinus 
whereas IgGi was the dominant subgroup against Timothy grass. This is 
probably due to the various factors such as route and duration of exposure 
mentioned earlier.
A further factor contributing to the production of IgG is the suggestion that 
some of the IgG antibodies present in the serum are actually directed against 
IgE, termed IgG anti-IgE antibodies. These have been shown to be present in 
both dogs and humans (Scheur et a l, 1991; Carini & Fratazzi 1992; 
Hammerberg et a l, 1997). These antibodies are found in normal, parasitised 
and atopic humans and dogs but the highest levels are found in atopies. In 
atopies IgGi and IgGj subgroups contribute to the bulk of these antibodies. In 
humans the highest levels of IgG anti-IgE was found in those patients with the 
highest levels of IgE and there was a direct correlation between these two 
parameters. From a diagnostic viewpoint IgG anti-IgE is important because in 
serological tests these antibodies could mask IgE and result in low levels of 
IgE being recorded.
Perhaps the most important function of IgG antibodies in allergic disease is in 
hyposensitisation therapy of both human and canine subjects. 
Hyposensitisation has been shown to cause an increase in serum total IgG 
levels in the dog (Hites et a l, 1989) and it has been suggested that it is these 
antibodies which mediate the clinical response to hyposenstisation therapy 
(McHugh et al, 1990). Allergen specific subgroups IgGi and IgG4 have been 
shown to dominate different stages of immunotherapy in people (Djurup & 
Mailing, 1985; McHugh et a l, 1990). Allergen specific IgGi has been shown 
by McHugh et a l (1990) to increase after three months of hyposensitisation 
therapy and then to plateau, whereas although allergen specific IgG4 also
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increases over this time it continues to rise until the end of therapy after twelve 
months and dominates the response (Aalberse et aL, 1983). In general 
increased levels of allergen specific IgG4  have been shown to be associated 
with clinical improvement of human patients receiving hyposensitisation 
(McHugh et al., 1990; Devey et a l, 1976; Rowntree et al., 1985). This is 
contradicted by one author (Djiirup & Mailing, 1987) who observed that high 
allergen specific IgG4 levels were associated with a failure of immunotherapy. 
In an attempt to explain this anomaly, Aalberse et al. (1998) suggested that the 
failure of hyposensitisation in association with increased allergen specific 
IgG4 levels, may have been due to the production of IgG4 antibodies against 
allergens not involved in the disease process.
The way in which these IgG antibodies contribute to the success of 
hyposensitisation is still much debated. The classical theory is that they act as 
‘blocking’ antibodies, binding to the allergens before IgE, and thus preventing 
degranulation of mast cells (Aalberse et al., 1998). It has been shown that 
serum with high levels of IgG4 can block IgE mediated histamine release from 
peripheral blood basophils (Clinton et a l, 1989). Aalberse et al. (1998) 
suggested that IgG binds to a particular allergen and this antigen antibody 
(AgAb) complex then binds to the mast cell surface via allergen specific IgG. 
The allergen bound IgG then interacts with the Fc gamma receptor which 
causes down-regulation of mast cell activation (Daeron, 1997).
It can be seen from this that IgG has an important role to play in the 
pathogenesis and therapy of atopic dermatitis in both human and veterinary 
medicine with much remaining to be discovered.
IgA
Immunoglobuin A (IgA) is the major antibody associated with mucous 
membranes and is the major mediator of surface immunity. IgA is generally 
involved in binding to bacteria and inhibiting infection. In atopic humans 
reduced secretions of IgA have been observed although actual serum levels 
were no different between atopies and non-atopics (Imayama et al., 1994).
In the dog Hill et al. (1995) observed that serum total IgA concentrations were 
significantly lower in atopic and parasitised dogs compared with healthy dogs 
(p<0.05) and suggested that this was caused by similar down-regulatory 
mechanisms in atopic and parasitised dogs due to altered, rather than primary, 
immune functions.
1.2.2.2 Inflammatory mediators Involved in the pathogenesis of 
atopic dermatitis
As mentioned above inflammatory mediators such as histamine, cytokines and 
complement are all involved in the pathogenesis of atopic dermatitis. It is 
beyond the scope of this review to include all of the current knowledge of 
these mediators but a short discussion of the major players will be given.
Histamine
Histamine is probably the most important factor in the pathogenesis of atopic 
dermatitis. Its effects are easily observed and quantified and as such histamine 
is used as a control factor in intradermal skin testing. As mentioned earlier 
histamine is released from degranulating mast cells. Histamine generally acts 
as a pro-inflammatory mediator but can have anti-inflammatory effects (Scott, 
et a l, 1995). Pro-inflammatory effects are mediated via HI receptors and 
induce pruritus. Anti-inflammatory effects are mediated through H2 receptors 
and an increase in cAMP.
Cytokines
Cytokines are glycoproteins, produced by leukocytes and other cells, which 
act as intercellular messengers. They are mainly involved in inflammatory 
processes and are important in the activation of T and B cells and the clinical 
presentation of atopic dermatitis. Interleukins, tumour necrosis factors (TNF) 
and colony stimulating factors (CSF) are all classified as cytokines.
Many cytokines contribute to the pathogenesis of atopic dermatitis. However, 
the main cytokines involved include, interleukin 1 (IL-1) which is necessary 
for the Th2 response and interleukin 4 which is the most important interleukin 
in the promotion of Th2 differentiation. Th2 cells produce IL-4 which allows a
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positive feedback loop. The original source of IL4 is not known although it 
has been suggested that it may come from T cell subsets, mast cells or 
basophils (Zlotnil, 1993).
Continued elevation of IL-4 has been demonstrated in allergic human infants 
after six months of age whereas in non-atopics IL-4 levels decreased after five 
months of age (Bjorksten, 1999). It is possible that this is the original source 
of IL-4. It has been suggested that the exaggerated production of IL-4, IL-13 
and IL-5, which promote Th2 production, may be the underlying pathogenesis 
of allergy (Hnilca & Angarano 1996).
Arachidonic acid pathway
The arachidonic acid pathway is important in the pathogenesis of 
inflammation and contributes to the clinical signs observed in atopic 
dermatitis. Arachidonic acid is the major fatty acid in the cell membrane. 
Following damage to tissues, phospholipase A2 is activated and arachidonic 
acid is released from the cell membrane. Enzymes can then act on this and 
depending on the dominant enzymes, either follow the lipoxygenase pathway 
or the cyclooxygenase pathway both of which result in the formation of pro- 
inflammatory mediators.
Lipoxygenase products have been shown to be formed in significant amounts 
in canine atopic skin (Thomsen et a l , 1991). Interfering with the formation of 
these inflammatory mediators from arachidonic acid is the basis for using 
essential fatty acids in the Jreatmenl of atopic dermatitis.
1.2.3 Pathophysiology of Pruritus
The main clinical feature of atopic dermatitis is pruritus. As such the 
pathophysiology of pruritus requires some mention. The main problem in 
veterinary medicine is that it is impossible to say for definite that a dog is 
pruritic. We can only observe the clinical consequences likely to be caused 
by pruritus such as scratching and self trauma.
Pruritus is a sensation mediated by way of nerve fibres and humoral 
mediators mentioned earlier. Physiologists have divided the sensation of itch 
into two types -  firstly a rapid localised itch and secondly a slow burning
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diffuse itch. Both of these different sensations are transmitted by different 
nerye fibres. Myelinated nerves which transmit rapid impulses (called A 
fibres) are associated with the rapid itch and non-myelinated fibres which 
transmit slow impulses (C fibres) are associated with the diffuse itch (Sture,
1994). The humoral mediators of pruritus are wide and varied, some of 
which have been mentioned earlier.
1.2.4 Genetic background to the pathogenesis of atopic 
dermatitis.
The actual mode of inheritance of atopic dermatitis is not clear, although it is 
widely accepted that there is a familial predisposition for the disease (Reedy et 
a l , 1997a). Studies of human atopy as early as 1916, by Cooke and Vander 
Veer, concluded that atopy was inherited as a dominant trait with variable 
penetrance. Current genetic theories on human atopy consider recessive or 
multiple genes (Hopkin 1995). Humans have an JgE associated marker on 
chromosome 5q3JJ specifically localised to the IL-4 gene region 
(Romagnani, 1994). Near here are segments coding for IL-13, JL-5 and GM- 
CSF which are all involved in the Th2 response (Marsh et a l, 1995; Holgate et 
a l, 1995). It has been suggested by Romagnani (1994) that if promoter 
regions here are over-expressed under normal stimulation, there is increased 
IL-4 production and thus Th2 stimulation. Early reports of canine atopic 
dermatitis by Schwartzman & Rockey (1967) observed that often, involvement 
of dam, sire or siblings was found in relation to a number of atopic cases.
Schwartzman et a l, (1971) attempted to breed a colony of atopic dogs. They 
found that there was a familial tendency to develop atopy but results were not 
consistent with a  simple recessive or simple incomplete dominant hypothesis. 
However, they were consistent with the inheritance of an autosomal dominant 
gene mutation controlling histamine release i f  one assumed that the gene only 
determined whether release occurred, the amount of histamine released 
depending on other factors.
As mentioned earlier, de Week et a l (1998) demonstrated that the 
predisposition to become a high IgE responder was inherited in a dominant
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manner. The high IgE responder trait was found to be present in all oifspiing 
of a couple in which one of the parents was also a  high responder. It was also 
observed that only dogs with the high IgE responder trait could go on to 
develop atopic dermatitis (Mayer, et a l 1998). However, this is not the only 
controlling factor for the development of atopy as not all high responders will 
go on to demonstrate clinical signs of atopy and therefore other factors must 
also be involved.
1.2.5 Influence of external factors on the pathogenesis of atopic 
dermatitis
Jt has been suggested that infection with both bacteria and/or viruses can 
influence the development of atopic dermatitis. Various authors in human 
medicine have suggested that exposure to viruses such as parainfluenza and 
respiratory syncitial virus (RSV) can be related to the development of atopy 
(reviewed by Frick & Brooks, 1983). A similar finding was shown in the dog 
by Frick & Brooks (1983) who demonstrated that pups vaccinated against 
canine distemper before receiving pollen extracts had significantly more 
reaginic antibodies to subsequent pollen exposure than in control dogs. These 
authors associated this response to the breakthrough theory of Katz (1978) 
and suggested that virus infections or virus exposure may selectively delete 
suppressor T lymphocytes and result in a naturally occurring allergic 
breakthrough.
Parasitism has also been suggested as a contributing factor to the 
development of atopic dermatitis. Parasites naturally cause an increase in the 
production of IgE antibodies in both animals and humans. A potentiation 
effect of parasite antigens has been suggested by Bloch et al. (1972) with 
both people and rats suffering from parasite infestations demonstrating high 
serum IgE levels against pollen allergens.
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1.3 Clinical aspects of atopic dermatitis
1.3.1 ClinicaJ presentation of canine atopic dermatitis
It is widely accepted that the principal clinical finding in atopic dermatitis is
that of pruritus (reviewed by Scott, 1981; Willemse, 1986; Carlotti & 
Costargent, 1994). This pruritus can present itself in a variety of ways over a 
number of different sites. The only evidence that a dog is pruritic may be 
increased licking or chewing without any resultant skin lesion. This can 
however escalate into frequent scratching and self trauma.
The main areas affected in atopic dermatitis are the ears, periocular area, 
muzzle, feet, ventrum, extensor surface of the carpal joints and flexor aspect 
of tarsal joints (Scott, 1981; Willemse & Van den Brom, 1983; Willemse, 
1986; Nesbitt, 1978). Any of these areas can be affected alone but it is more 
usual for multiple areas to be affected, especially as the disease progresses, 
often resulting in generalized pruritus (reviewed by Scott, 1981). Otitis externa 
is by far the commonest presenting sign followed by conjunctivitis (Scott, 
1981; Willemse & Van den Brom, 1983). Scott (1981) observed that 55% of a 
group of 100 atopic dogs suffered from otitis externa in addition to other skin 
problems. However, only 3% of the atopic dogs in that study had otitis externa 
alone. The clinical findings in atopic dogs with otitis externa can be confused 
with non-atopic dogs with ear disease. Scott (1981) described atopic dogs as 
having pruritus, erythema and oedema of the ear canal with a minimum 
amount of exudation in addition to ear disease flaring in conjunction with skin 
disease and an excellent response to glucocorticoids and hyposensitisation.
Primary lesions such as erythema, papules and wheals have been reported but 
are rarely seen (reviewed by Scott, 1981; Willemse & Van den Brom, 1983). It 
is more common to find secondary lesions such as excoriations, alopecia, 
pyoderma or even lichenification in the worst cases. Lichenification of the 
extensor and flexor surfaces was found to be significantly less common 
(p<0.001) in atopic dogs that showed no skin test reactivity when compared 
with those who did react (Willemse, 1986).
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Respiratory problems such as those observed in human atopies are rare in the 
dog (Schwartzman, 1984). However, Willemse & Van den Brom (1983) 
observed that 22.4 % of a group of atopic dogs suffered from increased 
sneezing and reverse sneezing has been included as one of the diagnostic 
criteria by Willemse (1986). Other clinical findings which are inconsistently 
seen include seborrhoeic skin disease, hyperhidrosis (Scott, 1981) and 
discoloration of the coat (Willemse & Van den Brom, 1983; Willemse, 1986). 
Schwartzman et a l (1971) reported that once affected the dog maintains its 
atopic state throughout life.
1.3.2 Epidemiology 
1.3.2.1 Prevalence
Atopic dermatitis is a relatively common disease of people with one study 
demonstrating that 2-3% of children younger than five years of age were 
affected by atopic dermatitis (Walker & Warin, 1956).
Atopy is the second most common allergic skin disease of dogs next to flea 
bite hypersensitivity (Reedy et al., 1997a). The reported incidence varies 
between studies and depends on the groups of dogs in those studies. Of the 
general population of dogs, between 10% and 15% were reported as being 
atopic (Chamberlain, 1974). At dermatological referral centres the lowest 
prevalence of atopy was 3-4 % of the cases seen by Halliwell & Schwartzman 
(1971). Scott (1981) diagnosed 8% of referral cases as atopic and 30% of 
cases seen by Nesbitt (1978) were diagnosed as atopic.
1.3.2.2 Age of onset
The age at which clinical signs consistent with atopy are first recognized is of 
major importance in the diagnosis of atopic dermatitis - indeed this parameter 
is included in Willemse's diagnostic criteria (1986). The usual age of onset is 
between one and three years (reviewed by Scott, 1981; Halliwell & 
Schwartzman, 1971) with a first occurrence of atopy being rare in dogs 
younger or older than this. Scott (1981) noted that 58% of dogs presenting
with atopic dermatitis were one year of age with only 12% being two or four 
years of age. Willemse (1986) reported similar findings with 75.5% of atopic 
dogs presenting at Jess than 3 years of age.
It is rare for dogs to be diagnosed as atopic between six months and one year 
of age (Scott, 1981). Scott only observed 2% of atopic dogs in the six to eight 
months age group. However it should be noted that these studies examined 
dogs in referral clinics and often dogs may have been affected by atopic 
dermatitis for a period of months before being seen at a referral centre.
In a study of progeny of atopic dogs by Schwartzman (1984) no clinical 
evidence of atopic dermatitis was found in dogs less than 12 months of age, 
and no positive intradermal skin tests were demonstrated by dogs less than six 
months old However, one exception to this was a  group of highly inbred 
atopic dogs observed by Reedy et a l (1997a) which demonstrated significant 
clinical signs consistent with atopic dermatitis by the time they were six 
months old
The incidence of atopy also decreases in dogs older than three years. Again, 
Scott (1981) only found 2% of dogs presenting with atopy in the six to seven 
years age group. A possible explanation for older dogs developing atopy is if 
they have been moved frequently as young dogs and have not remained in the 
same environment long enough to demonstrate clinical allergy. (Reedy et a l, 
1997a).
1.3.2.3 Breed predisposition
Breed predispositions for the development of atopic dermatitis have been 
shown by a number of studies. However, the predominant breeds often differ 
between different areas of the world, probably due to distinct gene pools in 
these areas. Even, within the United Kingdom breed differences were found 
by Sture et a l (1995) with a higher percentage of atopic West Highland white 
terriers and boxers in London than in Edinburgh. (14.3% and 9.5% compared 
to 8% and 4.6% respectively). However, no information as to the difference in
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the numbers of these breeds in the general population in Edinburgh and 
London was given, which may bias the findings.
In America the breeds mainly affected have been reported as the wire-haired 
terrier (Halliwell & Schwartzman, 1971), Cairn terrier, West Highland white 
terrier, lhasa apso, wire-haired fox terrier, dalmatian, pug, Irish setter, Boston 
terrier and miniature schnauzer (Scott 1981).
In Europe, Carlotti & Costargent (1994) found that setters (Irish, English, and 
Gordon) were the breeds most often diagnosed as atopic with the Pyrenean 
shepherd, fox terriers and Lahradors also over-represented In the Netherlands, 
Willemse & van den Brom (1983) found boxers (13.5%) terriers (13.5%), 
German shepherd dogs (13%) and poodles (5.8%) to be the breeds most often 
diagnosed as atopic.
A decreased incidence of atopic dermatitis was found by Scott (1981) in the 
cocker spaniel, dachshund, standard poodle, toy poodle and German 
shorthaired pointer. Carlotti & Costargent (1994) also found that the cocker 
spaniel and dachshund were under-represented. Although most studies have 
concentrated on pedigree breeds, mongrels can also be affected by atopic 
dermatitis (Reedy et al., 1997a). The breed predilections seen in dogs are 
somewhat different to the findings in human medicine. Caucasians have been 
reported as being more prone to developing atopic dermatitis but no 
significant difference has been shown between races (Leung eial^  1993).
1.3.2.4 Sex
Sex predilections towards the development of atopic dermatitis for both male 
and female dogs have been suggested by different authors. Halliwell & 
Schwartzman (1971) and Scott (1981) found that females were more likely to 
be atopic. Schick & Fadok, (1986) observed that bitches had a significant 
predilection (p<0.05) for developing clinical signs of atopy. Scott (1981) also 
observed this. An explanation for this predisposition for female atopies was 
given by Reedy et al. (1997a) who suggested that intracellular cGMP levels 
were raised due to oestrogens. As cGMP is involved in the degranulation of
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mast cells, higher levels of cGMP could lead to increased release of histamine 
and other mediators of pruritus, and thus more female animals could present 
with clinical signs of atopic dermatitis. However, Nesbitt (1978) found that 
male dogs were more likely to be atopic with 56J%  of the atopic population 
being male. No sex predilection was observed by Willemse & van den Brom 
(1983).
From this it appears likely that due to the number of factors involved in the 
pathogenesis of atopic dermatitis it would be very difficult to find a sex 
predilection for atopic dermatitis.
1.3.2.5 Seasonality
Clinical signs of atopic dermatitis are often seasonal coinciding with 
pollination of grasses, weeds or trees, although this depends on an individual’s 
hypersensitivity (Halliwell & Schwartzman, 1971). Early studies on atopic 
dermatitis in the dog concentrated on hypersensitivity to ragweed pollen where 
dogs had a definite seasonal pattern, (Schwartzman & Rockey, 1967), with 
clinical signs paralleling the ragweed pollen season. Halliwell & Schwartzman 
(1971) also found the majority of ragweed allergy cases (53%) were seasonal. 
Seasonality of clinical signs can help with a diagnosis of atopic dermatitis. 
Seasonal dermatitis is more likely to be caused by pollen from grasses, trees, 
flowering plants; a perennial problem is more likely to be caused by house 
dust or household antigens (Willemse, 1986). Also, cases which initially 
present as seasonal can become perennial problems (Halliwell & 
Schwartzman, 1971). That study found 22% of cases were originally seasonal 
progressing to non-seasonal and 25% were completely non-seasonal. Scott et 
al. (1995) found that a progression from seasonal to non-seasonal disease 
occurred in 15% of atopic dogs.
1.4 Environment
As mentioned earlier atopy in the dog was associated with positive intradermal 
skin tests against allergens such as pollens, house dust mites or mould. The
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environment that an animal is kept in is therefore important as this will control 
the level of these allergens to which an animal is exposed.
1.4.1 Pollens
For a pollen to be a major allergen there are a number of prerequisites that 
must be met Namely, there must be a large amount of that pollen in the 
environment, the pollen must be small enough to become windbome (pollens 
spread by animal means are rarely a cause of human allergy) - this usually 
means less than 50um in size; and the pollen allergens must be water soluble 
to be absorbed (Matthiesen et a l , 1991; Reedy et a l, 1997b). Ragweed is the 
best known example of a pollen that meets these criteria and most studies 
have concentrated on this. However, the United Kingdom is essentially free of 
ragweed.
In the United Kingdom, Hyde (1960) observed that the pollen season lasted 
from mid-January to late September. This comprised three phases - firstly 
mainly tree pollens from January to May; secondly grass pollens in June/July; 
and finally dicotyledenous herbs in August and September. Moulds, 
depending on their methods of spore release, tend to peak during wet 
conditions in spring and autumn (Reedy et a l, 1997b).
Pollen counts are affected by a variety of environmental factors - firstly the 
weather. As a large number of plants release their pollen after rainfall, pollen 
counts can increase after wet weather. However, during periods of rainfall, 
pollen in the atmosphere can be washed out of the sky, hence lowering the 
pollen counts (Hyde, 1960). Generally, rainfall of more than 2mm can cause a 
reduction in pollen levels.
The time of day can also influence pollen counts as pollen shedding is not 
uniform throughout the day (Hyde, 1960; Reedy et a l, 1997b). Usually the 
best conditions for pollination are mid-day/aftemoon when the air is likely to 
be at its warmest.
The location of the pollen station is important with most stations being located 
in towns, on the roofs of tall buildings. Obviously pollen levels here are going 
to be different to those encountered by a dog at ground level.
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Therefore pollen calendars can only be used as a rough guide to the likely 
types and levels of pollen that an animal will be exposed to. Indeed some of 
the pollens likely to be found at ground level, such as the heavier or sticky 
pollens, are not important in human medicine but may well be very important 
in canine medicine (Nesbitt, 1978).
Another difference between human and canine medicine is that most of the 
problems associated with pollens in people are due to their being inhaled and 
resulting in asthma/hay fever. However, in the dog cutaneous disease is the 
predominant clinical finding. Although it was initially believed that allergens 
were inhaled by the dog, this theory is being questioned and the possibility of 
percutaneous absorption of allergens receiving more attention (Reedy et al. 
1997a). This means that the pollens thought to be important in human and 
canine medicine may not be the same and species not thought important in 
human medicine may indeed be pathogenic in canine medicine.
In addition to a pollen allergy, there is some proof that dogs could be allergic 
to the actual constituents of a plant, for example when a dog walks over 
freshly cut grass. This may explain the predominance of pedal dermatitis in 
atopic dogs. People have been shown to develop signs of hayfever when in 
contact with cut grass (Varney et aL, 1991). It has also been suggested that cut 
grass can produce a ‘grass juice’ which is released as an aerosol (Brown 
1989).
The major pollens in the United Kingdom are the grasses (Poacaea) between 
the months of June and August and the Urticacaea (Bagni, et a l, 1976). 
Grasses are responsible for between 10 and 30% of all pollen mediated 
allergies (Reedy et a l 1997b) and are the most common pollen allergy in 
Europe (Weeke & Spieksma, 1991). The most widely distributed grasses in 
Europe associated with grass pollen allergens are Poa pratensis (Kentucky), 
Festuca eliator (meadow fescue), Dactylis glomerata (orchard), Lolium 
perenne (perennial ryegrass) and Phleum pratense (Timothy). In the United 
Kingdom, Anthozantum odoratum (sweet vernal grass), Holcus lanatus 
(velvet) and Agrostis alba (redtop) may also be the cause of pollinosis.
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Cross reactivity has been demonstrated between most temperate zone grasses 
with one study (Dirksen & Osterballe, 1980) noting that Timothy grass could 
be used to identity grass allergy in 75% of allergic individuals. Studies of the 
particular grass allergens have found that single grass species can have 20-30 
allergenic components (Mathiesen & Lowenstein, 1991), with the naming of 
these allergens being the subject of international agreement (Marsh, et a l , 
1986). In general, pollen allergens have to be water soluble and have a 
molecular size of 5000 -70000 daltons. Again these characteristics are based 
on human medicine but there are no such figures for canine models. 
Suggestions have been made that these allergens have biochemical properties 
such as enzymic activity but no such findings have been made with the only 
physiological finding being that they can produce an IgE response. (Leiferman 
& Gleich, 1976; Esch & Klapper, 1989.)
Other plants have been shown to be involved in allergies (See Table 1.1). 
However, a lot of plants such as mugwort and plantain do not tend to produce 
very high levels of pollen.
Cross reactivity between groups of trees or plants is possible (Halmepuro et 
a l, 1984). Alder (Alnus\ Birch (Betula\ Ash (Fraxinus) and Hazel (Corylus) 
are all related and there may be some cross reactivity between these species. 
These trees shed large amounts of windspread pollens which are very good at 
releasing their allergenic potential when they come into contact with mucous 
membranes. Due to the cross reaction between these species hyposensitisation 
of people against birch often protects against other tree pollens.
Oak (Ffigacaea), Beech (Fagus) and Chestnut (Castanea) only play a small 
part in human allergies. Olive pollen, although important in the Mediterranean 
has not been isolated in Britain.
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1.4.2 Fungal Spores
Fungi are universal in distribution and fungal spores can comprise the bulk of the 
suspended allergenic peptides in an area depending on the weather conditions and 
land usage. Most fungi of allergenic significance are nonpathogenic saprophytes 
and disperse their spores in dry weather conditions (Reedy et al., 1997b) eg. 
Cladosporium spp., Altemaria spp., Aspergillus spp., Penicillium spp. and 
Rhizopus spp.
Cladosporium is the most abundant single type of fungus in Great Britain and is 
the commonest fungal cause of asthma. Botrytis and Altemaria are less common 
but accepted causes of summer asthma. Larger numbers of Cladosporium, 
Altemaria and Botrytis are found in the summer whereas Penicillium is found in 
the same quantities all year round (Hyde, 1960). Tee et al. (1987) demonstrated 
that most humans allergic to a fungus tended to be sensitive to all antigenically 
related fungi.
1.4.3 House Dust Mites
Dust mites have been described as the major allergens in house dust (Halliwell & 
Kunkle, 1978). There are two species of house dust mites in the domestic 
environment - Dermatophagoides pteronyssinus and D. farinae. From each of 
these species, three groups of allergens have been isolated (Noli et a l, 1996). 
These are named Der p  I-III and Der /I-III. Within groups I - III of each species 
these allergens seem to be homoJogues but between D. farinae and D. 
pteronyssisinus they seem to be antigenically unrelated. Groups J and II of both 
species have shown immediate type hypersensitivity reactions in mite allergic 
humans but are probably not important in the dog (Noli et al., 1996).
Reactions to both D. farinae and D. pteronyssinus have been demonstrated in dogs. 
However reactions seem to be more common to D. farinae (Sture et al., 1995) than 
D. pteronyssinus. Noli et al. (1996) observed that D. pteronyssinus was a relatively 
unimportant allergen in the dog. This agrees with work by Carlotti & Costargent 
(1994).
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1.4.4 Ectoparasites
Flea allergy is the most common allergic skin disorder in dogs and cats. (Reedy et 
ah, 1997c). It is a problem in its own right and can complicate other allergic 
conditions. Many dogs have been shown to have high concentrations of IgE to 
biting insects and other insects. Pucheu-Haston et ah (1996) demonstrated that 
there was some cross reactivity as well as some distinct allergens between flea 
(Ctenocephalides felis), black ant (Camponotus spp), cockroach, and black fly 
(<Simulium spp.). Allergy to ectoparasites can complicate the diagnosis of atopic 
dermatitis and may also interfere with serological tests as dogs can suffer from 
both conditions.
L5 Diagnosis of atopic dermatitis
In addition to examining the clinical history and presenting signs many 
diagnostic tests have been incorporated into the diagnosis of atopic dermatitis in 
both canine and human medicine. One of the earliest tests was the Prausnitz 
Kustner test.
1.5.1 Prausnitz Kustner test
This test was recorded in 1921 (Prausnitz & Kustner) and demonstrated the 
existence of a skin sensitising antibody in the serum of allergic individuals which 
could transfer the clinical signs of allergy via injection of this serum to non- 
allergic individuals.
1.5.2 Passive Cutaneous Anaphylaxis (PCA) Test
This test is derived from the PK test and is a classic method used to measure 
reaginic IgE antibodies in various species of mammals (Peng et ah, 1993). 
Disadvantages are that it takes a long time to run -  three days, and the sacrifice of 
a dog is required. In addition results are not consistent from dog to dog. Hence 
this method could only be used for research purposes and has been replaced with 
other more effective tests as discussed below.
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1.5.3 Intradermal skin testing
Intradermal skin testing is a method of assessing an individual’s response to a 
variety of allergens in an attempt to identity those which are pathogenic, and is 
used in both human and veterinary medicine. Intradermal skin testing was first 
recorded in the medical literature by Blackley in 1873, but is now utilised in the 
diagnosis of atopic skin disease in humans, dogs, cats and even birds.
Allergens are made up in solutions and injected intradermally. The way in which 
allergens are prepared differs between companies and there are no standards for 
this. Different preparations may contain different antigenic epitopes and this can 
account for differing IDST results between animals tested with different allergen 
preparations. In addition most of the allergens are designed for use in human 
dermatology rather than specifically for use in cats and dogs.
There are different ways of expressing the concentration of an allergen solution 
as described below (modified from Halliwell & Gorman, 1989):
1. Protein Nitrogen Units (PNU) -One PNU is equivalent to 10'5mg of
nitrogen precipitated with phosphotungstic acid
2. Noon units -  One noon unit is 1ml of an extract made from lmg of pollen
in 1 litre of extracting fluid.
3. Micrograms/ml -  Extracts are standardised to the content of a particular
protein allergen.
4. Weight/volume -  The weight of allergen extracted in a given volume of
extraction fluid.
The concentrations of these allergens can also differ between manufacturers. 
There is much controversy as to the ideal allergen concentrations to use in 
veterinary dermatology. The average concentration used for IDST was 100- 
300PNU/ml (Bunde et a l , 1997). However, Codner & Lessard (1993) applied 
different allergen concentrations to different allergens ranging from 100 PNU/ml 
for house dust, 250 PNU/ml for Rhizopus up to 500 PNU/ml for wool.
Allergens can sometimes be used as mixtures, however, this can lead to 
problems. Firstly there is a  dilution factor when allergens are present as mixtures 
(Schick & Fadok, 1986) and mould extracts have been shown to contain 
proteolytic enzymes which may reduce the allergenic activity of a protein 
(Rosenbaum et al., 1996).
Storage of allergens can also influence their stability. The material which 
allergens are kept in (whether it is a glass or plastic bottle), the presence or not of 
preservative and the temperature at which they are stored have all been shown to 
adversely affect the antigenicity of allergen extracts (Halliwell, 1987). Glycerine 
is often used as a preservative for allergen extracts and Kleinbeck et al. (1989) 
demonstrated that 6.25% glycerine could give a positive IDST result making a 
diagnosis of atopy difficult.
Allergens are generally kept at 4°C but Halliwell (1987) demonstrated that 
allergens kept at this temperature could lose up to 52% of their biological 
activity. These suggestions have been opposed by Rees et al. (1997) who did not 
find any change in biological activity between allergens stored at 4°C or 22°C. 
Similarly, Halliwell (1987) and Campbell & Hall (1993) demonstrated that 
allergens stored in plastic syringes lost a higher percentage of their biological 
activity than those stored in glass syringes. It seems that the veterinary 
dermatologist cannot win!
When it comes to the interpretation of IDST there exists as much confusion. 
There is no standard method for the assessment of a positive IDST result in 
veterinaiy medicine. Most practitioners use a scale of 0 or 1-4 with 0 or 1 
representing a negative result equal to the negative control injection (saline) and a 
score of 4 equal to the positive histamine control. Results between this are 
applied arbitrarily.
However, the confusion does not end here. Cross reactions between allergens 
have been observed. Kleinbeck et al. (1989) observed that there was cross 
reaction between phylogenetically related species of pollen. In addition, although 
a positive intradermal skin test proves that a dog is sensitised to an allergen (if for 
the time being we ignore the possibility of cross reaction) it does not mean that
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the dog is necessarily allergic. These positive results in non-atopic animals are 
often referred to as false positive results, although whether this is a true 
description or not is debatable. Such clinically irrelevant positive IDST results 
are known to be relatively common in the dog especially to allergens such as 
house dust (DeBoer, 1989).
From these findings it is clear that the practice of intradermal skin testing in 
veterinary medicine requires standardisation in both the allergens used and in the 
interpretation of results in order to allow sensible analysis of results between 
different authors. Only after this will advances be made in the study of veterinary 
allergic skin disease.
1,5.4 Serology
In humans serological tests to measure IgE antibodies utilise an IgE myeloma, to 
obtain pure fractions of IgE. However, no such myeloma has been found in the dog 
and this makes accurate measurement of canine IgE difficult. (Halliwell & Kunkle, 
1978).
Polyclonal or monoclonal antibodies can be used in serological tests each of which 
has their own advantages and disadvantages. For example, monoclonal antibodies 
recognise a limited number of epitopes and therefore should be more specific than 
polyclonal antibodies. However, due to the small number of epitopes to which the 
monoclonal antibodies are attracted the affinity these antibodies have for the IgE 
molecule may be reduced (Peng et a i, 1993).
1.5.4.1 Radioallergosorbent assay
The first serological test developed to measure allergen specific IgE in serum was 
the radioallergosorbent assay or RAST (Wide et al. 1967). This involved binding 
of allergens to a solid phase such as a paper disc and then incubating them with the 
serum sample being tested. Following washing the discs were then incubated with 
a radio-labelled anti-IgE antibody which would bind to any IgE that had bound to 
the allergen. After washing the radioactivity present was measured thus facilitating 
assessment of the amount of allergen specific IgE present.
Intradermal skin testing is regarded as the ‘gold standard’ (Esch & Grier, 1997) in 
both human and veterinary medicine. Due to this authors often attempt to correlate 
serological results with IDST. Halliwell & Kunkle (1978) found good agreement 
between RAST and IDST results for ragweed allergen in dogs with 89% 
agreement between positive IDST and positive RAST. Where negative IDST 
results are obtained alongside positive RAST results it has been suggested that this 
may be due to high levels of serum IgE and that these RAST results are false 
positives (Griffin et a l 1990). This does however assume that IDST is 
demonstrating a true result and any test which does not agree with this is giving a 
false result. This hypothesis remains to be proved and it is possible that the 
positive results in the RAST test are indeed positive and that allergen specific 
serum IgE is present in dogs which do not demonstrate a clinical allergy. Halliwell 
& Kunkle (1978) suggested that the reason for the poor correlation between RAST 
and IDST results was due to the dynamics of IgE being different in both tests and 
that there were different levels of allergen purity in both tests.
1.5.4,2 Enzyme linked immunosorbent assay
The enzyme linked immunosorbent assay or ELISA was first reported in 1971 in 
human medicine (Engvall & Perlmann, 1971) and is now widely used in both 
human and veterinary medicine. The ELISA test is based on a similar method to 
that used in the RAST test. However, instead of using radio-labelled anti-IgE 
antibody the ELISA incorporates enzyme linked anti-IgE antibody which 
following incubation with an enzyme activator, causes a colour change which 
indicates the amount of IgE present
A number of problems with the ELISA test have been observed. Halliwell (1994) 
reported that high levels of IgE can cause non-specific binding; incorrect cut off 
points between positive and negative results can lead to errors; detection of IgG 
instead of IgE can occur; or poor techniques such as inadequate washing of wells 
may be present He also suggested that false negatives could be obtained due to 
poor allergen preparation; poor adsorption onto the solid phase; poor anti-IgE 
preparation; outdated labelled antibody; a high level of IgG antibody which may
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compete with IgE for allergen; poor technique such as inadequate incubation; 
testing for allergens in groups; or testing at the incorrect season when the level of 
allergen specific IgE may be lower.
As in the case ofKASTs the results of ELISA tests are often compared with IDST. 
Good correlation between allergen specific circulating IgE and IDST / challenge 
test results in atopic humans has been found (reviewed by Lockey et al., 1992). 
Bunde et al., (1997) observed excellent correlation between ELISA and IDST 
where identical allergens were used in both tests.
In comparing these tests, sensitivity and specificity are usually examined. 
Sensitivity is defined as the proportion of true positive results detected and 
specificity as the proportion of true negative results (Thrusfield, 1995). In the dog, 
the sensitivity of ELISA tests is often found to be good (Bond et al., 1994; Codner 
& Lessard, 1993) reaching 100% for some individual allergens (Miller et al., 
1993). However, very poor specificity has been recorded for different allergens 
with a mean of 43.8% (Bond et a l, 1994). The reason for this poor specificity is 
the high number of positive ELISA results in clinically normal dogs. The 
predictive value of a positive test has been found to be poor but that of a negative 
result good (Bond et al', 1994). As such, negative ELISA results are believed to be 
reliable (Kleinbeck et al. 1989; Codner & Lessard, 1993); indeed Codner & 
Lessard (1993) went as far as to state that a negative ELISA result could reliably 
rule out a diagnosis of atopy.
Correlation is another method by which IDST and ELISAs are compared. In 
veterinary medicine correlation coeficients between IDST and ELISA tests were 
found to be different for different allergens, but in general correlation was poor 
(Anderson & Sousa, 1993; Codner & Lessard, 1993; Bond et al., 1994).
As mentioned above the main area of discrepancy between ELISA and IDST 
results is that of positive ELISA results but negative IDST (Halliwell & Kunkle, 
1978; Kleinbeck et al., 1989; Griffin et al., 1990; Anderson & Sousa, 1993; 
Codner & Lessard, 1993; Bond et al. 1994; Griffin, 1994). These disparities may 
be due to differing levels of bound and free circulating IgE. If mast cells are 
saturated with allergen specific IgE which is directed against a different allergen to
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that against which there is circulating IgE then differing results will be obtained on 
each test (Kleinbeck el aL, 1989). It is also possible that dogs with high serum 
total IgE but a low IDST score may possess fewer cutaneous mast cells or have 
mast cells in a slate of continuous degranulation, with only a few able to respond at 
the time if IDST. However, if  this were the case then surely these dogs would 
demonstrate mild clinical signs of atopic dermatitis as the clinical signs of atopic 
skin disease are primarily controlled by the release of such mediators of pruritus. 
Other explanations have been put forward by different authors to explain the 
disagreement between IDST and serological tests. For example it is possible that 
serological tests contain allergenic epitopes which are not exposed in natural 
allergens (Alaba, 1997, Lowenstein & Marsh, 1983). This would lead to the 
development of false negative results.
Different allergens will have different abilities to bind to microwell plates and so 
serological results will differ for different allergens (Canterero et a l , 1980, Pesce 
e ta l , 1977).
In the majority of reports comparing IDST and serological tests the allergens 
incorporated into each test are produced by different companies and so the 
allergenic epitopes that are present may be different This was illustrated by Bunde 
et a l, (1997) who observed that when identical allergens were used for both tests 
agreement between clinical presentation, IDST and ELISA was very good at 
82.3%.
The interpretation of IDST is subjective (as discussed earlier). Where dogs have a 
high degree of positive IDST results correlation with ELISA has been shown to be 
good at 90%. However, where IDST results were not clear cut, the correlation with 
ELISA fell to 50% (Esch & Grier, 1997).
The use of mixed allergens in ELISA tests can lead to discrepancies due to a lower 
concentration of allergen resulting in false negatives (Bond et a l , 1994).
The specificity of the serological test for IgE is very important. Where the ELISA 
is not totally specific for IgE, other antibodies such as IgG can be measured as 
well. This is a common problem where polyclonal antibodies are incorporated into 
the assay.
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It has also been suggested that there may be different types of IgE present -  one 
free in the circulation, and one bound to mast cells (Griffin et al., 1990).
The presence of IgG anti-JgE antibodies may interfere with the measurement of 
JgE concentrations with lower levels of serum IgE being recorded than were 
actually present. This has been shown to be a problem by Hammerberg et a l, 
(1997).
Non-specific binding of IgE may take place in the wells of the ELISA where there 
is a high serum IgE concentration. This will result in the development of so called 
false positive or clinically irrelevant ELISA results. Indeed Griffin et al. (1990) 
and Codner & Lessard (1993) observed that there was a statistically significant 
correlation between the level of serum IgE and the number of positive ELISA 
results in non-atopic dogs.
The relationship between bound and circulating IgE has not been fully explained. 
Schwartzman (In Anderson & Sousa, 1993) commented that serum levels of total 
IgE are probably in dynamic equilibrium with IgE bound to mast cells. If IgE 
levels were low then most would be bound and not free in the circulation and so 
the IDST would be more sensitive. He also suggested that there may be a 
difference in mast cell affinity for JgE and this could affect the levels of bound or 
free IgE-
Of the positive ELISA results in non-atopic dogs found by a number of authors, 
the highest incidence were found against mould allergens (Griffin et a l, 1990; 
Anderson & Sousa, 1993; Day et a l, 1996). Bunde et a l (1997) suggested that 
there may be a difference in the sensitivity of ELISA in detecting fungal specific 
IgE but were unsure as to the significance of this. In comparing atopic and non- 
atopic dogs Codner & Lessard observed that ELISA results for fungal allergens 
were significantly higher in atopies than non-atopics. This was the only group of 
allergens in which such a difference was observed. In addition sensitivity to fungal 
allergens was more common with serological testing than IDST. However, the 
reason for these differences was not known.
A seasonal variation in ELISA results has been observed by Halliwell & Kunkle 
(1978). These authors found a marked variation in IgE levels against ragweed in
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September and June and from this suggested that it is important to lake into 
account the time of year that a dog is being tested.
From these findings it can be seen that correlation between ELISA and IDST 
testing is often poor but the reasons for this are wide and varied and much work is 
still required in this area.
1.5.4.3 Immunodot
The immunodot test was first described in 1994 by Aubert & Frei for use in human 
medicine as a  means of determining serum allergen specific IgE levels. This was 
later adapted for use in the dog (de Week, personal communication).
The immunodot test consists of a  nitrocellulose strip to which various groups of 
allergens are bound. Following incubation of test serum and washing, monoclonal 
anti-IgE antibodies are added The test is then similar to an ELISA with washing 
steps and the addition of developing antibodies which in the presence of canine 
IgE develop a blue colour which can be evaluated by the naked eye or by 
measuring reflective density.
The immunodot test is easy to run and is reported to have a sensitivity of 84.5% 
and specificity of 94% in human medicine (Aubert & Frei, 1994). The immunodot 
test has been predominantly used by Hammerling & de Week (1998) in the dog, 
the main advantage of this method being the use of monoclonal dog anti-IgE 
antibodies in the detection of canine IgE. This assay has been reported to have a 
sensitivity ranging from 54-100% for different allergen groups when compared 
with IDST (Hammerling & de Week, 1998).
1.5.4.4 Other serological methods
Heska® ALLERCEPT™ is a modified ELISA test, which has recently been 
introduced. This test is based around the high affinity Fc IgE receptor (Fc^RI) 
found on mast cells and basophils. The a  subunit of this receptor has been 
reproduced by Heska and is incorporated into an ELISA test in the place of anti- 
IgE monoclonal or polyclonal antibodies. Comparing IDST and the ALLERCEPT
methods have shown an overall sensitivity of 86%, specificity of 92% and an 
overall accuracy of 90% (Bevier et al, 1997).
Other serological methods such as liquid gold methodology (Alaba, 1997) and the 
polymerase chain reaction (Foster, 1997) have been used in the study of atopic 
dermatitis but are generally research tools rather than diagnostic tests. No further 
explanation of the methodology behind them will be given here.
1,6 Therapeutics of atopic dermatitis
1.6.1 Hyposensitisation
Hyposensitisation has been used in human medicine since 1911 (Noon & Cantab) 
and in veterinary medicine since 1941 (Wittich). Hyposensitisation or 
immunotherapy involves sequential injections of a solution containing small 
amounts of allergens to which a person or animal is allergic. The quantities of 
allergens given are gradually increased and in so doing, the immune system is 
gradually exposed to these allergens. The exact regime used varies between 
vaccine manufacturers. There is however, always a risk of anaphylaxis when using 
hyposensitisation vaccines.
The immunological responses to hyposensitisation have not been fully explained 
but the widest believed theory is that hyposensitisation causes the formation of IgG 
antibodies which act as ‘blocking’ antibodies. These IgG molecules hind to 
allergen before IgE can do so. In addition IgG may be able to bind to the mast cell 
and prevent degranulation by interfering with IgE cross linkage.
Hyposensitisation vaccines can be based on IDST, ELISA or a standard mixture of 
allergens. The main aim of hyposensitisation is to eliminate the allergic reaction 
which occurs when the dog is exposed to particular allergens. The degree of 
improvement demonstrated by animals receiving hyposensitisation therapy is 
however variable with a slight reduction in pruritus through to a complete cure 
being classed as a success. A lot depends on the expectations of the owners and 
generally success is defined as any improvement in the degree of pruritus 
demonstrated by the dog.
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The success rate of hyposensitisation in the dog is reported to be somewhere 
around 63% (Chamberlain, 1969). Nesbitt (1978) reported a success rate of 
between 82.1-85.7% after six months therapy with up to 51.4% of dogs showing 
some improvement after three months therapy.
Where hyposensitisation was based on IDST results Willemse et a l (1984) 
achieved a success rate of 70% and DeBoer reported a success rate of 68% (1989). 
Kleinbeck et a l (1989) observed that hyposensitisation protocols based on ELISA 
results were equal to or greater than those immunotherapies based on IDST. Scott 
(1981) suggested that a hyposensitisation vaccine does not need to contain all of 
the allergens to which a dog is allergic.
Reasons for the variation in the success of hyposensitisation have been suggested 
by Miller et al. (1993). These include an animals inherent ability to respond, the 
accuracy of the diagnosis of atopy, the accuracy of the allergy test results, the type 
and numbers of allergens in the immunotherapy protocol, the immunotherapy 
protocol used, the exogenous allergy load during immunotherapy and the 
development of other non-allergic pruritic skin disease during the course of the 
treatment. From this it may appear surprising that any animals respond favourably 
to hyposensitisation.
Miller et a l (1993) observed that there was no correlation between the age of 
onset, duration of disease, number of serological allergens included in the vaccine 
or the number of positive IDST results not included in the vaccine and the success 
of hyposensitisation. However, Nesbitt et a l (1978) found that the younger dogs 
showed the best response to hyposensitisation.
Possible complications with hyposensitisation include the risk of anaphylaxis, 
nodule development at the site of injection; increased pruritus following 
vaccination and pain and swelling at the injection site following injection with 
aqueous allergens in propylene glycol (Nesbitt, 1978).
There is as much variation in the concentration of hyposensitisation vaccines as 
there is in the test allergens. Nesbitt (1978) suggested that the maximum dose of 
alum precipitated extracts is 10,000PNU/ml and exceeding this can result in
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pruritus and restlessness, Chamberlain (1969) used the same concentration injtialJy 
but gradually increased this by 2500PNU/ml per allergen.
1.6.2 Other therapeutic measures
Other methods of treatment for atopic dermatitis include avoidance of the inciting 
agent, and symptomatic therapy including the use of glucocorticoids, 
antihistamines and essential fatty acids which will all relieve pruritus. However, a 
discussion of the pharmacological background to these treatments is beyond the 
scope of this review.
L 7 Summary
It can be seen from this review that a lot of work has been carried out on the 
pathogenesis, diagnosis and treatment of atopic dermatitis in both people and dogs. 
Many factors appear to be involved ranging from genetics through to the 
environment that animals are kept in. Common factors have been shown between 
humans and animals but there are many discrepancies as well 
The aims of this study are to examine both clinical and serological parameters in 
atopic and non-atopic dogs. Much work has been carried out on serum total IgE 
but it is intended to expand on this, especially as the GDBA dogs are known to 
have very low levels of parasite exposure. In addition work on serum IgG has 
concentrated more on human atopies than canine, something which it is intended to 
rectify with this study.
Much work in the veterinary field has concentrated on the clinical aspects of atopic 
dermatitis. Due to the excellent clinical histories of the GDBA dogs the aim is to 
identify important clinical parameters and ages of onset which could be applied in 
the prediction and diagnosis of atopic dermatitis.
The environment that animals are kept in is known to be important in the 
pathogenesis of atopic dermatitis, with dogs exposed to pollens, house dust mites 
and moulds being at a greater risk of developing atopy. Hence it is hoped to
k  o
identify significant environmental factors and possibly ways of preventing dogs 
from coming into contact with them.
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Chapter 2 Materials & Methods
2.1 Animals
The clinical, historical and serological parameters of 240 dogs were examined 
(See Appendix A for details). Dogs came from four distinct environmental groups, 
namely Guide Dogs for the Blind Association (GDBA) working dogs, Glasgow 
University Veterinary School referral cases (GUVS), racing greyhounds and 
laboratory beagles.
GDBA dogs are kept both as household pets and in kennels during their training 
and working lives. Pet dogs and laboratory beagles were therefore included for 
comparative purposes. Both GDBA dogs and laboratory beagles received 
stringent parasite control measures throughout their lives. Greyhounds were 
examined as a population known to be exposed to high levels of parasites, 
although they also received some form of intermittent anthelmintic therapy.
2.1.1 GDBA Dogs
Clinical and serological parameters of 143 GDBA dogs were studied over a 
period of three years. In addition the clinical records o f a  further 21 GDBA dogs 
were examined. GDBA dogs are predominantly Golden Retriever and Labrador 
Retriever crosses. In addition there are a small number o f German Shepherd Dogs 
and other breeds such as curly coated Retrievers. Breeding and whelping of 
GDBA dogs mainly takes place at the breeding centre in Tollgate, England. 
However, a small number of GDBA dogs are bom in breeders’ houses. Bitches 
and puppies are kept in the one area until the pups are folly weaned by six weeks 
of age. At this age they are taken to puppy walkers’ homes where they will remain 
until entering training kennels at nine to twelve months of age. Training of dogs at 
the kennels takes twelve to eighteen months after which dogs will begin their 
working lives and stay in the homes o f their owners.
Dogs were first examined by the Centre Veterinary Surgeon on entering kennels 
at nine to twelve months of age. When they entered kennels dogs were randomly
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assigned to the study by kennel staff and their clinical progress was followed 
throughout their time in kennels. After leaving kennels, dogs are sent anywhere in 
the United Kingdom so a detailed clinical examination was not always possible 
but correspondence with the home vet was undertaken in order to allow dogs in 
the study to be monitored Any dogs at Forfar kennels found to develop skin 
disease, which had not been initially assigned to the study, were thereafter 
included.
As the majority of GDBA dogs are bred at the GDBA centre in England very few 
dogs under eight weeks of age were seen at Forfar and so only low numbers are 
included in the study.
Whilst with die puppy walker the dogs are kept as pets in a household and are 
exposed to a  wide variety of allergens including house dust mites. They are also 
exposed to other household pets such as cats, other dogs or even pet birds.
Once in kennels the dogs are kept in groups o f two or three. These groups do not 
remain constant and the animals are continually exposed to a large number of 
other GDBA dogs. Whilst training individuals are given access to a town 
environment and thus meet dogs outwith the GDBA population. In the kennels 
dogs are kept on a tiled floor with shredded paper bedding Outside is a concrete 
run. Both kennels and runs are cleaned twice daily with dilute bleach. Dogs are 
allowed access on a daily basis to a fenced grass area for exercise. This area is 
surrounded by trees and farmland.
All dogs are kept under a strict regime of veterinary care and parasite control. 
Vaccinations against Distemper, Parvovirus (Nobi-vac Puppy DP®, Intervet) and 
Leptospirosis (Nobi-vac L®, Intervet) are given at six weeks old, followed by 
Distemper, Parvovirus, Hepatitis, Parainfluenza (Nobi-vac DHPPi®, Intervet) and 
Leptospirosis (Nobi-vac L®, Intervet) at twelve weeks o f age and a final 
Leptospirosis (Nobi-vac L®, Intervet) vaccine at sixteen weeks old. Yearly full 
booster vaccinations are given thereafter. Intranasal kennel cough vaccinations are 
not routinely given.
Parasite control begins with the treatment of nursing bitches and their pups with 
fenbendazole (Panacur®, Hoechst UK Ltd), at a dose of lg/2.2kg, at two, five, 
and eight weeks post whelping. Subsequently, the pups received 
febentel/praziquantei/pyrantel combination (Drontal Plus®, Bayer), at a dose of 
5mg praziquantel/kg (i.e. one tablet/1 Okg) at tweJve weeks, six months and twelve 
months of age. The dogs were then routinely wormed with Drontal Plus® at six 
monthly intervals. Faecal samples taken from all the dogs at eight-ten months of 
age were uniformly negative. All the dogs were treated monthly with fipronil 
(Frontline®, Rhone Merieux) or permethrin (Exspot®, Mallinkrodt Veterinary) 
spot-on once a month to control ectoparasites and no parasites were found on 
clinical examination. These dogs are considered to be essentially free of parasites.
GDBA dogs recruited into the study were ultimately assigned to one of three 
groups: atopic dogs, dogs with clinical signs consistent with atopic dermatitis but 
skin test negative and non-atopic dogs. Dogs which showed signs of skin disease 
which did not meet the criteria of atopic dermatitis were classified as skin 
problem dogs and were removed from this study. This was essential to ensure that 
potential atopies which had not been given a definitive diagnosis prior to the 
termination of the study were excluded from the non-atopic group.
A. A diagnosis of atopic dermatitis was based on the following three criteria:
L Meet WiJJemse’s criteria of at least three major and three minor categories of 
skin disease (Willemse, 1986) listed below.
Major features: Pruritus
Morphology & distribution -  involvement of the face, 
digits, lichenification of the flexor surface of the tarsal joint 
and/or extensor surface of the carpal joint
Chronic/ relapsing dermatitis
Family history and/or breed predisposition.
Minor features: Onset before three years of age
Facial erythema and cheilitis
Bilateral conjunctivitis
Superficial staphylococcal pyoderma
Hyperhydrosis
Immediate skin test reactivity to inhalents
Elevated allergen specific IgE
Willemse also included elevated allergen specific IgG<] as a minor criterion but 
this could not be included nsjt was not possible to carry out this serological assay.
2. At least one positive result on IDST
3. There was no suggestion of food hypersensitivity based on an eight week 
restriction diet and subsequent challenge.
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B. Dogs were assigned to the skin test negative group if:
1. They met Willemse’s criteria of at Jeast three major and three minor 
categories of skin disease (Willemse, 1986).
2. Negative results were obtained on intradermal skin testing.
3. There was no suggestion of food hypersensitivity based on an eight week 
restriction diet and subsequent challenge.
C. Dogs were assigned to the non-atopic group if they were:
1. Aged over three years by 31/8/98
2. Had no history of multiple episodes of atopic type skin disease consistent with 
Willemse’s criteria (1986).
3. Had no evidence of recurring episodes of any skin disease.
Application of these criteria to the GDBA population (143 dogs) allowed the 
allocation of dogs to the different groups as follows:
A. Atopic dogs found which demonstrated positive results on IDST (n=18).
B. Atopic dogs which demonstrated negative IDST results but met all of the 
other criteria for a diagnosis of atopic dermatitis (n=2).
C. Non-atopic dogs without any recurring skin disease (n=96).
D. Problem dogs which demonstrated recurrent episodes of skin disease but did 
not meet the criteria for atopic dermatitis (n=27). These dogs were excluded 
from further studies.
2.1.2 Greyhounds
23 racing greyhounds undergoing routine biochemical and haematological 
examinations were also studied, details of which are shown in Appendix A. These 
dogs were all National Racing Greyhound Club (NRGC) registered and were 
being blood sampled as part of a clinical work up due to a poor performance 
whilst racing. Clinical examination of these dogs was carried out by the referring 
veterinary surgeon and all dogs studied were free of clinical skin disease at the
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time of blood sampling and had no history of recurrent skin disease. All dogs 
were housed in outdoor kennels either built of concrete or wood and are kept on 
newspaper or sawdust bedding. In general these dogs were not allowed into a 
household environment However, it was noted that such dogs are exposed to 
large numbers of fleas both in kennels and at the race track. All twenty three dogs 
in this study were known to be treated regularly (minimum of three to four times 
a year) with proprietary anthelmintics (personal communication with referring 
veterinary surgeon). All dogs had received up to date vaccinations against 
distemper, parvovirus, leptospirosis and hepatitis.
2.1.3 Laboratory beagles
33 laboratory beagles were also studied (described in Appendix A). In each case 
excess serum from blood samples taken for assessment of antiviral antibodies was 
available for analysis. These dogs were from a closed colony of dogs in England. 
It was not possible to examine them personally but communication with the 
referring veterinary surgeon confirmed that these dogs were free of skin disease at 
the time of sampling and had no history of recurrent skin disease. These dogs 
were kept indoors at all times and did not have any access to outdoor allergens. 
Clinical examinations have not revealed the presence of ectoparasites and these 
dogs did not receive any ectoparasite therapy. They were housed in concrete and 
steel buildings with sawdust and paper bedding and were allowed plastic toys. All 
dogs received vaccinations against distemper, hepatitis, parvovirus, parainfluenza 
(Nobivac DHPPi®, Intervet) and leptospirosis (Nobivac L®, Intervet) at six, nine 
and twelve weeks of age. This vaccination was then repeated annually. Breeding 
bitches were also vaccinated with the same regime at every oestrus. Endoparasite 
control was given with fenbendazole (Panacur, ® Hoechst Roussel Vet Ltd.) at 
two, five, eight and twelve weeks of age at a dosage of 50mg fenbendazole/kg 
body weight for three consecutive days. At twenty eight weeks of age and every 
four months thereafter fenbendazole was given on one occasion at lOOmg/kg 
body weight. Pregnant bitches were treated with fenbendazole at a dosage of
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25mg/kg body weight daily from day forty two of pregnancy until two days post 
whelping. These dogs are believed to be free of parasites.
2.1.4 Glasgow University Veterinary School (GUVS) Referral Cases
Cases referred to the Dermatology Clinic at Glasgow University Veterinary
School (GUVS) with clinical signs consistent with atopic dermatitis were 
included in this study. Theseforty seven dogs were kept as household pets and 
were exposed to both indoor and outdoor allergens. All dogs had access to grass 
areas and other animals. A variety of breeds and ages of dogs were examined as 
shown in Appendix A. The parasite control measures of these dogs before 
attending GUVS varied widely often being irregular or unknown although all 
dogs had received up to date vaccinations against distemper, leptospirosis, 
parvovirus and hepatitis. The criteria required for a diagnosis of atopic dermatitis 
were based on those described above for GDBA dogs. Of these forty seven dogs, 
forty were found to give at least one positive reaction on IDST and were classified 
as atopic and seven gave negative IDST and were classified as skin test negative.
2.2 Clinical examination
GDBA and GUVS referral cases were given a full clinical examination by the 
author. A full skin examination involving collection and examination of coat 
brushings, skin scrapings and hair pluckings was carried out on all dogs with 
evidence of skin disease. Fungal culture and microscopic examination were 
performed on these samples. Impression smears of skin lesions were also taken 
where deemed necessary. Skin biopsies were taken from any swellings or non- 
responsive skin lesions. Where internal medical problems were detected 
haematological and biochemical profiles were examined and appropriate therapy 
instigated.
A standard treatment protocol was followed for both GDBA and GUVS dogs with 
skin disease. All GUVS referred cases were treated with fipronil (Frontline® 
spray, Rhone Merieux) at a dosage of 3ml per kg bodyweight. This treatment was 
not required for GDBA dogs as these were all routinely given treatment for
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ectoparasites. All GDBA dogs with recurrent skin disease were treated with 
phosmet (VetKem Sponge On®, Sanofi Animal Health) as part of the GDBA 
protocol on skin disease.
Where a pyoderma was evident on clinical examination antibacterial therapy with 
cephalexin (Ceporex®, Mallinkrodt Veterinary Ltd.) at 30mg/kg body weight 
twice daily was given for a minimum period of two weeks. Most cases required a 
minimum of four weeks treatment. Yeast infections were treated with 
chlorhexidine/enilconazole shampoo (Malaseb® Leo Laboratories Ltd.), 
according to manufacturer’s advice twice weekly for a minimum of two weeks.
Any dogs which demonstrated recurrent skin disease were placed on restriction 
diets of either home prepared chicken and rice or commercially available catfish 
and rice (Pedigree Select Protein). Dogs were not allowed any food other than this 
diet and water for a minimum of six weeks up to a maximum time of twelve 
weeks. All dogs which underwent intradermal skin testing were also placed on 
this restriction diet and were only diagnosed as atopic if there was no 
improvement whilst on this diet.
2.3 Intradermal skin test
Prior to performing an intradermal skin test all therapy with corticosteroids, 
antihistamines and evening primrose oil was stopped Corticosteroid therapy was 
stopped for a minimum of four weeks up to a maximum of three months where 
depot injections had been given. Antihistamine therapy and evening primrose oil 
were stopped for at least two weeks prior to intradermal skin testing.
At the time of intradermal skin testing dogs were sedated with domosedan 
(Domitor®, Pfizer Ltd.) at a dosage of 0.4mg per 10kg body weight given 
intramuscularly along with butorphanol (Torbugesic®, Willows Francis 
Veterinary) at 4mg per 10kg body weight also given intramuscularly. Once 
sedation had taken effect, usually after 10-15 minutes, the dog was placed in 
lateral recumbency and the lateral thorax clipped A total of 48 marker pen spots 
were applied to the flank in order to highlight the site of the intradermal
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injections. Allergens produced and supplied by ARTU Biologicals (Netherlands) 
were used for intradermal skin testing (See Table 2.1). Injections of 0.05ml of 
each allergen, a positive control (histamine, concentration unknown) and a 
negative control (saline) were each administered intradermally with a 27 gauge 
needle. After thirty minutes the diameter, colour and degree of oedema of any 
wheals which developed at the site of injections were recorded A result was 
considered positive where the diameter of the wheal was equal to or greater than 
the average of the positive and negative controls.
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Table 2.1 Intradermal skin test allergens used in study.
Group Allergen Concentration
Controls Histamine O.lmg/ml
Physiological phosphate buffer Unknown
Mites ' Dermatophagoides farinae lOONU/ml
Dermatophagoides pteronyssinus 1 OONU/ml
Acarus siro lOONU/ml
Tvrophagus putrescentiae 1 OONU/ml
Indoor Flea l.OOONU/ml
Mosauito Unknown
Cat epithelia lOOug/ml
Human epithelia lOug/ml
Sheep’s wool lOug/ml
Feathers Unknown
Tobacco Unknown
Trees Alder l,000N U/m l
Ash l.OOONU/ml
Beech l.OOONU/ml
Birch l.OOONU/ml
Elder l.OOONU/ml
Elm l.OOONU/ml
Hazel l.OOONU/ml
Horse chestnut l.OOONU/ml
Oak l.OOONU/ml
Poplar l.OOONU/ml
Willow l.OOONU/ml
Grass Bent grass l.OOONU/ml
Cocksfoot l.OOONU/ml
Couch grass lOOONU/ml
Meadow fescue l.OOONU/ml
Orchard grass l.OOONU/ml
Perennial ryegrass l.OOONU/ml
Sweet vernal grass l.OOONU/ml
Timothy l.OOONU/ml
Plants Daisy l.OOONU/ml
Dandelion l.OOONU/ml
Dwarf ragweed l.OOONU/ml
Golden Rod l.OOONU/ml
- Lamb’s auarter l.OOONU/ml
Muawort l.OOONU/ml
Nettle l.OOONU/ml
Plantain l.OOONU/ml
Rape l.OOONU/ml
Sorrel l.OOONU/ml
Wall oellitorv l.OOONU/ml
Moulds A ltem aria a ltem ata 1 OOug/ml
Aspergillus lOOug/ml
Cladosporium 1 OOug/ml
Penicillium lOOug/ml
Phomae betae 1 OOug/ml
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2.4 Blood sampling
Dogs from the GDBA and GUVS populations which were undergoing intradermal 
skin testing were blood sampled at the time of testing whilst under sedation. 
Blood samples of at least 5ml were taken by jugular venipuncture, placed in a 
glass tube without any additives and allowed to clot at room temperature. Samples 
were then centrifuged at 3,000 rpm and 5° Celsius for ten minutes. The resultant 
serum was then removed and divided into 0.5ml aliquots. These were stored at 
-20°C until required for testing.
Serum from other GDBA dogs and greyhounds was obtained from blood samples 
taken for health profiles prior to elective surgery or at the time of routine health 
checks. Serum obtained from laboratory beagles was surplus to samples taken for 
viral antibody assessment as explained earlier.
At the time of sampling the ninety six non-atopic GDBA dogs ranged in age from 
56 to 3161 days with an average of 619 days; eighteen atopic GDBA dogs ranged 
in age from 125-2892 (average of 1265 days); nine IDST negative dogs with 
recurrent skin disease ranged in age from 246-2885 days (average 1388). Ages of 
beagles and greyhounds were only available in years rather than days -  twenty 
three greyhounds ranged in age from 3-12 years (average of 1667days) and thirty 
three beagles ranged in age from 2-6 years (average of 1360 days); forty atopic 
GUVS dogs ranged in age from 288-2941 days (average 1265 days). Ages of dogs 
at sampling are shown in Appendix A.
2.5 Serological Tests
Due to the limitations of the amount of serum obtained from each dog it was not 
possible to carry out all of the serological tests on every dog. In addition the 
various serological kits and reagents and intradermal skin test used in this study 
by necessity came from different manufacturers. This is an important point when 
considering the correlation of serological and IDST results but could not be 
avoided.
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2.5.1 Enzyme Linked Immunosorbent Assay (ELISA)
A commercially available ELISA test for the detection of canine allergen specific
serum IgE produced by AlerCHEK Inc. Portland, USA was used for this analysis. 
Allergens incorporated into this test are designed specifically for the European 
market and the test itself has been validated by the company (personal 
communication Richard Robinson, Operations Manager, AlerCHEK Inc.).
Serum samples were defrosted at room temperature for ten minutes and 0.6ml of 
each serum sample mixed with 2.4 ml of unspecified specimen diluent provided 
by AlerCHEK. This mixture was incubated at 4°C for twenty four hours. This 
incubation was required in order to bind serum proteins which can bind non- 
specifically to the plates (Kemeny & Challacombe, 1988).
Following this incubation, lOOul of each diluted sample was added to each 
allergen coated well. Each serum was tested against eleven outdoor antigen panels 
and a negative control on one plate and eleven indoor antigen panels and a 
positive control on another plate. All wells contained one allergen as described in 
Table 2.2 apart from house dust mites which contained both Dermatophagoides 
farinae and D. pteronyssinus; feathers which contained a mixture of feathers and 
Mucor which contained different species of mucor. Both plates were incubated at 
22°C for two hours. The wells were then decanted and washed five times with the 
wash buffer provided which had been diluted with deionised water at a 
concentration of one to fifteen.
To each well, lOOul of rabbit anti-canine IgE was added, followed immediately 
with lOOul of conjugated peroxidase goat anti-rabbit IgG. This was incubated at 
22°C for three hours. The well contents were then decanted and washed five times 
with buffer as described above.
To each well, lOOul of 3,3’,5-5’ tetramethylbenzidine hydrochloride 
(TMB)/peroxide was added and the plate incubated at 22°C for thirty minutes. 
This resulted in the formation of a blue colour in the positive control well, a clear 
colourless negative control and varying shades of blue in the test samples (See 
Fig. 2.1). The intensity of blue colour formation was assessed subjectively,
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compared to a reference panel and graded from zero (colourless) to four (intense 
blue).
In order to stop the colour development lOOul of 0.18N sulphuric acid was added 
to each well resulting in a change of the blue colour to yellow where present (See 
Fig 2.2). The colour intensity was then read on a microplate reader (Bio-tek 
Instruments, Inc. Winooski, VT), at 450nm with the plate zeroed on the negative 
control well. The resulting optical density correlates with the degree of positivity 
where 0-0.149 is equal to a negative result; 0.150-0.249 is equal to a Grade 1 
positive; 0.250-0.349 is equal to a Grade 2 positive; 0.350-0.449 is equal to a 
Grade 3 positive and greater than 0.45 is equal to a Grade 4 positive which was 
the highest result.
Results were then tabulated and examined with statistical packages where 
required.
Table 2.2 Allergens inchided in ELISA
Group Allergens
OUTDOOR ALLERGENS Orchard grass
Timothy grass
Kentucky blue
Fescue.
Poplar
Birch
Sheep’s sorrel
English plantain
Mugwort
Dandelion
Nettle
INDOOR ALLERGENS Flea
Mixed dust mites -  
D. farinae 
D. pteronyssinus
Mixed feathers
Alternaria
Aspergillus
Rhizopus
Kapok
House dust
Cat epithelium
Human epithelium
Mixed Mucor
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2.5.2 Immunodot
The Immunodot test (Centre Medical des Grand Places/HESKA, Switzerland) 
consists of multiple nitrocellulose strips with spots containing various allergens 
which when incubated with serum bind to IgE and IgG. Following the addition of 
an anti-IgE antibody, which binds specifically to IgE, and the subsequent addition 
of an enzyme colour development takes place where IgE is detected (See Fig. 
2.3). Different groups of allergens are present on different strips with the three 
strips used in this study being the Outdoor panel, Indoor panel and a Topscreen 
(See Table 2.3 for further details).
Serum samples were defrosted at room temperature for ten minutes. 0.5ml of the 
serum was then added to 0.5ml Tris Buffered Saline (TBS) which had previously 
been diluted one in ten with distilled water and contained 4% Microcide III. The 
resulting 1ml solution was then added to a well containing the appropriate strip 
and incubated at 22°C on a horizontal shaker for two hours for both Indoor and 
Outdoor panels and overnight for the Topscreen panel.
After this time serum was removed from the well and the strips washed three 
times for five minutes each time with 1.5 ml of the diluted TBS described above 
on a horizontal shaker at 22°C. To each strip 1ml of the revealing horseradish 
peroxidase monoclonal anti-IgE antibody mixture was added and incubated at 
22°C on the horizontal shaker for two hours. Revealing antibody was then 
removed and the strips washed for fifteen minutes as described above.
Developer was prepared by adding fifteen graduated drops of chromogen (4- 
chloro-l-naphthol) and two graduated drops of enzyme substrate containing 3% 
hydrogen peroxide to 10ml distilled water. To each strip, 1ml of the resultant 
developer was then added and incubated for fifteen minutes.
Developer was then removed and the strips washed under running tap water for 
one minute. The strips were then blotted diy and allowed to completely dry at 
room temperature for twenty four hours. Resultant colour development was 
assessed subjectively on a scale of 1-4 (where 1= negative, no colour; 2= positive 
control, some colour; 3= strong positive, 4= highly positive). Strips were also
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scanned with an optical densitometer (AGFA Scanner, model 420oe at a reflective 
density of lkV) and the resultant optical density recorded for statistical analysis.
Table 2.3 Allergens included in Topscreen, Outdoor and Indoor Immunodot
allergen panels.
TEST
STRIP
GROUP CONSTITUENTS OF GROUP
TOP
SCREEN
Total IgE
Outdoor Six grasses, Rye, Birch, Oak, Hazel, Ribwort, Olive, 
Wall pellitory, Jerusalem Cedar
Indoor Dermatophagoid.es. farinae, D. pteronyssinus, Acarus 
siro, Tyrophagus putrescentiae, Cat flea, Human 
dander, Cat epithelia.
Foods A Cow’s milk, Hen’s egg, Soybean, Maize flour, Wheat.
Foods B Lamb, Beef, Pork, Cod, Sole, Peanut.
Moulds Alternaria altemata, Aspergillus fumigatus, 
Cladosporium herbarum, Penicillium notatum, 
Candida albicans.
OUTDOOR Total IgE
Grasses Cocksfoot, meadow fescue, perennial ryegrass, 
timothy, kentucky blue grass, velvet grass /yorkshire.
Trees Birch, Oak, Hazel.
Mugwort/Ribwort
Olive/Wall pellitory.
INDOOR House dust 
mites
D. farinae, D. pteronyssinus
Storage mites A. siro, T. putrescentiae
Cat flea
Human dander
Cat epithelia
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2.5.3 Radial Immunodiffusion
Radial immunodiffusion is a quantitative method used in the analysis of 
immunoglobulins. Antibody against IgGi is incorporated into agar. The test serum 
(containing IgGi) is placed in an antigen well in the agar and allowed to diffuse 
through the agar. This results in the development of an antigen-antibody precipitin 
ring around the well. The diameter of the precipitate ring reflects the 
concentration of IgGi present By applying known concentrations of anti IgGi 
antibody, it is possible to create a logarithmic graph from which unknown IgGi 
concentrations can be calculated.
Analysis of serum total IgGi levels was carried out with a commercially available 
radial immunodiffusion method (Bethyl Laboratories, Inc., Montgomery, USA).
In addition to the test samples, three control samples of known IgGi concentration 
were supplied by the manufacturer. These controls were known to contain 
205mg/dl, 825mg/dl and 1650mg/dl of IgGi. To each diffusion plate well was 
added 5ul of either a control sample or one of eleven test samples, so that each 
plate contained all three controls and eleven tests. Plates were then incubated at 
22°C for twenty four hours. This resulted in the formation of a precipitation ring, 
the diameter of which was measured in millimeters and recorded (See Fig 2.4). 
Ring diameters were plotted on a logarithmic graph and the resultant serum IgGi 
concentration calculated from this as shown in Fig. 2.5. Resultant serum IgGi 
concentrations were recorded. Results from the different groups of dogs were 
examined statistically.
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Fig. 2.5 Logarithmic graph of reference serum IgG( concentration in relation to
precipitin ring diameter.
2.6 Statistical methods
Various statistical tests were used in the analysis of data collected in this study. A 
brief summary of the background to these tests follows.
The paired t test is a way of comparing two groups of data from a population with 
normal distribution and the same variances. The test gives a probability value (p) 
to the two groups being the same and that the differences between them are due to 
chance. A low p value, usually less than 0.05 or 0.01 is considered indicative of a 
significant difference between the two groups and thus not due to chance.
The Kolmogorov-Smimov two sample test is a method of detecting whether or 
not the results are from one population or two distinct populations. Where the 
only variations between the two groups are considered to be within random 
variation no significant difference will be found between the groups. The 
Kolmogorov-Smimov test is a method of detecting when the results are 
sufficiently far apart to be considered significant and indicative of two 
populations.
One way analysis of variance (ANOVA) is a method of comparing data when 
different levels of only one factor are being compared. The number of 
observations in each group do not need to be the same size but it is assumed that 
the data comes from a normally distributed population -  otherwise transformation 
is required prior to analysis. The test indicates evidence of a significant difference 
between the groups.
Two way analysis of variance is a method of comparing data classified according 
to two variables, however the method is most effective when there are the same 
number of observations in each group. Where different numbers of observations 
are present in each group a General Linear model may be used in order to deal 
with the imbalance in the design. Following the identification of significant 
differences amongst groups using ANOVA, the Newman Keuls multiple range 
test was used to test for differences between particular groups.
The association between different serological tests and intradermal skin testing 
was examined using correlations. Pearson’s correlation coefficient (r) can take a 
value between -1 to +1. The correlation between two variables is positive if high 
values of one variable correspond with high values of the other variable whereas a 
negative correlation is obtained if one variable increases when the other 
decreases. A correlation coefficient close to zero indicates that there is no linear 
correlation between the variables and they are unrelated.
The Mann Whitney test is a non-parametric method for comparing data from two 
independent groups. This test requires that the observations in each group are 
ranked in order and the sum of ranks used to obtain a p value which is indicative 
of the significance between the two groups.
The confidence interval is a range of values which we can be confident contains 
the true population parameter. In assessing the confidence interval of an 
estimated mean that interval extends either side of the mean by a multiple of the 
standard error. Confidence intervals are usually based on a 90%, 95% or 99% 
chance of including the true population value. Where confidence intervals are 
calculated whether 90%, 95% or 99% was used will be stated.
Sensitivity is defined as the proportion of true positives which are correctly 
detected by the test. Specificity is defined as the proportion of true negatives that 
are correctly detected by the test (Thrusfield, 1995). The predictive value of a test 
depends on sensitivity, specificity and prevalence of a disease in a particular 
population. The efficacy is a means of determining how well the diagnostic 
method works in both affected and non-affected animals.
Data was stored on Microsoft Excel version 5.0, 1995 and statistical analyses 
carried out using Minitab for Windows Release 11.21, 1996.
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Chapter 3 Examination of the clinical histories of atopic 
and non-atopic GDBA dogs
3.1 Introduction
The aim of this part of the study was to determine if any differences could be 
identified between atopic and non-atopic dogs in the age of onset of skin 
problems and the type of skin conditions presented
The usual age of onset of clinical signs of atopic dermatitis in the dog are between 
one and three years (Scott, 1981). It is rare for dogs younger than this to present 
with atopic dermatitis (Scott, 1981) with only 2% of atopies presenting between 
six-eight months of age. In support of this is work by Schwartzman (1984) who 
could not find any evidence of atopic dermatitis in the progeny of atopic dogs by 
the age of twelve months. The only exception to this is work by Reedy et al. 
(1997b) who observed clinical evidence of atopic dermatitis by the age of six 
months.
It was anticipated that differences in the type of skin disease presented and the age 
of onset of these conditions could contribute to a diagnostic plan so that dogs 
which would go on to develop atopic dermatitis could be identified before a year 
of age. This prediction would be of benefit because GDBA dogs begin their 
training at a year old but do not develop clinical signs, diagnostic for atopic 
dermatitis, until two to three years old. At this point dogs are often unable to work 
after much time and money has been spent on their training (as explained in 
2. 1. 1).
3.2 Materials & Methods
Clinical histories of thirty dogs from the GDBA population described in section 
2.1.1 were examined. Fifteen of these dogs had previously been diagnosed as 
atopic, based on clinical findings and intradermal skin testing. At the time of the 
study these dogs ranged in age from two to eleven years. Fifteen non-atopic dogs
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were chosen at random by the Kennel Assistants based on the criteria that, all 
dogs were older than four years of age by 31/8/98 and that there were no skin 
problems suggestive of atopy in the clinical history i.e. although otitis externa and 
pyoderma are included in Willemse’s criteria as clinical signs of atopic dermatitis, 
dogs were only excluded from being atopic if they had a history of repeated 
episodes of these conditions as non-atopic dogs can have isolated cases of otitis 
externa. A lower age limit of four years rather than three years was chosen to 
ensure that the chance of these dogs still developing atopic dermatitis was 
minimised as much as possible, although it is recognised that it is possible for a 
dog to develop atopic dermatitis after 4 years of age, this is uncommon. Willemse 
& Van den Brom (1983) reported that 75.5% of cases of atopic dermatitis 
developed before three years of age. The dogs chosen were aged between four and 
eleven years. All thirty dogs were either Golden Retrievers, Labrador Retrievers 
or crosses of these two breeds. Detailed clinical histories were available for all of 
the dogs from birth to twenty one months of age. Further details of these thirty 
dogs are given in Appendix A.
Clinical histories were examined for mention of any skin problems, excluding 
viral papillomas and pressure sores. These conditions were excluded as both 
occurred at specific times in the history of the kennels. For example bedding was 
only introduced to the kennels at the start of this study and prior to this pressure 
sores were very common. However, due to the introduction of bedding materials 
younger dogs had fewer cases of pressure sores. Also, outbreaks of viral 
papillomas were seen during the history of the kennels but there were times when 
no dogs were affected. As it was not consistently present throughout the time 
being studied it was not felt appropriate to include this criterion as this could 
adversely influence the results. During this discussion atopic type skin conditions 
were based on the criteria of Willemse (1986) and included pruritus, otitis 
externa, conjunctivitis, pedal dermatitis, pyoderma, erythema, dandruff and anal 
gland disease. ‘Any skin condition’ describes atopic type conditions in addition
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to skin problems such as alopecia and wounds but does not include viral 
papillomas or pressure sores.
The age at which dogs first presented any skin condition or an atopic type skin 
problem was recorded and a survival type curve of time to event produced for 
both of these findings. Atopic and non-atopic dogs were compared for any 
significant differences in the age at which they first presented with atopic or any 
skin conditions using a Kolmogorov-Smimov two sample statistical test.
Also, the frequency of presentation of particular skin conditions in atopic and 
non-atopic dogs was examined. In order to compare the two groups of dogs, the 
expected length of time a particular skin condition took to resolve, had to be 
determined. This was defined in non-atopic dogs as the length of time between 
first being examined by the centre vet until complete resolution of the problem. 
Only conjunctivitis, otitis externa, pedal dermatitis and acute moist dermatitis or 
pyoderma were observed often enough to allow statistical evaluations to be 
carried out. Acute moist dermatitis and pyoderma were both used by the centre 
vet to describe infectious skin disease and could not be differentiated on the 
clinical records -  therefore both conditions had to be included as one. Statistical 
analysis of these results was carried out to obtain a 90% non-parametric 
confidence interval for the median times to resolution in order to define the 
expected duration of each skin condition.
These results for non-atopic dogs were then applied to the clinical histories of 
atopies. This meant that where an episode of skin disease in an atopic dog lasted 
twice as long as expected in a non-atopic dog, the atopic dog was described as 
being affected by two episodes of skin problems. This is necessary because atopic 
dogs can suffer from prolonged episodes of skin disease which do not respond 
quickly to treatment and this fact has to be taken into account when comparing 
both groups of dogs. However, as not all atopic dogs suffer from longer episodes 
of skin disease, the duration of skin disease in atopic and non-atopic dogs was not 
compared
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The cumulative number of episodes of particular skin conditions in atopic and 
non-atopic dogs, at various ages, were analysed using a Mann Whitney statistical 
test. This allowed the identification of the most significant diagnostic parameters. 
Analyses were undertaken using the Minitab version 11.21 (1996) statistical 
software package.
Sensitivity, specificity and predictive value of the above classifications were 
examined in order to identify the most suitable model to use as a diagnostic 
indicator for atopic dermatitis based on the number of episodes of skin problems 
at difference ages.
3.3 Results
Studies of the skin conditions in atopic and non-atopic dogs revealed that otitis 
externa was the commonest condition in both atopic and non-atopic dogs 
followed by conjunctivitis (See Appendix B). Conditions other than atopic type 
skin conditions observed in both atopic and non-atopic dogs included juvenile 
cellulitis, wounds, alopecia, lick granulomas and infected nailbeds.
Examination of the age at which dogs first demonstrated any kind of skin 
condition, (Figure 3.1) excluding viral papillomas and pressure sores, revealed 
that 50% of atopic dogs had demonstrated skin problems by the age of seven 
months compared with twelve months for the non-atopic dogs. Examination of the 
demonstration of atopic type skin conditions (Figure 3.2) revealed that 50% of 
atopic dogs were affected by the age of eight months compared with twelve 
months for non-atopies. All fifteen atopic dogs had suffered from some form of 
skin condition by the age of eleven months and atopic type skin conditions by 
fifteen months compared with twenty two months for the development of both 
atopic and any kind of skin condition in all fifteen non-atopic dogs (Figs 3.1 & 
3.2).
Survival curve analyses of the number of atopic and non-atopic dogs affected by 
skin problems by particular ages revealed that atopic dogs were consistently 
affected by skin disease at a younger age than the non-atopic dogs.
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Comparison of the survival type curves of atopic and non-atopic dogs with a 
Kolmogorov-Smimov test (Table 3.1) revealed a significant difference between 
both groups of dogs at ten months of age for any skin conditions (p<0.01) and 
atopic type skin conditions (p<0.02).
Examination of the length of an episode of atopic type skin conditions in non- 
atopic dogs (Table 3.2 and Appendix C) revealed the estimated expected duration 
of each particular skin condition as: seven days for conjunctivitis; seven days for 
otitis externa; seven days for pedal dermatitis and fourteen days for pyoderma. 
Examination of the number of episodes of skin disease in atopic and non-atopic 
dogs at differing ages, shown in Appendix B, was carried out with a Mann 
Whitney test (results shown in Table 3.3 and Appendix D). This revealed a 
significant difference between atopies and non-atopics (p<0.025, p<0.042) at nine 
months for the total number of episodes of both atopic type skin conditions and 
any skin conditions respectively. No significant difference was evident until 
twelve months between atopies and non-atopic for otitis externa (p<0.002) and 
eighteen months for conjunctivitis (p<0.02). No difference was observed between 
the two groups in the number of episodes of pedal dermatitis or pyoderma. 
Sensitivity, the number of atopic dogs from the fifteen atopies in the study which 
agreed with the criteria of x  number of episodes by y  months of age, and 
specificity, the number of non-atopic dogs in the study which were not affected by 
x  number of episodes by y  months of age were found to be best for four episodes 
or more of atopic type skin conditions by the age of fifteen months (Table 3.4). 
Sensitivity for these criteria was 60% and specificity 93.3%.
For any skin condition, excluding viral papillomas and pressure sores, sensitivity 
of 66.7% and specificity of 86.7% were found for four episodes or more by the 
age of 15 months (Table 3.5). The prevalence of atopic dermatitis in the general 
population has been reported as between 10% and 15% (Chamberlain, 1974). 
Therefore a prevalence of 10% was used for statistical evaluation. Using this, the
7 0 '
best predictive value for a diagnosis of atopy in these thirty dogs was four or more 
episodes of atopic type skin disease by the age of fifteen months (Table 3.4).
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Table 3.1 Results of Kolmogorov-Smimov two sample test examining the 
age which any skin disease or atopic type skin disease developed in groups 
of atopic and non-atopic dogs
Formula required for Kolmogorov Smirnov test:
mn
X2 = 4D2m, „ m + n
Where X2 = Chi Squared distribution
D = The maximum difference between survival 
curves of atopic and non-atopic dogs. 
m= Number of atopic dogs.
n= Number of non-atopic dogs.
1. For any skin condition with a maximum difference between the two 
groups at ten months old:
X2 = 4 x (60/100)z X 15x15 .
15+15
X2 = 10.8
From this a critical value of p<0.01 was obtained for df=2.*
2. For atopic type skin conditions with a maximum difference between the 
two groups at ten months old:
X2 = 4 x (53.3/100)2 x 15x15 .
15+15
X2 = 8.5
From this a critical value of p<0.02 was obtained for df=2*
* From Siegel & Castellan, 1988.
Table 3.2. The duration of episodes of atopic type skin conditions in 15 
non-atopic dogs between birth and 21 months of age and results of 90% 
non-parametric confidence interval.
Duration of problem (days)
Episode
number
Conjunctivitis Otitis externa pedal dermatitis Pyoderma
1 5 5 7 17
2 26 7 7 12
3 7 7 7 10
4 17 7 5 10
5 7 7 5 7
6 7 7 * 5
7 5 5 * 20
8 6 22 * 7
9 5 7 * 7
10 7 10 * 5
11 7 7 * 14
12 7 7 * 14
13 5 5 * ♦
14 7 7 * *
* No more episodes of this particular skin condition were observed.
Results of 90% non-parametric confidence interval analysis of above data 
(See Appendix C) revealed the expected duration of each skin condition 
as:
Conjunctivitis 7 days
Otitis externa 7 days
Pedal dermatitis 7 days
Pyoderma 14 days
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Table 3.3 Examination of the number of episodes of individual skin 
diseases in atopic and non-atopic GDBA dogs by different ages with a 
Mann Whitney test. (Original data in Appendix B; calculations in
Appendix D).
Parameter Age (months) Level at which test is 
significant (p value).
Otitis externa 3mths 1.000
6mths 0.756
9mths 0.507
12mths 0.010
15mths 0.071
18mtbs 0.013
21mths 0.005
Conjunctivitis 3mths *
6mths 1.000
9mths 0.756
12mths 0.678
15mths 0.101
18mths 0.029
21mths 0.040
Pedal dermatitis 3mths *
6mths *
9mths *
12mths 1.000
15mths 0.709
18mths 0.152
21mths 0.078
Pyoderma 3mths *
6mths *
9mths *
12mths 0.272
15mths 0.229
18mths 0.199
21mths 0.300
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Table 3.3 continued
Parameter Age Level at which test is 
significant, (p value)
Atopic skin conditions 3mths 0.804
6mths 0.237
9mths 0.025
12mths 0.004
15mths 0.01
18mths 0.001
21mths 0.0003
Any skin conditions 3mths 0.804
6mths 0.351
9mths 0.042
12mths 0.002
15mths 0.003
18mths 0.002
21mths 0.001
*Test could not be carried out as results identical / virtually identical. 
Those figures in bold are significant. (p< 0.05).
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Table 3.4 Sensitivity, specificity and predictive value results for the 
number of episodes of atopic type skin conditions demonstrated by atopic
dogs by different ages.
Sensitivity of number of episodes of atopic type skin conditions
Age ( months)
No. episodes 12mths 15mths 18mths
3 46.6% 73.3% 100%
4 33.3% 60% 86.7%
5 26.7% 53.3% 80%
Specificity of number of episodes of atopic type skin conditions
Age ( months)
No. episodes 12mths 15mths 18mths
3 100% 73.3% 40%
4 100% 93.3% 53.3%
5 100% 100% 66.7%
Predictive value of a positive test for 10% prevalence
Predictive value =  Prevalence x Sensitivity_______ .
(Prevalence x Sensitivity) + [(l-Prevalence)x(l-Specificity)]
Age ( months)
No. episodes 12mths 15mths 18mths
3 1 0.234 0.156
4 1 0.49 0.171
5 1 1 0.211
Note: Figures in bold indicate best result
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Table 3.5 Sensitivity, specificity and predictive value results for the 
number of episodes of any skin conditions demonstrated by atopic dogs by
different ages.
Sensitivity of number of episodes of any skin conditions
Age ( months)
No. episodes 9mths 12mths 15mths
3 5.3% 86.7% 100%
4 40% 66.7% 86.7%
5 26.7% 60% 86.7%
Specificity of number of episodes of any skin conditions
Age ( months)
No. episodes 9mths 12mths 15mths
3 86.7% 40% 20%
4 100% 86.7% 26.7%
5 100% 100% 46.7%
Predictive value of a positive test for 10% prevalence.
Age ( months)
No. episodes 9mths 12mths 15mths
3 0.308 0.138 0.122
4 1 0.359 0.116
5 1 1 0.153
Note: Figures in bold indicate best result
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3.4 Discussion
Atopic dermatitis is characterised as a pruritic skin condition, which is 
often familial and generally affects particular breeds (Scott, 1981, 
Willemse, 1986). All thirty dogs in this particular study were Retrievers, 
Labrador Retrievers and their crosses which are breeds known to be 
predisposed to developing atopy (Willemse, 1986).
Most cases of atopic dermatitis become clinically evident between the ages 
of one and three years (Scott, 1981). However, clinical signs of skin 
problems can present themselves before this age but as they are often 
minor they may not be regarded as significant by an owner. The clinical 
histories of the working dogs in this study are highly detailed and in this 
respect minor skin conditions which may not be observed in pet dogs have 
been recorded.
Diagnosis of atopic dermatitis before one year of age is difficult as 
diagnosis often relies on a history of chronic relapsing skin problems. 
Willemse & van den Brom (1983) observed that only 27% of atopic dogs 
had developed clinical signs of atopic dermatitis by one year of age, 
whereas Scott (1981) found that 64% of atopic dogs had developed signs 
by one year old.
Examination of the clinical histories of the working dogs described here 
revealed that there was indeed a significant difference between atopic and 
non-atopic dogs in the age at which dogs first demonstrated skin problems. 
This difference was evident by ten months of age. Examination of both 
atopic type skin conditions and any skin conditions revealed that the atopic 
dogs were significantly younger than the non-atopic dogs in the age at 
which they first demonstrated such skin problems.
Atopic dogs were found to first present with atopic type skin conditions or 
any skin problems at a younger age than non-atopics. From this it can be 
concluded that the age at which dogs first demonstrate skin problems can 
be included in the diagnostic criteria of atopic dermatitis and examination 
of a dog’s history is important in the diagnosis of atopy. The only problem 
is that these conditions may often be so minor that when applied to pet 
dogs, episodes may not be recognised by owners. However, this should not
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be a problem in the GDBA population where puppy walkers could be 
informed of the clinical signs to look for.
Evidence of pruritus is the most common presenting clinical sign in canine 
atopic dermatitis (Scott, 1981). However, it can be difficult to assess as it 
is subjective in nature and relies on the opinion of the owner. As it is 
normal for all dogs to demonstrate a degree of pruritus, diagnosis can 
prove difficult. In the kennels, working dogs are not observed at all times 
and pruritus may not be diagnosed unless it is very obvious. Therefore 
pruritus is not mentioned regularly in the clinical histories and it could not 
be included as a major sign in this study.
Most commonly mentioned skin problems were conjunctivitis, otitis 
externa, pyoderma and pedal dermatitis and statistical analysis of these 
parameters was possible. Other conditions such as anal gland disease were 
too infrequent to include in statistical analysis and each mention of such 
condition had to be included as an episode of disease.
Otitis externa and conjunctivitis were the most common conditions 
recorded. It is possible that this is because both conditions are easy to 
identify when a dog is being groomed, whereas pedal dermatitis and 
pyoderma can go unnoticed.
In the diagnosis of atopic dermatitis the main problem is that the initial 
presentation of skin disease alone is not sufficient to make a 
diagnosis.Instead diagnosis is commonly based on repeated episodes 
which obviously take time to become apparent. In addition, these repeated 
episodes of skin disease in both humans and dogs can become chronic, 
taking a long time to resolve. It was therefore necessary to determine the 
expected duration of atopic type skin conditions in non-atopic dogs. This 
gave some surprising results. The expected duration of otitis externa in 
non-atopic dogs was found to be only seven days which is rather low as 
usually cases of otitis externa in GDBA dogs would be treated for a 
minimum of fourteen days. It is possible that this is due to iatrogenic cases 
of ear disease as a result of over zealous cleaning, and the misdiagnosis of 
cases of otitis externa by kennel staff. It has been noted that individual 
dogs with large amounts of wax have been referred to the centre veterinary 
surgeon as otitis externa and such cases are often recorded as otitis
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externa. These had to be included in this study as it was not possible to 
differentiate them from true cases of otitis externa. Similarly cases of pedal 
dermatitis were expected to last for seven days which again appears a 
rather short time. It is possible that these cases are due to trauma as many 
dogs tend to jump up onto the wire mesh kennel doors. However, such 
cases are equally presented in atopic and non-atopic populations and it is 
fair to include them in this study.
Comparison of atopic and non-atopic dogs revealed that there was indeed a 
significant difference in the number of episodes of both atopic type skin 
lesions and any skin lesions as early as nine months of age. This is 
younger than would be expected as most diagnoses of atopy are not made 
before one year of age. However, it is likely that most atopic dogs do 
indeed begin to show clinical signs of disease at this young age, but that 
the process of diagnosis, often involving relapsing skin conditions, with 
dogs often being referred to dermatologists means that the recorded age of 
presentation is older. Indeed, Reedy at al. (1997a) reported that a group of 
inbred atopic dogs demonstrated clinical signs of atopic dermatitis at six 
months of age.
There was very little difference in the numbers of dogs presenting with 
atopic type skin lesions or all skin lesions. This is due to the fact that the 
majority of skin conditions presenting in all these dogs are of an atopic 
type. This makes diagnosis of atopy difficult.
Of the individual skin conditions described, a significant difference was 
noted between the number of episodes of otitis externa experienced by 
atopies and non-atopics by the age of twelve months (p<0.01). A 
significant difference was found for the number of episodes of 
conjunctivitis by eighteen months of age (p<0.029). There was no 
significant difference between atopic and non-atopic dogs in the number of 
episodes of pedal dermatitis or pyoderma. Examination of the cumulative 
total of all episodes of atopic type skin problems revealed the most 
significant difference between atopies and non-atopics was at nine months 
of age (p<0.025). However, there was veiy little difference between the 
total number of episodes of atopic type skin problem and the total number 
of episodes of any skin problem, with a significant difference also present
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for any skin condition (p<0.042) at nine months of age. From this it 
appears that for diagnostic purposes it is better to examine the total number 
of episodes of atopic type skin conditions or indeed any skin conditions 
rather than relying on one particular skin condition.
The finding that atopic dogs as young as nine months of age have 
significantly more episodes of skin disease than non-atopics contradicts 
work by Schwartzman (1984) who could not find any clinical evidence of 
atopic dermatitis in dogs less than twelve months of age. However, the 
work described in the present study could not detect atopy in dogs as 
young as those studied by Reedy et al (1997b), who observed that dogs 
could demonstrate clinical signs consistent with a diagnosis of atopic 
dermatitis by the time they were six months of age. In order for such an 
observation to withstand statistical scrutiny increased numbers of dogs 
would have to be studied.
Retrospective examination of clinical findings revealed a significant 
difference between atopic and non-atopic dogs by nine months of age. 
However, in order to apply this data in the prediction of atopic dermatitis, 
dogs who show four or more episodes of atopic type skin disease by 
fifteen months should be considered at risk of developing atopic 
dermatitis. Sensitivity of this finding was 60% and specificity 93%. 
Although the sensitivity is lower than desired the high specificity means 
that there would be a low chance of non-atopic dogs being identified as 
possible atopies. This would allow dogs to be assessed at the beginning of 
their training and a decision could be made about their future before they 
go through two years of training.
3.5 Conclusions
It is apparent from this study that atopic dogs demonstrate clinical 
evidence of skin problems both of an atopic and non-atopic nature at a 
younger age than non-atopic dogs. It is therefore important that the clinical 
history of a suspected atopic dog is examined in some detail and that the 
age at which dermatological disease of any sort was first recognised is 
included in the diagnostic parameters of canine atopic dermatitis.
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In addition, examination of the cumulative number of episodes of atopic 
type skin conditions or any skin problems are a better diagnostic indicator 
than episodes of any one particular form of skin disease. Analysis of the 
number of episodes of skin problems should therefore be carried out in 
suspected atopic dogs. Those animals affected by four or more episodes of 
aKin problems by the age of fifteen months should be investigated further 
as candidates for the development of atopic dermatitis.
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/Chapter 4 Studies of serum total IgE in non-atopic 
and atopic dogs.
4.1 Introduction
In human medicine serum total IgE concentrations are used as a diagnostic 
indicator of atopic dermatitis (Gurevitch et a l 1973; Jones et ah, 1975; 
Juhlin et al, 1969). In general atopic people have significantly higher 
concentrations of serum total IgE than non-atopics. However, in the dog 
no such differences have been found; indeed dogs as a population have 
been shown to have much higher serum total IgE levels than humans 
(Schwartzman & Rockey, 1967). It has been suggested (Halliwell & 
Kunkle, 1978) that this is due to the high levels of parasites to which dogs 
are exposed, as the major antibody response to parasites is IgE .
The first aim of this study was to assess the serum total IgE concentrations 
of atopic and non-atopic GDBA dogs which are considered free of 
parasites in order to determine whether or not atopies and non-atopics 
could be differentiated on the basis of serum total IgE concentrations. 
Serum total IgE concentrations of atopic GUVS dogs, non-atopic 
greyhounds and non-atopic laboratory beagles were also examined for 
comparative purposes.
It has been suggested (Griffin et al., 1990) that where non-atopic dogs 
have high serum total IgE concentrations non-specific binding of IgE in 
the ELISA can occur and lead to positive results. These positive ELISA 
results in non-atopic animals are often called false positives. The second 
aim was to estimate the number of positive ELISA results in non-atopic 
GDBA dogs, in relation to serum total IgE concentrations, to establish 
whether or not our findings agreed with current theories.
Thirdly, serum total IgE concentrations of non-atopic GDBA dogs were 
examined in relation to age. In human medicine serum total IgE 
concentrations have been shown to increase with age up to twenty-thirty 
years old (Johansson et al, 1970). The aim here was to assess if any age 
related differences in serum total IgE levels were identifiable in the dog.
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4.2 Materials & Methods
Initial assessment of the immunodot test was carried out. This involved 
applying serial dilutions of an IgE containing serum to the Topscreen test 
(as described below) and assessing the results. The initial serum was 
diluted 50:50 with Tris Buffered Saline (TBS).The resultant diluted serum 
was then diluted again 50:50 with TBS. This was repeated a further four 
times.
The serum total IgE concentrations of five groups of dogs were examined. 
Blood samples were obtained from non-atopic GDBA dogs, atopic GDBA 
dogs, non-atopic greyhounds, non-atopic beagles and atopic GUVS dogs 
as described section 2.1. Details of these dogs are given in Appendix A. 
Serum total IgE concentrations were assessed in fifty five non-atopic 
GDBA dogs. These were predominantly Labrador Retrievers, Golden 
Retrievers (and their crosses) and German Shepherd Dogs. In addition 
Curly Coat Retrievers, Flat Coated Retrievers and Collie crosses were 
represented. At the time of sampling these dogs were aged from 56 -  2365 
days, with a mean age of 575 days.
Twelve atopic GDBA dogs were included in this study. These dogs were 
of similar breeds to the non-atopic dogs and were aged from 429-2687 
days, with a mean age of 1182 days, at the time of sampling.
Serum total IgE concentrations were examined from fifteen non-atopic 
greyhounds and twenty five non-atopic laboratory beagles. At the time of 
sampling greyhounds ranged in age from 3-6 years (accurate ages in days 
were not available for greyhounds or beagles) with a mean of 1606 days, 
and the age of beagles ranged from 3-5 years, with a mean of 1299 days.
A total of twenty eight atopic GUVS dogs were also examined. A wide 
variety of breeds were represented including Staffordshire Bull Terriers 
and English Setters in addition to Labradors and German Shepherd Dogs. 
The age of atopic GUVS dogs ranged from 305 to 2941 days (mean 1272 
days).
All non-atopic dogs were older than three years by 31/8/98 and did not 
have any history of multiple episodes of atopic type skin disease based on 
Willemse’s criteria (1986). Atopic dogs were diagnosed as such based on
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clinical history, intradermal skin testing and serological testing as 
described in section 2.3-2.5.
GDBA dogs and beagles were assumed to be essentially free of parasites, 
although no post mortems were carried out to confirm this assumption. 
However, the treatment regimes for both groups of animals are such that 
the influence of parasites is minimal.
Blood samples were obtained and stored as described in section 2.4. Serum 
total IgE concentrations were evaluated using an Immunodot serological 
test kit (CMG / Heska, Switzerland) described in 2.5.2. Initially this 
involved an Outdoor panel of test strips but was later replaced by the 
manufacturer with a Topscreen panel. Resultant colour formation on this 
test strip indicated a positive result. The degree of colour formation is 
proportional to the concentration of serum total IgE and was assessed 
using an Optical Densitometer (AGFA, Scanner, model 420oe) to give a 
reflective density value, for comparative purposes.
Allergen specific ELISA analysis of the serum samples was carried out on 
forty three of the dogs undergoing total serum IgE analysis. It was not 
possible to assess allergen specific IgE in all fifty five non-atopic dogs due 
to the limitations of the amount of serum available. ELISA assays were 
carried out with a commercially available ELISA produced by AlerCHEK 
Inc., Portland, USA as described in section 2.5.1. Positive results obtained 
in the ELISA for these non-atopic dogs were considered clinically 
irrelevant results.
Statistical analysis of these results was carried out using one way Analysis 
of Variance (ANOVA) and the Newman Keuls multiple range test. Trends 
of association between variables were examined using Pearson’s 
correlation coefficient, with r values close to 0 indicating no evidence of 
association. Analyses were undertaken using the Minitab version 11.21 
(1996) statistical software package.
4.3 Results
Examination of serial dilutions of IgE did reveal a gradual decrease in 
colour formation of the total IgE spot on the Immunodot strip (Fig. 4.1).
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Analysis of serum total IgE levels in atopic and non-atopic dogs revealed a 
high degree of overlap between groups (See Fig. 4.2). All five groups 
contained dogs with a wide range of serum total IgE concentrations. 
Comparing serum total IgE concentrations of atopic and non-atopic 
GDBA dogs did not reveal any significant difference between these two 
groups (See Table 4.1, 4.2 & Appendix E6). Both groups of dogs 
contained individuals with high and low serum IgE concentrations. In 
addition, there was no significant difference between any combination of 
non-atopic beagles, atopic GUVS dogs, non-atopic GDBA dogs and 
atopic GDBA dogs. Indeed, non-atopic GDBA dogs with excellent 
parasite control could not be differentiated from atopic GUVS dogs 
receiving variable parasite control measures.
However, the one group where a significant difference in serum IgE 
concentrations was noted, was the group of non-atopic greyhounds, which 
demonstrated significantly higher serum IgE concentrations than all other 
groups of dogs (p<0.05) (See Table 4.1 & 4.2).
A large number of positive results were observed in non-atopic GDBA 
dogs, against a wide variety of allergens. No particular allergen was found 
to predominate (See Fig.4.3). Examination of the number of these positive 
ELISA results for each dog and that dog’s serum total IgE concentration 
revealed a Pearson’s correlation coefficient of -0.102 (see Appendix E7), 
indicating that there was no correlation between these two parameters (See 
Fig. 4.4). Indeed closer examination of these results revealed that some 
dogs with high serum total IgE reflective density levels up to 0.567 did not 
produce any positive ELISA results.
Further examination of the clinical histories of atopic dogs with low serum 
total IgE concentrations revealed that the dog with the lowest serum total 
IgE concentration had received ear treatment containing prednisolone two 
weeks prior to IDST/blood sampling and intermittent prednisolone tablets 
for three months up until eight weeks before IDST. The dog with the 
second lowest serum total IgE concentration had received an injection of 
dexamethasone four months prior to IDST/blood sampling.
Examination of the age of non-atopic GDBA dogs at the time of sampling 
and serum total IgE concentration did not reveal any correlation,
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(Pearson’s correlation 0.000, Appendix E8), with young and old dogs 
exhibiting a wide variety of serum total IgE levels as shown in Fig. 4.5.
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Table 4.1 -  Comparison of serum total IgE reflective densities in different 
groups of dogs (Appendix E.6)
Group Mean Range Standard deviation Sample
size
Non-atopic GDBA 0.182 0.008-0.567 0.143 55
Atopic GDBA 0.203 0.006-0.467 0.144 12
Greyhounds 0.498 0.011-0.684 0.167 15
Beagles 0.275 0.000-0.735 0.202 25
Atopic GUVS 0.206 0.010-0.718 0.172 28
Table 4.2 One way analysis of variance/ Newman Keuls Multiple Range
Test. (See Appendix E.6).
A significant difference (p<0.05) was observed amongst the five groups of 
dogs described above. Further examination with a Newman Keuls multiple 
range test revealed that:
1. Greyhounds were significantly different to all other groups
2. No significant difference was present between non-atopic GDBA dogs, 
atopic GDBA dogs, beagles and atopic GUVS dogs
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4.4 Discussion
The production of IgE antibodies is mainly directed against parasites and is 
involved in hypersensitivity reactions (Bloch et a l, 1972, Tizard, 1987b). 
Serum IgE levels in non-atopic humans are relatively low at 300ng/ml 
(Johansson et a l, 1970), compared with that of dogs where serum total IgE 
levels can be as high as 350ug/ml (Rockey & Schwartzman, 1967).
In human medicine serum IgE levels have been shown to be significantly 
higher in atopic patients compared with non-atopics (Gurevitch et a l, 1973, 
Jones et al, 1975, Juhlin et a l, 1969). However, this is not the case in the dog 
with no such significant difference being observed in veterinary medicine 
(Halliwell & Kunkle, 1978). The reason for the high level of total serum IgE 
in the dog is assumed to be the high level of parasitism to which dogs are 
exposed and subsequently infested (Halliwell & Kunkle, 1978). This results in 
parasitised atopic and non-atopic dogs having similar serum total IgE 
concentrations.
It is known that due to the excellent parasite control measures applied by the 
GDBA these dogs have extremely low levels of parasite exposure and are 
known to be free of endoparasites. Therefore it would be expected that atopic 
GDBA dogs would have significantly higher serum total IgE concentrations 
than non-atopic GDBA dogs. However, this is not the case. Non-atopic 
GDBA dogs in this study demonstrated a wide variety of serum total IgE 
concentrations similar to those observed in atopic GDBA dogs. No significant 
difference was found in serum total IgE levels between atopic and non-atopic 
GDBA dogs. Similar findings were reported by DeBoer & Hill (1999) who 
did not find and correlation between serum total IgE concentrations at six- 
twelve weeks of age and the development of atopic dermatitis in West 
Highland Terriers. These dogs also showed a wide range of serum total IgE 
concentrations.
Examining only the non-atopic GDBA dogs and non-atopic beagles it appears 
rather surprising that a number of these dogs had high levels of serum total 
IgE. Both of these groups of dogs underwent stringent parasite control
measures and it is unlikely that parasite burdens are responsible for inducing 
serum IgE production. A more likely reason for these serum total IgE 
concentrations is the ‘high’ and ‘low’ responder theory put forward by de 
Week et al., (1998) following original work by Katz (1978). Katz 
demonstrated that a group of inbred mice exhibited a wide range of serum 
total IgE concentrations and he divided these animals into groups of ‘high’ or 
‘low’ responders. This phenotype was found to be restricted to the IgE 
antibody class and was not found with IgG. Katz (1978) also observed that the 
low responder phenotype corresponded to the non-atopic population. Similar 
work by de Week (1998) demonstrated similar findings in the canine 
population -  namely that particular dogs demonstrated high levels of serum 
total IgE and that other dogs demonstrated low levels. Results in this study 
from the non-atopic GDBA dogs and beagles would appear to agree with this. 
Although parasitism and hypersensitivity reactions may influence serum IgE 
levels, there appears to be a dominant phenotypical variation also controlling 
serum total IgE concentrations. The division of animals into groups of high or 
low responders would suggest that there is a bimodal distribution of serum 
total IgE response, however this is not the case. There is some area of overlap 
between both high and low responders as can be seen from Fig 4.1.
The non-atopic GDBA dogs studied here have shown no evidence of being 
atopic. However, some of these dogs were high responders. As de Week 
(1998) suggested that only the dogs with increased serum total IgE 
concentrations went on to develop atopic dermatitis it would be reasonable to 
expect that these dogs could develop atopic dermatitis. From the results of this 
study it would appear that although a dog may have the ability to become 
atopic (i.e. high responder) they do not necessarily become so and other 
controlling factors must be involved. Mayer et al. (1998) suggested that genes 
other than those controlling serum IgE concentrations may be involved in the 
development of atopic dermatitis.
Conversely, as de Week, et al, (1998), suggested that only high responders 
go on to develop atopic dermatitis it appears surprising that examination of
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atopic GDBA dogs revealed dogs with low serum total IgE concentrations. It 
is possible that these findings are due to previous corticosteroid therapy, as 
the two dogs with the lowest serum total IgE concentrations had received 
some form of corticosteroid medication before blood sampling. 
Dexamethasone has been shown to have approximately twenty times the 
anti-inflammatory activity of prednisolone (Intervet UK Ltd., data sheet). It 
is possible that these steroid therapies are responsible for the low serum total 
IgE concentrations. Although, it has been stated that there is no requirement 
to stop corticosteroid therapy prior to ELISA testing (Anderson & Sousa, 
1993) recent work has suggested that such treatment may indeed influence 
serum IgE concentrations (McCall et a l, 1998).
Comparison of non-parasitised GDBA atopic dogs or parasitised GUVS 
atopic dogs did not reveal any significant difference. It is fair to assume that if 
serum total IgE concentrations are influenced by parasite burdens then the 
serum total IgE concentrations of GUVS dogs would be higher than GDBA. 
However, from our results this does not appear to be the case.
Examination of non-atopic greyhounds revealed significantly higher levels of 
serum total IgE. Greyhounds as a breed are known to be exposed to high 
levels of parasites (Jacobs, 1978, Walker & Jacobs, 1982). As this 
examination was retrospective it was not possible to examine the faecal 
parasite egg count of these dogs. However, a negative result on such an 
examination does not conclusively prove that a dog does not have a parasite 
burden. It is possible that dogs possessing latent larvae of Toxocara canis may 
have elevated serum IgE levels.
Also, fleas are known to be a common problem in many greyhound kennels 
(personal communication with referring veterinary surgeon) and it is possible 
that this may have an influence on the serum total IgE concentrations. 
However, this is unlikely as these dogs had no history of demonstrating flea 
allergy. Halliwell et al (1987) demonstrated that where dogs underwent 
continual exposure to fleas low only levels of serum total IgE were present.
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It is also possible that as a breed greyhounds may inherently produce higher 
levels of serum total IgE, although no work has been carried out in this area. It 
is also possible that because only fifteen greyhounds were examined (in 
comparison to fifty five non-atopic GDBA dogs) we may by chance have 
serum total IgE levels of high responding dogs. Further work is required in 
this area.
It has been suggested by Griffin et al. (1990) that there may be a correlation 
between serum total IgE concentration in non-atopic dogs and the number of 
so called false positive ELISA results i.e. where non-atopic dogs demonstrate 
positive ELISA results. Griffin suggested that where non-atopic dogs have 
high levels of serum total IgE non-specific binding of IgE to the test well is 
more likely to occur with the production of a positive result. However, this 
study did not reveal any such correlation. This difference may be due to the 
fact that Griffin’s study only included fifteen dogs whereas this study 
examined forty three non-atopic dogs.
It has been shown that IgG anti-IgE antibodies are present in both atopic and 
non-atopic dogs (Hammerberg et a l , 1997) and it has been suggested that 
these antibodies may interfere with the assessment of serum total IgE levels, 
due to non-specific binding of IgG antibodies to the well resulting in lower 
levels of serum total IgE being recorded than are actually present. In this study 
the use of Immunodot technique should have minimised this error. However, 
if IgG anti-IgE antibodies did manage to interfere with the detection of serum 
total IgE it would mean that lower levels of total serum IgE were recorded 
than were present and therefore dogs which actually had high levels of serum 
total IgE and a high number of positive ELISA results were identified as 
having low levels of serum total IgE. However, this appears unlikely. 
Although IgG anti-IgE allergen specific antibodies can interfere with ELISA 
testing resulting in a low number of positive ELISA results, it is possible that 
the IgG anti-IgE antibodies are directed against different epitopes from those 
detected by the ELISA test. An assessment of IgG anti-IgE antibodies was not 
possible in this study and further work in this area is required.
Examination of serum total IgE levels in non-atopic people have 
demonstrated that there is an increase in such levels until twenty-thirty years 
of age (Johansson et al, 1970). Examination of this parameter in the non- 
atopic canine population did not reveal such a correlation; indeed there was 
no obvious correlation between age and serum IgE levels. This may be due 
to the high and low responders discussed above with this trait being obvious 
at a very young age. No work has demonstrated the youngest age at which 
this trait can be identified. Secondly, the lack of correlation may be due to 
the small number of samples from dogs under six months of age. It is 
possible that any correlation in the dog is present at a much younger age and 
this was not obvious from the results that were available.
4.5 Conclusions
This study has demonstrated that dogs as a population can exhibit a wide 
range of serum total IgE concentrations. This means that even in non­
parasitised animals serum total IgE concentrations cannot be used to 
distinguish atopic and non-atopic dogs. Therefore, although serum total IgE 
concentrations can be used as a diagnostic parameter in human medicine this 
is not that case in canine medicine.
A group of greyhounds has been shown to have significantly higher serum 
total IgE concentrations than GDBA and GUVS atopic dogs. Whether this is 
due to a breed predisposition or a high level of parasitism requires further 
study.
No correlation could be observed between serum total IgE concentrations and 
either the number of positive ELISA results in non-atopic animals or the 
animal’s age.
In summary, serum total IgE concentrations cannot be used as a diagnostic 
indicator of atopic dermatitis with further work being required on the 
environmental and genetic factors controlling the production of serum IgE-
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Chapter 5 SeasonaJ variation of seroiogicai resuits
5.1 Introduction
Clinical presentations of canine atopic dermatitis are often seasonal, being 
more common during the summer when pollens and house dust mites 
(common allergens) are present at higher levels (Halliwell &. Schwartzman, 
1971). In die diagnosis o f atopic dermatitis serological tests in both human 
and canine medicine incorporate cut off points used to identify positive 
reactions for individual allergens. However, these values remain constant 
throughout the year and there is no allowance for any increase in serum IgE 
levels in non-atopic individuals due to increased exposure to particular 
allergens at different times of the year.
Assessing allergen exposure in canine medicine presents particular problems, 
not normally encountered in human medicine. Dogs at ground level are 
exposed to different allergens than humans and therefore pollens which are 
not regarded as pathogenic in human medicine may well be involved in the 
pathogenesis o f canine atopy. In addition, pollen grains may gather on the 
ground after pollination periods have finished so that canine exposure to these 
pollens may be longer than that expected for people.
The aim of this study was to examine whether or not there was any seasonal 
variation in the serum allergen specific IgE levels of non-atopic dogs. Due to 
the complicating factors of canine pollen exposure a  study of the pollens to 
which dogs are exposed was initiated. This was carried out by examining 
faecal pollen content. Previously faecal pollen content has been studied in 
herbivores to identify areas where they have been feeding (Caulton, 1988). 
However, to date no such study has been carried out in carnivores to identify 
the pollens that are ingested either by inhalation then swallowing, by 
grooming themselves or others or by licking the environment.
10 1
5.2 Materials & Methods
A total of seventy four non-atopic GDBA dogs (described in section 2.1.1) 
were included in the serological study. These dogs were blood sampled on one 
occasion prior to elective surgery and excess serum was analysed for an 
allergen specific IgE response with an AlerCHECK ELISA as described in 
section 2.5.1. These serological results are summarised in Appendix F.
The samples were collected over the three years of the study and in order to 
investigate seasonal effects the dogs were grouped according to the month of 
sampling. For each Indoor and Outdoor allergen the mean optical density 
value of allergen specific IgE detected by ELISA was plotted against each 
month of sampling.
Similar evaluation of results could not be carried out for Immunodot results 
due to the smaller numbers tested and thus the small numbers of dogs in each 
month. Comparison of ELISA results for individual allergens on a monthly 
basis was carried out using one way Analysis of Variance (ANOVA) and the 
Newman Keuls multiple range test.
Fresh faecal samples were collected from fourteen GDBA dogs chosen at 
random by the kennel staff. Two dogs were sampled each month for six 
months from February to July. Samples from four dogs were available in June, 
two in the early part of the month and two later on. These fourteen dogs had 
been resident in the kennels for a minimum of two months prior to sampling 
and were not part of the serological study.
It had been hoped to extend this study for a longer period of time but this was 
not possible. Faecal analysis was carried out by Dr E Caulton of the Scottish 
Centre for Pollen Studies in Edinburgh. The basic method involved the 
desiccation of each faecal sample. Of the resultant material one gram then 
underwent acetolysation and slide preparation (as described in Appendix H). 
Slides of faecal material were examined at x40 magnification and pollen types 
identified and counted. Dependent on the amount of faecal material available 
either two or three slides were prepared for each dog. For the purpose of
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comparison the mean number of each species of pollen grain present on a 
slide was calculated for each dog.
5.3 Results
The influence of month of sampling on the mean optical density value of 
allergen specific IgE detected by ELISA is illustrated in Figures 5.1 and 5.2. 
These revealed an apparent seasonal variation in the mean allergen specific 
ELISA results for outdoor allergens with peak ELISA results in August for a 
number of outdoor allergens including Kentucky grass, poplar, Timothy grass, 
sorrel and nettle. A smaller peak in mean ELISA results for outdoor allergens 
was also noted earlier in the year around May for birch, dandelion, nettle and 
mugwort. The manufacturer’s cut off point for a positive reaction with the 
ELISA test is an optical density of above 0.15. It can be seen from Fig. 5.2 
that in August the mean ELISA results for all of the outdoor allergens were 
above 0.15 and that in January, February, May, July and September at least 
one outdoor allergen gave a mean value above this cut off point.
No clear cut seasonal variation was observed for indoor allergens (Fig 5.1). 
Fewer mean indoor allergen optical density results were above 0.15, with the 
highest mean ELISA results being observed for Rhizopus in August. Mucor, 
house dust mites and Rhizopus were the only allergens that gave mean results 
above 0.15. ELISA results for mite allergens peaked in July. This contrasts 
with the mean ELISA optical density results for dust allergens which were 
consistently low (< 0.08) throughout the year.
Statistical evaluation (One Way ANOVA & Newman Keuls MRT) of these 
results revealed that allergen specific IgE concentrations against Kentucky 
grass (Poapratensis) in August were indeed significantly higher than all other 
months (Table 5.1 & Appendix G). Allergen specific IgE concentrations 
against poplar allergen were significantly higher in August than February and 
September. Altemaria specific IgE concentrations were found to be 
significantly higher in November than all other months. The only anomaly 
would appear to be the ELISA results for cat epithelium which were
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significantly higher in February than in January. However, examination of 
these results with one way Analysis of Variance did not find reveal any 
significant difference between concentrations of cat epithelium specific IgE 
throughout the year.
Pollen grains were present in faecal samples throughout the months from 
January to July (See Table 5.2). The lowest mean number of pollen grains was 
observed in January with only 6.6 pollen grains present per slide for Andy. 
This contrasts with the greatest average number of pollen grains per slide of 
120 in May for Eddie. Overall the greatest number of pollen grains observed 
per slide was in May and June.
A wide and varied selection of pollen taxa were observed throughout the year 
with the most predominant pollen found in faecal samples being Graminae 
which was present in all fourteen faecal samples throughout the six months 
(See Table 5.4, Fig 5.3 & Fig 5.4). Unfortunately it is not possible to 
determine particular species of Graminae present in faecal samples as the 
damage these pollen grains receive in passing through the dog’s digestive 
system eradicates the subtle differences between different species of pollen 
grains. The number of Graminae pollen grains counted was 36 times greater 
than pine pollen grains, which was the next most common pollen observed. 
This was followed by dandelion, ragwort and ash.
The largest number of taxa observed in the one faecal sample was in March 
for dog Weaver (Table 5.3) when 11 different taxa were found; these included 
Graminae, Pinus, Acer and Plantago. This contrasts with the faetal simple 
from Rachel in July where only Graminae were observed.
Peak levels of pollen were preselit in the faecal samples in May. Individual 
types of pollen which were foiliid to peak at this time of year included 
Graminae, pine, dandelion, and legunies.
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Table 5.1 Summary of One Way Analysis of Variance and Newman Keuls 
Multiple Range Test findings for seasonal variation of ELISA results
(See Appendix G)
Allergen p value Multiple Range Test results
Flea 0.510 N o significant difference amongst seasonal groups
Mites 0.124 No significant difference amongst seasonal groups
Feathers 0.294 No significant difference amongst seasonal groups
Alternaria
Aspergillus
0.026
0.625
November greater than all other groups
No significant difference amongst seasonal groups
Rhizopus 0.410 N o significant difference amongst seasonal groups
Kapok 0.356 No significant difference amongst seasonal groups
Dust 0.428 No significant difference amongst seasonal groups
Cat epithelium 0.122 February greater than January
Human epithelium 0.844 N o significant difference amongst seasonal groups
M ucor 0.734 N o significant difference amongst seasonal groups
Orchard grass 0.066 No significant difference amongst seasonal groups
Timothy grass 0.024 N o significant difference amongst seasonal groups
Kentucky grass 0.001 August greater than all other months
Fescue 0.077 N o significant difference amongst seasonal groups
Poplar 0.037 August greater than September and February
Birch 0.577 No significant difference amongst seasonal groups
Sorrel 0.048 N o significant difference amongst seasonal groups
Plantain 0.056 N o significant difference amongst seasonal groups
Mugwort 0.517 N o significant difference amongst seasonal groups
Dandelion 0.698 N o significant difference amongst seasonal groups
Nettle 0.178 No significant difference amongst seasonal groups
NOTE -  Entries in bole are significant.
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Table 5.2 Total number of taxa and means of pollen grains 
found in faecal samples.
No. Name Date
sampled
Mean number of 
pollen grains 
observed per slide
Total number of taxa 
observed per faecal 
sample
1 Jenny Feb 1998 9.6 4
2 Andy Feb 1998 6.6 3
3 Yulie Mar 1998 17.0 5
4 Weaver Mar 1998 49.6 12
5 Jed Apr 1998 12.0 3
6 Uffa Apr 1998 50.0 5
7 Lana May 1998 14.2 8
8 Eddie May 1998 120.0 10
9 Fraser June 1998 50.0 2
10 Mary June 1998 44.6 8
11 Amos June 1998 36.5 8
12 Mungo June 1998 27.5 2
13 Omar July 1998 33,5 2
14 Rachel July 1998 15.5 1
Table 5.3 Different taxa found in dog Weaver’s faecal sample 
in March.
Pollen Average number of grains per slide
Graminae (Grasses) 43.66
Corylus (Hazel) 0.33
Ulmus (Elm) 0.33
Taxus (Yew) 0.33
Caryophylaceae (eg Campion) 0.33
Acer (Sycamore) 0.66
Pinus (Pine) 1.66
Plantago (Plantain) 1
Taraxacum (Dandelion) 0.33
Larix (Larch) 0.33
Senecio (Ragwort) 0.33
Alnus (Alder) 0.33
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Table 5.4 Detailed examination of pollen distribution amongst faecal
samples
Taxon Total
number of 
pollen 
grains 
counted
Number of 
faecal 
samples 
where Taxa 
present
Mean (standard 
deviation) 
number of pollen 
grains per faecal 
sample
Per-centage of 
total recorded for 
each taxon
Graminae (grass) 1586 14 113.3(118.3) 91.04
Pinus (Pine) 44 10 4.4 (3.5) 2.52
Taraxacum
(Dandelion)
10 4 2.5 (1.9) 0.57
Senecio (Ragwort) 9 4 2.3(1.5) 0.51
Fraxinus (Ash) 9 4 2.3 (0.9) 0.51
Taxus (Yew) 8 5 1.6 (0.5) 0.45
Plantago (Plantain) 6 4 1.5 (1.0) 0.34
Betula (Birch) 5 2 2.5 (2.1) 0.28
Calluna/Erica
(Heathers)
4 3 1.3 (0.6) 0.22
Ulmus (Elm) 3 3 1.0 (0.0) 0.17
Tilia (Lime) 3 3 1.0 (0.0) 0.17
Acer
(Sycamore/Mapel)
2 1 - 0.11
Brassica type (Oil 
seed rape)
2 1 - 0.11
Alnus (Alder) 2 1 - 0.11
Caryophylaceae (eg 
Campion)
2 1 - 0.11
Urtica (Nettle) 2 1 - 0.11
Larix (Larch) 1 1 - 0.06
Leguminosae (eg. 
Vetch)
1 1 - 0.06
Corylus (Hazel) 1 1 - 0.06
Quei"Cus(tydk) 1 1 - 0.06
FagUS (Beebh) i 1 0.06
Uniabhtiked 20 5 4.0 (4.0) 1.16
- Sample size tbb small for meaningful examination of ckta.
5.4 Discussion
The seasonal variation of serum allergen specific IgE is an area which has 
received little attention. Recent work by McCall et a l (1998) has illustrated 
that there is indeed a seasonal variation in allergen specific antibody 
concentrations in suspected atopic dogs tested in the USA. This agrees with 
work by Halliwell & Kunkle (1978) who demonstrated there was a seasonal 
variation in RAST results for ragweed specific IgE in atopic dogs. In addition 
this author suggested that the time of year when dogs are tested should be 
taken into account in the interpretation of results. However, work by Miller et 
al. (1992) did not find any such seasonal variation in allergen specific IgE 
concentrations in atopic dogs.
Commercially available ELISA tests used for the diagnosis of canine atopic 
dermatitis utilise a cut off point where optical density or reflectivity results 
greater than a set value are deemed as indicative or suggestive of atopic 
dermatitis. In general these cut off points remain constant throughout the year 
and are assumed to incorporate any variations in serum IgE concentration 
which might occur in non-atopic dogs due to differences in exposure. The 
ELISA test used in this study uses a cut off point of 0.15, where any optical 
density results greater than this are deemed positive and suggestive of atopic 
dermatitis in that particular dog.
This study of non-atopic dogs revealed that there is indeed a seasonal 
variation for pollen allergens in allergen specific IgE concentrations assessed 
by ELISA. Although different numbers of dogs were examined each month, 
the lowest numbers were present between December and March, whereas the 
significant difference was found most often for August in comparison with the 
rest of the year.
In addition many of these non-atopic dogs demonstrated allergen specific IgE 
concentrations which were above the positive cut off point for this test. If 
these serological results were to be relied upon in the diagnosis of atopic 
dermatitis then these dogs would have been classed as atopic. Although it has 
been suggested by Willemse (1986) that serological results alone cannot be
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relied upon in the diagnosis of atopic dermatitis and that other clinical 
parameters need to be included, it is known that many practitioners rely on 
such serological tests in the diagnosis of atopic dermatitis. The situation is 
further complicated by the fact that dogs with skin diseases such as 
pyoderma, flea allergic dermatitis or food allergy can present with clinical 
signs very similar to those observed in atopic dermatitis and if these dogs gave 
an ELISA result above 0.15 they could be falsely diagnosed as atopic. It is 
clear that in the interpretation of serological results, the time of year or 
particular pollen levels should be taken into account in order that non-atopic 
dogs are not falsely diagnosed as atopic. It may also be of benefit to vary the 
positive cut off point throughout the year in order to avoid positive ELISA 
results in non-atopic animals. One potential problem is that dogs in different 
areas of the country will be exposed to different allergen levels at different 
times of the year and from year to year. Results presented here therefore 
support the work by Willemse (1986), and suggest that serological tests alone 
cannot be used in the diagnosis of atopic dermatitis due to the variation in 
basal IgE levels following allergen exposure in non-atopic dogs.
Examination of the pollens with which dogs come into contact provided 
interesting findings. As expected, grasses were the predominant pollens and 
were present in all samples between February to July. Unfortunately it was not 
possible to identify particular species of grasses from faecal samples due to 
the damage that they receive in passing through the digestive system. This 
would have been helpful in the design of an intradermal skin test as the 
predominant grass allergens could have been included.
The second most common pollen was Pinus. This is not thought to be 
allergenic in human medicine but pine extracts are available for IDST (ARTU 
Biologicals, Netherlands) in the dog although at present pine is not 
incorporated into IDST panels for GDBA dogs. It is hoped that in future pine 
can be included in IDST panels.
For pollens to be regarded as allergens they have to meet a number of criteria 
including being present in large qiiahtities and being water soluble
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(Matthiesen et al., 1991). Pine pollen is certainly present in large quantities 
although its water solubility remains to be observed. The high levels of pine 
pollen with which dogs are coming into contact are probably due to the 
number of pine trees situated above the kennel runs. Hence, the pollen does 
not need to be windbome as it merely has to fall onto the dogs. In addition to 
pine, ragwort and yew allergens should also be incorporated into the IDST as 
these were also relatively common.
In humans, pollens need to be relatively small to become windbome before 
they are regarded as possible allergens. However, dogs come into contact with 
pollens on the ground and so different pollens may be important. In general, 
pollen counts are carried out on top of buildings and the pollens present at that 
level may be different from those with which dogs are coming into contact. 
Both dandelion and plantain pollens were present in the faecal samples. Both 
of these pollens are present in the air at low concentrations and are not thought 
to be important in human allergies. However, due to their presence here in 
appreciable quantities it is important that their potential significance is 
investigated.
Comparing pollen levels throughout the year with allergen specific IgE levels 
from the ELISA test did reveal a similar pattern for grasses. However, it has to 
be taken into account that the serological results are the mean of samples from 
three subsequent years whereas the faecal pollen levels were taken in the one 
year. Therefore any comparisons do not take into account any annual variation 
in the pollen concentrations (Fig. 5.6). These demonstrate the difference in 
total pollen levels throughout two years of the study -  to date no such pollen 
calendars have been made for the final year of the study from the same source. 
However, certain plants are known to pollinate at the same time each year 
with little variation from year to year.
Mean allergen specific IgE concentrations as determined by optical density for 
outdoor allergens in gerieral showed a dramatic peak in August. Unfortunately 
it was not possible to obtain faecal pollen analysis for August which would 
have been most interesting. On initial examination this peak in grass specific
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IgE levels appears an anomaly as grass pollen levels are known to decrease 
from July onwards. However, personal communication with Dr Caulton 
(Scottish Centre for Pollen Studies, Edinburgh) has revealed that in August 
during harvesting there is a temporary increase in pollen levels due to settled 
pollen becoming airborne again and this is demonstrated on the pollen count 
from Edinburgh in 1943 (See Fig 5.5, Hyde, 1960) shown below. This may 
well be relevant here as the kennels at Forfar are surrounded by arable land.
Fig. 5.5 Total pollen levels in Edinburgh, 1943 (From Hyde, 1960)
It is also possible that an increase in serum allergen specific IgE 
concentrations takes time to develop and therefore would not be expected to 
be simultaneous with the pollen levels. Primary immune responses are known 
to take fifteen-twenty days to reach a peak and secondaiy responses seven-ten 
days (Tizard, 1987a). Whether these responses are primary or secondary is not 
known but it is feasible that the peak serum IgE concentrations seen in August 
are due to the increased levels o f pollen in July.
Serum allergen specific IgE levels are higher in August than those observed 
for May. This may be due to very high levels of allergen exposure or 
alternatively may be due to a second stimulation allergen response with even 
higher levels of serum IgE developing on subsequent exposure to an allergen.
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5.5 Conclusion
In conclusion this study has provided evidence to support the existence of a 
seasonal variation in serum allergen specific IgE concentrations at different 
times of the year. Although it must be taken into consideration that different 
numbers of dogs were present in each month it appears likely that these levels 
correspond with the variation in allergen exposure. Care must therefore be 
taken in the interpretation of ELISA results in the diagnosis of atopic 
dermatitis as there is a real risk of non-atopic dogs exposed to high levels of 
allergens being falsely diagnosed as atopic.
In addition we have shown that canine pollen exposure can be assessed by 
faecal examination. The findings suggest that dogs are exposed to levels of 
particular pollens different to those thought to be important in human 
medicine and additional pollens may need to be incorporated into the standard 
canine IDST.
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Chapter 6. Examination of serological results in atopic 
and non-atopic dogs.
6.1 Introduction
The objectives of this study were to examine allergen specific IgE levels by 
ELISA and Immunodot in atopic and non-atopic working GDBA dogs, atopic 
pet GUVS dogs, and non-atopic greyhounds and beagles. The aim was to 
identify whether or not there were any significant differences in the mean 
allergen specific serum IgE optical/reflective densities between atopies and 
non-atopics which could be used as markers in the diagnosis of atopic 
dermatitis. In addition the author hoped to pinpoint any differences between 
working GDBA dogs, greyhounds, beagles and GUVS dogs in their response 
to different allergens in order to assess the influence which exposure may have 
on serological results.
6.2 Materials & Methods
Five groups of atopic and non-atopic dogs described in section 2.1 were 
included in this study. Serum samples underwent serological testing with 
ELISA and Immunodot tests as described in sections 2.5.1 and 2.5.2. A 
breakdown of the dogs included in each group is shown below.
Description ELISA Immunodot
Indoor Outdoor Topscreen
Non-atopic GDBA 74 42 50 11
Atopic GDBA 14 8 7 4
Non-atopic greyhounds 12 4 4 2
Non-atopic beagles 8 4 6 9
Atopic GUVS 32 24 21 15
Table 6.1 Number of serological tests carried out on individual dogs in each 
group.
Due to a shortage of serum it was not possible to perform every serological 
test on every sample. When comparing atopic and non-atopic groups of dogs, 
beagles and greyhounds were separated as these dogs were kept under 
different environmental conditions and received different parasite control 
measures. For other comparative purposes beagles and greyhounds were 
examined as one group. Serological results of both ELISA and Immunodot 
tests for these dogs were examined for statistical significance with a General 
Linear Model method in Minitab version 11.21 (1996). The general linear 
model allows us to compare the four groups of dogs described when there are 
different numbers of dogs in each group and is a similar method to the two 
way ANOVA
6.3 Results
Results are shown in Tables 6.2-6.37 and Appendix F. Statistical analysis of 
this data is shown in Appendices I and J.
Examination of the mean allergen specific serum IgE optical densities, of each 
group of atopic and non-atopic dogs determined by ELISA revealed many 
serological results, which were below that considered significant by the 
manufacturers (optical density of 0.15). A similar finding was made with the 
Immunodot test with most results below the level of a positive reflective 
density of 0.147.
Mean ELISA results greater than 0.15, and thus considered positive, were 
found in non-atopic greyhounds for fescue grass (0.162) (Table 6.16) and 
poplar allergens (0.154) (Table 6.17). Atopic GDBA dogs only demonstrated a 
positive mean ELISA result for dandelion allergen (0.153) (Table 6.22).
A similar examination of Immunodot results in non-atopic greyhounds and 
non-atopic beagles revealed a mean reflective density of greater than 0.147 
(equal to a Grade 2, positive result) for house dust mite allergens (0.168) 
(Table 6.24) and the group of Indoor allergens (0.155) (Table 6.34) by both 
groups.
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Non-atopic beagles demonstrated a particularly high mean reflective density 
of 0.265 against the group of moulds (Table 6.37).
The lowest mean optical densities assessed by ELISA were shown by all four 
groups against cat (mean < 0.051) and human epithelium (mean < 0.057) 
(Tables 6.10 & 6.11 respectively). Similarly the lowest reflective densities 
assessed by Immunodot were shown by all four groups against Flea allergens 
with the beagles having the lowest results of all (mean of 0.000) against flea 
allergens (Table 6.26).
Beagles as a group demonstrated low serum IgE optical/reflective densities for 
many allergens including human epithelium assessed on both ELISA and 
Immunodot (Tables 6.11 & 6.24 respectively) and dust mites, storemites and 
flea, assessed by Immunodot (Tables 6.24, 6.25 & 6.26). This contrasts with 
allergen specific IgE optical densities of the beagles against dust mites, 
assessed by ELISA, where beagles had the highest mean (Table 6.3). 
Comparison of atopic and non-atopic dogs revealed that ELISA results were 
significantly higher in atopies (GDBA and GUVS) than non-atopics (GDBA 
and greyhounds), against Alternaria (p<0.036) and Aspergillus (p<0.05) 
(Tables 6.5 & 6.6). A difference was seen in results when beagles rather than 
greyhounds were included in the non-atopic group. Here atopic dogs had 
significantly higher optical density results against Aspergillus (p<0.013y> than 
non-atopics but no such significant difference for Alternaria (Tables 6.6 & 
6.5).
A similar examination of Immunodot results did not reveal any significant 
differences between atopic and non-atopic dogs (GDBA and greyhounds) 
against any allergens (Tables 6.24-6.37). Replacement of non-atopic 
greyhounds with non-atopic beagles, revealed atopic dogs to have significantly 
higher allergen specific IgE reflective densities against dustmites (p<G.G29) 
(Table 6.24), the Indoor group of allergens (p<0.G34) (Table 6.34) and tree 
allergens (p<0.03G) (Table 6.30). Non-atopic dogs were found to have 
significantly higher serum IgE reflective densities against foods group 2 
(p<0.027) (Table 6.36) and moulds (p<0.000) (Table6.37).
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Where serological results of greyhounds and beagles were grouped together 
for a particular allergen atopic dogs (GDBA & GUVS) had significantly 
higher optical/reflective density results than non-atopics (GDBA, greyhounds 
& beagles) against Alternaria (p<0,024) and Aspergillus (p<0.021) as assessed 
by ELISA (Tables 6.5 & 6.6) and the dustmites (p<0.028) and the Indoor 
group of allergens (p<0.035) assessed by Immunodot (Tables 6.24 & 6.34). 
Non-atopic dogs were found to have a significantly higher reflective density 
than atopies against foods group 2 allergens (p<0.045) and moulds (p<0.000) 
assessed by Immunodot (Tables 6.36 & 6.37).
Comparison of GDBA (atopic and non-atopic ) and non-GDBA (GUVS and 
greyhounds) revealed that GDBA dogs had significantly higher
optical/reflective densities against Mucor (p<0.043) assessed by ELISA (Table
6.12) and cat epithelium (p<0.004) assessed by Immunodot (Table 6.28). Non- 
GDBA dogs (GUVS and greyhounds) were found to have significantly higher 
serum IgE optical/reflective densities than GDBA dogs against Fescue 
(p<0.030) assessed By ELISA (Table 6.16) and Grasses (p<0.001) and Trees 
(p<0.001) assessed by Immunodot (Tables 6.29 & 6.30).
Replacement of greyhounds with beagles in the non-atopic group revealed 
atopic and non-atopic GDBA dogs to have significantly higher
optical/reflective densities than atopic and non-atopic non-GDBA dogs against 
Mucor (p<0.010) assessed by ELISA (Table 6.12), and cat epithelium 
(pO.OOO) and olive/wall pellitory (p<0.026) assessed by Immunodot (Tables 
6.28 & 6.32). Non-GDBA dogs were found to have significantly higher 
reflective densities of serum IgE than GDBA dogs against grasses (p<0.000) 
and moulds (p<Q.0QO) as assessed by Immunodot (Tables 6.29 & 6.37). 
Grouping beagles and greyhounds together in the non-GDBA group along 
with GUVS atopic dogs revealed GDBA dogs to have significantly higher 
optical/reflective densities against Mucor (p<0.G08) assessed by ELISA (Table
6.12) and cat epithelium (p<0.00(>) assessed by Immunodot (Table628). 
Non-GDBA dogs (beagles, greyhounds and GUVS) were found to have
significantly higher reflective densities than GDBA dogs against grass
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(p<0.000) and moulds (p<0.000) assessed by Immunodot (Tables 6,29 & 
6.37),
Interaction, where there Is a relationship between the atopic status of a dog and 
whether the dog is a GDBA dog or not was found for flea allergens (p<0.050), 
human epithelium (p<0.034) tree allergens (p<0.043) and moulds (p<0.001) 
all assessed by Immunodot (Tables 6.26, 6.27, 6.30 & 6.37} when beagles 
rather than greyhounds were included in the non-atopic group. In addition 
grouping greyhounds and beagles revealed an interaction between the groups 
for moulds (p<0.019) alsnassessed by Immunodot (Table 6.37).
The way in which dogs were grouped influenced the statistical results. 
Different results were found between the use of beagles or greyhounds alone 
or grouped together for Alternaria, Fescue grass, dust mite, flea, human 
epithelium, tree, olive/wall pellitory, group of Indoor allergens, Foods group 
1, and moulds.
As a significant difference was found between atopic and non-atopic dogs for 
Alternaria and Aspergillm  with the ELISA test these findings were applied to 
the GDBA population. The mean ELISA result for non-atopic GDBA dogs for 
Alternaria was 0.088. Assuming that an ELISA result greater than 0.088 
would suggest that a dog was atopic gave a sensitivity of 64.3% and a 
specificity of 60.8%. The mean ELISA result for Aspergillus in non-atopic 
GDBA dogs was 0.092. Assuming that an ELISA result greater than 0.092 
would suggest that a dog was atopic gave a sensitivity of 50% and a specificity 
of 58.1%.
Examination of the correlation between serum total IgE concentrations 
assessed by Immunodot and the responses for Alternaria and Aspergillus 
assessed by ELISA (see Appendix K) did not reveal any correlation (Pearson’s 
correlation coefficient of -0.031 for Alternaria and -0.284 for Aspergillus 
respectively).
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Table 6.2 Mean flea specific IgE optical densities, as determined by ELISA, in
different groups of atopic and non-atopic dogs, and results of General Linear
Model examination of this data.
Mean ELISA Results for Flea (non-atopic / non-GDBA = Greyhound)
GDBA NON-GDBA
ATOPIC 0.058 0.077
NON-ATOPIC 0.073 0.069
No significant difference between atopic and non-atopic groups (F=0.03, p=0.852) 
No significant difference between GDBA and non-GDBA groups (F=0.15, p=0.704) 
No significant interaction between atopic and GDBA groups (F=0.38, p=0.538)
Mean ELISA Results for Flea (non-atopic /  non-GDBA = Beagle)
GDBA NON-GDBA
ATOPIC 0.058 0.077
NON-ATOPIC 0.073 0.060
No significant difference between atopic and non-atopic groups (F=0.00, p=0.957) 
No significant difference between GDBA and non-GDBA groups (F=0.02, p=0.901) 
No significant interaction between atopic and GDBA groups (F=0.63, p=0.429)
Mean ELISA Results for Flea (non-atopic / non-GDBA = Greyhound & Beagle)
GDBA NON-GDBA
ATOPIC 0.058 0.077
NON-ATOPIC 0.073 0.065
No significant difference between atopic and non-atopic groups (F=0.01, p=0.921)
No significant difference between GDBA and non-GDBA groups (F=0.1, p=0.751)
No significant interaction between atopic and non-atopic groups (F=0.65, p=0.422)
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Table 6.3 Mean house dust mite specific IgE optical densities, as determined
by ELISA, in different groups of atopic and non-atopic dogs, and results of
General Linear Model examination of this data.
Mean ELISA Results for house dust mites (non-atopic / non-GDBA = Greyhound)
GDBA NON-GDBA
ATOPIC 0.123 0.128
NON-ATOPIC 0.117 0.139
No significant difference between atopic and non-atopic groups (F=0.03, p=0.859) 
No significant difference between GDBA and non-GDBA groups (F=1.00, p=0.320) 
No significant interaction between atopic and GDBA groups (F=0.41, p=0.521)
Mean ELISA Results for house dust mites (non-atopic /  non-GDBA = Beagle)
GDBA NON-GDBA
ATOPIC 0.123 0.128
NON-ATOPIC 0.117 0.141
No significant difference between atopic and non-atopic groups (F=0.05, p=0.832)
No significant difference between GDBA and non-GDBA groups (F=0.91, p=0.343)
No significant interaction between atopic and GDBA groups (F=0.40, p=0.528)
Mean ELISA Results for house dust mites (non-atopic / non-GDBA = Greyhound & 
Beagle)
GDBA NON-GDBA
ATOPIC 0.123 0.128
NON-ATOPIC 0.117 0.140
No significant difference observed between atopic and non-atopic groups (F=0.05, p=0.825) 
No significant difference observed between GDBA and non-GDBA groups (F=0.126, 
p=0.263)
No significant interaction observed between atopic and GDBA groups (F=0.54, p=0.465)
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Table 6.4 Mean feather specific IgE optical densities, as determined by
ELISA, in different groups of atopic and non-atopic dogs, and results of
General Linear Model examination of this data.
Mean ELISA Results for feathers (non-atopic /  non-GDBA = Greyhound)
GDBA NON-GDBA
ATOPIC 0.060 0.088
NON-ATOPIC 0.071 0.077
No significant difference observed between atopic and non-atopic groups (F=0.00, p=0.981) 
No significant difference observed between GDBA and non-GDBA groups (F=1.92, p=0.168) 
No significant interaction observed between atopic and GDBA groups (F=0.82, p=0.366)
Mean ELISA Results for feathers (non-atopic / non-GDBA = Beagle)
GDBA NON-GDBA
ATOPIC 0.060 0.088
NON-ATOPIC 0.071 0.085
No significant difference observed between atopic and non-atopic groups (F=0.11, p=0.740) 
No significant difference observed between GDBA and non-GDBA groups (F=2.55, p=0.113) 
No significant interaction observed between atopic and GDBA groups (F=0.28, p=0.597)
Mean ELISA Results for feathers (non-atopic /non-GDBA = Greyhounds & Beagles)
GDBA NON-GDBA
ATOPIC 0.060 0.088
NON-ATOPIC 0.071 0.080
No significant difference observed between atopic and non-atopic groups (F=0.03, p=0.860) 
No significant difference observed between GDBA and non-GDBA groups (F=0.292, 
p=0.090)
No significant interaction observed between atopic and GDBA groups (F=0.76, p=0.386)
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Table 6.5 Mean Alternaria specific IgE optical densities, as determined by
ELISA, in different groups of atopic and non-atopic dogs, and results of
General Linear Model examination of this data.
Mean ELISA Results for Alternaria (non-atopic /  non-GDBA = Greyhound)
GDBA NON-GDBA
ATOPIC 0.109 0.107
NON-ATOPIC 0.088 0.071
Significant difference observed between atopic and non-atopic groups (F=4.50, p=0.036).
No significant difference observed between GDBA and non-GDBA groups (F=0.49, 
p=0.484).
No significant interaction observed between atopic and GDBA groups (F=0.29, p=0.591). 
Mean ELISA Results for Alternaria (non-atopic / non-GDBA = Beagle)
GDBA NON-GDBA
ATOPIC 0.109 0.107
NON-ATOPIC 0.088 0.076
No significant difference observed between atopic and non-atopic groups (F=3.04, p=0.084). 
No significant difference observed between GDBA and non-GDBA groups (F=0.22, 
p=0.640).
No significant interaction observed between atopic and GDBA groups (F=0.10, p=0.748). 
Mean ELISA Results for Alternaria (non-atopic /  non-GDBA = Greyhounds & Beagles)
GDBA NON-GDBA
ATOPIC 0.109 0.107
NON-ATOPIC 0.088 0.062
Significant difference observed between atopic and non-atopic groups (F=5.22, p=0.024)
No significant difference observed between GDBA and non-GDBA groups (F=0.49, p=0.483)
No significant interaction observed between atopic and GDBA groups (¥=021 , p=0.603)
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Table 6.6 Mean Aspergillus specific IgE optical densities, as determined by
ELISA, in different groups of atopic and non-atopic dogs, and results of
General Linear Model examination of this data.
Mean ELISA Results for Aspergillus (non-atopic / non-GDBA = Greyhound)
GDBA NON-GDBA
ATOPIC 0.106 0.115
NON-ATOPIC 0.092 0.092
Significant difference observed between atopic and non-atopic groups (F=3.92, p=0.050).
No significant difference observed between GDBA and non-GDBA groups (F=0.00, 
p=0.952).
No significant interaction observed between atopic and GDBA groups (F=0.01, p=0.941). 
Mean ELISA Results for Aspergillus (non-atopic / non-GDBA = Beagle)
GDBA NON-GDBA
ATOPIC 0.106 0.115
NON-ATOPIC 0.092 0.066
Significant difference observed between atopic and non-atopic groups (F=6.35, p=0.013).
No significant difference between GDBA and non-GDBA groups (F=0.47, p=0.494).
No significant interaction between atopic and GDBA groups (F=1.86, p=0.175).
Mean ELISA Results for Aspergillus (non-atopic /  non-GDBA = Greyhounds & Beagles)
GDBA NON-GDBA
ATOPIC 0.106 0.115
NON-ATOPIC 0.092 0.081
Significant difference observed between atopic and non-atopic groups (F=5.46, p=0.021)
No significant difference observed between GDBA and non-GDBA groups (F=0.01, p=0.927)
No significant interaction observed between atopic and GDBA groups (F=0.85, p=0.358)
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Table 6.7 Mean Rhizopus specific IgE optical densities, as determined by
ELISA, in different groups of atopic and non-atopic dogs, and results of
General Linear Model examination of this data.
Mean ELISA Results for Rhizopus (non-atopic /  non-GDBA = Greyhound)
GDBA NON-GDBA
ATOPIC 0.086 0.063
NON-ATOPIC 0.100 0.076
No significant difference observed between atopic and non-atopic groups (F=0.380, p=0.541). 
No significant difference observed between GDBA and non-GDBA groups (F=1.18,
p=0.280).
No significant interaction observed between atopic and GDBA groups (F=0.00, p=0.973). 
Mean ELISA Results for Rhizopus (non-atopic /  non-GDBA = Beagle)
GDBA NON-GDBA
ATOPIC 0.086 0.063
NON-ATOPIC 0.100 0.037
No significant difference observed between atopic and non-atopic groups (F=0.07, p=0.794). 
No significant difference observed between GDBA and non-GDBA groups (F=3.20, 
p=0.076).
No significant interaction observed between atopic and GDBA groups (F=0.71, p=0.401). 
Mean ELISA Results for Rhizopus (non-atopic /  non-GDBA = Greyhounds & Beagles)
GDBA NON-GDBA
ATQPIC 0.086 0.063
NON-ATOPIC 0.100 0.060
No significant difference observed between atopic and non-atopic groups (F=0.08, p=0.778)
No significant difference observed between GDBA and non-GDBA groups (F=2.65, p=0.106)
No significant interaction observed between atopic and GDBA groups (F=0.p20, p=0.657)
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Table 6.8 Mean kapok specific IgE optical densities, as determined by ELISA,
in different groups of atopic and non-atopic dogs, and results of General
Linear Model examination of this data.
Mean ELISA Results for kapok (non-atopic /  non-GDBA = Greyhound)
GDBA NON-GDBA
ATOPIC 0.084 0.065
NON-ATOPIC 0.077 0.049
No significant difference observed between atopic and non-atopic groups (F=0.40, p=0.529). 
No significant difference observed between GDBA and non-GDBA groups (F=1.75,
p=0.188).
No significant interaction observed between atopic and GDBA groups (F=0.06, p=0.811). 
Mean ELISA Results for kapok (non-atopic /  non-GDBA = Beagle)
GDBA NON-GDBA
ATOPIC 0.084 0.065
NON-ATOPIC 0.077 0.044
No significant difference observed between atopic and non-atopic groups (F=0.48, p=0.492). 
No significant difference observed between GDBA and non-GDBA groups (F=1.72, 
p=0.193).
No significant interaction observed between atopic and GDBA groups (F=0.11, p=0.736). 
Mean ELISA Results for kapok (non-atopic /  non-GDBA = Greyhounds & Beagles)
GDBA NON-GDBA
ATOPIC 0.084 0.064
NON-ATOPIC 0.077 0.047
No significant difference observed between atopic and non-atopic groups (F=0.60, p=0.441)
No significant difference observed between GDBA and non-GDBA groups (F=2.41, p=0.123)
No significant interaction observed between atopic and GDBA groups (F=0.11, p=0.741)
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Table 6.9 Mean dust specific IgE optical densities, as determined by ELISA,
in different groups of atopic and non-atopic dogs, and results of General
Linear Model examination of this data.
Mean ELISA Results for dust (non-atopic /  non-GDBA = Greyhound)
GDBA NON-GDBA
ATOPIC 0.044 0.042
NON-ATOPIC 0.050 0.046
No significant difference between atopic and non-atopic groups (F=0.47, p=0.496). 
No significant difference between GDBA and non-GDBA groups (F=0.17, p=0.683). 
No significant interaction between atopic and GDBA groups (F=0.01, p=0.920).
Mean ELISA Results for dust (non-atopic /  non-GDBA = Beagle)
GDBA NON-GDBA
ATOPIC 0.044 0.042
NON-ATOPIC 0.050 0.057
No significant difference observed between atopic and non-atopic groups (F=1.58, p=0.212). 
No significant difference between GDBA and non-GDBA groups (F=0.09, p=0.768).
No significant interaction between atopic and GDBA groups (F=0.32, p=0.572).
Mean ELISA Results for dust (non-atopic /  non-GDBA = Greyhounds & Beagles)
GDBA NON-GDBA
ATOPIC 0.044 0.042
NON-ATOPIC 0.050 0.051
No significant difference observed between atopic and non-atopic groups (F=l. 12, p=0.292) 
No significant difference observed between GDBA and non-GDBA groups (F= 0.01, 
p=0.905)
No significant interaction observed between atopic and GDBA groups (F=0.05, p=0.832)
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Table 6.10 Mean cat epithelium specific IgE optical densities, as determined
by ELISA, in different groups of atopic and non-atopic dogs, and results of
General Linear Model examination of this data.
Mean ELISA Results for cat epithelium (non-atopic /  non-GDBA = Greyhound)
GDBA NON-GDBA
ATOPIC 0.034 0.036
NON-ATOPIC 0.038 0.051
No significant difference between atopic and non-atopic groups (F=2.57, p=0.111). 
No significant difference between GDBA and non-GDBA groups (F=1.67, p=0.198). 
No significant interaction between atopic and GDBA groups (F=0.83, p=0.363).
Mean ELISA Results for cat epithelium (non-atopic /  non-GDBA = Beagle)
GDBA NON-GDBA
ATOPIC 0.034 0.036
NON-ATOPIC 0.038 0.037
No significant difference observed between atopic and non-atopic groups (F=0.15, p=0.700). 
No significant difference between GDBA and non-GDBA groups (F=0.01, p=0.923).
No significant interaction between atopic and GDBA groups (F=0.07, p=0.798).
Mean ELISA Results for cat epithelium (non-atopic /  non-GDBA = Greyhounds & 
Beagles)
GDBA NON-GDBA
ATOPIC 0.034 0.036
NON-ATOPIC 0.038 0.046
No significant difference observed between atopic and non-atopic groups (F=1.53, p=0.218) 
No significant difference observed between GDBA and non-GDBA groups (F=-0.81, 
p=0.371)
No significant interaction observed between atopic and GDBA groups (F=0.23, p=0.632)
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Table 6.11 Mean human epithelium specific IgE optical densities, as
determined by ELISA, in different groups of atopic and non-atopic dogs, and
results of General Linear Model examination of this data.
Mean ELISA Results for human epithelium (non-atopic / non-GDBA = Greyhound)
GDBA NON-GDBA
ATOPIC 0.033 0.034
NON-ATOPIC 0.047 0.057
No significant difference between atopic and non-atopic groups (F=2.96, p=0.088). 
No significant difference between GDBA and non-GDBA groups (F=0.26, p=0.612). 
No significant interaction between atopic and GDBA groups (F=0.14, p=0.706).
Mean ELISA Results for human epithelium (non-atopic / non-GDBA = Beagle)
GDBA NON-GDBA
ATOPIC 0.033 0.034
NON-ATOPIC 0.047 0.025
No significant difference observed between atopic and non-atopic groups (F=0.04, p=0.835). 
No significant difference between GDBA and non-GDBA groups (F=0.81, p=0.370).
No significant interaction between atopic and GDBA groups (F=1.04, p=0.310).
Mean ELISA Results for human epithelium (non-atopic non-GDBA = Greyhounds & 
Beagles)
GDBA NON-GDBA
ATOPIC 0.033 0.034
NON-ATOPIC 0.047 0.044
No significant difference observed between atopic and non-atopic groups (F=1.58, p=0.211)
No significant difference observed between GDAB and non-GDBA groups (F=0.01, p=0.922)
No significant interaction observed between atopic and GDBA groups (F=0.06, p=0.808).
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Table 6.12 Mean Mucor specific IgE optical densities, as determined by
ELISA, in different groups of atopic and non-atopic dogs, and results of
General Linear Model examination of this data.
Mean ELISA Results for Mucor (non-atopic /  non-GDBA = Greyhound)
GDBA NON-GDBA
ATOPIC 0.141 0.076
NON-ATOPIC 0.109 0.083
No significant difference between atopic and non-atopic groups (F=0.33, p-0.564). 
Significant difference between GDBA and non-GDBA groups (F=4.19, p=0.043).
No significant interaction between atopic and GDBA groups (F=0.75, p=0.387).
Mean ELISA Results for Mucor (non-atopic /  non-GDBA = Beagle)
GDBA NON-GDBA
ATOPIC 0.141 0.076
NON-ATOPIC 0.108 0.044
No significant difference observed between atopic and non-atopic groups (F=1.71, p=0.193). 
Significant difference between GDBA and non-GDBA groups (F=6.92, p=0.010).
No significant interaction between atopic and GDBA groups (F=0.00, p=0.996).
Mean ELISA Results for Mucor (non-atopic /  non-GDBA = Greyhounds & Beagles)
GDBA NON-GDBA
ATOPIC 0.141 0.076
NON-ATOPIC 0.109 0.067
No significant difference observed between atopic and non-atopic groups (F=1.09, p=0.298) 
Significant difference observed between GDBA and non-GDBA groups (F=7.27,
p=0.008)
No significant interaction observed between atopic and GDBA groups (F=0.34, p=0.560)
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Table 6.13 Mean Orchard grass specific IgE optical densities, as determined
by ELISA, in different groups of atopic and non-atopic dogs, and results of
General Linear Model examination of this data.
Mean ELISA Results for Orchard grass (non-atopic / non-GDBA = Greyhound)
GDBA NON-GDBA
ATOPIC 0.089 0.118
NON-ATOPIC 0.093 0.109
No significant difference between atopic and non-atopic groups (F=0.01, p=0.911). 
No significant difference between GDBA and non-GDBA groups (F=1.35, p=0.247). 
No significant interaction between atopic and GDBA groups (F=0.13, p=0.722).
Mean ELISA Results for Orchard grass (non-atopic /  non-GDBA = Beagle)
GDBA NON-GDBA
ATOPIC 0.089 0.118
NON-ATOPIC 0.093 0.061
No significant difference observed between atopic and non-atopic groups (F=1.50, p=0.223). 
No significant difference between GDBA and non-GDBA groups (F=0.00, p=0.944).
No significant interaction between atopic and GDBA groups (F=2.09, p=0.151).
Mean ELISA Results for Orchard grass (non-atopic / non-GDBA = Greyhounds & 
Beagles)
GDBA NON-GDBA
ATOPIC 0.089 0.118
NON-ATOPIC 0.93 0.090
No significant difference observed between atopic and non-atopic groups (F=0.47, p=0.496) 
No significant difference observed between GDBA and non-GDBA groups (F=0.56, p=0.456) 
No significant interaction observed between atopic and GDBA groups (F=0.92, p=0.340)
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Table 6.14 Mean Timothy grass specific IgE optical densities, as determined
by ELISA, in different groups of atopic and non-atopic dogs, and results of
General Linear Model examination of this data.
Mean ELISA Results for Timothy grass (non-atopic / non-GDBA = Greyhound)
GDBA NON-GDBA
ATOPIC 0.113 0.144
NON-ATOPIC 0.116 0.148
No significant difference between atopic and non-atopic groups (F=0.02, p=0.880). 
No significant difference between GDBA and non-GDBA groups (F=2.02, p=0.158). 
No significant interaction between atopic and GDBA groups (F=0.00, p=0.983).
Mean ELISA Results for Timothy grass (non-atopic / non-GDBA = Beagle)
GDBA NON-GDBA
ATOPIC 0.113 0.144
NON-ATOPIC 0.116 0.092
No significant difference observed between atopic and non-atopic groups (F=1.04, p=0.309). 
No significant difference between GDBA and non-GDBA groups (F=0.02, p=0.895).
No significant interaction between atopic and GDBA groups (F=1.30, p=0.257).
Mean ELISA Results for Timothy grass (non-atopic /  non-GDBA = Greyhounds & 
Beagles)
GDBA NON-GDBA
ATOPIC 0.113 0.144
NON-ATOPIC 0.116 0.125
No significant difference observed between atopic and non-atopic groups (F=0.16, p=0.690)
No significant difference observed between GDBA and non-GDBA groups (F=1.03, p=0.313)
No significant interaction observed between atopic and GDBA groups (F=0.29, p=0.588)
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Table 6.15 Mean Kentucky grass specific IgE optical densities, as determined
by ELISA, in different groups of atopic and non-atopic dogs, and results of
General Linear Model examination of this data.
Mean ELISA Results for Kentucky grass (non-atopic /  non-GDBA = Greyhound)
GDBA NON-GDBA
ATOPIC 0.103 0.132
NON-ATOPIC 0.103 0.133
No significant difference between atopic and non-atopic groups (F=0.00, p=0.983). 
No significant difference between GDBA and non-GDBA groups (F=1.63, p=0.204). 
No significant interaction between atopic and GDBA groups (F=0.00, p=0.995).
Mean ELISA Results for Kentucky grass (non-atopic /  non-GDBA = Beagle)
GDBA NON-GDBA
ATOPIC 0.102 0.132
NON-ATOPIC 0.103 0.098
No significant difference observed between atopic and non-atopic groups (F=0.45, p=0.503). 
No significant difference between GDBA and non-GDBA groups (F=0.23, p=0.635).
No significant interaction between atopic and GDBA groups (F=0.49, p=0.487).
Mean ELISA Results for Kentucky grass (non-atopic / non-GDBA = Greyhounds & 
Beagles)
GDBA NON-GDBA
ATOPIC 0.103 0.132
NON-ATOPIC 0.103 0.119
No significant difference observed between atopic and non-atopic groups (F=0.10, p=0.753)
No significant difference observed between GDBA and non-GDBA groups (F=1.20, p=0.276)
No significant interaction observed between atopic and GDBA groups (F=0.12, p=0.730)
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Table 6.16 Mean Fescue grass specific IgE optical densities, as determined by
ELISA, in different groups of atopic and non-atopic dogs, and results of
General Linear Model examination of this data.
Mean ELISA Results for Fescue grass (non-atopic / non-GDBA = Greyhound)
GDBA NON-GDBA
ATOPIC 0.093 0.126
NON-ATOPIC 0.102 0.162
No significant difference between atopic and non-atopic groups (F=l. 15, p=0.286). 
Significant difference between GDBA and non-GDBA groups (F=4.79, p=0.030).
No significant interaction between atopic and GDBA groups (F=0.44, p=0.510).
Mean ELISA Results for Fescue grass (non-atopic /  non-GDBA = Beagle)
GDBA NON-GDBA
ATOPIC 0.093 0.126
NON-ATOPIC 0.102 0.084
No significant difference observed between atopic and non-atopic groups (F=0.52, p=0.474). 
No significant difference between GDBA and non-GDBA groups (F=0.11, p=0.744).
No significant interaction between atopic and GDBA groups (F=l .22, p=0.272).
Mean ELSA Results for Fescue grass (non-atopic / non-GDBA = Greyhounds & Beagles)
GDBA NON-GDBA
ATOPIC 0.093 0.126
NON-ATOPIC 0.102 0.095
No significant difference observed between atopic and non-atopic groups (F=0.14, p=0.710)
No significant difference observed between GDBA and non-GDBA groups (F=2.60, p=0.109)
No significant interaction observed between atopic and GDBA groups (F=0.01, p=0.934)
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Table 6.17 Mean poplar specific IgE optical densities, as determined by
ELISA, in different groups of atopic and non-atopic dogs, and results of
General Linear Model examination of this data.
Mean ELISA Results for poplar (non-atopic / non-GDBA = Greyhound)
GDBA NON-GDBA
ATOPIC 0.113 0.101
NON-ATOPIC 0.109 0.154
No significant difference between atopic and non-atopic groups (F=0.97, p=0.328). 
No significant difference between GDBA and non-GDBA groups (F=0.45, p=0.505). 
No significant interaction between atopic and GDBA groups (F=1.34, p=0.249).
Mean ELISA Results for poplar (non-atopic /  non-GDBA = Beagle)
GDBA NON-GDBA
ATOPIC 0.113 0.101
NON-ATOPIC 0.109 0.080
No significant difference observed between atopic and non-atopic groups (F=0.22, p=0.642). 
No significant difference between GDBA and non-GDBA groups (F=0.58, p=0.449).
No significant interaction between atopic and GDBA groups (F=0.09, p=0.761).
Mean ELISA Results for poplar (non-atopic /non-GDBA = Greyhounds & Beagles)
GDBA NON-GDBA
ATOPIC 0.113 0.101
NON-ATOPIC 0.109 0.124
No significant difference observed between atopic and non-atopic groups (F=0.19, p=0.664)
No significant difference observed between GDBA and non-GDBA groups (F=0.01, p=0.993)
No significant interaction observed between atopic and GDBA groups (F=0.40, p=0.530)
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Table 6.18 Mean birch specific IgE optical densities, as determined by ELISA,
in different groups of atopic and non-atopic dogs, and results of General
Linear Model examination of this data.
Mean ELISA Results for bircb (non-atopic / non-GDBA = Greyhound)
GDBA NON-GDBA
ATOPIC 0.140 0.104
NON-ATOPIC 0.112 0.095
No significant difference between atopic and non-atopic groups (F=0.42, p=0.517). 
No significant difference between GDBA and non-GDBA groups (F=0.85, p=0.359). 
No significant interaction between atopic and GDBA groups (F=0.12, p=0.730).
Mean ELISA Results for birch (non-atopic / non-GDBA = Beagle)
GDBA NON-GDBA
ATOPIC 0.140 0.104
NON-ATOPIC 0.112 0.057
No significant difference observed between atopic and non-atopic groups (F=1.42, p=0.235). 
No significant difference between GDBA and non-GDBA groups (F=2.07, p=0.153).
No significant interaction between atopic and GDBA groups (F=0.09, p=0.770).
Mean ELISA Results for birch (non-atopic / non-GDBA = Greyhounds & Beagles)
GDBA NON-GDBA
ATOPIC 0.140 0.104
NON-ATOPIC 0.112 0.080
No significant difference observed between atopic and non-atopic groups (F=1.07, p=0.303)
No significant difference observed between GDBA and non-GDBA groups (F=1.79, p=0.183)
No significant interaction observed between atopic and GDBA groups (F=0.01, p=0.930)
1 3  9
Table 6.19 Mean sorrel specific IgE optical densities, as determined by
ELISA, in different groups of atopic and non-atopic dogs, and results of
General Linear Model examination of this data.
Mean ELISA Results for sorrel (non-atopic / non-GDBA = Greyhound)
GDBA NON-GDBA
ATOPIC 0.070 0.092
NON-ATOPIC 0.101 0.104
No significant difference between atopic and non-atopic groups (F=0.85, p=0.359). 
No significant difference between GDBA and non-GDBA groups (F=0.27, p=0.605). 
No significant interaction between atopic and GDBA groups (F=0.16, p=0.689).
Mean ELISA Results for sorrel (non-atopic /  non-GDBA = Beagle)
GDBA NON-GDBA
ATOPIC 0.071 0.092
NON-ATOPIC 0.101 0.079
No significant difference observed between atopic and non-atopic groups (F=0.11, p=0.740). 
No significant difference between GDBA and non-GDBA groups (F=0.00, p=0.976).
No significant interaction between atopic and GDBA groups (F=0.74, p=0.391).
Mean ELISA Results for sorrel (non-atopic / non-GDBA = Greyhounds & Beagles)
GDBA NON-GDBA
ATOPIC 0.071 0.092
NON-ATOPIC 0.101 0.094
No significant difference observed between atopic and non-atopic groups (F=0.61, p=0.434)
No significant difference observed between GDBA and non-GDBA groups (F=0.11, p=0.739)
No significant interaction observed between atopic and GDBA groups (F=0.49, p=0.487)
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Table 6.20 Mean plantain specific IgE optical densities, as determined by
ELISA, in different groups of atopic and non-atopic dogs, and results of
General Linear Model examination of this data.
Mean ELISA Results for plantain (non-atopic / non-GDBA = Greyhound)
GDBA NON-GDBA
ATOPIC 0.116 0.108
NON-ATOPIC 0.103 0.116
No significant difference between atopic and non-atopic groups (F=0.01, p=0.918). 
No significant difference between GDBA and non-GDBA groups (F=0.01, p=0.919). 
No significant interaction between atopic and GDBA groups (F=0.25, p=0.618).
Mean ELISA Results for plantain (non-atopic /  non-GDBA = Beagle)
GDBA NON-GDBA
ATOPIC 0.116 0.108
NON-ATOPIC 0.103 0.082
No significant difference observed between atopic and non-atopic groups (F=0.67, p=0.413). 
No significant difference between GDBA and non-GDBA groups (F=0.40, p=0.528).
No significant interaction between atopic and GDBA groups (F=0.07, p=0.791).
Mean ELISA Results for plantain (non-atopic / non-GDBA = Greyhounds & Beagles)
GDBA NON-GDBA
ATOPIC 0.116 0.108
NON-ATOPIC 0.103 0.103
No significant difference observed between atopic and non-atopic groups (F=0.22, p=0.639)
No significant difference observed between GDBA and non-GDBA groups (F=0.06, p=0.811)
No significant interaction observed between atopic and GDBA groups (F=0.03, p=0.836)
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Table 6.21 Mean mugwort specific IgE optical densities, as determined by
ELISA, in different groups of atopic and non-atopic dogs, and results of
General Linear Model examination of this data.
Mean ELISA Results for mugwort (non-atopic / non-GDBA = Greyhound)
GDBA NON-GDBA
ATOPIC 0.119 0.093
NON-ATOPIC 0.095 0.106
No significant difference between atopic and non-atopic groups (F=0.03, p=0.861). 
No significant difference between GDBA and non-GDBA groups (F=0.07, p=0.796). 
No significant interaction between atopic and GDBA groups (F=0.40, p=0.528).
Mean ELISA Results for mugwort (non-atopic / non-GDBA = Beagle)
GDBA NON-GDBA
ATOPIC 0.119 0.093
NON-ATOPIC 0.095 0.044
No significant difference observed between atopic and non-atopic groups (F=1.28, p=0.261). 
No significant difference between GDBA and non-GDBA groups (F=1.45, p=0.230).
No significant interaction between atopic and GDBA groups (F=0.15, p=0.698).
Mean ELISA Results for mugwort (non-atopic / non-GDBA = Greyhounds & Beagles)
GDBA NON-GDBA
ATOPIC 0.119 0.093
NON-ATOPIC 0.095 0.104
No significant difference observed between atopic and non-atopic groups (F=0.45, p=0.502)
No significant difference observed between GDBA and non-GDBA groups (F=0.59, p=0.445)
No significant interaction observed between atopic and GDBA groups (F=0.06, p=0.814)
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Table 6.22 Mean dandelion specific IgE optical densities, as determined by
ELISA, in different groups of atopic and non-atopic dogs, and results of
General Linear Model examination of this data.
Mean ELISA Results for dandelion (non-atopic / non-GDBA = Greyhound)
GDBA NON-GDBA
ATOPIC 0.153 0.097
NON-ATOPIC 0.118 0.072
No significant difference between atopic and non-atopic groups (F=0.71, p=0.401). 
No significant difference between GDBA and non-GDBA groups (F=1.97, p=0.163). 
No significant interaction between atopic and GDBA groups (F=0.02, p=0.901).
Mean ELISA Results for dandelion (non-atopic / non-GDBA = Beagle)
GDBA NON-GDBA
ATOPIC 0.153 0.097
NON-ATOPIC 0.118 0.042
No significant difference observed between atopic and non-atopic groups (F=1.27, p=0.262). 
No significant difference between GDBA and non-GDBA groups (F=2.66, p=0.105).
No significant interaction between atopic and GDBA groups (F=0.07, p=0.799).
Mean ELISA Results for dandelion (non-atopic / non-GDBA = Greyhounds & Beagles)
GDBA NON-GDBA
ATOPIC 0.153 0.097
NON-ATOPIC 0.117 0.060
No significant difference observed between atopic and non-atopic groups (F=0.129, p=0.258)
No significant difference observed between GDBA and non-GDBA groups (F=3.13, p=0.079)
No significant interaction observed between atopic and GDBA groups (F=0.00, p=0.965)
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Table 6.23 Mean nettle specific IgE optical densities, as determined by
ELISA, in different groups of atopic and non-atopic dogs, and results of
General Linear Model examination of this data.
Mean ELISA Results for nettle (non-atopic /  non-GDBA = Greyhound)
GDBA NON-GDBA
ATOPIC 0.121 0.088
NON-ATOPIC 0.109 0.087
No significant difference between atopic and non-atopic groups (F=0.08, p=0.784). 
No significant difference between GDBA and non-GDBA groups (F=1.14, p=0.288). 
No significant interaction between atopic and GDBA groups (F=0.04, p=0.836).
Mean ELISA Results for nettle (non-atopic / non-GDBA = Beagle)
GDBA NON-GDBA
ATOPIC 0.121 0.088
NON-ATOPIC 0.109 0.087
No significant difference observed between atopic and non-atopic groups (F=0.78, p=0.379). 
No significant difference between GDBA and non-GDBA groups (F=2.55, p=0.113).
No significant interaction between atopic and GDBA groups (F=0.20, p=0.654).
Mean ELISA Results for nettle (non-atopic /  non-GDBA = Greyhounds & Beagles)
GDBA NON-GDBA
ATOPIC 0.121 0.088
NON-ATOPIC 0.109 0.090
No significant difference observed between atopic and non-atopic groups (F=0.39, p=0.531)
No significant difference observed between GDBA and non-GDBA groups (F=2.31, p=0.131)
No significant interaction observed between atopic and GDBA groups (F=0.01, p=0.933)
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Table 6.24 Mean dustmite specific IgE reflective densities, as determined by
Immunodot, in different groups of atopic and non-atopic dogs, and results of
General Linear Model examination of this data.
Mean Immunodot Results for dust mite (non-atopic /  nonGDBA = Greyhounds)
GDBA NON-GDBA
ATOPIC 0.051 0.168
NON-ATOPIC 0.027 0.063
No significant difference observed between atopic and non-atopic groups (F=2.23, p=0.140) 
No significant difference observed between GDBA and non-GDBA groups (F=3.12, p=0.081) 
No significant interaction observed between atopic and GDBA groups (F=0.85, p=0.360)
Mean Immunodot Results for dust mite (non-atopic /  nonGDBA = Beagles)
GDBA NON-GDBA
ATOPIC 0.052 0.168
NON-ATOPIC 0.027 0.000
Significant difference observed between atopic and non-atopic groups (F=4.97, p=0.029)
No significant difference observed between GDBA and non-GDBA groups (F=1.08, p=0.303) 
No significant interaction observed between atopic and GDBA groups (F=0.2.75, p=0.102)
Mean Immunodot Results for dust mites (non-atopic /  nonGDBA = Greyhounds & 
Beagles )
GDBA NON-GDBA
ATOPIC 0.051 0.168
NON-ATOPIC 0.027 0.032
Significant difference observed between atopic and non-atopic groups (F=5.05, p=0.028)
No significant difference observed between GDBA and non-GDBA groups (F=2.87, p=0.094)
No significant interaction observed between atopic and GDBA groups (F=2.42, p=0.124)
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Table 6.25 Mean storemite specific IgE reflective densities, as determined by
Immunodot, in different groups of atopic and non-atopic dogs, and results of
General Linear Model examination of this data.
Mean Immunodot Results for storemites (non-atopic /  nonGDBA = Greyhounds)
GDBA NON-GDBA
ATOPIC 0.038 0.081
NON-ATOPIC 0.046 0.077
No significant difference observed between atopic and non-atopic groups (F=0.01, p=0.911) 
No significant difference observed between GDBA and non-GDBA groups (F=2.81, p=0.098) 
No significant interaction observed between atopic and GDBA groups (F=0.08, p=0.776)
Mean Immunodot Results for storemites (non-atopic /  nonGDBA = Beagles)
GDBA NON-GDBA
ATOPIC 0.038 0.081
NON-ATOPIC 0.046 0.000
No significant difference observed between atopic and non-atopic groups (F=2.65, p=0.0.108) 
No significant difference observed between GDBA and non-GDBA groups (F=0.00, p=0.951) 
No significant interaction observed between atopic and GDBA groups (F=4.10, p=0.046)
Mean Immunodot Results for storemites (non-atopic /  nonGDBA = Greyhounds & 
Beagles )
GDBA NON-GDBA
ATOPIC 0.038 0.081
NON-ATOPIC 0.046 0.039
No significant difference observed between atopic and non-atopic groups (F=0.81, p=0.370)
No significant difference observed between GDBA and non-GDBA groups (F=0.92, p=0.339)
No significant interaction observed between atopic and GDBA groups (F=1.89, p=0.173)
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Table 6.26 Mean flea specific IgE reflective densities, as determined by
Immunodot, in different groups of atopic and non-atopic dogs, and results of
General Linear Model examination of this data.
Mean Immunodot Results for flea (non-atopic /  non-GDBA = Greyhounds)
GDBA NON-GDBA
ATOPIC 0.012 0.019
NON-ATOPIC 0.016 0.010
No significant difference observed between atopic and non-atopic groups (F=0.16, p=0.690) 
No significant difference observed between GDBA and non-GDBA groups (F=0.01, p=0.921) 
No significant interaction between atopic and GDBA groups (F=1.22, p=0.272)
Mean Immunodot Results for flea (non-atopic /  nonGDBA = Beagles)
GDBA NON-GDBA
ATOPIC 0.012 0.019
NON-ATOPIC 0.016 0.000
No significant difference observed between atopic and non-atopic groups (F=1.66, p=0.202) 
No significant difference observed between GDBA and non-GDBA groups (F=0.62, p=0.435) 
Significant interaction observed between atopic and GDBA groups (F=3.98, p=0.050)
Mean Immunodot Results for flea (non-atopic /  nonGDBA = Greyhounds & Beagles )
GDBA NON-GDBA
ATOPIC 0.012 0.019
NON-ATOPIC 0.016 0.005
No significant difference observed between atopic and non-atopic groups (F=1.03, p=0.312)
No significant difference observed between GDBA and non-GDBA groups (F=0.17, p=0.681)
No significant interaction observed between atopic and GDBA groups (F=3.49, p=0.065)
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Table 6.27 Mean human epithelium specific IgE reflective densities, as 
determined by Immunodot, in different groups of atopic and non-atopic dogs, 
and results of General Linear Model examination of this data.
Mean Immunodot Results for human epithelium (non-atopic /  non-GDBA = 
Greyhounds)
GDBA NON-GDBA
ATOPIC 0.048 0.051
NON-ATOPIC 0.062 0.059
No significant difference between atopic and non-atopic groups (F=0.94, p=0.355)
No significant difference between GDBA and non-GDBA groups (F=0.00, p=0.998)
No significant interaction between atopic and GDBA groups (F=0.07, p=0.787)
Mean Immunodot Results for human epithelium (non-atopic / nonGDBA = Beagles)
GDBA NON-GDBA
ATOPIC 0.048 0.051
NON-ATOPIC 0.062 0.015
No significant difference observed between atopic and non-atopic groups (F=0.087, p=0.355) 
No significant difference observed between GDBA and non-GDBA groups (F=3.57, p=0.063) 
Significant interaction observed between atopic and GDBA groups (F=4.64, p=0.034)
Mean Immunodot Results for human epithelium (non-atopic /  nonGDBA = Greyhounds 
& Beagles )
GDBA NON-GDBA
ATOPIC 0.048 0.051
NON-ATOPIC 0.062 0.037
No significant difference observed between atopic and non-atopic groups (F=0.00, p=0.988)
No significant difference observed between GDBA and non-GDBA groups (F=1.26, p=0.265)
No significant interaction observed between atopic and GDBA groups (F=2.07, p=0.154)
Table 6.28 Mean cat epithelium specific IgE reflective densities, as
determined by Immunodot, in different groups of atopic and non-atopic dogs,
and results of General Linear Model examination of this data.
Mean Immunodot Results for cat epithelium (non-atopic / non-GDBA = Greyhounds )
GDBA NON-GDBA
ATOPIC 0.043 0.011
NON-ATOPIC 0.038 0.025
No significant difference observed between atopic and non-atopic groups (F=0.46, p=0.501) 
Significant difference observed between GDBA and non-GDBA groups (F=8.96, p=0.004)
No significant interaction observed between atopic and GDBA groups (F=1.54, p=0.218)
Mean Immunodot Results for cat epithelium (non-atopic /  nonGDBA = Beagles)
GDBA NON-GDBA
ATOPIC 0.043 0.011
NON-ATOPIC 0.038 0.000
No significant difference observed between atopic and non-atopic groups (F=l. 10, p=0.299) 
Significant difference observed between GDBA and non-GDBA groups (F=23.04,
p=0.000)
No significant interaction observed between atopic and GDBA groups (F=0.22, p=0.642)
Mean Immunodot Results for cat epithelium (non-atopic /  nonGDBA = Greyhounds & 
Beagles)
GDBA NON-GDBA
ATOPIC 0.043 0.011
NON-ATOPIC 0.038 0.013
No significant difference observed between atopic and non-atopic groups (F=0.04, p=0.836) 
Significant difference observed between GDBA and non-GDBA groups (F=21.01,
p=0.000)
No significant interaction observed between atopic and GDBA groups (F=0.22, p=0.641)
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Table 6.29 Mean grass specific IgE reflective densities, as determined by
Immunodot, in different groups of atopic and non-atopic dogs, and results of
General Linear Model examination of Ibis data.
Mean Immunodot Results for grass (non-atopic /  non-GDBA = Greyhounds)
GDBA NON-GDBA
ATOPIC 0.021 0.056
NON-ATOPIC 0.022 0.044
No significant difference observed between atopic and non-atopic groups (F=0.50, p=0.481) 
Significant difference observed between GDBA and non-GDBA groups (F=12.13, p=0.001)
No significant interaction observed between atopic and GDBA groups (F=0.62, p=0.433)
Mean Immunodot Results for grass (non-atopic /  nonGDBA = Beagles)
GDBA NON-GDBA
ATOPIC 0.021 0.056
NON-ATOPIC 0.022 0.046
No significant difference observed between atopic and non-atopic groups (F=0.39, p=0.536) 
Significant difference observed between GDBA and non-GDBA groups (F=14.45, p=0.00)
No significant interaction observed between atopic and GDBA groups (F=0.50, p=0.481)
Mean Immunodot Results for grass (non-atopic /  nonGDBA = Greyhounds & Beagles )
GDBA NON-GDBA
ATOPIC 0.021 0.056
NON-ATOPIC 0.022 0.045
No significant difference observed between atopic and non-atopic groups (F=0.58, p=0.450)
Significant difference observed between GDBA and non-GDBA groups (F=17.94, p=0.000)
No significant interaction observed between atopic and GDBA groups (F=0.73, p=0.395)
Table 6.30 Mean tree specific IgE reflective densities, as determined by
Immunodot, in different groups of atopic and non-atopic dogs, and results of
General Linear Model examination of this data.
Mean Immunodot Results for tree (non-atopic /  non-GDBA = Greyhounds)
GDBA NON-GDBA
ATOPIC 0.020 0.030
NON-ATOPIC 0.019 0.045
No significant difference observed between atopic and non-atopic groups (F=2.12, p=0.149) 
Significant difference observed between GDBA and non-GDBA groups (F=12.94, p=0.001)
No significant interaction observed between atopic and GDBA groups (F=2.56, p=0.113)
Mean Immunodot Results for tree (non-atopic /  nonGDBA = Beagles)
GDBA NON-GDBA
ATOPIC 0.020 0.030
NON-ATOPIC 0.019 0.010
Significant difference observed between atopic and non-atopic groups (F=4.91, p=0.030)
No significant difference observed between GDBA and non-GDBA groups (F=0.03, p=0.857) 
Significant interaction observed between atopic and GDBA groups (F=4.22, p=0.043)
Mean Immunodot Results for tree (non-atopic /  nonGDBA = Greyhounds & Beagles )
GDBA NON-GDBA
ATOPIC 0.020 0.030
NON-ATOPIC 0.019 0.024
No significant difference observed between atopic and non-atopic groups (F=0.48, p=0.492)
No significant difference observed between GDBA and non-GDBA groups (F=3.08, p=0.083)
No significant interaction observed between atopic and GDBA groups (F=0.28, p=0.600)
Table 6.31 Mean mugwort specific IgE reflective densities, as determined by
Immunodot, in different groups of atopic and non-atopic dogs, and results of
General Linear Model examination of this data.
Mean Immunodot Results for mugwort (non-atopic /non-GDBA = Greyhounds)
GDBA NON-GDBA
ATOPIC 0.056 0.061
NON-ATOPIC 0.051 0.061
No significant difference observed between atopic and non-atopic groups (F=0.07, p=0.787) 
No significant difference observed between GDBA and non-GDBA groups (F=0.88, p=0.351) 
No significant interaction observed between atopic and GDBA groups (F=0.09, p=0.759)
Mean Immunodot Results for mugwort (non-atopic /  nonGDBA = Beagles)
GDBA NON-GDBA
ATOPIC 0.056 0.061
NON-ATOPIC 0.051 0.036
No significant difference observed between atopic and non-atopic groups (F=3.80, p=0.055) 
No significant difference observed between GDBA and non-GDBA groups (F=0.39, p=0.534) 
No significant interaction observed between atopic and GDBA groups (F=1.73, p=0.192)
Mean Immunodot Results for mugwort (non-atopic /  nonGDBA = Greyhounds & 
Beagles)
GDBA NON-GDBA
ATOPIC 0.056 0.061
NON-ATOPIC 0.051 0.046
No significant difference observed between atopic and non-atopic groups (F=2.05, p^O. 156)
No significant difference observed between GDBA and non-GDBA groups (F=0.00, p=0.969)
No significant interaction observed between atopic and GDBA groups (F=0.53, p=0.469)
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Table 6.32 Mean olive/wall pellitory specific IgE reflective densities, as
determined by Immunodot, in different groups of atopic and non-atopic dogs,
and results of General Linear Model examination of this data.
Mean Immunodot Results for olive/wall pellitory ( non-atopic /  non-GDBA = 
Greyhounds)
GDBA NON-GDBA
ATOPIC 0.083 0.056
NON-ATOPIC 0.083 0.071
No significant difference observed between atopic and non-atopic groups (F=0.09, p=0.765) 
No significant difference observed between GDBA and non-GDBA groups (F=0.57, p=0.452) 
No significant interaction observed between atopic and GDBA groups (F=0.09, p=0.768)
Mean Immunodot Results for olive/wall pellitory (non-atopic /  nonGDBA = Beagles)
GDBA NON-GDBA
ATOPIC 0.083 0.056
NON-ATOPIC 0.083 0.007
No significant difference observed between atopic and non-atopic groups (F=l. 18, p=0.281) 
Significant difference observed between GDBA and non-GDBA groups (F=5.14, p=0.026)
No significant interaction observed between atopic and GDBA groups (F=l. 19, p=0.279)
Mean Immunodot Results for olive/wall pellitory (non-atopic /  nonGDBA = Greyhounds 
& Beagles )
GDBA NON-GDBA
ATOPIC 0.083 0.056
NON-ATOPIC 0.083 0.032
No significant difference observed between atopic and non-atopic groups (F=0.33, p=0.566)
No significant difference observed between GDBA and non-GDBA groups (F=3.59, p=0.061)
No significant interaction observed between atopic and GDBA groups (F=0.34, p=0.562)
Table 6.33 Mean Outdoor specific IgE reflective densities, as determined by
Immunodot, in different groups of atopic and non-atopic dogs, and results of
General Linear Model examination of this data.
Mean Immunodot Results for Outdoor group of allergen (non-atopic /  non-GDBA = 
Greyhounds)
GDBA NON-GDBA
ATOPIC 0.067 0.079
NON-ATOPIC 0.058 0.063
No significant difference observed between atopic and non-atopic groups (F=0.13, p=0.726) 
No significant difference observed between GDBA and non-GDBA groups (F=0.06, p=0.802) 
No significant interaction observed between atopic and GDBA groups (F=0.01, p=0.920)
Mean Immunodot Results for Outdoor group (non-atopic / nonGDBA = Beagles )
GDBA NON-GDBA
ATOPIC 0.067 0.079
NON-ATOPIC 0.058 0.061
No significant difference observed between atopic and non-atopic groups (F=0.31, p=0.578) 
No significant difference observed between GDBA and non-GDBA groups (F=0.11, p=0.739) 
No significant interaction observed between atopic and GDBA groups (F=0.04, p=0.852)
Mean Immunodot Results for Outdoor group (non-atopic /  nonGDBA = Greyhounds & 
Beagles )
GDBA NON-GDBA
ATOPIC 0.067 0.079
NON-ATOPIC 0.058 0.062
No significant difference observed between atopic and non-atopic groups (F=0.33, p=0.568)
No significant difference observed between GDBA and non-GDBA groups (F=0.13, p=0.723)
No significant interaction observed between atopic and GDBA groups (F=0.04, p=0.852)
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Table 6.34 Mean Indoor specific IgE reflective densities, as determined by
Immunodot, in different groups of atopic and non-atopic dogs, and results of
General Linear Model examination of this data.
Mean Immunodot Results for Indoor group (non-atopic /  non-GDBA = Greyhounds)
GDBA NON-GDBA
ATOPIC 0.123 0.155
NON-ATOPIC 0.100 0.080
No significant difference observed between atopic and non-atopic groups (F=1.26, p=0.271) 
No significant difference observed between GDBA and non-GDBA groups (F=0.01, p=0.916) 
No significant interaction observed between atopic and GDBA groups (F=0.30, p=0.589)
Mean Immunodot Results for Indoor group (non-atopic /  nonGDBA = Beagles )
GDBA NON-GDBA
ATOPIC 0.123 0.155
NON-ATOPIC 0.100 0.044
Significant difference observed between atopic and non-atopic groups (F=4.86, p=0.034)
No significant difference observed between GDBA and non-GDBA groups (F=0.18, p=0.673) 
No significant interaction observed between atopic and GDBA groups (F=l .88, p=0.179)
Mean Immunodot Results for Indoor group (non-atopic /  nonGDBA = Greyhounds & 
Beagles)
GDBA NON-GDBA
ATOPIC 0.123 0.155
NON-ATOPIC 0.100 0.051
Significant difference observed between atopic and non-atopic groups (F=4.80, p=0.035)
No significant difference observed between GDBA and non-GDBA groups (F=0.11, p=0.740)
No significant interaction observed between atopic and GDBA groups (F=1.74, p=0.195)
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Table 6.35 Mean foods group 1 specific IgE reflective densities, as
determined by Immunodot, in different groups of atopic and non-atopic dogs,
and results of General Linear Model examination of this data.
Mean Immunodot Results for Foods group 1 (non-atopic /  non-GDBA = Greyhounds)
GDBA NON-GDBA
ATOPIC 0.018 0.028
NON-ATOPIC 0.028 0.023
No significant difference observed between atopic and non-atopic groups (F=0.09, p=0.762) 
No significant difference observed between GDBA and non-GDBA groups (F=0.11, p=0.744) 
No significant interaction observed between atopic and GDBA groups (F=0.93, p=0.342)
Mean Immunodot Results for Foods group 1 (non-atopic / nonGDBA = Beagles )
GDBA NON-GDBA
ATOPIC 0.018 0.028
NON-ATOPIC 0.028 0.026
No significant difference observed between atopic and non-atopic groups (F=0.19, p=0.662) 
No significant difference observed between GDBA and non-GDBA groups (F=0.21, p=0.647) 
No significant interaction observed between atopic and GDBA groups (F=0.58, p=0.453)
Mean Immunodot Results for Foods group 1 (non-atopic /  nonGDBA = Greyhounds & 
Beagles)
GDBA NON-GDBA
ATOPIC 0.018 0.028
NON-ATOPIC 0.028 0.025
No significant difference observed between atopic and non-atopic groups (F=0.19, p=0.668)
No significant difference observed between GDBA and non-GDBA groups (F=0.21, p=0.651)
No significant interaction observed between atopic and GDBA groups (F=0.68, p=0.414)
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Table 6.36 Mean foods group 2 specific IgE reflective densities, as determined
by Immunodot, in different groups of atopic and non-atopic dogs, and results
of General Linear Model examination of this data.
Mean Immunodot Results for Foods group 2 (non-atopic /  non-GDBA = Greyhounds)
GDBA NON-GDBA
ATOPIC 0.022 0.029
NON-ATOPIC 0.039 0.025
No significant difference observed between atopic and non-atopic groups (F=0.33, p=0.572) 
No significant difference observed between GDBA and non-GDBA groups (F=0.09, p=0.763) 
No significant interaction observed between atopic and GDBA groups (F=0.78, p=0.384)
Mean Immunodot Results for Foods group 2 (non-atopic / nonGDBA = Beagles )
GDBA NON-GDBA
ATOPIC 0.022 0.029
NON-ATOPIC 0.039 0.054
Significant difference observed between atopic and non-atopic groups (F=5J6, p=0.027) 
No significant difference observed between GDBA and non-GDBA groups (F=l .34, p=0.254) 
No significant interaction observed between atopic and GDBA groups (F=0.16, p=0,696)
Mean Immunodot Results for Foods group 2 (non-atopic /  nonGDBA = Greyhounds & 
Beagles)
GDBA NON-GDBA
ATOPIC 0.022 0.029
NON-ATOPIC 0.039 0.049
Significant difference observed between atopic and non-atopic groups (F=4.29, p=0.045)
No significant difference observed between GDBA and non-GDBA groups (F=0.80, p=0.378)
No significant interaction observed between atopic and GDBA groups (F=0.01, p=0.911)
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Table 6.37 Mean mould specific IgE reflective densities, as determined by
Immunodot, in different groups of atopic and non-atopic dogs, and results of
General Linear Model examination of this data.
Mean Immunodot Results for moulds (non-atopic /  non-GDBA = Greyhounds)
GDBA NON-GDBA
ATOPIC 0.039 0.082
NON-ATOPIC 0.089 0.104
No significant difference observed between atopic and non-atopic groups (F=3.24, p=0.083) 
No significant difference observed between GDBA and non-GDBA groups (F=2.18, p=0.151) 
No significant interaction observed between atopic and GDBA groups (F=0.51, p=0.480)
Mean Immunodot Results for moulds (non-atopic /  nonGDBA = Beagles )
GDBA NON-GDBA
ATOPIC 0.039 0.082
NON-ATOPIC 0.089 0.265
Significant difference observed between atopic and non-atopic groups (F=4L54, p=0.000) 
Significant difference observed between GDBA and non-GDBA groups (F=37.08, p=0.000) 
Significant interaction observed between atopic and GDBA groups (F=13.65, p=0.001)
Mean Immunodot Results for moulds (non-atopic /  nonGDBA = Greyhounds & Beagles)
GDBA NON-GDBA
ATOPIC 0.039 0.082
NON-ATOPIC 0.089 0.235
Significant difference observed between atopic and non-atopic groups (F=23.07, p=0.000)
Significant difference observed between GDBA and non-GDBA groups (F=20.25, p=0.000)
Significant interaction observed between atopic and GDBA groups (F=6.04, p=0.019)
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6,4 Discussion
Serological tests have been shown by a number of authors to have a tendency 
for a high sensitivity and poor specificity due to the large number of so called 
false positive results which these tests produce (Bond et al, 1994; Codner & 
Lessard, 1993). This is said to be the case when non-atopic dogs are shown to 
have levels of allergen specific serum IgE which would be positive by these 
tests.
Based on these reports it would be expected that no differences would be 
observed between atopic and non-atopic dogs in their serological results. 
Indeed Bond et al., (1994), in a study of thirty dogs, did not find any 
significant difference in allergen specific serum IgE concentrations between 
atopic and non-atopic dogs. However, this was not the case in this present 
study. Here atopic dogs were shown to have significantly higher optical 
densities of allergen specific serum IgE against Altemaria, Aspergillus, 
indicated by ELISA; and significantly higher serum IgE reflective densities for 
Indoor allergens, dustmites and trees as indicated by Immunodot.
Other authors have found atopic dogs to give higher ELISA results for mould 
allergens than non-atopics. Codner & Lessard (1993) noted that dogs 
suspected of being atopic demonstrated significantly higher ELISA results for 
fungal allergens than clinically normal dogs but these authors did not offer any 
explanations for this. A high number of clinically irrelevant positive ELISA 
results for mould allergens were observed by Griffin et al. (1990), Anderson & 
Sousa (1993) and Day et al. (1996). These results are classed as false positive 
because they did not agree with any IDST positive results towards mould 
allergens. This is similar to the findings in this study where very few positive 
IDST results were observed against mould allergens (See Appendix L).
It is possible that the higher optical density results observed against mould 
allergens are not true reflections of the immune response. Instead they may 
reflect the attraction which serum IgE has for mould allergens in particular and 
that non-specific binding of IgE is taking place in the ELISA test. From this it 
would be expected that animals with higher serum total IgE concentrations 
would have higher optical density results against moulds.
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However examination of the correlation between serum total IgE reflective 
densities (assessed by Immunodot) and the optical density of ELISA results 
for Altemaria and Aspergillus did not reveal any significant correlation with a 
correlation coefficient of -0.031 and -0.284 respectively (See Appendix K). It 
is possible that this discrepancy could be due to the different methods of 
measuring serum total IgE and allergen specific IgE.
It is possible that there is a cross reaction occurring between Malassezia and 
Altemaria /  Aspergillus. Cross reactions between serum against Malassezia 
furfur and moulds have been reported in humans (Nordvall & Johansson, 
1990). Although clinical disease due to Malassezia was rare in the atopic dogs, 
Malassezia was recovered from ears (both diseased and normal). Further work 
is required in this area.
Examination of the sensitivity and specificity of Altemaria and Aspergillus 
ELISA results in identifying atopic dogs demonstrated better results for 
Altemaria. These results were fair with a sensitivity of 64.3% and specificity 
of 60.8%. It is proposed that these findings for Altemaria be included in the 
predictive model of atopic dermatitis, but that these findings cannot be 
examined in isolation due to the lower sensitivity and specificity than desired. 
House dust mites have been shown to be important allergens in the 
pathogenesis of canine atopic dermatitis (Sture et al., 1995, DeBoer, 1989). It 
is not surprising therefore that atopic dogs had significantly higher (p<0.029) 
reflective density values for house dust mite specific serum IgE than non- 
atopics assessed by Immunodot. However it is surprising that no such 
difference was noted with the ELISA test.
The likeliest reason for these findings is that the ELISA is showing falsely 
increased levels of house dust mite specific serum IgE. However why this 
should be the case for house dust mites and not for all of the other allergens is 
not known. It is possible that there may be some cross reaction between house 
dust mites and storage mites, but it is unlikely that the greyhounds and beagles 
are exposed to storage mites either. Storage mites have been shown to be 
present in cereal products (Reedy et al., 1997b) and it is possible that storage 
mites could be present in dry dog food. If the dogs are fed such a diet they
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may be exposed to these allergens. However no information was available on 
the food supply of the beagles and greyhounds.
It is also possible that the increased levels of house dust mite specific serum 
IgE may indeed be a true reflection of the antibody status of these dogs. Non- 
atopic dogs have been shown to demonstrate positive IDST results to house 
dust mite allergens (DeBoer, 1989). It possible that these dogs do indeed have 
circulating levels of house dust mite specific IgE and yet do not demonstrate 
clinical evidence of atopic dermatitis. However, if this were to be the case 
these dogs would have to either have met house dust mites at some point in 
their lifetime or to have been exposed to another allergen which can cross 
react with house dust mite specific IgE. The possibility of a cross reacting 
epitope seems the likeliest explanation due to the difference in results between 
ELISA and Immunodot tests. As different serological tests incorporate 
different allergen epitopes (Esch, 1997) this seems the most likely explanation 
for the differing results.
As the groups of dogs were kept in different environments it was interesting to 
note differences in the serum IgE responses of the dogs. Indeed differences 
were observed against a number of allergens including grass, trees, cat 
epithelium, wall pellitory and moulds.
GDBA dogs had significantly higher levels of serum IgE against cat 
epithelium than non-GDBA dogs (p<0.004, where the non-GDBA group 
included greyhounds, and p<0.000 where the non-GDBA group included 
beagles), even though none of the results for any dogs were considered 
positive. As the GDBA dogs are exposed to cats on a daily basis as part of 
their training this would suggest that exposure has a stimulatory effect on 
serum IgE concentrations against cat allergens. It is however, interesting to 
note that this difference was only detected with the Immunodot test and not 
the ELISA.
GDBA dogs were found to have significantly lower allergen specific serum 
IgE optical/reflective densities against Fescue, grasses (as a group) and trees 
than non-GDBA dogs. This shows agreement between the ELISA test in 
assessing fescue specific IgE and the Immunodot in assessing grass specific 
IgE. The main reason for these increased levels of allergen specific IgE in the
non-GDBA dogs was the higher levels of IgE directed against fescue and trees 
by the greyhounds. Although all dogs other than the beagles are exposed to 
grass allergens it is possible that the greyhounds are exposed to higher levels 
of grass than the other groups due to training methods. This supports the 
theory that increased exposure can lead to increased serum IgE concentrations. 
Examination of the actual optical density results for fescue in these 
greyhounds revealed that many of these non-atopic dogs had levels consistent 
with a diagnosis of atopic dermatitis. This would suggest that the level of a 
positive reaction based on the ELISA test may need to be altered and may 
have to be different for different allergens.
It was expected that the beagles would have significantly lower grass specific 
serum IgE oplical/refleclive densities than the other groups, as these dogs are 
kept indoors. It is not known whether beagles could be exposed to pollen 
allergens via the air conditioning but this may explain these results.
Mould specific IgE reflective densities assessed by Immunodot were highest 
in the non-atopic beagles. Indeed many of these results were considered 
positive. Although no study has been carried out to assess mould exposure in 
these animals it is possible that these dogs are exposed to high levels of mould 
although whether this would be any higher than that to which the GDBA 
kennels dogs are exposed is not known.
The way in which dogs are grouped had an obvious influence on statistical 
results. This was demonstrated by comparing atopic dogs, non-atopic GDBA 
dogs and either non-atopic greyhounds or non-atopic beagles. When 
greyhounds and beagles were examined individually different results were 
obtained than when these two groups were considered together. This is due to 
the fact that greyhounds and beagles demonstrated different serological results 
with one group often having significantly higher optical/reflective densities for 
individual allergens than the other, and on considering these dogs together the 
predominant group influenced the final result. Although both of these groups 
consisted of non-atopic dogs it illustrated the fact that different backgrounds 
can influence the results and suggests that allergen exposure has an effect on 
serum IgE concentrations.
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Interaction was found between the groups for a number of allergens. 
Interaction demonstrates that two factors, whether dogs belong to the GDBA 
population or not and whether dogs are atopic or not, both have an effect on 
the results. The combined effect of both factors gives a result in excess of that 
which would be expected from the combined effects of each parameter. 
Interaction was highest for mould specific IgE assessed by Immunodot where 
the highest mean was found for non-atopic, non-GDBA dogs. The reason for 
this is not known but suggests that there may be a background level of serum 
IgE produced in non-atopic dogs against mould allergens. Whether this result 
is due to an increased level of exposure in these dogs is not known, but is a 
possibility worth further study.
6.5 Can elusion
In summary, significantly higher mould specific serum IgE optical densities 
were found in atopic dogs than non-atopics with the ELISA test. Similar 
results have been observed by a number of other authors. Sensitivity and 
specificity ofAlternaria results were 64.3% and 60.8% respectively. Although 
these results were below the level considered positive by the manufacturers 
and therefore does not suggest that the atopic dogs are allergic to mould 
allergens, this is a useful finding and should be incorporated as a parameter in 
the diagnosis of canine atopic dermatitis, combined with other factors.
It also appears that a dog’s surroundings may have an influence on allergen 
specific serological results. It would therefore be useful to be aware of the 
environment in which animals are kept when assessing serological parameters.
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Chapter 7 Comparison of intradermaf skin testing, ELISA 
atju mmmiiutlui assays in s  topic and non-atopic dogs.
7.1 Introduction
Many authors have attempted to correlate the results from intradermal skin 
testing with those of serological tests in both human and veterinary medicine 
with varying success (Lockey, et al, 1992; Bunde et al, 1997; Bond et al, 
1994). The general opinion appears to be that the degree of correlation 
between IDST and serological tests for negative results is good but correlation 
is poor when results are positive in either test. The aim of this study was to 
examine the correlation between intradermal skin testing, ELISA and 
Immunodot test results to determine if any one serological test gave a better 
correlation with intradermal skin testing.
7.2 Materials & Methods
A total of forty six atopic dogs, fourteen ifom the GDBA population and thirty 
two from the GUVS pet dog population were included in this study. All of 
these dogs underwent IDST and ELISA testing and had at least one positive 
result on IDST. Different numbers of these dogs also underwent Immunodot 
testing dependent on the availability of serum for each dog — thirty five dogs 
underwent Indoor Immunodot testing, thirty one dogs underwent Outdoor 
Immunodot testing and twenty seven underwent Topscreen testing. Further 
details of these dogs are given in Appendix L.
In addition to these atopic dogs, IDST and serological results of a total of nine 
dogs with clinical signs consistent with a diagnosis of atopic dermatitis (as 
described in section 2.1.1) but with negative IDST results were included 
(called skin problem dogs). As it was not possible to carry out IDST on 
healthy non-atopic dogs for ethical reasons, serological results for the seyenty 
four non-atopic GDBA dogs also described in section 2.1.1 were included for 
comparative purposes. Serological results of all dogs are given in Appendix F.
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A positive result on ELISA was defined as an optical density (450nm) of equal 
to or greater than 0.15. A positive result to any house dust mite was recorded 
as a positive for hoipe dust mites as a group. A positive Immunodot test was 
defrned as any blue polour formation on the Immunodot strip. The number of 
dogs with a positive result was calculated for each individual IDST allergen 
and each serological test allergen panel.
Sensitivity, specificity and efficacy of serological test results in relation to 
IDST results were examined. Sensitivity was defined as the number of dogs 
with positive results on both IDST and serological testing as a proportion of 
the total number of dogs with positive results on IDST alone. Specificity was 
defined as the number of dogs with negative results on both IDST and 
serological testing as a proportion of the total number of dogs with negative 
results on IDST alone. Efficacy was defined as the percentage of concordant 
positive or negative iQSLCtiom among all cases. Sensitivity, specificity and 
efficacy of ELISA testing in relation to Immunodot was also examined. 
Examination of die correlation coefficient of IDST and serological results for 
atopic and non-atopic groups of dogs was carried out. In addition correlation 
of Topscreen and individual Indoor or Outdoor Immunodot panels was carried 
out only in IDST positive dogs as this was the only group of dogs where both 
types of Immunodot tests had been carried out. For the purposes of correlation 
only the presence or not of a positive result was recorded and not the degree of 
positivity.
7.3 Results
Tabulated results are shown in Appendices L and M, and Tables 7.1-7.6.
The number of positive results for each allergen produced by IDST and 
serological testingin atopic dogs are shown in Table 7.1. This revealed house 
dust mites to be the predominant allergens with the highest number of positive 
results by both IDST and Immunodot screening methods i.e. 89.1% positive 
by IDST and 45.7% positive by Immunodot. The ELISA method also revealed 
37% of atopic dogs with positive reactions against HDM, but this was lower
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than the number of positive reactions obtained against grasses with 45.7% of 
atopic dogs demonstrating positive reactions. In addition, with ELISA the 
number of positive reactions against HDM was the same as the number of 
positives against moulds (37%).
When examining the serological results of IDST negative dogs (Table 7.2), 
results were similar to those described above with the highest number of 
positive reactions present against house dust mites and different grasses. One 
difference was the greater proportion of positive reactions against different 
tree allergens on ELISA. Also, no positive reactions against HDM were found 
on Jmmunodof.although fewer IDST negative dogs were tested.
Serological results of non-atopic dogs were similar to those of atopic and skin 
problem dogs (See Table 7,3) .in that non-atopic dogs demonstrated a number 
of positive reactions to various allergens, the predominant allergens being 
moulds, house dust mites and grasses. In this instance the proportion of 
positive reactions was less with the Immunodot test methods than the ELISA. 
Overall when comparing different combinations of IDST and serological tests 
the sensitivity was found to be poor but the specificity was in general quite 
good (See Table 7.4). The best sensitivity was 53.3% when comparing IDST 
and Immunodot results for house dust mites. Specificities of 100% were found 
for a number of allergens but were more common when the Immunodot test 
was compared with ELISA or IDST than when comparing IDST with ELISA. 
Efficacy was variable but was greater than 75% for a number of allergens for 
all comparisons of IDST and serological tests.
Comparison of Topscreen Immunodot and either indoor or outdoor 
Immunodot screens (see Appendix M) revealed a correlation of 0,73 for 
indoor results. Outdoor results could not be correlated as all results were 
negative. Examination of the sensitivity, specificity and efficacy of these two 
tests revealed the best results for house dust mites. An efficacy of 100% was 
achieved for grasses and mugwort but as all results were negative this may be 
an overestimation.
Correlation values between serological tests and IDST were not particularly 
good (Table7.6). The best results were obtained for house dust mites followed 
by storage mites, comparing Immunodot with IDST. House dust mite analysis
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with Immunodot gave a better correlation with IDST than ELISA. Other 
comparisons gave a low and often negative correlation.
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7.4 Discussion
Many authors have attempted to compare IDST and serological tests with 
most authors not finding any evidence of correlation between the two 
methods. (Miller et al, 1993; Bond et al, 1994; Codner & Lessard, 1993). 
Most work has concentrated on the RAST and ELISA methods of serological 
testing with little published work being available for the Immunodot test as 
this is a relatively recent development in veterinary medicine (Hammerling & 
deWeck, 1998, Zunic, 1998).
In this present study the majority of positive results on both IDST and 
serology were obtained against house dust mites and grasses. Positive 
serological results were not restricted to atopic dogs and were seen in IDST 
negative, skin problem dogs and in non-atopic dogs. Positive results against 
these allergens in atopic dogs are commonly found (DeBoer, 1989). These 
substances are the main allergens to which dogs are exposed and subsequently 
develop allergies. However, the reason for the high number of positive 
reactions against these allergens in non-atopic dogs is not known.
However it is possible that the IDST negative dogs with atopic type skin 
disease may indeed be allergic to these allergens. Hyposensitisation of atopic 
dogs based entirely on ELISA results has been shown to be as successful as 
hyposensitisation based on IDST (Willemse et al, 1984). The underlying 
mechanisms in atopic dermatitis may involve more than percutaneous 
exposure of allergens to sensitised mast cells. If this was the case then not all 
atopic dogs would react on IDST.
This does not explain the positive serological results in non-atopic dogs. 
Positive IDST results have been recorded in non-atopic dogs against house 
dust mites and it is known that IDST results cannot be relied upon alone in the 
diagnosis of atopic dermatitis (Willemse, 1986). It therefore appears that this 
finding also applies to serological results. Positive results for allergens to 
which an animal is not clinically allergic are considered to be the major 
problem with ELISA tests evaluated by Bond et al, (1994), and Codner &
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Lessard (1993). Many reasons for the development of these positive 
serological results have been put forward including non-specific binding of 
IgE; differences in the concentrations of bound or free serum IgE; and the 
detection of different antigenic epitopes by different test methods (Esch, 
1997) . In this study very few positive results were observed with the 
Immunodot test for IDST negative dogs and non-atopic dogs. From this it 
would appear that the Immunodot test gives results which agree better with 
IDST than ELISA and on this basis the Immunodot results appear more 
reliable than ELISA.
The ELISA test demonstrated a high number of positive results against mould 
allergens for all three groups of atopic and non-atopic dogs. This was not 
demonstrated on IDST or Immunodot tests. The high number of positive 
ELISA results for mould allergens agrees with work by a number of authors 
(Griffin et al, 1990, Anderson & Sousa, 1993, Day et al, 1996) who also 
found a high number of positive reactions against mould allergens. The reason 
for this is unknown, but it has been suggested that there may be a high degree 
of non-specific binding between IgE and moulds. The sensitivity of the 
ELISA test for mould allergens was thought to be an important factor by 
Bunde et al (1997) but the reason behind this was not given. When atopic and 
non-atopic dogs were compared, atopies were found to have significantly 
higher ELISA results for fungal allergens than non-atopics (Codner & 
Lessard, 1993), as discussed in the previous chapter. However, the reason for 
this was not known. In this study a greater percentage of atopic dogs 
demonstrated positive results for moulds than IDST negative or non-atopic 
dogs and it would appear that this is an important finding.
Examination of the sensitivity and specificity of serological tests compared 
with IDST revealed a poor sensitivity but a good specificity with many results 
being 100% specific. This is unexpected as most work to date has found that 
serological tests have a good sensitivity but poor specificity often around 10% 
(Miller et al, 1993; Bond et al, 1994; Codner & Lessard, 1993). The main 
reason for our results was the high number of negative results for a number of
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allergens, in particular with the Immunodot test. Most other authors have 
found that serological tests are prone to giving positive results in atopic and 
non-atopic dogs with a sensitivity of between 43-100% (Miller et al, 1993, 
Bond et al, 1994, Codner & Lessard, 1993). Sensitivity in this study was 
found to be between 0-40% when IDST and ELISA tests were compared. 
Sensitivity of Immunodot compared to IDST was also poor ranging from 0- 
53.3%. Previous studies have concentrated on between twenty-forty dogs. 
This study examined a total of 129 atopic and non-atopic dogs and it is 
possible that the differences observed between this study and other authors 
work is due to the differing numbers examined.
Although sensitivity was poor, specificity for most allergens was good and as 
such the efficacy of serological tests in comparison to IDST and each other 
was good. The one allergen for which results were not particularly good was 
house dust mites where a higher number of positive results were obtained on 
IDST than serology. It is possible that this finding is due to percutaneous 
exposure of allergens with differing levels of skin associated house dust mite 
specific IgE and free circulating IgE although further work is required in this 
area. Both ELISA and Immunodot serological tests are designed so that a 
positive result is indicated by a colour change which is the same for all 
allergens. It is possible that this indicator requires to be different for different 
allergens and this so called ‘cut off point’ requires to be increased for house 
dust mite allergens.
Correlation between serology and IDST was poor as has been described by 
other authors (Anderson & Sousa, 1993; Bond et al, 1994; Codner & Lessard, 
1993). The best correlation was obtained between house dust mites on 
Immunodot and IDST (correlation coefficient of 0.454)
Comparison of IDST and Immunodot tests by Hammerling & de Week (1998) 
for house dust mites demonstrated a sensitivity of 100% and specificity of 
60%. This compares with results in this study of 53.3% sensitivity and 100% 
specificity. However, differences between these two comparisons are due to 
the fact that Hammerling & de Week combined results for Topscreen and
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Indoor Immunodot i.e, where a dog demonstrated a positive result on either 
Topscreen or Indoor Immunodot panels, then this was considered as a positive 
result for house dust mites. This assumes that a positive Topscreen Indoor 
result is due to house dust mites. However, on comparing results from 
Topscreen and Indoor in our study although the best correlation of 0.730 was 
obtained for HDM (i.e. the majority of the positive results on Topscreen were 
due to house dust mite reactions) it was not 100%. The efficacy of results in 
the present study for house dust mites and those for Hammerling & de Week 
(1998) were similar at 66% and 78% respectively. Comparison of IDST with 
Immunodot, examining storage mites, revealed a poor sensitivity, better 
specificity and similar efficacy for our results with those of Hammerling & de 
Week.
When comparing ELISA results with Immunodot from house dust mites, 
again Hammerling & de Week grouped Topscreen and Indoor results. 
However, even with this discrepancy results of this study compare favourably 
(with those of Hammerling & de Week) with sensitivity of 46.7% (48%), 
specificity 63.6% (75%) and efficacy 56.8% (67%) respectively. Overall, 
however both groups of results were poor.
We have to ask however, if direct comparison of these different test results is 
justified. IDST has been regarded as the ‘gold standard’ for many years (Esch, 
1997). Measurement of serum IgE is a comparatively recent development in 
allergy diagnosis yet therapies based entirely on serological testing rather than 
IDST have been shown to be successful (Willemse et al, 1984). In addition 
clinically irrelevant positive results are known to occur in IDST as indicated 
earlier. Exactly how bound and free IgE are related in humans and in dogs is 
not known and because of this it might not be possible to directly correlate 
IDST and serological tests.
In addition, when comparing different tests a reasonable comparison can only 
be made when the same epitopes are being detected. This is supported by the 
work by Bunde et al. (1997) where identical allergens were used in both IDST 
and ELISA and the correlation between both tests was found to be very good
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with 80% correlation between IDST and serology overall. Ragweed and 
grasses had an even better agreement of 96.8% between IDST and serology. 
This suggests that animals can produce IgE against different epitopes on the 
one compound as positive results can be obtained on one test and not another 
and thus using different allergens sources (as is the case in most studies) will 
result in lower correlation. As correlation results in this study were best for 
house dust mites with the Immunodot and IDST this suggested that the 
epitopes in these two tests may be very similar.
On measuring serology, complicating factors such as IgG anti-IgE need to be 
taken into account (Hammerling et al, 1997). Manufacturers of the ELISA 
test acknowledge that IgG can interfere with results either by binding to IgE in 
the sample or binding to IgE sites in the test kit. However, the Immunodot test 
claims to be more specific for IgE. This might explain the difference in the 
sensitivity and specificity of both tests and hence the better correlation of the 
Immunodot test with IDST.
7.5 Conclusion
In conclusion this study has demonstrated that although good sensitivity and 
specificity results can be obtained for particular allergens with serological 
tests in comparison to IDST no one test gives results which are identical to 
those obtained with IDST. Positive results were obtained against a number of 
allergens in non-atopic dogs with the predominant allergens being house dust 
mites. Whether these results are true ‘false positives’ or do indeed illustrate 
the presence of house dust mite specific serum IgE remains to be proved. 
However, a high proportion of atopic dogs have positive results for mould 
specific serum IgE suggesting that this may be important in the diagnosis of 
canine atopic dermatitis.
Sensitivity and specificity of serological tests in comparison to IDST was 
better for Immunodot than ELISA suggesting that the Immunodot method 
may be more accurate than the ELISA methods. This does however assume
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that the IDST method is the most reliable, a fact which still remains to be 
proved.
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Chapter 8 Studies of serum total lgG1
8.1 Introduction
The majority of work on atopic dermatitis in both human and veterinary 
medicine has concentrated on the role of IgE antibodies. However, it has 
been suggested that IgG antibodies may also be important (Djurup & 
Mailing, 1987; McHugh et al. 1990; Hill et al. 1995). Serum IgG levels are 
influenced by a number of factors including hypersensitivity reactions, 
parasitic infestations and infections. Hill et al. (1995) demonstrated that 
serum total IgG levels of atopic dogs were significantly higher than those of 
healthy non-atopic dogs. Similarly, Hites et al. (1989) found that allergen 
specific IgG was higher in atopic than non-atopic dogs. In addition the 
presence of endoparasites has been associated with a significant increase in 
serum total IgG levels as compared to healthy controls (Hill et al., 1995). 
Flea allergic dermatitis (Halliwell & Longino, 1985) and staphylococcal 
antigens (Morales etal., 1994) can also induce raised serum IgG levels.
Four different IgG subgroups have been identified in both people and dogs 
termed IgG], IgG2 , IgG3 , and IgG4 . Subgroups IgG] and IgG* have been 
shown to be the dominant subgroups in both human and canine subjects with 
atopic disease (Djurup & Mailing, 1987; McHugh et al., 1990; and Day & 
Corato 1996).
IgG antibodies have been shown to be produced against IgE antibodies in 
both humans and dogs (Scheur et al., 1991; Carini et al. 1992, Hammerberg 
et al., 1997). These have been shown to be mainly antibodies of the IgGi and 
IgG3 subgroups.
Increased levels of antigen specific IgG have been found in response to 
hyposensitisation in both human and veterinary medicine (Hites et a l, 1989) 
and these antibodies are thought to act as ‘blocking’ antibodies. Correlation 
with the success of hyposensitisation has been attempted by various authors
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but there is some disagreement in this area. Djurup & Mailing (1987) 
concluded that an increase in antigen specific IgG4  was associated with 
failure of hyposensitisation. However, this contradicts McHugh et a l (1990) 
and other authors (Devey et al, 1976; van der Giessen et a l, 1976) who 
found that serum antigen specific levels of IgG4  rose significantly in 
successfully hyposensitised patients. The initial response to 
hyposensitisation in humans has been shown to be dominated by IgGi 
followed later by an increase in serum IgGi. (Aalberse, 1983).
In the dog, antigen specific IgG has been shown to rise following 
hyposensitisation (Hites et a l, 1989) but no mention was made of the clinical 
success of this treatment. Carlotti (1996) has suggested that no correlation 
between serum IgG levels following hyposensitisation and clinical success in 
the dog may exist.
The aims of this study were firstly to assess the total serum IgGi 
concentration in atopic and non-atopic dogs kept under different parasite 
control regimes. Secondly, the response to hyposensitisation with respect to 
serum IgGi levels before and after hyposensitisation therapy, was examined.
8.2 Materials & Methods
A total of seventy eight atopic and non-atopic dogs were examined. These 
were thirteen non-atopic GDBA dogs without skin disease; ten non-atopic 
GDBA dogs with skin disease at the time of sampling (pyoderma diagnosed 
on clinical examination); seventeen atopic GDBA dogs; fourteen non- 
atopic greyhounds without skin disease at the time of sampling; and twenty 
four atopic GUVS pet dogs, as described in Appendix N. All dogs 
underwent a dermatologies examination before sampling and atopic 
dermatitis was diagnosed as described in section 2.1 and 2.2.
Parasite control measures varied between different groups. Both atopic and 
non-atopic GDBA dogs received excellent parasite control measures as
18 1
described in section 2.1.1. GUVS dogs received a variety of parasite 
control measures and their parasite status prior to examination at GUVS 
was not known. Greyhounds were known to receive regular parasite control 
therapy but were also known to be exposed to large numbers of both endo- 
and ectoparasites.
Atopic dogs undergoing hyposensitisation treatment were given an alum 
precipitated vaccine containing up to eight different allergens (ARTU 
Biologicals, Netherlands. See Table 8.2) based firstly on the results of 
IDST then serological tests. This hyposensitisation vaccine was given by 
subcutaneous injection in the scruff. All dogs received the same injection 
regime of increasing doses of vaccine based on manufacturer’s instructions 
(See Table 8.3). After six months’ therapy dogs were re-assessed and 
examined for the presence of skin disease. During this period dogs had 
been treated by the home veterinary surgeon and had not been examined by 
the author. Owners were questioned as to how they felt about the dog’s 
overall condition -  whether there had been any improvement or not; if the 
dog was still pruritic and if so was this any better then previously; had any 
anti-pruritic treatment been prescribed for the dog at any time in the past 
six months.
The dog’s response was then scaled, based on these findings, and the dog 
allocated to one of the following groups:
1. Dogs required no or only occasional steroid or antihistamine therapy to 
relieve pruritus -  the clinical response was defined as GOOD.
2. Dogs were still pruritic and required intermittent therapy -  the clinical 
response was defined as FAIR.
3. There was no improvement in condition and the dogs required 
continuous therapy. The clinical response was defined as POOR.
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Blood samples from twelve dogs receiving hyposensitisation were obtained 
at the time of IDST and after six months hyposensitisation therapy. In 
addition serum was available from three dogs after twelve months therapy, 
and in one dog six months after the end of twelve months hyposensitisation. 
Serum IgGi concentrations were analysed using a radial immunodiffusion 
assay (VetRid, Bethyl :Laboratories Ltd., Texas) as described in section 
2.5.3. Analyses were undertaken using the Minitab version 11.21 (1996) 
statistical software package.
A One Way Analysis of Variance and Newman Keuls multiple range test of 
the loge of serum IgGi concentrations was carried out.
Serum values of IgGi were compared before and after hyposensitisation 
using a paired t test.
8.3 Results
Full results are given in Appendix N.
Comparison of serum IgGi levels in atopic and non-atopic dogs revealed 
the highest mean value of 418.5mg/dl in atopic pet dogs and the widest 
range of values, from lOmg/dl to 1550mg/dl in GDBA atopic dogs (Fig. 
8.1). The lowest mean values of 12.0mg/dl were observed in the non-atopic 
GDBA dogs with skin disease followed by a mean of 24.6mg/dl in the non- 
atopic GDBA dogs without skin disease. However, there was an area of 
overlap in all five groups.
Statistical evaluation of data, required the examination of the loge of serum 
IgGi concentrations in order to obtain results which were not distorted due 
to the skewed nature of this data (Table 8.1). This is due to the majority of 
results tending towards the lower range of concentrations. One Way 
Analysis of Variance of this data revealed that non-atopic working dogs 
with or without skin disease had significantly lower serum IgGi
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concentrations than atopic working dogs, non-atopic greyhounds and atopic 
pet dogs (p<0.000). There were no significant differences between any of 
the other groups. No significant difference was noted between those non- 
atopic dogs with pyoderma and those without, indeed non-atopic working 
dogs with pyoderma had a lower mean serum IgGi concentration than dogs 
without skin disease.
Serum IgGi concentrations of twelve atopic dogs after six months of 
hyposensitisation therapy were significantly higher than before the 
initiation of hyposensitisation (p<0.01) (Table 8.5).
In addition seven of the twelve atopic dogs which demonstrated a good 
clinical response to hyposensitisation were found to exhibit an increase in 
serum total IgGi concentrations varying from 51% to 583% of the original 
serum IgGi levels (Table 8.4, Fig. 8.2). This compares with three dogs 
which demonstrated a poor clinical response to hyposensitisation whose 
serum IgGi concentrations after six months were similar to or lower than 
the initial levels. No correlation was evident between the degree of increase 
in serum IgGi concentration and the degree of clinical improvement shown 
by an individual dog as the increase in IgGi ranged from 70mg/dl to 
455mg/dl where a good response was found. However, comparison of the 
increase in serum total IgGi concentrations pre- and post-hyposensitisation 
in dogs with a good response and those with a fair or poor response 
revealed a significant difference between the two groups (p<0.016).
Twelve months after initiation of hyposensitisation therapy, serum IgGi 
concentrations available from two dogs were found to be higher than the 
initial serum IgGi concentrations but lower than the levels after six months 
therapy (Table 8.6). The serum IgGi concentration was available for one 
dog eighteen months after initiation of therapy arid six months after the 
cessation of therapy. In this dog serum IgGi concentration was higher
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eighteen months after therapy than at the initiation of therapy. In addition 
this dog still demonstrated a good clinical response to hyposensitisation.
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Table 8.1 Statistical analysis of serum total IgGi concentrations in different 
groups of atopic and non-atopic dogs.
a. Examination of serum IgGi concentrations.
Group Number of 
dogs
Mean IgGi 
concentration 
(mg/dl)
Standard deviation
Non-atopic GDBA dogs 
without skin disease
13 24.6 32.6
Non-atopic GDBA dogs 
with skin 
disease
10 12.0 6.3
Atopic GDBA dogs 17 188.8 377.2
Non-atopic greyhounds 14 276.4 283.8
Atopic GUVS dogs 24 418.5 419.3
b. Results of Newman Keuls multiple range test on loge of serum IgGi 
concentrations (See Appendix N):
Non-atopic working dogs with or without skin disease significantly lower 
than other three groups.
c. Correlation of serum total IgE and serum IgGi concentrations
(See Appendix N):
Pearson correlation of 0.099. No correlation between serum total IgE and 
IgGi.
Table 8.2. Allergens included in individual hyposensitisation vaccines
Dog
Identification
Allergens in hyposensitisation vaccine
Palmer Dermatophagoides farinae, D. pteronyssinus, Acarus siro, 
Tyrophagus putrescentiae
Paul D. farinae, D. pteronyssinus, Fescue, Sorrel, Nettle
Kai D. farinae, D. pteronyssinus, Timothy, Italian ryegrass, Cat 
dander, Human epithelium
Chris D. farinae, D. pteronyssinus, A. siro, T. putrescentiae, Poplar, 
Horse Chestnut, Hazel, Elm.
Andrea D. farinae, D. pteronyssinus.
Macauly D. farinae, D. pteronyssinus, A. siro, T. putrescentiae.
Kerry D. farinae, A. siro, T. putrescentiae, Mosquito.
Rhuri Meadow fescue, Sweet vernal grass, Perennial ryegrass, Timothy
Brandy D. farinae, D. pteronyssinus, A. siro, T. putrescentiae, Timothy, 
Plantain, Dandelion, Birch,
Kerry II D. farinae, D. pteronyssinus, A. siro, T. putrescentiae, Orchard, 
Timothy, Fescue.
Budd D. farine, D. pteronyssinus, A. siro, T. putrescentiae, Orchard, 
Fescue.
Sally D. farine, D. pteronyssinus, A. siro, T. putrescentiae, Orchard
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Table 8.3 Injection regime when administering hyposensitisation therapy.
Day of injection Amount of vaccine injected 
subcutaneously
Day 1. 0.2ml
Day 15 0.4ml
Day 29 0.6ml
Day 43 0.8ml
Day 64 1.0ml
Day 85 1.0ml
Day 113 1.0ml
Day 141 1.0ml
Day 169 1.0ml
Injections of 1ml of vaccine are continued at four week intervals thereafter 
for the lifetime of the dog.
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Table 8.5 Results of paired t test on the difference between serum total IgGi 
concentrations pre- and post-hyposensitisation
Mean =127.5 
Standard deviation = 138.6 
p = 0.0087.
Therefore a significant difference was observed between the serum IgGi 
concentrations before and following 6 months hyposensitisation (p<0.01).
Table 8.6 Examination of change in serum total IgGi concentration post 
hyposensitisation in relation to clinical response.
Good response Poor/fair response
Number of dogs 7 5
Mean serum IgGi concentration (mg/dl) 200 26
p = 0.016
Therefore a significant difference was observed between the serum IgGi 
concentrations before and following 6 months hyposensitisation in those dogs 
with a good response compared to those dogs with a poor or fair response.
Table 8.7 Serum total IgGi concentrations in three dogs at 12 and 18 months 
after the initiation of hyposensitisation therapy.
Dog
number
Initial IgGi 
(mg/dl)
6mths IgGi 
(mg/dl)
12 mths IgGi 
(mg/dl)
18mths IgG] 
(mg/dl)
2. 35 215 250 -
3. 40 230 130 150
8. 365 820 430 -
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8.4 Discussion
Total serum IgG levels have been shown to be raised in both atopic and 
parasitised dogs (Hill et al., 1995). This report demonstrates a similar pattern 
with the subgroup IgGi. Serum levels of IgGi were significantly raised in both 
groups of atopic dogs as compared to non-atopic working dogs with or without 
skin disease. The reason for this increase in serum total IgGi levels in atopic 
dogs is unknown. Allergen specific IgG antibodies have been demonstrated in 
atopic dogs (Day et al., 1996), but the exact conditions required for IgGi 
production have not yet been identified although genetics, route of 
administration and dosage of antigen have all been suggested as important 
(Day & Mazza, 1995).
No significant difference was found between non-atopic GDBA dogs with or 
without pyoderma. This suggests that although IgGi may be influenced by the 
presence of infection this effect is not as potent as hypersensitivity or 
parasitism.
From this finding it appears that as serum total IgGi concentrations are higher 
in atopic dogs than non-atopics and that the presence of pyoderma has no 
effect on total IgGi concentrations measurement of serum total IgGi could be 
incorporated into the predictive model for the diagnosis of atopic dermatitis in 
the GDBA population.
Serum IgGi levels were also raised in greyhounds known to be exposed to 
higher numbers of parasites than non-atopic GDBA dogs. It has previously 
been suggested that encysted larvae of Toxocara canis may influence serum 
levels of IgE (Hill et a l, 1995). There are no studies to demonstrate the effect 
such larvae might h^ve on IgGi but the presence of such encysted larvae might 
perhaps explain the raised levels of serum IgGi found in dogs of unknown 
parasite status.
In general the serum IgGi levels found in the present study were lower than 
those described by Mazza et al. (1994), although the GUVS dogs and 
greyhounds were within those higher ranges. However, in that study no 
mention was made of the parasite control and parasitism might account for the 
higher levels of IgGi.
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The increase in serum IgGi levels following hyposensitisation therapy 
observed in this study follows a similar pattern to that found in human 
medicine. Serum antigen specific IgGi levels have been shown to increase 
following initiation of hyposensitisation and then decrease three months after 
beginning treatment (Aalberse, 1983). In the dogs studied here a similar 
picture was found where serum total IgGi concentrations increased initially 
and then decreased twelve months after beginning therapy. Although serum 
total IgGj concentrations twelve months after initiation of therapy were lower 
than those recorded after six months therapy they still remained higher than 
before beginning hyposensitisation. In the one dog where serum total IgGi 
concentrations were available eighteen months after beginning 
hyposensitisation serum total IgGi levels were still higher than at the 
beginning of therapy.
The fact that serum IgGi levels were found to remain above initial levels 
eighteen months after initiation of hyposensitisation would suggest that IgGi 
may be part of the long term response to hyposensitisation. Also this dog 
remained clinically well after six months without hyposensitisation, 
suggesting that IgGi may be linked to a clinical improvement.
Evidence to support the suggestion that an increase in serum IgGi 
concentrations is associated with clinical improvement is shown by the seven 
dogs which demonstrated an increase in serum IgGi concentrations and an 
obvious clinical improvement and the three dogs with a poor clinical response 
whose serum total IgGi concentrations following hyposensitisation were 
similar or lower than those at the beginning of therapy. Although only small 
numbers of dogs were examined here, this finding does suggest that an 
increase in serum total IgGi concentrations is associated with a good clinical 
response to hyposensitisation and further work is required in this area. As in 
most cases it can take 6-9 months for a clinical response to hyposensitisation 
to become evident (Reedy et al, 1997c), it is possible that measurement of 
serum total IgGi concentrations could be used as an indicator of the clinical 
response a dog will make to hyposensitisation before that clinical response is 
evident.
It is not surprising that there is no correlation between the degree of increase 
in serum IgGi levels and the degree of clinical improvement as in a vaccine
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response there is often no correlation between the size of increase in antibody 
levels -  only that there is an increase.
Although two dogs with a large increase in serum IgGi levels were thought to 
only have made a minor clinical improvement, there are two possible 
explanations for this. Firstly, the clinical response was partly based on the 
owner’s opinion which is subjective and influenced by each owner’s 
expectations; secondly some dogs do not manifest any clinical response to 
hyposensitisation until they have received nine months’ therapy. It is possible 
that these dogs are showing an increase in serum total IgGi levels prior to 
demonstrating a clinical response and that measurement of total IgGi levels 
will therefore prove useful in predicting a dog’s response to hyposensitisation. 
Further work on allergen specific IgGi levels following hyposensitisation 
would be useful in order to compare canine results with those of human 
medicine more fully. In addition as the IgGi test is quick and easy to run this 
may prove a valuable test in the examination of a dog’s response to 
hyposensitisation.
8.5 Conclusion
In conclusion this study has demonstrated that concentrations of serum IgGi 
are greater in atopic dogs than those of non-atopic dogs. In addition dogs with 
stringent parasite control measures had lower serum total IgGi concentrations 
than dogs where measures were less stringent This implies that in the 
assessment of canine serum total IgGi concentrations it is necessary to 
investigate the parasite status of a particular animal in order to determine 
whether or not any increase is due to an allergic or a parasitic pathogenesis.
In addition, although it has been demonstrated that in cases of pyoderma there 
is an increase in serum IgG concentrations this is not shown with the IgGi 
subgroup and therefore infection does not interfere with the assessment of 
serum IgGi concentrations.
Perhaps the most important finding was that the majority of serum 
concentrations of IgGi were raised following hyposensitisation suggesting that 
IgGi is involved in the response to hyposensitisation. In addition, although 
only small numbers were examined there is an indication that an increase in
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serum IgG] concentrations is associated with a clinical response to 
hyposensitisation.
Thus it is evident that IgGi is important in canine atopic dermatitis and further 
work is required in this area. In addition it is also apparent that measurement 
of serum total IgGi concentrations can be incorporated into the GDBA 
predictive model for the diagnosis of atopic dermatitis.
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Chapter 9. Final Discussion & Conclusions
9A Discussion
Canine atopic dermatitis is a disease which is commonly found in particular 
breeds and ages of dogs. Diagnosis can often be difficult with a number of 
different parameters being examined in any one dog.
The most obvious sign that a dog has atopic dermatitis is the clinical evidence 
of pruritus and skin lesions. Examination of the clinical presentation of dogs 
with atopic dermatitis and the types of skin conditions presented in this study 
agree with that described in the literature (Scott, 1981, Willemse & van den 
Brom, 1983, Willemse, 1986) -  namely repeated episodes of otitis externa, 
conjunctivitis, and pedal dermatitis.
Atopic dermatitis in dogs is usually diagnosed when animals are over one year 
of age (Scott, 1981, Willemse, 1986). However, this study has demonstrated 
that it is possible to differentiate atopic and non-atopic dogs younger than one 
year of age. Indeed groups of atopic and non-atopic dogs had significant 
differences in the number of episodes of skin disease by the age of nine 
months. It is possible that most atopic dogs in the general population 
demonstrate atopic dermatitis at this young age. Most published papers on the 
age of presentation of atopic dermatitis are from referral clinics (Halliwell & 
Schwartzman, 1971; Scott, 1981; Willemse 1986) and dogs will obviously be 
older before they are referred to such hospitals.
It was possible to demonstrate that the best predictive model for the diagnosis 
of atopic dermatitis in an individual dog was the presence of four or more 
episodes of atopic type skin disease (as described by Willemse, 1986) by the 
age of fifteen months. It was also shown that this finding could be used as a 
diagnostic indicator for individual GDBA dogs. Although this is within the 
age limit recorded in the literature for the diagnosis of atopic dermatitis (Scott, 
1981) it is towards the younger end of the range. In addition it would coincide 
with the beginning of GDBA dog training and if a diagnosis of atopic 
dermatitis could be made at this age then the dog could be withdrawn from the 
working dog population.
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The role of the antibody, IgE, in the pathogenesis of atopic dermatitis is 
undisputed. Some further information as to the role of serum total IgE in the 
diagnosis of atopic dermatitis in the dog has been gleaned in this study. In 
human medicine, serum concentrations of total IgE have been found to be 
greater in atopies than in non-atopics (Gurevitch et a l, 1973, Juhlin et a l, 
1969, Jones et al, 1975, Ogawa et al, 1971 and Wittig et a l, 1980). In 
addition serum IgE concentrations have been shown to be associated with the 
degree of disease at the time of sampling, with higher levels recorded when 
atopic people are suffering from active skin disease (Jones et a l, 1975, 
Johansson & Juhlin, 1970). It had already been suggested that the general dog 
population differed, (Halliwell & Kunkle, 1978, Schwartzman & Rockey, 
1967) with serum IgE concentrations in atopic and non-atopic dogs being 
indistinguishable. Indeed dogs have been shown to have much greater 
concentrations of serum total IgE than humans (Schwartzman & Rockey, 
1967). This has always been assumed to be due to the high levels of parasitism 
believed to exist in dogs (Halliwell & Kunkle 1978).
Results in this study have shown that in GDBA dogs with no history of 
parasite burdens, there is still no correlation between serum total IgE 
concentrations and the presence of atopy. Indeed non-atopic GDBA dogs 
studied here were found to have a wide range of serum total IgE 
concentrations which could not be differentiated from the atopic GDBA or 
GUVS dogs. Therefore serum total IgE cannot be used as a diagnostic 
indicator in the diagnosis of atopy in the dog even when the influence of 
parasitism is excluded
Non-atopic GDBA dogs showed a wide distribution of serum total IgE 
concentrations. These findings are similar to work by Katz (1978) and de 
Week et al, (1997). In work by de Week et a l, (1998) only high responders 
(i.e. dogs with high levels of serum total IgE) went on to develop atopic 
dermatitis. Examination of the non-atopic dogs in the GDBA population 
revealed dogs with serum total IgE concentrations towards the high end of the 
range. From de Week's results these dogs would be expected to develop atopic 
dermatitis. However, this is not the case as many of these dogs were over five 
years of age and are thus unlikely to develop atopic dermatitis. This suggests
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that the presence of high serum total IgE concentrations is associated with the 
development of atopic dermatitis but that this alone is not responsible for the 
development of atopic dermatitis and that other factors are involved.
Conversely de Week et al., (1998) observed that atopic dogs were within the 
group of high responders. However, in this present study atopic dogs were 
found with lower than expected serum total IgE concentrations. One possible 
explanation for this is that dogs had received some form of steroid therapy 
within three months of the tests. As corticosteroids have an 
immunosuppressive effect it is possible that they can depress serum total IgE 
concentrations. This agrees with recent work by McCall et ai, (1998) where it 
has been suggested that corticosteroid therapy does indeed reduce 
concentrations of serum total IgE.
Theoretically then, based on the work of de Week, it is possible to use 
measurements of serum total IgE concentrations, in order to find out if a dog is 
a ‘high’ or Tow’ responder and to use this as an indicator of the likelihood of 
an animal developing atopic dermatitis,. If a dog is a Tow’ responder 
(possibly less than the mean reflective density result of 0.182) then it would be 
less likely that that animal would be atopic. However, if the dog is a ‘high’ 
responder {i.e. reflective density above 0.182) then it does not confirm that the 
dog is atopic, but indicates the possibility of the dog becoming atopic. 
However, applying this data to the atopic GDBA population in this study this 
was not found to be the case as atopic dogs can have low serum total IgE 
concentrations and further work is required to identify all the factors 
controlling IgE production.
In human medicine serum total IgE concentrations have been shown to 
increase with age until the mid-twenties. Examination of the age of an animal 
in relation to serum total IgE concentrations did not reveal any correlation in 
non-atopic dogs. This suggests that it is not necessary to take into account the 
age of an animal when assessing serum total IgE concentrations and that age 
had no bearing on the results found in the present study. This contrasts with 
recent work by Racine et al.r (1999) who found that serum total IgE 
concentrations increased in a population of beagles until the age of 4 years. It 
is possible that the differences between this present study and that of Racine et
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al, are due to the different methods of serum total IgE analysis used in each 
study - Racine’s study used an ELISA whereas this present study used the 
Immunodot method to detect serum total IgE concentrations.
Examination of serum IgGi concentrations in atopic and non-atopic dogs 
revealed some important findings. IgG antibodies develop in normal dogs in 
response to allergens but the concentrations of serum total IgG has been 
shown to be significantly increased in dogs suffering from atopy, infections 
and parasitism (Hill, et a l, 1995). In atopic humans the response to allergens 
has been shown to be dominated by subgroups IgGi and IgG4 .
This study has shown that in the dog serum total IgGi concentrations are 
increased in dogs affected by atopic dermatitis and exposed to parasites. Non- 
atopic dogs with less stringent parasite control measures had significantly 
higher concentrations of serum IgGi than all GDBA dogs. Thus it seems likely 
that IgGi is influenced by both the presence of parasites and allergies. 
Although infection has been shown to have an influence on serum total IgG 
concentrations, examination of serum total IgGi concentrations in non-atopic 
dogs with or without skin disease did not reveal any significant difference. 
This is important because it means that examination of serum total IgGi 
concentration can be used as a diagnostic indicator in the diagnosis of atopic 
dermatitis in GDBA dogs even where there is concurrent skin disease.
Perhaps the most exciting finding was the observation that there is an increase 
in serum total IgGi concentration in dogs after receiving hyposensitisation 
vaccinations. Although previous work (Hites et a l, 1989) has demonstrated 
that there is an increase in serum total IgG levels after hyposensitisation, no 
work has been carried out on the subgroup IgGi. In addition, in the published 
papers no mention has been made of the clinical response of the dogs that 
were receiving hyposensitisation vaccinations. In this study an increase was 
found in serum total IgGi concentrations post hyposensitisation. However, the 
degree of increase in different dogs was variable. Comparison of pre- and 
posl-hyposensilisation serum total IgGi concentrations revealed a significant 
difference in the change in IgGi concentrations between dogs with a good 
response and those with a fair/poor response (p<0.016).
Although the numbers of dogs in this study were small, there is enough 
evidence to warrant further investigation of these findings. It is possible that
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the measurement of serum total IgGi concentrations could be used as an 
indicator of the clinical response of an animal receiving hyposensitisation 
therapy before a clinical response is evident.
The clinical presentation of dogs with atopic dermatitis has been shown to be 
seasonal (Halliwell & Schwartzman, 1971). In another study, the production 
of serum allergen specific IgE was shown not to be seasonal (Miller et a l, 
1992a). However, this present study has demonstrated that there is indeed a 
seasonal variation in allergen specific IgE concentrations in a group of non- 
atopic dogs when a sufficiently large number of dogs are examined over a 
three year period. This was found to be most evident for outdoor allergens but 
was not present for indoor allergens such as house dust mites possibly due to 
the greater seasonal variation in outdoor allergen concentrations than indoor 
allergens. In addition when examining the serological allergen specific results 
of non-atopic GDBA dogs, many dogs gave results which would have been 
considered indicative of atopic dermatitis based on the manufacturer’s design 
of the test This suggests that exposure levels need to be considered when 
using IgE assays as indicators of atopic dermatitis.
The author has also utilised a novel method of detecting which allergens dogs 
are exposed to. By examining faecal samples it was possible to detect the 
pollens to which dogs were exposed. The technique demonstrated that dogs 
were exposed to a wide variety of pollens including pine which is not at 
present included in the IDST panel. Fecal pollen counts could be used to tailor 
IDST or serology panels for individual dogs based on their exposure. Another 
possible use is for the identification of allergens thought not to be important in 
human allergies which may be important in canine atopy.
In examining the results of serological tests large numbers of positive results 
which did not correspond with IDST results were found. ELISA results alone 
demonstrated a significantly higher level of serum IgE specific for moulds in 
atopic dogs than non-atopic dogs, although very few of these results would 
have been considered positive by the ELISA test manufacturers. A number of 
other authors (Griffin et al., 1990, Codner & Lessard, 1993, Anderson & 
Sousa, 1993, Day et a l, 1996) have demonstrated finding increased allergen 
specific IgE results for mould allergens in atopic dogs compared to non­
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atopies, when using the ELISA method, but did not offer an explanation. 
However, it seems likely that it is due to the design of the ELISA test as this 
phenomenon does not occur with the Immunodot serological test and may be 
due to non-specific binding of IgE. Whatever the reason, as there was a 
significant difference in this response between atopic and non-atopic dogs it is 
possible that this test could be used as a diagnostic parameter in the diagnosis 
of atopy in the GDBA dogs.
The level of exposure to allergens was also found to be important when 
serological results of different groups of dogs were examined. This was most 
evident between non-atopic greyhounds and beagles where serum IgE specific 
for grass allergens was found to be significantly higher in greyhounds than 
beagles. This is probably due to the fact that greyhounds are exposed to high 
Jevels of grass, whereas laboratory beagles are not directly exposed to grass at 
all, although whether beagles come into contact with grass pollens or not is not 
known. It was also shown that the non-atopic greyhounds had significantly 
higher concentrations of grass specific serum IgE than atopic GDBA and 
GUVS dogs and that the mean of fescue specific IgE concentrations of non- 
atopic greyhounds was above that considered as positive by the manufacturer. 
From this it can be seen that exposure levels need to be taken in consideration 
when assessing if an animal may be allergic to a specific allergen, as high 
exposure levels may give a false positive result as far as a diagnosis of atopy is 
considered.
No correlation was found to be present between high serum total IgE 
concentrations and the number of positive ELISA results. Other authors 
(Griffin et al., 1990; Codner & Lessard, 1993) have demonstrated that positive 
ELISA results could be obtained in non-atopic dogs if there was a high 
concentration of serum total IgE due to non-specific binding of IgE in the 
ELISA Although that was not the case in this study, it is possible that it was 
due to the fact that most positive results were obtained with the ELISA test 
whereas serum total IgE concentrations were assessed with the Immunodot 
test.
The correlation between IDST and serological tests was, in general, poor. This 
agrees with previous work by other authors (Anderson & Sousa, 1993, Codner 
& Lessard, 1993, Bond et a l, 1994) where no agreement could be found
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between IDST and serological test methods. It was suggested that this was due 
to the IDST and serological tests being produced by different manufacturers 
and that these tests incorporated different antigenic epitopes. This was further 
illustrated by the good correlation found by Esch, (1997) when the same 
epitopes were incorporated into both IDST and serological tests. The best 
correlation in this present study was found between the Immunodot IDST for 
house dust mites, illustrating that there is probably some overlap in the 
epitopes detected by both tests.
9.2 Conclusions
In conclusion this study has led to the identification of a number of novel 
parameters which can be used in the diagnosis of canine atopic dermatitis. 
These findings can be usefully applied both to the group of GDBA dogs 
studied and to the wider canine population.
In summary:
■ Dogs from the GDBA population which demonstrate four or more 
episodes of atopic type skin disease before fifteen months of age are at an 
increased risk of developing atopic dermatitis
■ Serum total IgE concentrations are unrelated to the assumed parasite status 
of a dog population
■ Both high and low responders are present even in a dog population with 
long-term rigorous parasite control and high responders do not necessarily 
go on to develop atopic dermatitis
■ There is no correlation between serum total IgE concentration and age
■ Total serum IgE concentration cannot be used in the diagnosis of canine 
atopic dermatitis
■ There is a significant difference in serum total IgGi concentration between 
atopic and non-atopic groups of dogs in a population with long term 
rigorous parasite control.
■ Serum total IgGi cohcentrations in atopic dogs rise after hyposensitisation 
and there is a statistically significant difference in IgGi levels between 
those dogs which respond to hyposensitisation and those which do not
■ Agreement between IDST results and serological results was poor
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■ In the population examined atopic dogs have a variety of recurrent skin 
disease and as a group have an earlier onset of any sort of skin problems 
and a greater number of episodes of skin disease than non-atopics
■ Atopic dogs have higher levels of allergen specific serum IgE directed 
against moulds than non-atopics and are more likely to have a positive 
ELISA results for mould specific (Alternaria) IgE as determined by 
ELISA
■ It is possible to demonstrate canine pollen exposure by faecal analysis
■ There is a seasonal variation in allergen specific serum IgE concentrations 
in the dog
■ Exposure to allergens influences serum allergen specific IgE 
concentrations such that non-atopic dogs can demonstrate positive 
serological results
Thus by applying these findings to the environmental, clinical and serological
examination of GDBA dogs a more reliable diagnosis of atopic dermatitis can
be made at a younger age than is currently possible.
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9.3 Further work
Areas in this study where further work could be carried out are:
■ Studies of serum total IgGi in a larger group of dogs receiving 
hyposensitisation vaccinations
■ Faecal pollen analysis over a twelve month period and relate this to the 
pollen calendar
■ Incorporate pollens identified on faecal analysis in IDST.
■ Examine serum total IgE concentrations in greyhounds as a breed and in 
relation to parasite status
■ Analyse serum IgE specific for Malassezia and relate this to 
Altemaria/Aspergillus specific serum IgE
■ Examine seasonal variations in serological results in a larger group of 
dogs, with the same number of dogs examined every month
■ Implement predictive model, including both clinical and serological 
findings, to the GDBA population to determine practical applications of 
these results
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Appendix A1 Atopic and non-atopic GDBA dogs in clinical study
Atopic dogs
Name Breed Sex
Clova Labrador Female
Cassie Golden Retriever Female
Carlo Golden Retriever x Labrador Male
Cedar Golden Retriever x Labrador Female
Estelle Golden Retriever x Labrador Male
Enton Labrador x Golden Retriever/Labrador Male
Frey a Labrador Female
Griff Golden Retriever Male
Kai Golden Retriever x Labrador Male
Iliya Labrador Female
Jos Golden Retriever x Labrador Female
Opal Labrador Female
Pedro Golden Retriever x Labrador Male
Prince Labrador Male
Venice Labrador Female
Non-atopic dogs
Name Breed Sex
Alice Labrador x Golden Retirever/Labrador Female
Barney Labrador Male
Bertie Golden Retriever x Labrador Male
Brodie Labrador x Golden Retriever Male
Bunty Retriever Female
Clancy Labrador x Labrador/Curly Coated Retriever Female
Duke Labrador Male
Godfrey Labrador/GoJden Retriever x Golden Retriever Male
Innis Golden Retriever x Labrador Male
June Labrador x Golden Retriever Female
Nyle Labrador Male
Quintus Labrador Male
Wayne Golden Retriever x Labrador Male
Winnie Labrador Female
Yvette Labrador Female
2
Appendix A2 Non-atopic GDBA dogs included in serological studies
Name Breed Description Age at samplin;
1. Aaron GSD Tan 281
2. Abbie GSD Tan 524
3. Andy LxGR Yellow 1861
4. Angus LxGR Black 261
5. Babs GSD Tan 519
6. Barley L YelloVv 452
7. Barney L Yellow 2365
8. Becky L Yellow 472
9. Betsy GRxL Yellow 464
10. Betsy II GRxL Yellow 429
11. Blair GRxL Yellow 291
12. Bobby L Yellow 355
13. Bradley L Yellow 1139
14. Briar FCR Black 1168
15. Brodie GSD Tan 836
16. Broom CCR Black 90
17. Callum L Black 265
18. Carmel L Other 56
19. Casper L Black 2375
20. Cedar L Black 393
21. Cherie L Yellow 615
22. Chips L Yellow 255
23. Clive GRxL Yellow 668
24. Clover L Black 473
25. Craig L Yellow 3161
26. Curtis L Black 644
27. Daisy GRxL Yellow 69
28. Dalby GRxL Yellow 374
29. Daniel L Black 684
30. Darcy L Black 234
31. Delaney GRxL Yellow 279
32. Duke GRxL Yellow 1506
33. Duncan GR Golden 507
34. Ellie L Black 351
35. Emily L Yellow 1005
36. Eva GRxL Black 1833
37. Farley L Yellow 759
38. Frey a L Black 392
39. Gabby GR Golden 461
40. Gabby II GR Golden 429
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Name Breed Description Age at sampling (days)
41. Gaynor L Yellow
42. Glen L Yellow
43. Glennie GSD Tan
44. Grace GR Golden
45. Harry GR White
46. Henry GR Golden
47. Henry II GR Golgen
48. Hunter GRxL Yellow
49. Tke GSD Tan
50. IlJis GRxL Yellow
51. Isla L Yellow
52. Judy GR Golden
53. Katy L Yellow
54. Kay GR Golden
55. Lionel L Yellow
56. Lucy L Yellow
57. Magnus CCRxL Black
58. Martha GRxL Yellow
59. Mary GR Golden
60. Max L Yellow
61. Mel L GRxL Yellow
62. Melody GRxL Yellow
63. Mick L Yellow
64. Morven GR Golden
65. Nash L Yellow
66. Nelson L Yellow
67. Norma GRxL Yellow
68. Onyx LxGR Yellow
69. Paddy LxGR Yellow
70. Pascoe GRxL Black
71. Perry GRxL Yellow
72. Phoebe GRxL Yellow
73. Pippa L Yellow
74. Quizz GR Golden
75. Ria L Yellow
76. Rigsby L Yellow
77. Ryan GRxL Yellow
78. Sally GR Golden
79. Sally II GSD Tan
80. Sherry GRxL Yellow
81. Sid L Black
82. Star GR Golden
83. Tara L Black
84. Teal GRxL Black
85. Thomas L Yellow
601
634
344
457
245
284
465
262
318
276
747
428
439
404
608
554
258
407
215
638
1039
1500
160
1149
542
542
423
1708
691
280
793
564
781
439
401
251
270
455
520
472
544
442
882
247
544
u
Name Breed Description Age at sampling (days)
86. Velma GRxL Yellow 396
87. Victor L Black 253
88. Wade CCRxL Black 230
89 Wellington L Yellow 537
90. William GR Golden 526
91. Willow L Black 491
92. Wilson CCRxL Black 858
93. Yogi GRxC Yellow 308
94. Yuma GRxL Black 73
95. Yusef LxGR Yellow 1773
96. Zeus LxGR Yellow 466
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Appendix A3 Atopic GDBA dogs included in serological studies
Name Breed Description Age at sampling (days)
1. Abe! GSD Black & Tan 2689
2. Alana GSD Black & Tan 1709
3. Andrea GSD Black & Tan 1325
4. Carlo GRxL Yellow 429
5. Cedar II GRxL Yellow 565
6. Chris L Yellow 2687
7. Claire L Yellow 2892
8. Dusty GRxL Yellow 1830
9. Griff GR Golden 1820
10. Harris LxGR Yellow 630
11. Herbie GRxL Yellow 125
12. Keaton L Yellow 413
13. Kai GRxL Yellow 784
14. Opal L Yellow 1473
15. Palmer GRxL Black 916
16. Paul GRxL Black 908
17. Pedro GRxL Black 796
18. Reo L Yellow 776
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Appendix A4 Non-atopic greyhounds included in serological studies
Dog identification Age at sampling (years)*
1. 334 3
2. 335 4
3. 337 4
4. 338 3
5. 340 4
6. 341 4
7. 342 3
8. 343 3
9. 344 6
10. 345 6
11. 346 6
12. 347 6
13. 348 6
14. 349 6
15. 350 3
16. 371 3
17. 372 5
18. 373 12
19. 374 5
20. 381 4
21. 408 3
22. 460 3
23. 496 3
* Accurate ages in days were not available for these dogs
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Appendix A5 Non-atopic beagles included in serological studies
Dog identification Age at sam
1. 14985 3
2. 14989 o
3. 15363 3
4. 15364 nJ
5. 15923 4
6. 15926 4
7. 15945 3
8. 15946 3
9. 15947 3
10. 15948 5
11. 16161 5
12. 16166 5
13. 16167 J
14. 16168 5
15. 16169 5
16. 16615 '"y3
17. 16619 4
18. 16636 3
19. 16660 3
20. 16663 J
21. 16849 3
22. 16850 J
23. 16860 6
24. 16863 3
25. 16867 4
26. 16868 3
27 16869 5
28. 17527 4
29. 17531 4
30. 17536 3
31. 17541 4
32. 17545 3
33. 17550 4
* Accurate ages in days were not available for these dogs
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Appendix A6 GUVS atopic dogs included in serological studies
Name Breed Description
1. Alfred
2. Ben
3. Brandy
4. Budd
5. Fudge
6. Holly
7. Islay
8. Jess
9. Jock
10. Kara
11. Kassie
12. Kayla
13. Kerry
14. Kerry II.
15. Kim
16. Kyle
17. Libby
18. Lucy
19. Lucy II
20. Luke
21. Macauly
22. Maisie
23. Megan
24. Molly
25. Olwen
26. Rhuri
27. Raver
28. Sally
29. Sammie
30. Shane
31. Shannon
32. Sheena
33. Shogun
34. Shona
35. Skerry
36. Tanya
37. Teena
38. Tia
39. Toby
40. Tyson
GSP
Bull Terrier
Dalmatian
Labrador
Labrador
Yorkshire Terr
SBT
Cross breed 
Labrador 
Cross Breed 
GSD 
Boxer
Lakeland Terr
GSDxL
Labrador
Irish Setter
Bulldog
English Setter
Retriever
Great Dane
GSD
WHWT
Labrador
JRT
I Wolfhound
GSD
SBT
Labrador 
G Retriever 
GSD
Cairn Terrier 
Cross Breed 
GSD
Cairn Terrier
SBT
GSD
Cross breed 
Cross breed 
Labrador 
Boxer
Brown
Brown
Black & White
Yellow
Yellow
Black & Tan
Black
Black
Yellow
Bloack
Black & Tan
Brown
Brown
Tan
Yellow
Red
Black
Tricolour
Golden
Blue
Black &Tan
White
Yellow
Brown & White 
Grey
Black & Tan
Black
Black
Golden
Black & Tan
Black
Black
Black & Tan
Black
Black
Black & Tan
Black
Black
Yellow
Brown
Age at sampling (days)
1266
1100
750
915
815
820
2770
1440
640
770
468
550
643
2187
1865
2941
607
730
607
388
305
2653
2521
2203
498
719
1454
1092
2166
1007
730
2520
1640
740
1939
1470
1081
1490
1825
288
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Appendix A7 GDBA dogs with negative IDST and recurrent skin 
disease included in serological studies
Name Breed Description Age at sampling (days)
1. Barry GSD Black & Tan 1989
2. Riley CCR Chocolate 246
Appendix A8 GUVS dogs with recurrent skin disease but negative 
IDST results included in serological studies
Name Breed Description
1. Buster GSD Black & Tan
2. Kyle Keeshond Black & Tan
3. Oscar GR Golden
4. Oscar II Cross breed Black
5. Skye GSP Tan
6. Winston Rhodesian Tan
Ridgeback
7. Zac GSD Black & Tan
Age at sampling (days)
1492
1103
1929
2885
513
710
1629
10
Appendix B
Numbers of episodes of different skin conditions in atopic and
non-atopic GDBA dogs
&
statistical analysis of this data.
Appendix B1 Cumulative number of episodes of conjunctivitis at
particular ages in atopic and non-atopic GDBA dogs.
Dog
No.
Atopic Guide dogs - age Non-atopic guide dogs - age
3
mths
6
mth
9
mth
12
mth
15
mth
18
mth
21
mth
3
mth
6
mth
9
mth
12
mth
15
mth
18
mth
21
mth
1 0 0 0 1 1 3 6 1 1 1 1 1 5 6
2 0 0 0 0 0 0 0 0 0 0 1 3 3 3
3 0 0 0 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 0 0 2 2 0 0 0 0 0 0 0
5 0 0 0 0 0 1 1 0 0 0 0 0 0 0
6 0 0 0 0 0 0 0 0 0 0 0 0 0 0
7 0 0 0 0 0 0 0 0 0 0 0 0 0 0
8 0 0 0 2 4 9 10 0 0 0 0 0 0 0
9 0 0 1 1 2 2 2 0 0 0 0 0 0 0
10 0 0 0 0 1 3 3 0 0 0 0 0 0 1
11 0 1 2 2 3 5 5 0 0 0 0 0 0 0
12 0 0 0 0 2 2 2 0 0 0 0 0 0 0
13 0 0 0 0 1 1 1 0 0 0 1 1 1 1
14 0 0 0 0 0 0 0 0 0 0 0 0 0 0
15 0 0 0 0 2 6 8 0 0 0 0 0 0 0
1 2
Appendix B2 Cumulative number of episodes of otitis externa at
particular ages in atopic and non-atopic GDBA dogs.
Dog
No.
Atopic Guide dogs - age Non-atopic guide dogs - age
3
mth
6
mth
9
mth
12
mth
15
mth
18
mth
21
mth
3
mth
6
mth
9
mth
12
mth
15
mth
18
mth
21
mth
1 0 0 0 1 1 2 4 1 1 1 1 1 2 3
2 0 0 0 1 1 2 5 0 0 0 0 0 1 2
3 0 0 0 0 1 2 5 0 0 0 0 0 1 1
4 0 0 0 0 0 4 7 0 0 0 0 1 2 3
5 0 0 0 2 3 5 6 0 0 0 0 0 0 1
6 1 2 3 4 8 8 8 0 0 0 0 1 5 7
7 0 0 0 0 0 3 3 0 0 0 0 1 2 2
8 0 0 0 0 2 10 15 0 0 0 0 0 1 1
9 0 0 0 0 0 0 1 0 0 0 0 1 5 6
10 0 0 0 1 1 2 2 0 0 0 0 2 3 4
11 0 0 0 0 0 1 1 0 0 0 0 1 2 3
12 0 0 3 4 5 5 5 0 0 0 0 1 2 2
13 0 0 0 3 6 10 11 0 0 0 0 1 1 1
14 0 1 3 3 8 9 9 0 0 0 0 0 0 0
15 0 0 0 1 5 6 8 0 0 0 0 0 0 0
1 3
Appendix B3 Cumulative number of episodes of pedal dermatitis at
particular ages in atopic and non-atopic dogs.
Dog
No.
Atopic Guide dogs - age Non-atopic guide dogs - age
3
mth
6
mth
9
mth
12
mth
15
mth
18
mth
21
mth
3
mth
6
mth
9
mth
12
mth
15
mth
18
mth
21
mth
1 1 1 1 1 2 2 2 0 0 0 0 1 1 1
2 0 0 0 0 0 1 5 0 0 0 0 0 0 4
3 0 0 0 0 0 1 1 0 0 0 1 1 1 1
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 0 3 0 0 0 0 1 1 1
6 0 0 0 0 1 1 1 0 0 0 0 0 0 0
7 0 0 0 0 0 1 1 0 0 0 0 0 0 0
8 0 0 0 0 0 2 7 0 0 0 0 0 0 0
9 0 0 0 0 0 0 0 0 0 0 0 0 1 1
10 0 0 0 0 1 1 2 0 0 0 0 0 0 0
11 0 0 0 0 0 0 0 0 0 0 0 0 1 1
12 0 0 0 0 1 2 2 0 0 0 1 1 3 4
13 0 0 0 0 0 0 1 0 0 0 0 0 0 0
14 0 1 1 1 1 2 2 0 0 0 0 0 0 1
15 0 0 0 0 0 1 1 0 0 O’ 0 0 0 0
1 1*
Appendix B4 Cumulative number of episodes of pyoderma at
particular ages in atopic and non-atopic GDBA dogs
Dog
No.
Atopic Guide dogs - age Non-atopic guide dogs - age
3 6 9 12 15 18 21 3 6 9 12 15 18 21
mth mth mth mth mth mth mth mth mth mth mth mth mth mth
1 0 0 0 0 1 1 1 0 0 0 0 0 0 1
2 0 0 0 0 0 0 0 0 0 0 0 1 1 1
3 0 0 0 0 0 0 0 0 0 0 1 2 2 2
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 1 4 0 0 0 0 0 0 1
6 0 1 4 4 5 10 11 0 0 0 0 1 1 1
7 0 0 0 1 1 1 1 0 0 0 0 0 0 0
8 0 0 0 0 0 0 0 0 0 0 0 0 0 0
9 0 0 0 0 1 1 1 0 0 0 0 0 0 0
10 0 0 1 3 3 3 3 0 0 0 1 1 1 1
11 0 0 0 0 0 0 0 0 0 0 0 0 0 0
12 0 0 0 1 1 1 1 0 0 0 0 0 0 0
13 0 0 2 2 2 3 3 0 0 0 0 0 1 1
14 0 0 1 1 2 2 3 0 0 0 1 1 1 1
15 0 0 0 0 0 0 0 0 0 0 0 0 0 0
1 5
Appendix B5 Cumulativ e number of episodes of atopic type skin
disease at particular ages in atopic and non-atopic GDBA dogs
Dog
No.
Atopic Guide dags - age Non-atopic guide dogs - age
3 6 9 12 15 18 21 3 6 9 12 15 18 21
mth mth mth mth mth mth mth mth mth mth mth mth mth mth
1 1 1 1 3 5 8 14 2 2 2 2 3 8 It
2 0 0 0 1 1 4 11 0 0 0 1 4 5 10
3 0 0 0 0 1 3 6 0 0 0 2 3 4 4
4 0 0 0 0 0 6 9 0 0 0 0 1 2 3
5 0 1 1 3 4 8 15 0 0 0 0 t 1 3
6 1 3 7 8 14 19 20 0 0 0 0 2 6 8
7 0 0 0 I I 5 5 0 0 0 0 I 2 2
8 0 0 0 2 6 21 32 0 0 0 0 0 1 1
9 0 0 1 1 3 3 6 0 0 0 0 1 6 7
10 0 0 1 4 6 10 11 0 0 1 1 3 4 6
11 0 1 2 2 3 6 6 0 0 0 0 1 3 4
12 0 0 3 5 9 10 11 0 0 0 1 2 5 6
13 0 0 2 5 9 15 17 0 0 0 1 2 3 3
14 0 2 5 5 11 13 14 0 0 0 1 1 1 2
15 0 0 0 1 7 13 17 0 0 0 0 0 0 0
1 6
Appendix B6 Cumulative number of episodes of all skin conditions
(except warts and bedsores) at particular ages in atopic and non-
atopic GDBA dogs
Dog
No.
Atopic Guide dogs - age Non-atopic guide dogs - age
3 6 9 12 15 18 21 3 6 9 12 15 18 21
mth mth mth mth mth mth mth mth mth mth mth mth mth mth
1 1 1 1 3 5 8 13 2 2 2 2 3 8 11
2 0 0 0 1 3 5 12 0 0 0 1 4 5 10
3 0 0 0 0 1 3 6 0 0 0 3 4 5 5
4 0 0 0 4 6 13 18 0 0 0 0 3 4 5
5 0 1 I 3 4 8 15 0 0 0 0 1 2 6
6 I 3 7 8 15 21 22 0 0 0 0 3 7 9
7 0 0 0 2 2 6 6 0 0 0 0 2 3 3
8 0 0 0 2 6 21 32 0 0 0 0 0 1 2
9 0 0 1 1 3 3 6 0 0 0 0 1 6 9
10 0 0 1 4 6 10 11 0 0 1 1 3 4 6
11 0 1 2 2 3 6 6 0 0 0 0 2 4 5
12 0 0 3 5 9 10 11 0 0 0 1 3 6 7
13 0 0 2 6 10 16 19 0 01 0 2 3 5 5
14 0 3 6 6 12 14 15 0 0 1 3 3 6 8
15 0 0 0 1 9 15 19 0 0 0 0 0 0 0
17 _
Appendix C
90% non-parametric confidence interval analysis of the 
duration of episodes of atopic type skin conditions in IS 
atopic GDtRA dogs between birth and 21 months of age.
1 8
MTB > print cl-c5
Data Display
Row C o n j . O t i t i s P e d a l AMD
1 * * 4 17
2 4c 4 7
3 5 * 4
4 26 * 4
5 * * 4 12
6 + 5 4
7 4c 4 7
8 * 7 4
9 * 7 4
10 4c 4c 7
11 7 ★ 4
12 17 4r 4
13 7 4r 4
14 * 7 4
15 * ★ 4 10
16 ★ 4r 5
17 ★ 7 4
18 4c 7 4
19 7 ★ 4
20 5 4 4
21 ★ * 4 10
22 4 4 4 7
23 * 4 4 c
24 * 4 5
25 ★ 4 4
26 * 5 4
27
23
*
4
4
4
4
4
20
29 4 22 4
30 * 7 4
31
32
33
34
*
*
4
4c
10
4
4
4
4
4
35 4 7 4
36 ★ 4 4 14
37 7 4 4
38 * 4
39 5 4 4
40 ★ 4
41 7 4 4
42 7 4 4
43 7 4 4
44 5 4 *
45 * 4 4 14
46 7 4 4
47 * 4 *
MTB > D e s c r i b e  m ean  m e d i a n  c l
Descriptive Statistics
V a r i a b l e N N* Mean M e d i a n  T r  M ean S t D e v
C on  j . 14 33 8 . 5 0 7 . 0 0  7 . 3 3 5 . 85
V a r i a b l e M in Max Q 1 Q3
C o n j . 5 . 0 0 2 6 . 0 0 5 . 0 0 7 . 0 0
MTB > S I n t e r v a l  9 5 . 0  ' C o n j . ' .
1 9
M ean
1 . 5 6
Sign Confidence interval
S i g n  c o n f i d e n c e  i n t e r v a l  f o r  m e d i a n
C o n  j .
MTB > D e s c r i b e  m e a n  m e d i a n  c 2
A c h i e v e d
N N* M e d i a n C o n f i d e n c e C o n f i d e n c e I n t e r v a l
L4 33 7 .0 0 0 0 . 9 4 2 6 ( 5 . 0 0 0 , 7 . 0 0 0 )
0 . 9 5 0 0 ( 5 . 0 0 0 , 7 . 0 0 0 )
0 . 9 8 7 1 ( 5 . 0 0 0 , 7 . 0 0 0 )
P o s i t i o n
4
NLI
3
Descriptive Statistics
V a r i a b l e N N* M e an M e d i a n T r  M e an S t D e v SE M ean
O t i t i s 14 33 7 . 8 6 7 . 0 0 6 .  92 4 . 2 6 1 .  14
V a r i a b l e M in Max Q i Q3
o t i t i s 5 . 0 0 2 2 . 0 0 S . 50 7 . 0 0
MTB > s i n t e r v a l  9 5 . 0  ‘O t i t i s * .
Sign Confidence Interval
S i o n  c o n f i d e n c e  i n t e r v a l  f o r  m e d i a n
O t i t i s
N
14
M e d i a n
7 . 000
MTB > D e s c r i b e  m ean  m e d i a n  c3
Descriptive Statistics
A c h i e v e d  
C o n f i d e n c e  
0 . 9 4 2 6  
0 . 9 5 0 0  
0 . 9 8 7 1
C o n f i d e n c e  I n t e r v a l  P o s i t i o n
C 7 . 0 0 0 ,  7 . 0 0 0 )  4
6 . 8 9 7 ,  7 . 0 0 0 )  NLI
5 . 0 0 0 ,  ' . 0 0 0 )  • 3
V a r i a b l e N N* M ean M e d i a n  T r  M ean S t D e v SE Mean
P e d a l 5 42 6 . 2 0 0 7 . 0 0 0  5 . 2 3 0 1 . 0 9 5 0 . 490
V a r i a b l e M in Max Q l Q3
P e d a l 5 . 000 7 . 000 5 . 0 0 0 7 . 0 0 0
MTB > S i n t e r v a l  9 5 . 3  P e d a l ' .
Sign Confidence interval
S i g n  c o n f i d e n c e  i n t e r v a l  f o r  m e d i a n
A c h i e v e d
N N* M e d i a n  C o n f i d e n c e  C o n f i d e n c e  I n t e r v a l  P o s i t i o n  
P e d a l  5 -Z ” . 0 0 0  0 . 9 3 7 5  5 . 2 0 0 ,  " . 0 0 0 )  1
T h e  h i g h e s t  a t t a i n a b l e  c o n f i d e n c e  h a s  b e e n  a c h e i v e d .
MTB > D e s c r i b e  m ean  m e d i a n  c 4
Descriptive Statistics
V a r i a b l e IT N* M ean M e d i a n  T r  M ean S t D e v  SE M ean
AMD 12 35 10 . 6 7 1 0 . 0 0  1 0 . 5  0 4 . 3 3  1 . 3 9
V a r i a b l e M in Max Q l Q3
AMD 5 . 00 2 0 . 0 0 7 . 0 0 1 4 . 0 0
2 0
MTB > Sinterval 95.0 'AMD
Sign Confidence Interval
S i g n  c o n f i d e n c e  i n t e r v a l  f o r  m e d i a n
AMD
N
12
M e d i a n
1 0 . 0 0
A c h i e v e d
C o n f i d e n c e
0 . 8 5 4 0
0 . 9 5 0 0
0 . 9 6 1 4
C o n f i d e n c e  I n t e r v a l  P o s i t i o n  
{ 7 . 0 0 ,  1 4 . 0 0 )  4
( 7 . 0 0 ,  1 4 . 0 0 )  NLI
{ 7 . 0 0 ,  1 4 . 0 0 )  3
MTB > D e s c r i b e  mean, m e d i a n  c 5
Descriptive Statistics
V a r i a b l e
o t h e r
V a r i a b l e
o t h e r
M in
3 . 0 0 0 0
N *
46
Max 
3 . 0 0 0 0
M ean  M e d i a n  T r  M e an  
3 . 0 0 0 0  3 . 0 0 0 0  3 . 0 0 0 0
Q l
MTB > S i n t e r v a l  9 5 . 0  ‘ o t h e r 1 .
Sign Confidence Interval
S t D e v  SE M ean
Q3
S i g n  c o n f i d e n c e  i n t e r v a l  f o r  m e d i a n
A c h i e v e d
N M e d i a n  C o n f i d e n c e
o t h e r  M o t  e n o u g h  d a t a .
: o n f i d e n c e  I n t e r v a l  P o s i t i o n
MTB >
21
Appendix D
Mann Whitney confidence interval and test o f the cumulative
number o f episodes of particular skin conditions in 15 atopic
and 15 non-atopic GDBA dogs.
22
Appendix D1
Mann Whitney confidence interval and test o f the cumulative
number o f episodes of otitis externa in 15 atopic and 15 non-
atopic GDBA dogs.
2 3
MTB > Mann-Whitney 95.0 '3mths' T;
SUBC> Alternative 0.
Mann-Whitney Confidence Interval and Test
3mths N =  15 Median = 0.0000
3 N = 15 Median = 0.0000
Point estimate for ETA1-ETA2 is -0.0000
95.4 Percent Cl for ETA1-ETA2 is (-0.0000,0.0000)
W »  232.5
Test o f ETA1 = ETA2 vs ETAI not — ETA2 is significant at 1.0000 
The test is significant at 1.0000 (adjusted for ties)
Cannot reject at alpha = 0.05
MTB > Mann-Whitney 95.0 '6roths’ ’6’;
SU B O  Alternative 0.
Mann-Whitney Confidence Interval and Test
6mths N = 15 Median = 0.0000
6 N = 15 Median = 0.0000
Point estimate for ETA1-ETA2 is 0.0000
95.4 Percent Cl for ETA1-ETA2 is (0.0001,-0.0002)
W = 240.5
Test o f ETAI = ETA2 vs ETAI not = ETA2 is significant at 0.7557 
The test is significant at 0.5501 (adjusted for ties)
Cannot reject at alpha = 0.05
MTB > Mann-Whitney 95.0 '9mths' '9’;
SUBC> Alternative 0.
Mann-Whitney Confidence Interval and Test
9mths \  = 15 Median = 0.000
9 N = 15 . Median = 0.000
Point estimate for ETA 1-ETA2 is 0.000
95.4 Percent Cl for ETA1-ETA2 is (-0.000,0.000)
W = 249.0
Test of ETAI = ETA2 vs ETAI not = ETA2 is significant at 0.5069 
The test is significant at 0.2609 (adjusted for ties)
Cannot reject at alpha = 0.05
MTB > Mann-Whitney 95.0 '12mtbs' ’12’;
SUBC> Alternative 0.
Mann-Whitney Confidence Interval and Test
12mths N = 15 Median = 1.000
12 N = 15 Median -  0.000
Point estimate for ET AI-ETA2 is 1 000
95.4 Percent Cl for ETA1-ETA2 is (0.000,2.000)
W = 295.0
Test of ETAI = ETA2 vs ETAI not = ETA2 is significant at 0.0101 
The test is significant at 0.0021 (adjusted for ties)
MTB > Mann-Whitney 95.0 'ISmths1 '15';
SUBC> Alternative 0.
2 4
Mann-Whitney Confidence Interval and Test
15mths N = 15 Median = 1.000
15 N =  15 Median = 1.000
Point estimate for ETAI -ETA2 is 1.000
95.4 Percent Cl for ETA1-ETA2 is (-0.001,4 000)
W = 276.5
Test of ETAI = ETA2 vs ETAI not = ETA2 is significant at 0.0712 
The test is significant at 0.0570 (adjusted for ties)
Cannot reject at alpha = 0.05
MTB > Mann-Whitney 95.0 T8mths' T8';
SU B O  Alternative 0.
Mann-Whitney Confidence Interval and Test
18mths N =  15 Median = 4.000
18 N =  15 Median = 2.000
Point estimate for ETA1-ETA2 is 2.000
95.4 Percent Cl for ETA1-ETA2 is (-0.001,5.000)
W = 293.0
Test o f ETAI = ETA2 vs ETAI not = ETA2 is significant at 0.0128 
The test is significant at 0.0113 (adjusted for ties)
MTB > Mann-Whitney 95.0 ’21mths' *21';
SU B O  Alternative 0.
Mann-Whitney Confidence Interval and Test
21mths N =  15 Median = 5.000
21 N = 15 Median = 2.000
Point estimate for ETA1-ETA2 is 3.000
95.4 Percent Cl for ETA1-ETA2 is (0.999,6.000)
W = 300.5
Test of ETAI = ETA2 vs ETAI not = ETA2 is significant at 0.0051 
The test is significant at 0.0048 (adjusted for ties)
MTB >
25
Appendix D2
Mann Whitney confidence interval and test o f the cumulative
number of episodes of conjunctivitis in 15 atopic and 15 non-
atopic GDBA dogs.
26
MTB > Mann-Whitney 95.0 '3 filths' '3';
SU B O  Alternative 0.
* ERROR * Completion o f computation impossible.
* ERROR * All values in column are identical.
MTB > Mann-Whitney 95.0 '6mihs' *6';
SU B O  Alternative 0.
Mann-Whitney Confidence interval and Test
6mths N = 15 Median *= 0.0000
6 N = 15 Median = 0.0000
Point estimate for ETAI -ETA2 is -0.0000
95.4 Percent Cl for ETA1-ETA2 is (-0.0000,0.0000)
W = 232.5
Test o f ETAI = ETA2 vs ETAI not = ETA2 is significant at 1.0000 
The test is significant at 1.0000 (adjusted for ties)
Cannot reject at alpha = 0.05
MTB > Mann-Whitney 95.0 '9mths' '9';
SUBC> Alternative 0.
Mann-Whitney Confidence Interval and Test
9mths N ~ 15 Median = 0.0000
9 N = 15 Median = 0.0000
Point estimate for ETA 1-ETA2 is 0.0000
95.4 Percent Cl for ETA1-ETA2 is (0.0001,-0.0002)
W = 240.5
Test of ETAI = ETA2 vs ETAI not = ETA2 is significant at 0.7557 
The test is significant at 0.5501 (adjusted for ties)
Cannot reject at alpha = 0.05
MTB > Mann-Whitney 95.0 T2mths' '12'.
SUBC> Alternative 0.
Mann-Whitney Confidence Interval and Test
12mths N = 15 Median = 0.0000
12 N =  15 Median = 0.0000
Point estimate for ETAi -ETA2 is 0.0000
95.4 Percent Cl for ETA1-ETA2 is (0.0002,-0.0001)
W = 243.0
Test o f ETAI = ETA2 vs ETAI not = ETA2 is significant at 0.6783 
The test is significant at 0.5742 (adjusted for ties)
Cannot reject at alpha = 0.05
MTB > Mann-Whitney 95.0 T 5mths'' 15';
SUBC> Alternative 0.
Mann-Whitney Confidence Interval and Test
15mths N = 15 Median = 1.000
15 N = 15 Median = 0.000
Point estimate for ETAI-ETA2 is 0.000
95.4 Percent Cl for ETAI-ETA2 is (-0 001,1.000)
2 7  _
W = 272.5
Test o f ETAI = ETA2 vs ETAI not = ETA2 is significant at 0.1013 
The test is significant at 0.0570 (adjusted for ties)
Cannot reject at alpha = 0.05
MTB > Mann-Whitney 95.0 'I8mths' '18';
SU B O  Alternative 0.
Mann-Whitney Confidence Interval and Test
18mths N = 15 Median = 2.000
18 N =  15 Median = 0.000
Point estimate for ETAI -ETA2 is 1.000
95.4 Percent Cl for ETA1-ETA2 is (0.000,3.001)
W = 285.5
Test o f ETAI = ETA2 vs ETAI not = ETA2 is significant at 0.0294 
The test is significant at 0.0159 (adjusted for ties)
MTB > Mann-Whitney 95.0 ’21mths' *21';
SUBC> Alternative 0.
Mann-Whitney Confidence Interval and Test
21mths N = 15 Median = 2.000
21 N =  15 Median = 0.000
Point estimate for ETAI -ETA2 is 1.000
95.4 Percent Cl for ETAI-ETA2 is (-0.001,3.000)
W = 282.5
Test of ETAI = ETA2 vs ETAI not = ETA2 is significant at 0.0401 
The test is significant at 0.0255 (adjusted for ties)
MTB >
2 8
Appendix D3
Mann Whitney confidence interval and test o f the cumulative
number of episodes of pedal dermatitis in 15 atopic and 15
non-atopic GDBA dogs.
29
MTB > Mann-Whitney 95.0 '3mths' '3';
SU B O  Alternative 0.
* ERROR * Completion of computation impossible.
* ERROR * All values in column are identical.
MTB > Mann-Whitney 95.0 'births' '6';
SU B O  Alternative 0.
* ERROR * Completion o f computation impossible.
* ERROR * All values in column are identical.
MTB > Mann-Whitney 95.0 '9mths' '9';
SU B O  Alternative 0.
* ERROR * Completion of computation impossible.
* ERROR * All values in column are identical.
MTB > Mann-Whitney 95.0 T2mths' '12';
SU B O  Alternative 0.
Mann-Whitney Confidence Interval and Test
12mths N =  15 Median = 0.0000
12 N =  15 Median- 0.0000 
Point estimate for ETAI-ETA2 is -0.0000
95.4 Percent Cl for ETA1-ETA2 is (0.0001,-0.0001)
W = 232.5
Test o f ETAI = ETA2 vs ETAI not = ETA2 is significant at 1.0000 
The test is significant at 1.0000 (adjusted for ties)
Cannot reject at alpha = 0 05
MTB > Mann-Whitney 95.0 T 5mthsr '15';
SU B O  Alternative 0.
Mann-Whitney Confidence Interval and Test
15mths N = 15 Median- 0.0000
15 N =  15 Median- 0.0000 
Point estimate for ETA J -ETA2 is -0.0000
95.4 Percent Cl for ETA1-ETA2 is (0.0000,-0.0000)
W = 242.0
Test o f ETAI = ETA2 vs ETAI not — ETA2 is significant at 0.7089 
The test is significant at 0.6404 (adjusted for ties)
Cannot reject at alpha = 0.05
MTB > Mann-Whitney 95.0 TSmths' T8';
SUBC> Alternative 0.
Mann-Whitney Confidence Interval and Test
ISmths \  = 15 Median— 1.000
18 N -  15 Median- 0.000 
Point estimate for ETA 1-ETA2 is 0.000
95.4 Percent Cl for ETA1-ETA2 is (-0.000,1.000)
W = 267.5
Test of ETAI = ETA2 vs ETAI not = ETA2 is significant at 0 .1524 
The test is significant at 0.1201 (adjusted for ties)
Cannot reject at alpha = 0.05
MTB > Mann-Whitney 95.0 ^lmths' *21’;
SUBC> Alternative 0.
Mann-Whitney Confidence Interval and Test
21mths N =  15 Median = 1.000
21 N = 15 Median = 1.000
Point estimate for ETA1-ETA2 is 1.000
95.4 Percent Cl for ETA1-ETA2 is (-0.001,2.001)
W = 275.5
Test of ETAI = ETA2 vs ETAI not = ETA2 is significant at 0.0779 
The test is significant at 0.0649 (adjusted for ties)
Cannot reject at alpha = 0.05
MTB >
31
Appendix D4
Mann Whitney confidence interval and test o f the cumulative
number of episodes o f pyoderma in 15 atopic and 15 non-
atopic GDBA dogs.
3 2
MTB > Mann-Whitney 95.0 ’3mths' *3';
SU B O  Alternative 0.
* ERROR * Completion o f computation impossible.
* ERROR * All values in column are identical.
MTB > Mann-Whitney 95.0 '6mths' '6';
SU B O  Alternative 0.
* ERROR * Completion o f computation impossible.
* ERROR * All values in column are identical.
MTB > Mann-Whitney 95.0 '9mths‘ '9';
SU B O  Alternative 0.
* ERROR * Completion o f computation impossible.
* ERROR * All values in column are identical.
MTB > Mann-Whitney 95.0 T2mths' ’12';
SU B O  Alternative 0.
Mann-Whitney Confidence Interval and Test
12mths N = 15 Median = 0.000
12 N = 15 Median = 0.000
Point estimate for ETAI -ETA2 is 0.000
95.4 Percent Cl for ETA1-ETA2 is (-0.000,1.000)
W = 259.5
Test o f ETAI = ETA2 vs ETAI not = ETA2 is significant at 0.2717 
The test is significant at 0.1726 (adjusted for ties)
Cannot reject at alpha = 0.05
MTB > Mann-Whitney 95.0 '15mths' '15';
SUBC> Alternative 0.
Mann-Whitney Confidence Interval and Test
15mths N = 15 Median = 1.000
15 N =  15 Median -  0.000
Point estimate for ETAI-ETA2 is 0.000
95.4 Percent Cl for ETA1-ETA2 is (0.001,1.000)
W = 262.0
Test o f ETAI = ETA2 vs ETAI not = ETA2 is significant at 0.2290 
The test is significant at 0.1784 (adjusted for ties)
Cannot rejeci at alpha = 0.05
MTB > Mann-Whitney 95.0 '18mths' '18';
SUBC> Alternative 0.
Mann-Whitney Confidence Interval and Test
18mths N = 15 Median = 1.000
18 N =  15 Median = 0.000
Point estimate for ETA1 -ETA2 is -0 000
95.4 Percent Cl for ETA1-ETA2 is (-0.000,0.999)
W = 264.0
3 3
Test o f ETAI = ETA2 vs ETAI not = ETA2 is significant at 0.1985 
The test is significant at 0.1602 (adjusted for ties)
Cannot reject at alpha = 0.05
MTB > Mann-Whitney 95 .0 ,2Imths’ *21*;
SUBC> Alternative 0.
Mann-Whitney Confidence Interval and Test
21mths N = 15 Median = 1.000
21 N =  15 Median = 1.000
Point estimate for ETAI -ETA2 is -0.000
95.4 Percent Cl for ETA1-ETA2 is (0.001,1.999)
W = 258.0
Test o f ETAI = ETA2 vs ETAI not = ETA2 is significant at 0.2998 
The test is significant at 0.2660 (adjusted for ties)
Cannot reject at alpha = 0.05
MTB >
3 4
Appendix D5
Mann Whitney confidence interval and test of the cumulative
number of episodes of atopic type skin conditions in 15 atopic
and 15 non-atopic GDBA dogs.
3 5
MTB > Mann-Whitney 95.0 ‘3mths' '3';
SU B O  Alternative 0.
Mann-Whitney Confidence Interval and Test
3mths N =  15 Median -  0.0000
3 N = 15 Median = 0.0000
Point estimate for ETA1-ETA2 is -0.0000
95.4 Percent Cl for ETA1-ETA2 is (-0.0001,0.0001)
W = 239.0
Test o f ETAI — ETA2 vs ETAI not = ETA2 is significant at 0.8035 
The test is significant at 0.6326 (adjusted for ties)
Cannot reject at alpha = 0.05
MTB > Mann-Whitney 95.0 '6mths' *6’;
SU B O  Alternative 0.
Mann-Whitney Confidence Interval and Test
6mths N = 15 Median = 0.000
6 N =  15 Median- 0.000 
Point estimate for ETAI -ETA2 is -0.000
95.4 Percent Cl for ETA1-ETA2 is (-0.000,1.000)
W = 261.5
Test o f  ETAI = ETA2 vs ETAI not = ETA2 is significant at 0.2372 
The test is significant at 0.0903 (adjusted for ties)
Cannot reject at alpha -  0.05
MTB > Mann-Whitney 95.0 r9mths' '9';
SU B O  Alternative 0.
Mann-Whitney Confidence Interval and Test
9mths N = 15 Median = 1.000
9 N = 15 Median = 0.000
Point estimate for ETAI-ETA2 is 1.000
95.4 Percent Cl for ETA1-ETA2 is (0.000,2.001)
W = 287.0
Test o f ETAI = ETA2 vs ETAI not -  ETA2 is significant at 0.0251 
The test is significant at 0.0093 (adjusted for ties)
MTB > Mann-Whitney 95.0' 12mths' '12*;
SU B O  Alternative 0.
Mann-Whitney Confidence Interval and Test
] 2mths N =  15 Median = 2.000
12 N =  15 Median = 0.000
Point estimate for ETA1-ETA2 is 2.000
95.4 Percent Cl for ETA1-ETA2 is (1.001,3.000)
W = 303.0
Test o f  ETAI = ETA2 vs ETAI not =  ETA2 is significant at 0.0037 
The test is significant at 0.0027 (adjusted for ties)
MTB > Mann-Whitney 95.0 'Ninths1 '15';
SUBC> Alternative 0.
Mann-Whitney Confidence Interval and Test
36
15mths N = 15 Median = 5.000
15 N =  15 Median = 1.000
Point estimate for ETAI -ETA2 is 3.000
95.4 Percent Cl for ETA1-ETA2 is (1.000,6.000)
W = 295.5
Test o f ETAI -  ETA2 vs ETAI not = ETA2 is significant at 0.0095 
The test is significant at 0.0084 (adjusted for ties)
MTB > Mann-Whitney 95.0 '18mths' '18';
SUBC> Alternative 0.
Mann-Whitney Confidence Interval and Test
18mths N =  15 Median = 8.000
18 N = 15 Median = 3.000
Point estimate for ETAI -ETA2 is 5.000
95.4 Percent Cl for ETA1-ETA2 is (2.002,9.000)
W = 314.0
Test ofETXl = ETA2 vs ETAI not = ETA2 is significant at 0.0008 
The test is significant at 0.0007 (adjusted for ties)
MTB > Mann-Whitney 95.0 71mths* '21';
SUBC> Alternative 0.
Mann-Whitney Confidence Interval and Test
21mths N = 15 Median = 11.000
21 N *  15 Median = 4.000
Point estimate for ETA1-ETA2 is 8.000
95.4 Percent Cl for ETA1-ETA2 is (4.000,10.998)
W = 320.5
Test of ETAI = ETA2 vs ETAI not -  ETA2 is significant at 0.0003 
The test is significant at 0.0003 (adjusted for ties)
MTB >
Appendix D6
Mann Whitney confidence interval and test o f the cumulative
number of episodes o f any skin conditions in 15 atopic and 15
non-atopic GDBA dogs.
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MTB > Mann-Whitney 95.0 '3mths' '31;
SU B O  Alternative 0.
Mann-Whitney Confidence Interval and Test
3mths N =  15 M edian- 0.0000 
3 N = 15 Median = 0.0000
Point estimate for ETA1-ETA2 is -0.0000
95.4 Percent Cl for ETA1-ETA2 is (-0 .0001 ,0 .0001)
W = 239.0
Test o f ETAI = ETA2 vs ETAI not = ETA2 is significant at 0.8035 
The test is significant at 0.6326 (adjusted for ties)
Cannot reject at alpha = 0.05
MTB > Mann-Whitney 95.0 'fimths* '6’;
SU B O  Alternative 0.
Mann-Whitney Confidence Interval and Test
6mths N =  15 Median = 0.000
6 N = 15 Median = 0.000
Point estimate for ETA1-ETA2 is 0.000
95.4 Percent Cl for ETA1-ETA2 is (0.000,1.000)
W = 255.5
Test o f ETAI =ETA2 vs ETAI not -  ETA2 is significant at 0.3507 
The test is significant at 0.2071 (adjusted for ties)
Cannot reject at alpha = 0.05
MTB > Mann-Whitney 95.0 r9mths' '9';
SUBC> Alternative 0.
Mann-Whitney Confidence Interval and Test
9mths N =  15 Median = 1.000
9 N = 15 Median = 0.000
Point estimate for ETA1-ETA2 is 1 000
95.4 Percent Cl for ETA1-ETA2 is (-0.000,2.000)
W = 282.0
Test o f ETAI = ETA2 vs ETAI not = ETA2 is significant at 0.0421 
The test is significant at 0.0210 (adjusted for ties)
MTB > Mann-Whitney 95.0 T2mths' '12';
SU B O  Alternative 0.
Mann-Whitney Confidence Interval and Test
12mths N = 15 Median = 3.000
12 N =  15 Median = 0.000
Point estimate for ETA1-ETA2 is 2.000
95.4 Percent Cl for ETA1-ETA2 is (1.000,4.000)
W = 306.5
Test o f ETAI * ETA2 vs ETAI not = ETA2 is significant at 0.0023 
The test is significant at 0.0018 (adjusted for ties)
MTB > Mann-Whitney 95.0 '15mths‘ T 5’;
SUBC> Alternative 0.
Mann-Whitney Confidence Interval and Test
3 9
15mths N =  15 Median = 6.000
15 N = 15 Median = 3.000
Point estimate for ETA1-ETA2 is 3.000
95.4 Percent Cl for ETA1-ETA2 is (1.000,6.001)
W = 305.5
Test o f ETAI = ETA2 vs ETAI not =  ETA2 is significant at 0.0026 
The test is significant at 0.QQ21 (adjusted for lies)
MTE > Mann-Whitney 95.0' troths' '18’;
SUBC> Alternative 0.
Mann-Wbftney Confidence Interval and Test
l&mths N = 15 Median = 10.000
18 N =  15 Median = 5.000
Point estimate for ETA1-ETA2 is 5.000
95.4 Percent Cl for ETA1-ETA2 is (1.999,10.000)
W = 307.5
Test ofETAl = ETA2 vs ETAI not = ETA2 is significant at 0.0020 
The testis significant at 00019 (adjusted for ties)
MTH > Mann-Whitney 95.0 71 mths( 7 1 
SUBC> Alternative 0.
Mann-Whitnsy CCnfid5»iCS Interval arsdTest
21mths N = 15 Median = 13.000
21 N =  15 Median = 6.000
Point estimate for ETA1-ETA2 is 7.000
95.4 Percent Cl for ETAI-ETA2 is (3 002,12.000)
W = 316.0
Test ofETAl = ETA2 vs ETAI not = ETA2 is significant at 0.0006 
The test is significant at 0.0005 (adjusted for ties)
MTB >
u o
Appendix E
Serum total IgE reflective density results in atopic and non-
atopic dogs
&
statistical analysis of this data.
Appendix £1 Serum total IgE reflective densities in non-atopic GDBA
Name Age in
dogs 
Total IgE No. false positive ELISA
days (R.D.) results
Thomas 544 0.008 *
Wade 230 0.009 5
Betsy 464 0.014 1
Paddy 691 0.015 0
Max 638 0.016 1
Wellington 537 0.025 7
Sid 544 0.025 *
Andy 1861 0.028 13
Kay 404 0.045 1
Mick 160 0.046 2
Duke 1506 0.055 *
Chips 255 0.060 *
Freya 392 0.063 1
Glennie 344 0.063 3
Ellie 351 0.070 0
Quizz 439 0.076 *
Katy 439 0.087 0
Isla 747 0.090 2
Abbie 524 0.092 0
Morven 1149 0.095 0
Farley 759 0.098 *
Cherie 615 0.103 *
Briar 1168 0.111 0
Clive 668 0.124 1
Bradley 1139 0.125 4
Brodie 836 0.127 1
Martha 407 0.131 *
Star 442 0.136 2
Clover 473 0.142 0
Carmel 56 0.149 1
Harry 245. 0.163 0
Ryan 270 0.163 *
Victor 253 0.181 0
Nelson 542 0.190 2
Aaron 281 0.193 13
Angus 261 0.215 *
Sally 455 0.223 15
Mel 1039 0.241 0
Illis 276 0.249 1
A2
Name Age in Total IgE No. false posi
days (R.D.) resu!
William 526 0.261 1
Cedar 393 0.274 0
Mary 215 0.293 0
Broom 90 0.308 *
Delaney 279 0.313 0
Barney 2365 0.335 2
Pippa 781 0.337 0
Zeus 466 0.363 0
Teal 247 0.364 9
Darcy 234 0.365 1
Blair 291 0.366 0
Callum 265 0.388 0
Yogi 308 0.404 *
Gaynor 601 0.493 5
Yusef 1773 0.515 0
Ria 401 0.567 0
NOTE: *■ No ELISA results were available for these samples due to a 
shortage of serum.
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Appendix E2 Total serum IgE reflective densities in atopic GDBA
dogs at the time of IDST.
Name Age (days) IgE Reflective density
Carlo 429 0.006
Cedar 565 0.012
Paul 908 0.106
Opal 1473 0.112
Kai 784 0.142
Chris 2687 0.183
Palmer 916 0.191
Griff 1820 0.247
Andrea 1325 0.25
Alana 1709 0.293
Reo 776 0.425
Pedro 796 0.467
u
Appendix E3 Total serum IgE reflective densities in non-atopie
greyhounds
Dog
identification
Age (years)* Total serum IgE 
(reflective density)
345 6 0.111
344 6 0.252
346 6 0.299
496 3 0.426
335 4 0.475
381 4 0.513
348 6 0.514
408 3 0.515
342 3 0.559
334 3 0.571
349 6 0.571
460 3 0.614
341 4 0.642
340 3 0.684
347 6 0.725
* Accurate ages nr days were not available for these dogs.
Appendix E4 Seram total IgE reflective densities in non-atopie beagles
Dog Age (y ears)* Total serum IgE
identification (reflective density)
14989 3 0.000
15948 5 0.000
15946 3 0.000
15945 3 0.013
16169 5 0.013
16167 3 0.024
17531 4 0.102
16168 5 0.180
16849 3 0.203
16636 3 0.229
16663 3 0.237
16660 3 0.304
17541 4 0.310
14985 3 0.317
15926 4 0.321
15947 3 0.322
16161 5 0.331
17527 4 0.403
17550 4 0.431
17536 3 0.436
16868 3 0.440
17545 3 0.440
16615 3 0.462
16619 4 0.629
16850 3 0.735
* Accurate ages in days were not available for these dogs.
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Appendix E5 Serum total IgE reflective densities in atopic GUVS dogs
at the time of D>ST
Name Age (days) IgE (Reflective density)
Sally 1092 0.010
Kim 1865 0.020
Tanya 1470 0.030
Toby 1825 0.031
Brandy 750 0.041
Lucy 607 0.048
Rhuri 719 0.063
Olwen 498 0.094
Maisie 2653 0.121
Kyle 2491 0.148
Ben 1100 0.151
Luke 388 0.153
Shane 1007 0.156
Sam 2166 0.170
Macauly 305 0.173
Islay 2770 0.183
Shona 740 0.190
Molly 2203 0.196
Budd 915 0.200
Fudge 815 0.210
Kerry 643 0.227
Jock 640 0.286
Skerry 1939 0.322
Lucy 730 0.347
Tia 1490 0.429
Sheena 2520 0.482
Kayla 550 0.561
Tyson 288 0.718
Appendix E6
One way ANOVA o f serum total IgE reflective density results in
atopic and non-atopic dogs.
48
MTB > print c i c2.
Data Display
Row Group IgE Reflective density
1
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20 
21 
22
23
24
25
26
27
28
29
30 
51
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
0.008 
0.009 
0.014 
0.015 
0.016 
0.025 
0.025 
0.028 
0.045 
0.046 
0.055 
0.060 
0.063 
0.063 
0.070 
0.076 
0.087 
0.090 
0.092 
0.095 
0.098 
0.103 
0.1 II 
0.124 
0.125 
0.127 
0.131 
0.136 
0.142 
0.149 
0 163 
0.163 
0.181 
0.190 
0.193 
0.215 
0.223 
0.241 
0.249 
0.261 
0.274 
0.293 
0.308 
0.313 
0.335 
0.337 
0.363 
0.364 
0.365 
0.366
49
51 1
52 1
53 1
54 1
55 1
56 2
57 2
58 2
59 2
60 2 
61 2 
62 2
63 2
64 2
65 2
66 2
67 2
68 3
69 3
70 3
71 3
72 3
73 3
74 3
75 3
76 3
77 3
78 3
79 3
80 3
81 3
82 3
83 4
84 4
85 4
86 4
87 4
88 4
89 4
90 4
91 4
92 4
93 4
94 4
95 4
96 4
97 4
98 4
99 4
100 4
101 4
102 4
103 4
104 4
105 4
106 4
107 4
108 5
0.388 
0.404 
0.493 
0.515 
0.567 
0.006 
0.012 
0.106 
0.112 
0.142 
0.183 
0.191 
0.247 
0.250 
0.293 
0.425 
0.467 
0.1 II  
0.252 
0.299 
0.426 
0.475 
0.513 
0.514 
0.515 
0.559 
0.571 
0.571 
0.614 
0.642 
0.684 
0.725 
0.000 
0.000 
0.000 
0.013 
0.013 
0.024 
0.102 
0.180 
0.203 
0.229 
0.237 
0.304 
0.310 
0.317 
0.321 
0.322 
0.331 
0.403 
0.431 
0.436 
0.440 
0.440 
0.462 
0.629 
0.735 
0.010
50
109 5 0.020
110 5 0.030
111 0.031
112 5 0 041
113 5 0.048
114 > 0 063
115 > 0 094
136 5 0.121
117 5 0.148
118 y 0 151
119 5 0.153
120 5 0.156
121 0.170
122 > 0 173
123 0 183
124 5 0.190
125 0 196
126 > 0200
127 5 0210
128 5 0.227
129 > 0.286
130 > 0.322
131 5 0.347
132 > 0.429
133 •> 0 482
134 5 0.561
135 0.718
MTB -
One-Way Analysis of Variance
Analysis of Variance for IgE Refl 
Source DF SS MS F P 
Group 4 1.2666 0.3(66 1176 (3 000
Error 130 3.5007 0.0269
Total 134 4.7672
Individual 95% CIs For Mean 
Based on Pooled St I3e v  
Level N Mean StDev — r  ---------- -
1 55 0.1817 0.1431
2 1 2 0.2028 0 1441 (------- *------)
5 S 5 0.4981 0.1671 {— *------ )
4 25 0 2753 0 2020 — )
5 28 0.2057 0.1717 (— *— 1
Pooled StDev -- 0.3641 0.15 0 30 0 45 0.60
MTB > %nk
Executing from file: C:\MTBWIN\MACROS\nk.MAC 
Newman-Keuls Multiple Range Test
Please enter the following info at the DATA> prompt :
Number of groups 
DATA>5
MS(error)
DATA> 0.0269
Dfif error)
DATA> 130
means o f each group 
DATA> 0.1817 
DATA> 0.2028 
DAT A> 0.4981 
DATA> 0.2753 
DATA> 0.2057
number o f observations in each group 
DATA> 55 
DAT A> 12 
DATA> 15 
DATA> 25 
DATA> 28
Results of Newman-Keuls multiple range test
Data Display
MS error 0.0269 df error: 130
Group Mean Count
Data Display
1 0.1817 55
•> 0.2028 12
3 0.4981 15
4 0.2753 25
5 0.2057 28
Data Display
Group 3 significantly different to group 1
52
Data Dispiay*
Group 3 significantly different to group 2
Data Display
Group 3 significantly different to group 5
Data Dispiay
Group 3 significantly different to group 4 
MTB >
53
Appendix E7
Correlation of serum total IgE reflective density results and the 
number of false positive ELISA results in non-atopie GDBA
dogs.
5 4
Worksheet size: 100000 ceiis
MTB > print cl c2 
Data Display
Row Total IgE No. false positive ELISAs
1 0.008 ★
2 0.009 5
3 0.014 1
4 0.015 0
5 0.016 1
6 0.025 7
7 0.025 *
8 0.028 13
9 0.045 1
10 0.046 2
11 0.055 ★
12 0.060 ★
13 0.063 1
14 0.063 3
15 0.070 0
16 0.076 ★
17 0.087 0
18 0.090 2
19 0.092 0
20 0.095 0
21 0.098 k
22 0.103 k
23 0.117 0
24 0.124 1
25 0.125 4
26 0.127 1
27 0.131 ★
28 0.136 2
29 0.142 0
30 0.149 1
31 0.163 0
32 0.163 ★
33 0.181 0
34 0.190 2
35 0.193 13
36 0.215 *
37 0.223 15
38 0.241 0
39 0.249 1
40 0.261 1
55
41 0.274 0
42 0.293 0
43 0.308 *
44 0.313 0
45 0.335 2
46 0.337 0
47 0.363 0
48 0.364 9
49 0.365 1
50 0.366 0
51 0.388 0
52 0.4Q4 ★
53 0.493 5
54 0.515 0
55 0.567 0
MTB >
Correlations (Pearson)
Correlation of Total IgE and No. false positive ELISAs = -0.102
56
Appendix E8
Correlation between age and serum total IgE reflective density 
results in non-atopic GDBA dogs.
57
Worksheet size: 100000 cells
MTB > print cl c2
Data Display
Row Age in days Total IgE
1 544 0.008
2 230 0.009
3 464 0.014
4 691 0.015
5 638 0.016
6 537 0.025
7 544 0.025
8 1861 0.028
9 404 0.045
10 160 0.046
11 1506 0.055
12 255 0.060
13 392 0.063
14 344 0.063
15 351 0.070
16 439 0.076
17 439 0.087
18 747 0.090
19 524 0.092
20 1149 0.095
21 759 0.098
22 615 0.103
23 1168 0.111
24 668 0.124
25 1139 0.125
26 836 0.127
27 407 0.131
28 442 0.136
29 473 0.142
30 56 0.149
31 245 0.163
32 270 0.163
33 253 0.181
34 542 0.190
35 281 0.193
36 261 0.215
37 455 0.223
38 1039 0.241
39 276 0.249
40 526 0.261
41 393 0.274
42 215 0.293
43 90 0.308
44 279 0.313
45 2365 0.335
46 781 0.337
47 466 0.363
58
»^MMM8lf^ WWWSiWMBrilftf,1grtoPfig!^ ^ a!lS4ai8wtag^ ^^  — -••• r,A ’- '  - ■--•■■ ■ -■........ .
48 247 0.364
49 234 0.365
50 291 0.366
51 265 0.388
52 308 0.404
53 601 0.493
54 1773 0.515
55 401 0.567
MTB >
Correlations (Pearson)
Correlation of Age in days and Total IgE = 0.000
59
Appendix F
Allergen specific serological results
60
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Appendix F10 Immunodot reflective density results for indoor allergen
specific IgE in non-atopic GDBA dogs.
Name Age at 
sampling 
(days)
Dustmites Storemites Flea Human Cat
Aaron 281 0.047 0.030 0.017 0.020 0.056
Abbie 524 0.011 0.027 0.013 0.043 0.025
Andy 1861 0.027 0.068 0.035 0.063 0.009
Angus 261 0.063 0.028 0.010 0.062 0.018
Barney 2365 0.025 0.080 0.018 0.068 0.036
Betsy 464 0.035 0.038 0.007 0.038 0.023
Blair 291 0.014 0.053 0.002 0.071 0.034
Bradley 1139 0.134 0.023 0.010 0.182 0.059
Brodie 836 0.009 0.046 0.002 0.067 0.038
Broom 90 0.058 0.083 0.020 0.088 0.040
Cherie 615 0.016 0.028 0.007 0.062 0.025
Clive 668 o.oia 0.029 0.015 0.081 0.034
Clover 473 0.006 0.029 0.003 . 0.020 0.059
Darcy 234 0.150 0.079 0.004 0.057 0.039
Delaney 279 0.025 0.061 0.021 0.054 0.015
Duke 1506 0.012 0.029 0.026 0.061 0.029
Ellie 351 0.009 0.031 0.095 0.180 0.077
Emily 1005 0.006 0.027 0.001 0.054 0.025
Farley 759 0.006 0.031 0.004 0.019 0.049
Freya 392 0.014 0.033 0.011 0.022 0.014
Gaynor 601 0.052 0.077 0.031 0.106 0.011
Glennie 344 0.006 0.038 0.005 0.053 0.024
Harry 245 0.045 0.077 0.034 0.055 0.017
Illis 276 0.008 0.035 0.002 0.046 0.049
Isla 747 0.016 0.027 0.027 0.028 0.019
Katy 439 0.029 0.063 0.027 0.070 0.019
Kay 404 0.014 0.061 0.027 0.077 0.020
Martha 407 0.008 0.030 0.008 0.028 0.068
Mary 215 0.032 0.092 0.008 0.095 0.017
Max 638 0.008 0.030 0.019 0.057 0.061
Mick 160 0.007 0.035 0.004 0.075 0.088
Morven 1149 0.012 0.031 0.035 0.080 0.027
Nelson 542 0.019 0.062 0.007 0.059 0.038
Paddy 691 0.007 0.032 0.003 0.043 0.019
Thomas 544 0.008 0.031 0.024 0.054 0.066
Victor 253 0.059 0.072 0.011 0.069 0.052
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Name Age at 
sampling 
(days)
Dustmites Storemites Flea Human Cat
Wade 230 0.008 0.035 0.015 0.034 0.085
Wellington 537 0.016 0.043 0.005 0.028 0.141
William 526 0.030 0.030 0.009 0.053 0.037
Yogi 308 0.014 0.126 0.020 0.074 0.012
Yusef 1773 0.043 0.035 0.031 0.082 0.026
Zeus 466 0.005 0.032 0.003 0.044 0.008
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Appendix F ll Im mu nodot reflective density results for indoor allergen
specific IgE in atopic GDBA dogs.
Name Age at Dustmites Storemites Flea Human Cat
Chris
sampling
(days)
2687 0.007
Andrea 1325 0.009
Carlo 429 0.007
Cedar II 565 0.058
Griff 1820 0.014
Kai 784 0.039
Opal 1473 0.019
Reo 776 0.258
epithelium
0.035 0.007 0.055 0.014
0.032 0.009 0.040 0.050
0.026 0.003 0.047 0.067
0.049 0.014 0.049 0.038
0.030 0.002 0.066 0.024
0.029 0.004 0.021 0.056
0.053 0.024 0.047 0.038
0.046 0.033 0.059 0.053
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Appendix F12 Immunodot reflective density results for indoor allergen
specific IgE in non-atopic greyhounds.
Dog
LD.
Age at
sampling
(years)
Dustmites Storemites Flea Human Cat
epithelium
340 4 0.043 0.067 0.005 0.062 0.008
342 3 0.054 0.086 0.016 0.055 0.060
334 3 0.024 0.059 0.005 0.057 0.015
335 4 0.132 0.097 0.015 0.063 0.018
Appendix F13 Immunodot reflective density results for indoor allergen 
specific IgE in non-atopic beagles.
Dog Age at Dustmites Storemites Flea Human Cat
LD. sampling
(years)
epithelium
15945 3 0 0 0 0 0
14989 3 0 0 0 0 0
15948 5 0 0 0 0.059 0
15946 3 0 0 0 0 0
8 1
Appendix F14 Immunodot reflective density results for indoor allergen
specific IgE in atopic GUVS dogs.
Name Age at Dustmites Storemites Flea Human Mould
Brandy
sampling
(days)
750 0.014
Budd 915 0.609
Fudge 815 0.256
Islay 2770 0.050
Jock 640 0.130
Kayla 550 0.008
Kerry II 2187 0.022
Kim 1865 0.039
Kyle 2941 0
Lucy 730 0.258
Lucy 607 0
Luke 388 0.044
Macauly 305 0.202
Maisie 2653 0.004
Olwen 498 0.159
Rhuri 719 0
Sally 1092 0
Shane 1007 0.005
Sheena 2520 0.562
Shona 740 0.740
Skerry 1939 0.175
Tanya 1470 0.063
Toby 1825 0.575
Tyson 288 0.107
0.023 0.039 0.061 0.002
0.282 0 0 0
0.101 0.029 0.107 0.011
0.005 0 0 0
0.088 0.043 0.070 0.019
0.024 0.012 0.061 0.020
0 0 0 0
0.056 0.013 0.071 0.024
0.002 0 0.021 0
0.068 0.009 0.059 0.034
0.028 0 0 0
0.100 0.012 0.102 0.007
0.042 0.050 0.118 0.007
0.037 0.074 0.103 0.047
0.118 0.068 0.143 0.012
0.019 0 0 0
0 0 0 0
0.040 0.024 0.070 0.003
0.261 0.021 0.040 0.015
0.505 0.011 0.055 0.004
0.067 0.024 0.052 0.018
0.038 0.010 0.049 0
0.015 0 0 0
0.028 0.017 0.045 0.041
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Appendix F15 Immunodot reflective density results for outdoor allergen
specific IgE in non-atopic GDBA dogs.
Name Age at sampling (days) Grass Tree Mugwort Olive
Aaron 281 0.015 0.008 0.024 0.054
Abbie 524 0.042 0.026 0.039 0.052
Andy 1861 0.037 0.030 0.090 0.103
Angus 261 0.013 0.006 0.032 0.034
Barney 2365 0.022 0.032 0.100 0.138
Betsy 464 0.016 0.027 0.069 0.057
Blair 291 0.007 0.007 0.052 0.070
Bradley 1139 0.008 0.036 0.117 0.086
Brodie 836 0.014 0.025 0.040 0.053
Broom 90 0.009 0.022 0.063 0.075
Callum 265 0.008 0.015 0.038 0.066
Cherie 615 0.009 0.018 0.052 0.109
Clive 668 0.011 0.016 0.049 0.142
Clover 473 0.011 0.011 0.025 0.120
Darcy 234 0.031 0.045 0.076 0.108
Delaney 279 0.141 0.044 0.050 0.022
Duke 1506 0.012 0.008 0.047 0.073
Ellie 351 0.007 0.018 0.024 0.103
Farley 759 0.006 0.005 0.019 0.025
Freya 392 0.030 0.012 0.030 0.010
Gaynor 601 0.034 0.040 0.070 0.040
Glennie 344 0.021 0.011 0.005 0.127
Harry 245 0.006 0.009 0.019 0.051
Illis 276 0.010 0.009 0.075 0.107
Isla 747 0.020 0.042 0.078 0.070
Katy 439 0.004 0.005 0.033 0.074
Kay 404 0.007 0.007 0.020 0.018
Martha 407 0.011 0.017 0.027 0.034
Mary 215 0.003 0.019 0.066 0.068
Max 638 0.039 0.010 0.093 0.066
Mick 160 0.022 0.013 0.050 0.078
Morven 1149 0.008 0.010 0.042 0.061
Nelson 542 0.021 0.020 0.062 0.050
Paddy 691 0.009 0.009 0.014 0.669
Pippa 781 0.021 0.008 0.046 0.056
Quizz 439 0.009 0.013 0.042 0.015
Ria 401 0.010 0.010 0.043 0.074
Ryan 270 0.008 0.021 0.126 0.008
Sally 455 0.021 0.004 0.029 0.099
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Name Age at sampling (days) Grass Tree Mugwort Olive
Sid 544 0.039 0.019 0.068 0.061
Star 442 0.008 0.017 0.021 0.131
Teal 247 0.014 0.013 0.041 0.044
Thomas 544 0.012 0.018 0.072 0.079
Victor 253 0.021 0.045 0.070 0.052
Wade 230 0.008 0.007 0.021 0.122
Wellington 537 0.035 0.009 0.023 0.130
William 526 0.056 0.046 0.083 0.069
Yogi 308 0.037 0.023 0.071 0.066
Yusef 1773 0.125 0.051 0.052 0.055
Zeus 466 0.009 0.006 0.047 0.060
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Appendix F16 Immunodot reflective density results for outdoor allergen
specific IgE in atopic GDBA dogs.
Name Age at sampling (days)
Chris 2687
Kai 784
Opal 1473
Carlo 429
Reo 776
Andrea 1325
Griff 1820
Grass Tree Mugwort Olive
0.019 0.013 0.064 0.083
0.009 0.003 0.020 0.053
0.047 0.040 0.066 0.077
0.017 0.008 0.022 0.063
0.023 0.035 0.084 0.065
0.008 0.025 0.069 0.130
0.026 0.013 0.065 0.107
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Appendix F17 Immunodot reflective density results for outdoor allergen
specific IgE in non-atopic greyhounds.
Dog I.D. Age at sampling 
(years)
Grass Tree Mugwort Olive
340 4 0.046 0.060 0.067 0.05
342 3 0.046 0.059 0.067 0.071
334 3 0.041 0.021 0.057 0.093
335 4 0.042 0.041 0.054 0.07
Appendix F18 Immunodot reflective density results for outdoor allergen 
specific IgE in non-atopic beagles.
DogLD. Age a t sampling 
(years)
Grass Tree Mugwort Olive
15945 3 0.057 0.035 0.053 0.020
16167 3 0.079 0.018 0.056 0.007
16169 5 0.078 0 0.038 0.013
14989 3 0.048 0.009 0.050 0
15948 5 0.011 0 0.010 0
15946 3 0.001 0 0.010 0
86
Appendix F19 Immunodot reflective density results for outdoor allergen
specific IgE in atopic GUVS dogs.
Name Age at sampling 
(days)
Grass Tree Mugwort Olive
Lucy II 607 0.050 0.031 0.081 0.061
Brandy 750 0.063 0.018 0.038 0.068
Budd 915 0.017 0.003 0.058 0.041
Fudge 815 0.056 0.032 0.067 0.046
Islay 2770 0.054 0.027 0.108 0,071
Jock 640 0.083 0.021 0.032 0.038
Kayla 550 0.063 0.016 0.069 0.091
Kerry II 2187 0.030 0.043 0.059 0.083
Kim 1865 0.066 0.009 0.061 0
Kyle 2941 0.070 0.068 0.062 0.061
Lucy 730 0.053 0.026 0.051 0.097
Luke 388 0.043 0.007 0.053 0.074
Macauly 305 0.041 0.031 0.042 0.111
Maisie 2653 0.032 0.040 0.051 0.013
Olwen 498 0.029 0.005 0.017 0.018
Rhuri 719 0.114 0.023 0.072 0
Sally 1092 0.057 0.044 0.061 0.014
Shane 1007 0.068 0.039 0.078 0.059
Tanya 1470 0.084 0.055 0.069 0.097
Toby 1825 0.073 0.069 0.074 0.054
Tyson 288 0.027 0.017 0.077 0.077
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Appendix F20 Immunodot reflective density results for Topscreen
allergen specific IgE in non-atopic GDBA dogs.
Name Age at 
sampling 
(days)
Outdoor Indoor Foods 1 Foods 2 Moulds
Abbie 524 0.022 0.049 0.041 0.029 0.081
Andy 1861 0.107 0.057 0.021 0.019 0.020
Betsy 464 0.020 0.017 0.026 0.022 0.098
Bradley 1139 0.042 0.092 0.008 0.013 0.070
Briar 1168 0.058 0.105 0.027 0.017 0.099
Callum 265 0.066 0.173 0.011 0.145 0.115
Carmel 56 0.054 0.059 0.021 0.040 0.127
Cedar 393 0.082 0.217 0.007 0.016 0.038
Chips 255 0.123 0.125 0.086 0.059 0.094
Delaney 279 0.027 0.072 0.021 0.027 0.129
Mel 1039 0.034 0.132 0.042 0.047 0.103
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Appendix F21 Immunodot reflective density results for Topscreen
allergen specific IgE in atopic GDBA dogs.
Name Age at 
sampling 
(days)
Outdoor
Andrea 1325 0.041
Paul 908 0.067
Pedro 796 0.120
Reo 776 0.038
Indoor Foods 1 Foods 2 Moulds
0.043 0.008 0.007 0.010
0.179 0.030 0.055 0.081
0.132 0.023 0.018 0.057
0.149 0.010 0.007 0.008
Appendix F22 Immunodot reflective density results for Topscreen 
allergen specific IgE in non-atopic greyhounds.
Name Age at sampling Outdoor Indoor Foods 1 Foods 2 Moulds 
(years)
345 6 0.029 0.068 0.021 0.024 0.070
344 6 0.097 0.092 0.025 0.026 0.137
Appendix F23 Immunodot reflective density results for Topscreen 
allergen specific IgE in non-atopic beagles.
Dog Age at sampling Outdoor Indoor Foods 1 Foods 2 Moulds
I.D. (years)
16849 3 0.057 0.034 0.007 0.060 0.285
16850 3 0.057 0.022 0.119 0.091 0.250
16868 3 0.050 0.023 0.002 0.036 0.272
17527 4 0.056 0.031 0.010 0.065 0.280
17531 4 0.090 0.079 0.019 0.068 0.249
17536 3 0.087 0.134 0.059 0.019 0.096
17541 4 0.051 0.024 0.002 0.021 0.278
17545 3 0.043 0.026 0.005 0.073 0.306
17550 3 0.060 0.023 0.008 0.051 0.367
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Appendix F24 Immunodot reflective density results for Topscreen
allergen specific IgE at in atopic GUVS dogs.
Name Age at Outdoor Indoor Foods 1 Foods 2 Moulds
Brandy
sampling
(days)
750 0.026
Budd 915 0.012
Fudge 815 0.196
Islay 2770 0.064
Jock 640 0.139
Kerry 643 0.017
Kyle 2941 0.056
Luke 388 0.096
Macauly 305 0.015
Maisie 2653 0.019
Olwen 498 0.039
Sam 2166 0.065
Shane 1007 0.023
Shona 740 0.041
Skerry 1939 0.374
0.097 0.012 0.022 0.093
0.205 0.023 0.040 0.133
0.340 0.013 0.015 0.142
0.076 0.016 0.014 0.061
0.172 0.049 0.048 0.142
0.037 0.053 0.033 0.117
0.093 0.020 0.023 0.060
0.102 0.018 0.024 0.043
0.158 0.053 0.043 0.054
0.054 0.020 0.023 0.033
0.098 0.037 0.022 0.05$
0.163 0.016 0.005 0.022
0.060 0.020 0.033 0.056
0.493 0.036 0.042 0.051
0.179 0.041 0.045 0.167
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Appendix G
S ta tistic a l a n a lysis o f  E L IS A  resu lts in  non-a top ic G D BA dogs 
fo r  each m onth  over a th ree  y ea r p erio d
,—  ■ ' - - ----   i„ ,1 i ..rtiifri n i II' _ •!*
Worksheet size: 100000 cells
Retrieving worksheet from file: D:\OLD3SEAS.MTW 
Worksheet was saved on 9/ 7/1998
One-Way Analysis of Variance
Analysis of Variance for Flea
Source DF SS MS
Month 11 0.09792 0.00890
Error 62 0.58777 0.00948
Total 73 0.68569
Level N Mean StDev
1 3 0.02667 0.03630
2 4 0.07600 0.03655
3 3 0.14067 0.15499
4 6 0.05050 0.03478
5 7 0.12129 0.16011
6 14 0.05086 0.02346
7 10 0.06730 0.06802
8 6 0.15700 0.24526
9 8 0.05788 0.03431
10 6 0.05267 0.04956
11 6 0.04933 0.02506
12 1 0.03900 0.00000
Pooled StDev = 0.09737
One-Way Analysis of Variance
Analysis of Variance for Mites
Source DF SS MS
Month 11 0.06262 0.00569
Error 62 0.22190 0.00358
Total 73 0.28452
Level N Mean StDev
1 3 0.07400 0.06202
2 4 0.15225 0.02584
3 3 0.10433 0.02991
4 6 0.11950 0.05981
5 7 0.12157 0.08431
6 14 0.10521 0.04942
7 10 0.17450 0.09182
8 6 0.10667 0.05381
9 8 0.09787 0.04625
10 6 0.07533 0.03565
11 6 0.12833 0.03587
12 1 0.07600 0.00000
Pooled StDev = 0.05982
One-Way Analysis of Variance
Analysis of Variance for Feathers
Source DF SS MS
Month 11 0.03242 0.00295
Error 62 0.14994 0.00242
Total 73 0.18236
Level N Mean StDev
1 3 0.02333 0.02173
2 4 0.11125 0.06798
3 3 0.07000 0.02835
4 6 0.07383 0.04362
F
0.94
P
0.510
Individual 95% Cls For Mean 
Based on Pooled StOev
( — * --------)
— + _ .  
- 0 . 1 2
F
1.59
 + _ .
0. 00
P
0.124
• )
■ )
■ )
----
0 . 1 2
- )
------- + - -
0.24
Individual 95% Cls For Mean 
Based on Pooled StDev
— +—  
0.000
(~____
— +—  
0.070
 + —
0.140
F
1 . 2 2
P
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9 2
5 7 0.07871 0.05014
6 14 0.07393 0.03433
7 10 0.06160 0.03925
8 6 0.10517 0.05274
9 8 0.07775 0.08969
10 6 0.03100 0.01733
11 6 0.06983 0.04005
12 1 0.04500 0.00000
Pooled StDev * 0.04918
One-Way Analysis of Variance
Analysis of Variance for Alterziar
Source DP SS MS
Month 11 0.06945 0.00631
Error 62 0.17813 0.00287
Total 73 0.24758
Level N Mean StDev
1 3 0.02600 0.02272
2 4 0.10850 0.04751
3 3 0.11900 0.06877
4 6 0.07633 0.06863
5 7 0.06171 0.03719
6 14 0.11729 0.06275
7 10 0.06350 0.04445
8 6 0.08083 0.03299
9 8 0.09787 0.05443
10 6 0.04317 0.01739
11 6 0.14050 0.08044
12 1 0.09100 0.00000
Pooled StDev - 0.05360
(  * }
0.000 0.060 0.120
P P
2.20 0.026
Individual 95% Cla For Mean 
Based on Pooled StDev 
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One-Way Analysis of Variance
Analysis of Variance for Aspergil
Source DP SS MS p P
Month 11 0.01651 0.00150 0. 82 0. 625
Error 62 0.11407 0.00184
Total 73 0.13058
Individual 95% Cls For Mean
Based on Pooled StDev
Level N Mean StDev -+■
1 3 0.07500 0.06528 (--------- *--------- }
2 4 0.10100 0.04519 ( -------*------ — )
3 3 0.06100 0.00721 (- -----*--------- )
4 6 0.10917 0.04936 (------*----—  )
5 7 0.07429 0.04102 (------*-----)
6 14 0.10186 0.03369 (-- *----)
7 10 0 .08550 0.05286 (----*-----)
8 6 0.10033 0.06332 (------*------ )
9 8 0.11025 0.Q2994 ( -------- *-------->
10 6 0.06800 0.03291 C------*------)
11 6 0.08783 0.03290 (------*------)
12 1 0.08400 0.00000 <
Pooled StDev = 0.04289 0.000 0.050 0.100
_,———t- —— *
0.150
One-Way Analysis of Variance
Analysis of Variance for Rhiropus
Source DP SS MS F . P
Month 11 0.1549 0.0141 1.06 0.410
Error 62 0.8259 0.0133
Total 73 0.9808
Individual 95% Cls For Mean 
Based on Pooled StDev
gry
Level If Mean StDev
1 3 0.0130 0.0115 (---
2 4 0.0850 0.0423 (-------*— )
3 3 0.0500 0.0200 (- — )
4 6 0.0550 0.0471 (------*---- -)
5 7 0.1153 0.1372 (-----* -)
6 14 0.0653 0.0460 (-- *---)
7 10 0.1169 0.1746 (----*■ )
8 6 0.1942 0.1420 (- ------)
9 8 0.1585 0.1907 (--- ’)
10 6 0.1180 0.0749 (-----* -)
11 6 0.0795 0.0450 (-----*— — )
12 1 0.0280 0.0000 ( ---------------- -)
Pooled StDev = 0.1154 -0.15 0.00 0 .15 0.30
One-Way Analysis of Variance
Analysis of Variance for Kapok
Source DF SS MS
Month 11 0,08160 0.00742
Error 62 0.40787 0.00658
Total 73 0.48947
Level N Mean StDev
1 3 0.01600 0.01386
2 4 0.11175 0.04961
3 3 0.03367 0.00569
4 6 0.04233 0,03173
5 7 0.09329 0.10568
6 14 0.06007 0.03858
7 10 0.07210 0.11190
8 6 0.14850 0.09949
9 8 0.11213 0.12250
10 6 0.08450 0.07893
11 6 0.05600 0.04531
12 1 0.02100 0.00000
Pooled StDev » 0.08111
F P
1,13 0,356
Individual 95V Cls For Mean 
Based on Pooled StDev
-------+------------- +--------------K------------- -t
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One-Way Analysis of Variance
Analysis of Variance for Dust 
Source DF SS MS
Month 11 0.01300 0.00118
Error 62 0.07081 0.00114
Total - 73 0.08381
Level N Mean StDev
1 3 0,02367 0.02122
2 4 0.09125 0.04523
3 3 0.05133 0.01380
4 6 0.03917 0.03952
5 7 0.06557 0.05281
6 14 0.04779 0.02765
7 10 0.04620 0.03753
8 6 0.05333 0.01563
9 8 0.04775 0.01773
10 6 0.03850 0.01560
11 6 0.05433 0.04814
12 1 0.02800 0.00000
Pooled StDev = 0.03379
F
1. 04
P
0.428
Individual 95% Cls For Mean 
Based on Pooled StDev
  ^ +---------------
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One-Way Analysis of Variance
Analysis of Variance for Cat
Source DF SS MS F P
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Month 11 0.013168 0.001197
Error 62 0.046442 0.000749
Total 73 0.059610
Level N Mean StDev
1 3 0.01000 0.01249
2 4 0.07525 0.03071
3 3 0.03167 0.00874
4 6 0.02917 0.02968
5 7 0.04943 0.03477
6 14 0.03600 0.02512
7 10 0.02900 0.02647
8 6 0.04550 0.02447
9 8 0.04588 0.02917
10 6 0.02167 0.01858
11 6 0.04500 0.03553
12 1 0.02500 0.00000
Pooled StDev = 0.02737
One-Way Analysis of Variance
Analysis of Variance for Human
Source DF SS MS
Month 11 0.02369 0.00215
Error 62 0.23365 0.00377
Total 73 0.25735
Level N Mean StDev
1 3 0.02267 0.02203
2 4 0.04600 0.01329
3 3 0.04167 0.00058
4 6 0.03200 0.03091
5 7 0.06557 0.07889
6 14 0.03264 0.01903
7 10 0.07840 0.12868
8 6 0.06750 0.06821
9 8 0.05063 0.03136
10 6 0.03417 0.01440
11 6 0.03417 0.03200
12 1 0.02000 0.00000
Pooled StDev = 0.06139
One-Way Analysis of Variance
Analysis of Variance for Mucor
Source DF SS MS
Month 11 0.1052 0.0096
Error 62 0.8478 0.0137
Total 73 0.9531
Level N Mean StDev
1 3 0.0350 0.0350
2 4 0.1102 0.0772
3 3 0.0680 0.0455
4 6 0.0490 0.0499
5 7 0.1803 0.2569
6 14 0.1135 0.0823
7 10 0.0912 0.1295
8 6 0.1247 0.0917
9 8 0.1576 0.1184
10 6 0.0912 0.0485
11 6 0.0995 0.0692
12 1 0.0920 0.0000
Pooled StDev = 0.1169
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One-Way Analysis of Variance
Analysis of Variance- for Orchard
Source
Month
Error
Total
DP
11
62
73
SS
0.14248
0.43677
0.57924
MS
0.01295
0.00704
F P
1.84 0.066
i n d i v i d u a l  95% CIb  F o r  Mean 
B a s e d  o n  P o o l e d  S tD ev  
L e v e l  N Mean S tD ev   + -----------------+-----------------+--
1 3 0 . 0 3 5 6 7  0 . 0 3 2 0 4  ( -------------* --------------)
2 4 0 . 1 3 6 2 5  0 . 0 8 6 7 1  ( ----------- * ----------- )
3 3 0 . 0 6 5 3 3  0 . 0 1 1 2 4  ( -------------* --------- — )
4 6 0 . 0 6 8 3 3  0 . 0 6 1 9 8 ----------------------{ -------- * ---------)
5 7 0 . 0 8 3 7 1  0 . 0 6 1 3 8 ---------------------------( ------ * --------)
6 14 0 . 0 7 1 5 0  0 . 0 3 3 0 9 ---------------------------( --- *-------)
7 10 0 . 0 9 6 3 0  0 . 0 7 3 1 6  ( ------* ------)
8 6 0 . 2 2 6 8 3  0 . 2 0 3 0 6  ( --------- *— -
9 8 0 . 0 9 5 6 3  0 . 0 9 4 7 9  ( --------*--------)
10 6 0 . 0 8 0 3 3  0 . 0 7 4 5 9  ( ----------* --------)
11 6 0 . 0 7 4 3 3  0 . 0 4 6 5 3 ----------------------{ -------- *-----------)
12 1 0 . 0 5 5 0 0  0 . 0 0 0 0 0  ( ------------------------- * ------------------------ )
P o o l e d  S t D e v  =* 0 . 0 8 3 9 3  0 . 0 0  0 . 1 2  0 . 2 4
One-Way Analysis of Variance
Analysis of Variance for Tintothy
Source
Month
Error
Total
Level
1
2
3
4
5
6
7
8 
9
10
11
12
DF
11
62
73
N
3
4 
3 
6
7 
14 
10
6
8 
6 
6 
1
SS
0.22907
0.57890
0.80797
Mean
0.05467 
0.15400 
0.08600 
0.08950 
0.10900 
08307 
13650 
28467 
09813 
0.07517 
0.11633 
0.07000
MS
0.02082
0.00934
F P
2.23 0.024
Pooled StDev = 0.09663
I n d i v i d u a l  95% Cls For Mean 
B a s e d  o n  P o o l e d  StDev
StDev --------------+----------------+--------------+------
0 .0 4 9 3 7  <------------- * ------------)
0 . 0 7 2 5 0  ( --------- * ------------)
0 . 0 1 8 0 3  ( -------------* ------------)
0 . 0 7 2 2 7  ( -------* -------- )
0 . 0 6 9 7 6  ( -------- * --------)
0 . 0 3 5 9 9  < - — *— )
0 . 1 1 3 5 5  ( ---- *------)
0 . 2 4 5 6 7  ( — t- * ------- }
0 . 0 5 9 0 7  ( - ------ *------ )
0 . 0 7 8 1 4  ( ---------* ------- )
0 . 0 5 0 4 0  ( --------- *--------)
0.00000 (  *----------------- )
0 . 0 0  0 . 1 5  0 . 3 0
One-Way Analysis of Variance
Analysis of Variance for Kentucky
Source DF SS MS F P
Month 11 0.33081 0.03007 3.43 0.001
Error 6 2 0.54355 0.00877
Total 73 0.87435
Individual 95% Cls For
Based on Pooled StDev
Level N Mean StDev
1 ■ 3 0.03600 0.03124 <--- _*-------}
2 4 0.11750 0.04371 (-----*----
3 3 0.07000 0.02234 (- ----*------)
4 € 0.08150 0.08602 (----*-----)
5 7 0.10686 0.09194 c— *--- )
6 14 Q.07593 0.02395 (--*— )
7 10 0.09220 0.08127 (-- *---)
8 6 0.32150 0.25951
9 8 0.08025 0.04098 (— *----)
10 6 0.06983 0.06513 (----*----)
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11 6 0.09517 0.04592
12 1 0.06600 0.00000
Pooled StDev - 0.09363
( ------* )
 * }
 +  + ------------------ — + -
0.00 0.15 0.30
One-Way Analysis of Variance
Analysis of Variance for Fescue 
Source DF SS MS 
Month 11 0.17612 0.01601 
Error 62 0.55819 0.00900 
Total 73 0.73431
T.Atral W Uaan Ctnatr
F P 
1.78 0.077
Individual 95% Cls For 
Based on Pooled StDev
Mean
1 3 0.03367 0.02916 *-------)
2 4 0.15200 0.05757 (------ — )
3 3 0,06533 0.01589 (- — *-------)
4 6 0.06133 0.05877 ( — — *--- )
5 7 0.09971 0.07327 C----*---)
6 14 0.08193 0.03614 (--*— }
7 10 0.09410 0.07599 (—
8 6 0.24467 0.22590 (~ ~)
9 8 0.11737 0.13998 (— *— )
10 6 0.07067 0.07639 (-— *— )
11 6 0,10050 0.03504 (— *— )
12 1 0.05800 0.00000 ( ------- --- )
Pooled StDev = G.09488 0 .00 0.15 0..30
One-Way Analysis of Variance
Analysis of Variance for Poplar
Source DF SS MS F P
Month 11 0.2945 0.0268 2.06 0.037
Error 62 0.8042 0.0130
Total 73 1.0987
Individual 95% Cls For Mean
Based on Pooled StDev
Level N Mean StDev _+------
1 3 0.0597 0.0610 < -)
2 4 0.1430 0.1028 (------ ---- }
3 3 0.0670 0.0078 ( -)
4 6 0.0535 0.0520 <---- *-----)
5 7 0.1121 0,. 1002 (----*--- -)
6 14 0.0822 0.0493 {-- *---)
7 10 0.0835 0.0830 (-- *----)
8 6 0.3082 0.3141 ~)
9 8 0.1125 0.0981 (---- -)
10 6 0.Q975 0.0589 (-----*---- -)
11 6 0.0998 0.0620 (-----*---- -)
12 1 0.0560 0.0000 ( ------------ -)
-+------
Pooled StDev - 0.1139 -0.16 0,.00 0.16 0.32
One-Way Analysis of Variance
Analysis of Variance for Birch
Source DF SS MS
Month 11 0.1573 0.0143
Error 62 1.0235 0.0165
Total 73 1.1807
Level N Mean StDev
1 3 0.0547 0.0577
2 4 0.0992 0.0363
3 3 0.0540 0.0144
4 6 0.0682 0.0496
5 7 0.1941 0.2658
F P
0.87 0.577
Individual 95% Cls For Mean 
Based on Pooled StDev
----------------+ -------------------------h-------------------------- + -------------------------+
(   *  )
(  *  )
(  * )
(  *  )
(  * ---------- )
97
6 14 0.0859 0.0477
7 10 0.1088 0.1302
8 6 0.1923 0.1248
9 8 0.1553 0.2034
10 6 0.0888 0.0535
11 6 0.0882 0.0496
12 1 0.0230 0.0000
Pooled StDev - 0.1285
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One-Way Analysis of Variance
Analysis of Variance for Sorrel
Source DF SS MS F p
Month 11 0.3008 0.0273 1.96 0.048
Error 62 0.8647 0.0139
Total 73 1.1655
Individual 95% Cls For Mean
Rased on Pooled StDev
Level N Mean StDev
1 3 0.2623 0.4060 (--- ------
2 4 0.1395 0.0701 (-------*-------)
3 3 0.1060 0.0210 <--------- *----------}
4 6 0.0720 0.0582 <-------*------ }
5 7 0.0660 0.0430 (-— ---— >
6 14 0.0719 0.0372 (--- *--- )
7 10 0.0691 0.0409 c— *---- )
8 6 0.2690 0.2854 (---- * ----- )
9 8 0.0780 0.0367 (----*----- )
10 6 0.0708 0.0835 (-------*-----)
11 6 0.0833 0.0367 C------- *------)
12 1 0.0900 0.0000 (----------- -- )
Pooled StDev =■ 0.1181 o .00 0.15 0 .30
One-Way Analysis of Variance
Analysis of Variance for Plantain 
Source DF s s  MS
Month 11 0.16727 0.01521
Error 62 0 . 4 9 4 5 6  0.00798
Total 73 0 . 6 6 i a 4
Level
1
2
3
4
5
6
7
8 
9
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11
12
N
3
4 
3 
6
7 
14  
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6
8 
6 
6 
1
Mean 
0.0206-7 
0.16225 
0.06233 
0.05300 
0.11043 
0.08671 
0.08920 
0.23833 
10812 
09650 
09567 
07300
StDev 
0.02875 
0.10489 
0.00757 
0.04483 
0.09828 
0.04736 
0.08727 
0.19949 
0.02171 
0.06386 
0.05631 
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F
1.91
P
0.056
Individual 95% Cls For Mean 
Based on Pooled StDev 
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One-Way Analysis of Variance
Analysis of Variance for Mugvort
Source DF SS MS F P
Month 11 0.1957 0.0178 0.93 0.517
Error 62 1.1837 0.0191
Total 73 1.3794
Individual 95% Cls For Mean 
Based on Pooled StDev 
Level N Mean StDev -----+--------- +--------- +—
9  8
1 3 0 . 0 1 6 3 0 , 0 2 8 3 ( - ---- ----------)
2 4 0 . 1 4 6 3 0 . 1 4 2 6 ( ------ - )
3 3 0 . 0 4 4 7 0 . 0 1 0 3 ( - --------------)
4 5 0 . 0 2 2 0 0 . 0 2 7 9 (* — )
5 7 0 . 1 3 0 9 0 . 2 1 4 2 ( ---- — *-----------)6 14 0 . 0 6 9 1 0 . 0 8 8 9 ( -----*- ■— )
7 10 0 . 1 0 6 6 0 . 1 6 1 1 <— -- * — )8 6 0 . 2 1 6 0 0 . 1 7 9 9 ( ---------- *—
9 8 0 . 1 1 3 0 0 . 1 9 1 5 ■—*---------)
10 6 0 . 1 0 9 5 0 . 1 3 0 4 ( -------- - * -----------)
11 6 0 . 0 4 8 0 0 . 0 1 8 5 ( ----------- -------- )
12 1 0 . 0 4 6 0 0 . 0 0 0 0 ( ---------------- -----)
F o o l e d S tD ev  = 0 . 1 3 8 2 - 0 . 1 6 0.00 0 . 1 6 0 . 3 2
One-Way Analysts of Variance
Analysis of Variance for Dandelio
Source DF SS MS F P
Month 11 0.2514 0.0229 0.74 0.698
Error 62 1.9188 0.0309
Total 73 2.1702
Individual 95% Cls For Mean
Based on Pooled StDev
Level N Mean StDev
1 3 0.0270 0.0234 ( — --------- )
2 4 0.2283 0.3547 (--
3 3 0.0407 0.0055 <- --------- }
4 6 0.0455 0.0477 (------* — )
5 7 0.1734 0.2300 ( -)
6 14 0,0807 0.0583 (--- — )
7 10 0.1666 0.2445 f-- -)
8 6 0.1665 0.1462 <- ----)
9 8 0.1458 0.2492 (- -)
10 6 0.1410 0.1291 ( — -)
11 6 0.0425 0.0301 (------* — )
12 1 0.0390 0,0000 ( -----------------
Pooled StDev * 0.1759 -0.20 -0 .00 0.20
One-Way Analysis of Variance
Analysis of Variance for Nettle
Source DF SS MS F P
Month 11 0.2364 Q.0215 1.44 0. 178
Error 62 0.9245 0.0149
Total 73 1.1609
Individual 95% Cls For Mean
Based on Pooled StDev
Level N Mean StDev
1 3 0.0367 0.0356 (— ----- *-------- )
2 4 0.1693 0.1592 (-------* " --- )
3 3 0.0523 0.0035 ------ *------ — )
4 6 0.0630 0.0764 (----------- )
5 7 0.1419 0.1909 (-----*---- ")
6 14 0.0796 0.0681 (---*---)
7 10 0.0873 0.0983 <-— *----)
8 6 0.2637 0.2602 (--
9 8 0.1071 0.0854 (-----*----)
10 6 0,1323 0.0973 -)
11 € 0.0788 0.0529 (-----*-----)
12 1 0.0240 0.0000 (--------- —  )
— ■— +-----
Pooled StDev = 0.1221 -0.16 o o o o H Cs 0
99
MTB > %nk
Executing from file: C: \MTBWIN\MACROS\nk.MAC
Newman—Keula Multiple Range Test
Please enter the following info at the DATA> prompt 
Number of groups
DATA> 12
MS(error)
DATA> 0.00948
Df(error)
DATA> 62
means of each group 
DATA> 0.02567 
DATA> 0.07600 
DATA> 0.14067 
DATA> 0.05050 
DATA> 0.12129 
DATA> 0.05086 
. DATA> 0.06730 
DATA> 0.15700 
DATA> 0.05788 
DATA> 0.05267 
DATA> 0.04933 
DATA> 0.03900
number of observations in each group
DATA> 3
DATA> 4
DATA> 3
DATA> 6
DATA> 7
DATA> 14
BATA> 10
DATA> 6
DATA> a
DATA> 6
DATA> 6
DATA> 1
Results of Nevman-Keuls multiple range test
Data Display
MS error: 0.00948
Group Mean
Data Display
df error: 
Count
62
1 0.02667 3
2 0.07600 4
3 0.14067 3
4 0.05050 6
5 0.12129 7
6 0.05086 14
7 0.06730 10
8 0.15700 6
9 0.05788 8
10 0.05267 6
11 0.04933 6
12 0.03900 1
1 0 0
F uzA  .
No individual groups are significantly different 
MTB > %nk
Executing from file: C: \MTBWlK\MACROS\nfc.MAC
Nevman-Keuls Multiple Range Test
Please enter the following info at the DATA> prompt 
Number of groups
DATA> 12
MS(error)
OATA> 0.00358
Df(error)
DATA> 62
means of each group 
DATA> 0.07400 
DATA> 0.15225 
DATA> 0.10433 
DATA> 0.11950 
DATA> 0.12157 
DATA> 0.16521 
DATA> 0.17450 
DATA> 0.10667 
DATA> 0.09787 
DATA> 0.07533 
DATA> 0.12833 
DATA> 0.07600
number of observations in each group
DATA> 3
DATA> 4
DATA> 3
DATA> 6
DATA> 7
DATA> 14
DATA> 10
DATA> 6
DATA> 8
DATA> 6
DATA> 6
DATA> 1
Results of Newman-Keuis multiple range test
Data Display
MS error: 0.00358 df error: 62
Group Mean Count
Data Display
1 0.07400 3
2 0.15225 4
3 0.10433 3
4 0.11950 6
5 0.12157 7
6 0.10521 14
7 0.17450 10
8 0.10667 6
9 0.09787 8
1 o 1
/VK7ES
10 0.07533 6
11 0.12833 6
12 0.07600 1
No Individual groups are significantly different 
MTR > %nk
Executing from file: C: \HTB»IN\MACRQS\nk.MAC
Nevman-Keuls Multiple Range Test
Please enter the following info at the DATA> prompt 
Number of groups
DATA> 12
MS(error)
DATA> 0.QQ242
Df{error)
DATA> 62
means of each group 
DATA> 0.02333 
DATA> 0.11125 
DATA> 0.07000 
DATA> 0.07383 
DATA> 0.07871 
DATA> 0.07393 
DATA> 0.06160 
DATA> 0.10517 
DATA> 0.07775 
BATA> 0.03100 
DATA> 0.06983 
DATA> 0.04500
number of observations in each group
DATA> 3 
DATA> 4 
DATA> 3 
DATA> 6 
DATA> 7 
DATA> 14 
DATA> 10 
DATA> 6 
DATA> 8 
DATA> 6 
DATA> 6 
DATA> 1
Results of Nevman-Keuls multiple range test
Data Display
MS error: 0.00242
Group Mean
Data Display
df error: 
Count
62
1 0 . 0 2 3 3 3 3
2 0 . 1 1 1 2 5 4
3 0 . 0 7 0 0 0 3
4 0 . 0 7 3 8 3 6
5 0 . 0 7 8 7 1 7
6 0 . 0 7 3 9 3 1 4
Fea th er s
1 0 2
7 0.06160 10
8 0.10517 6
9 0.07775 8
10 0.03100 6
11 0.06983 6
12 0.04500 1
No individual groups are significantly different 
MTB > %nk
Executing from file: C:\MTBWIN\MACROS\nk.MAC
Nevman-Keuls Multiple Range Test
Please enter the following info at the DATA> prompt 
Number of groups
DATA> 12
MS(error)
DATA> 0.00287
Df(error)
DATA> 62
means of each group 
DATA> 0.02600 
DATA> 0.10850 
DATA> 0.11900 
DATA> 0.07633 
DATA> 0 . 0 6 1 7 1  
DATA> 0.11729 
DATA> 0.06350 
DATA> 0.08083 
DATA> 0.09787 
DATA> 0.04317 
DATA> 0.41050 
DATA> 0.09100
number of observations in each group
DATA> 3 
DATA> 4 
DATA> 3 
DATA> 6 
DATA> 7 
DATA> 14 
DATA> 10 
DATA> 6 
DATA> 8 
DATA> 6 
DATA> 6 
DATA> 1
Results of Nevman-Keuls multiple range test
Data Display
MS error: 0.00287
Group Mean
Data Display
df error: 
Count
62
1 0.02600 3
2 0.10850 4
3 0.11900 3
1 0 3
4 0.07633 6
5 0.06171 7
6 0.11729 14
7 0.06350 10
8 0.08083 6
9 0.09787 8
10 0.04317 6
11 0.41050 6
12 0.09100 1
Data Display
Group 11 significantly different to group 1
Data Display
Group 11 significantly different to group 10
Data Display
Group 11 significantly different to group 5
Data Display
Group 11 significantly different to group 7
Data Display
Group 11 significantly different to group 4
Data Display
Group 11 significantly different to group 8
Data Display
Group 11 significantly different to group 12
Data Display
Group 11 significantly different to group 9
Data Display
Group 11 significantly different to group 2
Data Display
1 0 u
Group 11 significantly different to group 6
Data Display
Group 11 significantly different to group 3 
MTB > %nk
Executing from file: C:\MTBWIM\MiCBjOS\nk.MJLC
Nevman-Keuls Multiple Range Test
Please enter the following info at the DATA> prompt 
Number of groups
DATA> 12
MS(error)
DATA> 0.00184
Df(error)
DATA> 62
means of each group 
DATA> 0.07500 
DATA> 0.10100 
DATA> 0.06100 
DATA> 0.10917 
DATA> 0.07429 
DATA> 0.10186 
DATA> 0.08550 
DATA> 0.10033 
DATA> 0.11025 
DATA> 0.06800 
DATA> 0.08783 
DATA> 0.08400
number of observations in each group
DATA> 3
DATA> 4
DATA> 3
DATA> 6
DATA> 7
DATA> 14
DATA> 10
DATA> 6
DATA> 8
DATA> 6
DATA> 6
DATA> 1
Results of Nevman-Keuls multiple range test
Data Display
MS error: 0.00184
Group Mean
Data Display
df error: 
Count
62
1 0.07500 3
2 0.10100 4
3 0.06100 3
1 0 5
AsMGiuulS
4 0.10917 6
5 0.07429 7
6 0.10186 14
7 0.08550 10
8 0.10033 6
9 0.11025 8
10 0.06800 6
11 0.08783 6
12 0.08400 1
No individual groups are significantly different 
MTB > %nk
Executing from file: C:\MTBWIN\MACROS\nk.MAC
Nevman-Keuls Multiple R a n g e Test
Please enter the following info at the DATA> prompt : 
Number of groups
DATA> 12
MS(error)
DATA> 0.0133
Df(error)
DATA> 62
means of each group
DATA> 0,0130 
DATA> 0.0850 
DATA> 0.0500 
DATA> 0.0550 
DATA> 0.1153 
DATA> 0.0653 
DATA> 0.1169 
DATA> 0.1942 
DATA> 0.1585 
DATA> 0.1180 
DATA> 0.0795 
DATA> 0.0280
number of observations in each group
DATA> 3 
DATA> 4 
DATA> 3 
DATA> 6 
DATA> 7 
DATA> 14 
DATA> 10 
DATA> 6 
DATA> 8 
DATA> 6 
DATA> 6 
DATA> 1
Results of Nevman-Keuls multiple range test
Data Display
MS error: 0.0133 df error: 62
Group Mean Count
Data Display
1 0.0130 3
2 0.0850 4
3 0.0500 3
4 0.0550 6
5 0.1153 7
6 0.0653 14
7 0.1169 10
8 0.1942 6
9 0.1585 8
10 0.1180 6
11 0.0795 6
12 0.0280 1
No individual groups are significantly different 
MTB > %nk
Executing from file: C:\MTBWIN\MACROS\nJc.MAC
Nevman-Keuls Multiple Range Test
Please enter the following info at the DATA> prompt : 
Number of groups
DATA> 12
MS(error)
DATA> 0.00653
Df(error)
DATA> 62
means of each group 
DATA> 0.01600 
DATA> 0.11175 
DATA> 0.03367 
DATA> 0.04233 
DATA> 0.09329 
DATA> 0.06007 
DATA> 0.07210 
DATA> 0.14850 
DATA> 0.11213 
DATA> 0.08450 
DATA> 0.05600 
DATA> 0.02100
number of observations in each group
DATA> 3 
DATA> 4 
DATA> 3 
DATA> 6 
DATA> 7 
DATA> 14 
DATA> 10 
DATA> 6 
DATA> 8 
DATA> 6 
DATA> 6 
DATA> 1
Results of Nevman-Keuls multiple range test
Ka Pc*
Data Display
MS error: 0.00658 df error: 62
Group Mean Count
1 0 7
Data Display
1 0.01600 3
2 0.11175 4
3 0.03367 3
4 0.04233 6
5 0.09329 7
6 0.06007 14
7 0.07210 10
8 0.14850 6
9 0.11213 8
10 0.08450 6
11 0.05600 6
12 0.02100 1
No individual groups are significantly different 
MTB > %nk
Executing from file: C:\MTBWIN\MACROS\nk.MAC
Newman-Keuls Multiple Range Test
Please enter the following info at the DATA> prompt 
Number of groups
DATA> 12
MS(error)
DATA> 0.0014
Df(error)
DATA> 62
means of each group 
DATA> 0.02367 
DATA> 0.09125 
DATA> 0.05133 
DATA> 0.03917 
DATA> 0.06557 
DATA> 0.04779 
DATA> 0.04620 
DATA> 0.05333 
DATA> 0.04775 
DATA> 0.03850 
DATA> 0.05433 
DATA> 0.02800
number of observations in each croup
DATA> 3 
DATA> 4 
DATA> 3 
DATA> 6 
DATA> 7 
DATA> 14 
DATA> 10 
DATA> 6 
DATA> 8 
DATA> 6 
DATA> 6 
DATA> 1
Results of Newman-Keuls multiple range test
Data Display
MS error: 0.0014 df error: 62
1 0 8
i U v r
Group Mean Count
Data Display
1 0.02367 3
2 0.09125 4
3 0.05133 3
4 0.03917 6
5 0.06557 7
6 0.04779 14
7 0.04620 10
8 0.05333 6
9 0.04775 8
10 0.03850 6
11 0.05433 6
12 0.02800 1
No individual groups are significantly different 
MTB > %nJc
Executing from file: C :\MTBWXNAMACROS\nJc. MAC
Newman-Keuls Multiple Range Test (^ j\T
Please enter the following info at the DATA> prompt : 
Number of groups
DATA> 12
MS(error)
DATA> 0.0007 49
Df(error)
DATA> 62
means of each group 
DATA> 0.01000 
DATA> 0.07525 
DATA> 0.03167 
DATA> 0.02917 
DATA> 0.04943 
DATA> 0.03600 
DATA> 0.02900 
DATA> 0.0455 0 
DATA> 0.04588 
DATA> 0.02167 
DATA> 0.04500 
DATA> 0.02500
number of observations in each group
DATA> 3
DATA> 4
DATA> 3
DATA> 6
DATA> 7
DATA> 14
DATA> 10
DATA> 6
DATA> 8
DATA> 6
DATA> 6
DATA> 1
Results of Newman-Keuls multiple range test 
* ERROR * Specified F format is too small for variable 2.
1 0  9
* Macro exiting...
MTB > %nk
Executing from file: C:\MTBWlN\MACROS\nk.MAC
Newman-Keuls Multiple Range Teat
Please enter the following info at the DATA> prompt 
Number of groups
DATA> 12
MS(error)
DATA> 0.0377
Df(error)
DATA> 62
means of each group 
DATA> 0.02267 
DATA> 0.04600 
DATA> 0.04167 
DATA> 0.03200 
DATA> 0.0655 7 
DATA> 0.03264 
DATA> 0.07840 
DATA> 0.06750 
DATA> 0.05063 
DATA> 0.03417 
DATA> 0.03417 
DATA> 0.02000
number of observations in each group
DATA> 3
DATA> 4
DATA> 3
DATA> 6
DATA> 7
DATA> 14
DATA> 10
DATA> 6
DATA> 8
DATA> 6
DATA> 6
DATA> 1
Results of Nevman-Keuls multiple range test
Data Display
MS error: 0.0377
Group Mean
Data Display
df error: 
Count
62
1 0 .02267 3
2 0.04600 4
3 0,04167 3
4 0.03200 6
5 0. 06557 7
6 0.03264 14
7 0.07840 10
8 0.06750 6
9 0.05063 8
10 0.03417 6
11 0.03417 6
1 1 0
12 0 . 0 2 0 0 0  1
No individual groups are significantly different
MTB > %nk
Executing from file: C:\MTBWIN\MACROS\nk.MAC
Nevman-Keuls Multiple Range Test
Please enter the following info at the DATA> prompt 
Number of groups
DATA> 12
DATA> 0.
DATA> 62
DATA> 0 .
DATA> 0.
DATA> 0.
DATA> 0.
DATA> 0.
DATA> 0.
DATA> 0.
DATA> 0.
DATA> 0.
DATA> 0.
DATA> 0 .1
DATA> 0.1
DATA> 3
DATA> 4
DATA> 3
DATA> 6
DATA> 7
DATA> 14
DATA> 10
DATA> 6
DATA> 8
DATA> 6
DATA> 6
DATA> 1
MS(error)
Df(error)
0350
1102
0680
0490
1803
1135
0912
1247
1576
means of each group
0920
number of observations in each group
Results of Newman-Keuls multiple range test
Data Display
MS error: 0.0137
Group Mean
Data Display
df error: 
Count
62
1 0.0350 3
2 0.1102 4
3 0.0680 3
4 0.0490 6
5 0.1803 7
6 0.1135 14
7 0.0912 10
8 0.1247 6
1 1 1
9 0.1576 8
10 0.0912 6
11 0.0995 6
12 0.0920 1
No individual groups are significantly different 
MTB > %nk
Executing from file: C: \MTBWIN\MACROS\nJc.MAC
Newman-Keuls Multiple Range Test
Please enter the following info at the DATA> prompt : 
Number of groups
DATA> 12
MS(error)
DATA> 0.00704
Df(error)
BATA> 62
means of each group 
DATA> 0.03567 
DATA> 0.13625 
DATA> 0.06533 
DATA> 0.06833 
DATA> 0 . 0 8 3 7 1 
DATA> 0.07150 
DATA> 0.09630 
DATA> 0.22683 
DATA> 0.09563 
DATA> 0.08033 
DATA> 0.07433 
DATA> 0,05500
number of observations in each group
DATA> 3 
DATA> 4 
DATA> 3 
DATA> 6 
DATA> 7 
DATA> 14 
DATA> 10 
DATA> 6 
DATA> 8 
DATA> 6 
DATA> 6 
DATA> 1
Results of Newman-Keuls multiple range test
Data Display
MS error: 0.00704
Group Mean
Data Display
df error: 
Count
62
1 0.03567 3
2 0.13625 4
3 0.06533 3
4 0.06833 6
5 0.08371 7
1 1 2
6 0.07150 14
7 0.09630 10
8 0.22683 6
9 0.09563 8
10 0.08033 6
11 0.07433 6
12 0.05500 1
No individual groups are significantly different 
MTB > %nk
Executing from file: c:\MTBWIN\MACROS\nk.MAC
Newman-Keuls Multiple Range Test tAlcTH/
Please enter the following info at the DATA> prompt 
Number of groups
MS(error)
34
Df(error)
means of each group
DATA> 1 2
DATA> 0 .!
DATA> 6 2
DATA> O .i
DATA> 0 .
DATA> 0 .
DATA> 0.1
DATA> 0 .
DATA> 0 .
DATA> 0 .
DATA> 0 .
DATA> 0 .1
DATA> 0 .  !
DATA> 0 .
DATA> 0 .
DATA> 3
DATA> 4
DATA> 3
DATA> 6
DATA> 7
DATA> 1 4
DATA> 10
DATA> 5
DATA> 8
DATA> 6
DATA> 6
DATA> 1
08307
13650
28467
0 9 813
07517
11633
07000
number of observations in each group
Results of Newman-Keuls multiple range test
Data Display
MS error: 0.00934
Group Mean
Data Display
df error: 
Count
62
0.05467 
0.15400
1 1 3
3 0.08600 3
4 0.08950 6
5 0.10900 7
6 0.08307 14
7 0.13650 10
8 0.28467 6
9 0.09813 8
10 0.07517 6
11 0.11633 6
12 0.07000 1
No individual groups are significantly different 
MTB > %nk
Executing from file: C:\MTBWlN\MACROS\nk.MAC
Newman-Keuls Multiple Range Test
Please enter the following info at the DATA> prompt 
Number of groups
DATA> 12
MS(error)
DATA> 0 . 0 0 8 7 7
Df(error)
DATA> 62
means of each group 
DATA> 0.03600 
DATA> 0.11750 
DATA> 0.07000 
DATA> 0.08150 
DATA> 0.10686 
DATA> 0.07593 
DATA> 0.09220 
DATA> 0.32150 
DATA> 0.08025 
DATA> 0.06983 
DATA> 0.09517 
DATA> 0.06600
DATA> 3 
DATA> 4 
DATA> 3 
DATA> 6 
DATA> 7 
DATA> 14 
DATA> 10 
DATA> 6 
DATA> 8 
DATA> 6 
DATA> 6 
DATA> 1
number of observations in each group
Results of Newman-Keuls multiple range test
Data Display
MS error: 0.00877 df error: 62
Group Mean Count
Data Display
1 1 1*
1 0.03600 3
2 0.11750 4
3 0.07000 3
4 0.08150 6
5 0.10686 7
6 0.07593 14
7 0.09220 10
8 0.32150 6
9 0.08025 8
10 0.06983 6
11 0.09517 6
12 0.06600 1
Data Display
Group 8 significantly different to group 1
Data Display
Group 8 significantly different to group 12
Data Display
Group 8 significantly different to group 10
Data Display
Group 8 significantly different to group 3
Data Display
Group 8 significantly different to group 6
Data Display
Group 8 significantly different to group 9
Data Display
Group 8 significantly different to group 4
Data Display
Group 8 significantly different to group 7
Data Display
Group 8 significantly different to group 11
1 1 5
Data Display
Group 8 significantly different to group 5
Data Display
Group 8 significantly different to group 2 
MTB > %nk
Executing from file: C:\MTBWIN\MACROS\nk.MAC
Newman-Keuls Multiple Range Test
Please enter the following info at the DATA> prompt 
Number of groups
DATA> 12
MS(error)
DATA> 0.00800
Df(error)
DATA> 6 2
means of each group 
DATA> 0.03367 
DATA> 0.15200 
DATA> 0.06533 
DATA> 0.06133 
DATA> 0.09971 
DATA> 0.08193 
DATA> 0.09410 
DATA> 0.24467 
DATA> 0.11737 
DATA> 0.07067 
DATA> 0.10050 
DATA> 0.05800
number of observations in each croup
DATA> 3 
DATA> 4 
DATA> 3 
DATA> 6 
DATA> 7 
DATA> 14 
DATA> 10 
DATA> 6 
DATA> 8 
DATA> 6 
DATA> 6 
DATA> 1
Results of Newman-Keuls multiple range test
Data Display
MS error: 0.009 df error: 62
Group Mean Count
Data Display
(C^CUfc
1 1 6
1 0.03367 3
2 0.15200 4
3 0.06533 3
4 0.06133 6
5 0.09971 7
6 0.08193 14
7 0.09410 10
8 0.24467 6
9 0.11737 8
10 0.07067 6
11 0.10050 6
12 0.05800 1
No individual groups are significantly different 
MTB > %nk
Executing from file: C:\MTBWIN\MACROS\nk.MAC
Newman-Keuls Multiple Range Test
Please enter the following info at the DATA> prompt 
Number of groups
DATA> 12
DATA> 0.013
DATA> 62
MS(error)
Df(error)
DATA>
DATA>
DATA>
DATA>
DATA>
DATA>
DATA>
DATA>
DATA>
DATA>
DATA>
DATA>
0597
1430
0670
0535
1121
0822
0835
3082
1125
0975
0998
0560
means of each group
DATA> 
DATA> 
DATA> 
DATA> 
DATA> 
DATA> 14 
DATA> 10 
DATA> 6 
DATA> 8 
DATA> 6 
DATA> 6 
DATA> 1
number of observations in each group
Results of Newman-Keuls multiple range test
Data Display
MS error: 0.013 df error: 62
Group Mean Count
Data Display
1 0.0597 3
2 0.1430 4
3 0.0670 3
4 0.0535 6
5 0.1121 7
6 0.0822 14
7 0.0835 10
8 0.3082 6
9 0.1125 8
10 0.0975 6
11 0.0998 6
12 0.0560 1
Data Display
Group 8 significantly different to group 9
Data Display
Group 8 significantly different to group 2 
MTB > %nk
Executing from file: C:\MTBWIN\MACROS\nk.MAC
Newman-Keuls Multiple Range Test
Please enter the following info at the DATA> prompt : 
Number of groups
DATA> 12
MS ( error)
DATA> 0.0165
Df(error)
DATA> 62
means of each group
DATA> 0.0547 
DATA> 0.0992 
DATA> 0.0540 
DATA> 0.0682 
DATA> 0.1941 
DATA> 0.0859 
DATA> 0.1088 
DATA> 0.1923 
DATA> 0.1553 
DATA> 0.0888 
DATA> 0.0882 
DATA> 0.0230
number of observations in each group
DATA> 3 
DATA> 4 
DATA> 3 
DATA> 6 
DATA> 7 
DATA> 14 
DATA> 10 
DATA> 6
1 1 8
DATA> 8 
DATA> 6 
DATA> 6 
DATA> 1
Results of Newman-Keuls multiple range test
Data Display
MS error; 0.0165 df error; 62
Group Mean Count
Data Display
1 Q.Q547 3
2 0.0992 4
3 0.0540 3
4 0.0682 6
5 Q . 1941 7
6 0.0859 14
7 0.1088 10
8 0.1923 6
9 0.1553 8
10 0.0888 6
11 0.0882 6
12 0.0230 1
No individual groups are significantly different 
MTB > %nk
Executing from file: C:\MTBWIN\MACROS\nk.MAC
Newman-Keuls Multiple Range Test
Please enter the following info at the DATA> prompt 
Number of groups
DATA> 12
MSf error)
DATA> 0.0139
Dfferror)
DATA> 62
means of each group
DATA> 0.2623 
DATA> 0.1395 
DATA> 0.1060 
DATA> 0.0720 
DATA> 0 . 0 6 6 0  
DATA> 0.0719 
DATA> 0.0691 
DATA> 0.2690 
DATA> 0.0780 
DATA> 0.0708 
DATA> 0.0833 
DATA> 0.0900
number of observations in each group
DATA> 3 
DATA> 4 
DATA> 3 
DATA> 6 
DATA> 7
DATA> 14 
DATA> 10 
DATA> 6 
DATA> 8 
DATA> 6 
DATA> 6 
DATA> 1
Results of Newman-Keuls multiple range test
Data Display
MS error: 0.0139 df error: 62
Group Mean Count
Data Display
1 0.2623 3
2 0.1395 4
3 0.1060 3
4 0.0720 6
5 0.0660 7
6 0.0719 14
7 0.0691 10
3 0.2690 6
9 0.0780 8
10 0.0708 6
11 0.0833 6
12 0.0900 1
No individual groups are significantly different 
MTB > %nk
Executing from file: C:\MTBWIN\MACROS\nk.MAC
Newman-Keuls Multiple Range Test ,1^
Please enter the following info at the DATA> prompt : 
Number of groups
DATA> 12
MS(error)
DATA> 0.00798
Df(error)
DATA> 62
means of each group 
DATA> 0.03067 
DATA> 0.16225 
DATA> 0.06233 
DATA> 0.05300 
DATA> 0.11043 
DATA> 0.08671 
DATA> 0.05920 
DATA> 0.23833 
DATA> 0.10813 
DATA> 0.09650 
DATA> 0.09567 
DATA> 0.07300
number of observations in each croup
DATA> 3 
DATA> 4
1 2 0
DATA> 3 
DATA> 6 
DATA> 7 
DATA> 14 
DATA> 10 
DATA> 6 
DATA> 8 
DATA> 6 
DATA> 6 
DATA> 1
Results o f  Newman-Keuls multiple range test
Data Display
MS error: 0*00798
Group Mean
Data Display
df error: 
Count
62
1 0.09067 3
2 0.16225 4
3 0.06233 3
4 0.05300 6
5 0.11043 7
6 0.08671 14
7 0.05920 10
8 0.23833 6
9 0.10813 8
10 0.09650 6
11 0.09567 6
12 0.07300 1
No individual groups are significantly different 
MTB > %nk
Executing from file: C:\MTBWIN\MACROS\nk.MAC
Newman-Keuls Multiple Range Test j\  ^vV^ /N’
Please enter the following info at the DATA> prompt : 
Number of groups
DATA> 12
MS(error)
DATA> 0.0191
Df(error)
DATA> 62
means of each group
DATA> 0.0163
DATA> 0*1463
DATA> 0.0447
DATA> 0.0220
DATA> 0.1309
DATA> 0.0691
DATA> 0.1066
DATA> 0.2160
DATA> 0.1130
DATA> Q.1Q95
DATA> 0.0480
DATA> 0.0460
1 2 1
number of observations in each group
DATA> 3 
DATA> 4 
DATA> 3 
DATA> 6 
DATA> 7 
DATA> 14 
DATA> 10 
DATA> 6 
DATA> 8 
DATA> 6 
DATA> 6 
DATA> 1
Results of Newman-Keuls multiple range test
Data Display
MS error: 0.0-191 df error: 62
Group Mean Count
Data Display
1 0.0163 3
2 ■ 0.1463 4
3 0.0447 3
4 0.0220 6
5 0.13Q9 7
6 0.0691 14
7 0.1066 10
8 0.2160 6
9 0.113Q 8
10 0.1095 6
11 0.0480 6
12 0.0460 1
No individual groups are significantly different 
MTB >
Executing from file: C:\MTBWIN\MACROS\nk.MAC
Newman-Keuls Multiple Range Test 11 L
Please enter the following info at the DATA> prompt 
Number of groups
DATA> 12
MS(error)
DATA> 0.0309
Df(error)
DATA> 62
means of each group
DATA> 0.0270 
DATA> 0.2283 
DATA> 0,0407 
DATA> 0.0455 
DATA> 0.1734 
DATA> 0.0807 
DATA> 0.1666 
DATA> 0.1665 
DATA> 0.1458 
DATA> 0.1410
1 2 2
DATA> 0.0425 
DATA> 0.0390
number of observations in each group
DATA> 3
DATA> 4
DATA> 3
DATA> 6
DATA> 7
DATA> 14
DATA> 10
DATA> 6
DATA> 8
DATA> 6
DATA> 6
DATA> 1
Results of Newman-Keuls multiple range test
Data Display
MS error: 0.0309
Group Mean
Data Display
df error: 
Count
62
1 0.0270 3
2 0.2283 4
3 0.0407 3
4 0.0455 6
5 0.1734 7
6 0.0807 14
7 0.1666 10
8 0.1665 6
9 0.1458 8
10 0.1410 6
11 0.0425 6
12 0.0390 1
No individual groups are significantly different 
MTB > %nk
Executing from file: C:\MTBWIN\MACROS\nk.MAC
Newman-Keuls Multiple Range Test
Please enter the following info at the DATA> prompt : 
Number of groups
DATA> 12
DATA>
I
0.0149
DATA>
1
62
DATA>
I
0.0367
DATA> 0.1693
DATA> 0.0523
DATA> 0.0630
DATA> 0.1419
DATA> 0.0796
DATA> 0.0873
MS(error)
Df(error)
means of each group
1 2 3
DATA> 0.2637 
DATA> 0 , 1 0 7 1  
DATA> 0.1323 
DATA> 0.0788 
DATA> 0.0240
number of observations in each group
DATA> 3 
DATA> 4 
DATA> 3 
DATA> 6 
DATA> 7 
DATA> 14 
DATA> 10 
DATA> 6 
DATA> 8 
DATA> 6 
DATA> 6 
DATA> 1
Results of Newman-Keuls multiple range test
Data Display
MS error: 0.0149 df error: 62
Group Mean Count
Data Display
1 0.0367 3
2 0.1693 4
3 0.0523 3
4 0.0630 6
5 0.1419 7
6 0.0796 14
7 0.0873 10
8 0.2637 6
9 0.1071 8
10 0.1323 6
11 0.0788 6
12 0.0240 1
No individual groups are significantly different
1 2 i*
Appendix H 
Methodology of Pollen Analysis
1 2  5
Faecal pollen analysis (From Caulton, 1988)
Firstly the faecal sample was desiccated at 30°C for one week. One gram of 
the resultant material was removed, ground to a powder and placed in a 
boiling tube. To this was added 20ml of 10 per cent potassium hydroxide, and 
placed in a boiling water bath for 20 minutes. At five minute intervals distilled 
water was added to maintain the 10 per cent concentration. The contents were 
then filtered and the filtrate centrifuged at 2000 rpm for ten minutes. 
Supernatant was removed and the precipitate washed and centrifuged again as 
above. A few ml of glacial acetic acid were then added to the precipitate and 
the contents centrifuged as above. To the precipitate, 2.5ml of a mixture of 
acetic anhydride and concentrated sulphuric acid (9/1 w/v) were added. The 
tube was then placed in a hot water bath for three minutes. Then a few drops 
of glacial acetic acid were added to stop the reaction. The resultant precipitate 
was then washed and centrifuged twice as above. Then the precipitate was 
allowed to drain over filter paper for 10 minutes.
10ml of 30 per cent dilute glycerine and five drops of basic fuschine stain 
were added to the precipitate and stirred. One to two drops of this now pink 
coloured suspension were added to warmed slides and covered. These slides 
were then sealed with DPX after thirty minutes. After this time analysis of 
these slides could take place at x 40 magnification on a standard microscope.
1 2 6
Appendix I
Statistical analysis of ELISA results for atopic and non-atopic
GDBA and GUVS dogs, greyhounds and beagles
1 2  7
Appendix II
Stadsitical analysis o f ELISA results fo r atopic and non-atopic
dogs (non-GDBA/non-atopic ^greyhounds).
12 8
Worksheet size: 100000 cells
MTB > glm c3=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Flea
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.000060 0.000239 0.000239 0.03 0.852
GDBA 1 0.000907 0.000999 0 000999 0.15 0.704
Atopic*GDBA 1 0.002621 0.002621 0.002621 0 38 0.538 
Error 128 0.879609 0 879609 0.006872
Total 131 0.883196
Unusual Observations for Flea
Obs Flea Fit StDev Fit Residual Sr Resid 
19 0.317000 0.072959 0.009637 0.244041 2.96R
39 0.474000 0.072959 0.009637 0.401041 4.87R
64 0.656000 0.072959 0.009637 0.583041 7 08R
116 0.298000 0.076562 0.014654 0.221438 2.71R
R denotes an observation with a large standardized residual
MTB > tabJe cl c2;
SU BO  stats c3.
Tabulated Statistics
Rows Atopic Columns GDBA 
1 2 .All
1 14 32 46
0.05807 0.07656 0.07093 
0.04482 0.06152 0.05711
2 74 12 86
0.07296 0.06858 0.07235 
0.09692 0.06774 0.09308
All 88 44 132
0 07059 0.07439 0.07186 
0.09062 0.06257 0.08211
Cell Contents —
Flea:N
Mean
StDev
1 2  9
MTB > glm c4=c 1 c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 I 2 
GDBA 2 1 2
Analysis of Variance for Mites
Source DF Seq SS Adj SS Adj MS F P
Atopic I 0.001316 0.006119 0.000119 0.03 0.859
GDBA 1 0.003904 0.003758 0.003758 1.00 0 320
Atopic*GDBA 1 0.001560 0.001560 0.001560 0.41 0.521 
Error 128 0.481820 0.481820 0.003764
Total 131 0.488600
Unusual Observations for Mites
Obs Mites 
16 0.287000 
27 0.276000 
39 0.303000 
46 0.276000 
48 0 275000 
94 0.275000 
97 0 000000 
117 0 263000
Fit StDev Fit 
0.1I6905 
0 116905 
0.116905 
0.116905 
0.116905 
0 128J56 
0128156 
0.128156
Residual St Resid
0.007132 0.170095 2.79R
0.007132 0.159095 2 61R
0.007132 0.186095 3.05R
0.007132 0.159095 2.6IR
0.007132 0.158095 2.59R
0.010846 0.146844 243R
0 010846 -0 128156 -2.12R
0.010846 0 134844 2.23R
R denotes an observation with a large standardized residual
MTB > table c 1 c2,
SUBC> stats c4
Tabulated Statistics
Rows: Atopic Columns: GDBA
] 2 All
1 14 32 46
0.12329 0.12816 0.12667 
0.05247 0.06425 0.06037
2 74 12 86
0 1169! 0.13942 0.12005 
0 06243 0.05522 0.06167
All 88 44 J32
0.) 1792 0.13123 0.12236 
0.06072 0.06150 0 06107
Cell Contents —
Mites: N 
Mean 
StDev
1 3 o
MTB > aim c5=cl c2 cl *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Feathers
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.001587 0.000002 0.000002 0.00 0.981
GDBA 1 0.005494 0.005706 0.005706 1.92 0.168
Atopic*GDBA 1 0.002445 0.002445 0.002445 0.82 0.366
Error 128 0.379760 0.379760 0.002967
Total 131 0.389288
Unusual Observations for Feathers
Obs Feathers Fit StDev Fit Residual St Resid
3 0.180000 0 071257 0.006332 0.108743 2,01R
12 0 213000 0.071257 0.006332 0.141743 2 62R
?! 0 291000 0.071257 0.006332 0.219743 4 06R
94 0.208000 0.087844 0.009629 0.120156 2 24R
110 0.388000 0 087844 0.009629 0.300156 5.60R
R denoies an observation with a large standardized residual
MTB > table cl c2;
SU BO  statsc5.
Tabulated Statistics
Rows. Atopic Columns: GDBA 
1 2 All
1 14 32 46
0.05993 0.08784 0.07935 
0 03158 0.07091 0.06262
2 74 12 86
0.07126 0.07708 0.07207 
0.04998 0.05094 0.04985
All 88 44 132
0 06945 0 08491 0.07461 
0.04756 0.06567 0.05451
Cell Contents —
Feathers: N 
Mean 
StDev
MTB >
1 3  1
MTB > gim 06=^  I c2 c 1 *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Altemar
Source DF Seq SS Adj SS Adj MS F P
Atopic I 0.014507 0.016197 0.016197 4.50 0.036
GDBA J 0.001857 0.001775 0.001775 0.49 0.484
Atopic *GDB A 1 0.001046 0.001046 0.001046 0.29 0.591 
Error 128 0 460985 0 460985 0.003601
Total 131 0.478394
Unusual Observations for Altemar
Obs Altemar Fit StDev Fit Residual St Resid 
7 0.225000 0.087797 0 006976 0.137203 2 30R
17 0 268000 0.087797 0.006976 0.180203 3.02R
24 0.209000 0.087797 0.006976 0.121203 2.03R
59 0 233000 0.087797 0.006976 0.145203 2.44R
83 0.353000 0.109000 0.016039 0.244000 4.22R
106 0.226000 0.106813 0.010609 0.119188 2.02R
R denotes an observation with a large standardized residual
MTB > Table cl c2;
SUBC> stats c6.
Tabulated Statistics
Rows. Atopic Columns: GDBA 
1 2 All
1 14 32 46
0.10900 0.10681 0.10748 
0.07756 0.06226 0.06641
2 74 12 86
' 0 08780 0.07117 0.08548 
0.05824 0.03695 0.05588
.All 88 44 132
0.09117 0.09709 0.09314 
0.06169 0.05833 0.06043
Cell Contents —
AltemaF:N
Mean
StDev
MTB >
t 3 2
iMTB > gJmc7=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Aspergil
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.012784 0.007260 0.007260 2.74 0.100
GDBA 1 0.000336 0.000357 0.000357 0 13 0.714 
Atopic*GDBA 1 0.000386 0.000386 0.000386 0.15 0.703 
Error 128 0 328983 0.338983 0.002648
Total 131 0.352489
Unusual Observations? for .Aspergil
Obs Aspergil Fit StDev Fit Residua! St Resid
64 0 226000 0 091500 0 005982 0.134500 2.63R
93 0.232000 0.114750 0 009097 0.117250 2.31R
98 0.001000 0 114750 0 009097-0.113750 -2.25R
1 12 0.226000 0 114750 0.009097 0.111250 2.20R
118 0.333000 0 114750 0 009097 0.218250 4.31R
R denotes an observation with a large- standardized residual
MTB > table cJ c2:
SU B O  stats c7.
Tabulated Statistics
Rows Atopic Columns GDBA 
I 2 All
! 14 32 46
0.10614 0.11475 0.11213 
0 05266 0.07067 0 06525
2 74 12 86
0.09150 0.09133 0.09148 
0.04229 0.03992 0.04174
All 88 44 132
0 09383 0.10836 0.09867 
0 . 0 4 4 0 9  0.06418 0.05187
Cell Contents —
Aspergil :N 
Mean 
StDev
MTB >
1 3 3
MTB > glm c8=cl c2 cl *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
.Analysis o f Variance for Rhizopus
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.021017 0.003532 0 003532 0.38 0.541
GDBA 1 0.011134 0 011104 0.011104 1.18 0.280
Atopic*GDBA 1 0.000011 0.000011 0.000011 0.00 0.973
Error 128 1 205076 1.205076 0.009415
Total 131 1.237237
Unusual Observations for Rhizopus
Obs Rhizopus Fit StDev Fit Residual SfResid 
3 0 406000 0.099932 0 011279 0.306068 3.18R
27 0 588000 0.099932 0 011279 0 488068 5.06R
39 0.396000 0.099932 0 011279 0.296068 3.07R
54 0.615000 0.099932 0 011279 0.515068 5.34R
83 0.313000 0.085929 0 025932 0 227071 2.43R
101 0.318000 0.063125 0 017152 0.254875 2.67R
R denotes an observation with a large standardized residual
MTB > table cl c2:
SUBC> stats c8.
Tabulated Statistics
Rows. Atopic Columns GDBA 
I 2 All
1 14 32 46
0.08593 0.06313 0.07007 
0 07503 0.06724 0 06967
2 74 12 86
0.09993 0.07567 009655 
0.11591 0.03156 0.10835
All 88 44 132
0.09770 0.06655 0.08732 
0.11019 0.05955 0 09718
Cell Contents ~
Rhizopus:N
Mean
StDev
MTB >
1 3 U
MTB > glm c9=cl c2 c 1 *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis o f Variance for Kapok
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.000197 0 002572 0.002572 0.40 0.529
GDBA 1 0.011398 0.011269 0.011269 1.75 0.188 
Atopic*GDBA I 0.000370 0 000370 0.000370 0.06 0.811 
Error 128 0.824643 0 824643 0 006443
Total 131 0 836609
Unusual Observations for Kapok
Obs Kapok Fit StDev Fit Residual St Reskl 
3 0.319000 0.077257 0 009331 0.241743 3.03R
27 0.383000 0 077257 0 009331 0 305743 3.84R
39 0.320000 0.077257 0 00933 1 0.242743 3.04R
54 0.410000 0.077257 0 009331 0.332743 4.I7R
79 0 479000 0.084286 0 021452 0.394714 5.10R
101 0.308000 0.064875 0 014189 0.243125 3.08R
R denotes an observation with a large standardized residual
MTB > table cl c2:
SUBC> stats c9
Tabulated Statistics
Rows: Atopic Columns GDBA 
1 2 All
1 14 32 40
0 08429 0.06487 0.07078 
0.12341 0.06438 0.08565
2 74 12 86
0.07726 0.04925 0.07335 
0.08188 0.02815 0 07718
.All 88 44 132
0.07837 0.06061 0.07245 
0.08893 0.05692 0.07991
Cell Contents —
Kapok. N 
Mean 
StDev
MTB >
1 3 5
MTB > glm c 10=e 1 c2 c 1 *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Dust
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.001348 0.000489 0.000489 0.47 0.496
GDBA I 0 000179 0.000176 0.000176 0 17 0.683
Atopic*GDBA 1 0.000011 0.000011 0 000011 0 01 0.920
Error 128 0 134485 0.134485 0.001051
Total 131 0.136023
Unusual Observations for Dust
Obs Dust Fit StDev Fit Residual St Resid
1 0.123000 0 050027 0 003768 0.072973 2.27R
12 0.136000 0.050027 0.003768 0.085973 2.67R
17 0.115000 0 050027 0 003768 0.064973 2.02R
73 0.160000 0 050027 0 003768 0 109973 3 42R
79 0.155000 0.044357 0 008663 0.110643 3.54R
R denotes an observation with a large standardized residual
MTB > table cl c2.
SU B O  stats c 10
Tabulated Statistics
Rows: Atopic Columns GDBA 
I 2 All
1 14 32 46
0.044357 0.042125 0.042804 
0.040636 0.026655 0.031 106
2 74 12 S6
0.050027 0.046333 0.049512 
0.033883 0.025553 0.032744
All 88 44 132
0.049125 0.043273 0.047174 
0.034849 0.026131 0.032223
Cell Contents —
DustN
Mean
StDev
MTB >
1 3 6
MTB > glm cl l=cl c2 cl *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Cat
Source DF Seq SS Ad) SS Adj MS F P
Atopic 1 0.0005974 0.0019071 0.0019071 2.57 0 111
GDBA 1 0 0012931 0.0012403 0.0012403 1.67 0.198
Atopic*GDBA 1 0.0006172 0.0006172 0.0006172 0.83 0.363 
Error 128 0.0949040 0.0949040 0.0007414
Total 131 0.0974117
Unusual Observations for Cat
Obs Cat Fit StDev Fit Residual St Resid 
1 0.115000 0.037919 0 003165 0.077081 2.85R
17 0.103000 0.037919 0.003165 0 065081 2.4IR
60 0.101000 0.037919 0 003165 0.063081 2.33R
R denotes an observation with a large standardized residual
MTB > table cl c2;
SUBC> stats c 11.
Tabulated Statistics
Rows Atopic Columns GDBA 
1 2 All
1 14 32 46
0.033714 0.036031 0 035326 
0.019201 0.024843 0.023083
2 74 12 86
0.037919 0 051333 0.039791 
0.028576 0.032148 0.029273
All 88 44 132
0.037250 0.040205 0.038235 
0.027252 0.027511 0.027269
Cell Contents —
Cat.N
Mean
StDev
MTB >
1 3 7
MTB >glm cl2=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
.Analysis of Variance for Human
Source DF Seq SS AdjSS Adj MS F P
Atopic 1 0.006477 0.006786 0.006786 2.96 0.088
GDBA 1 0.000622 0.000595 0.000595 0.26 0.612
Atopic*GDBA I 0.000329 0.000329 0.000329 0 14 0.706 
Error 128 0 293724 0.293724 0.002295
Total 131 0.301151
Unusual Observations for Human
Obs Human Fit StDev Fit Residual St Resid
8 0 197000 0.047419 0.005569 0.149581 3.14R
39 0 226000 0.047419 0 005569 0.178581 3.75R
48 0 434000 0.047419 0 005569 0.386581 8 13R
R denotes an observation with a large standardized residual
MTB > table cl c2;
SUBC> stats c l2.
Tabulated Statistics
Rows Atopic Columns; GDBA 
1 2 .All
1 14 32 46
0 033071 0.034469 0.034043 
0.020281 0.023903 0.022646
2 74 12 86
0 047419 0.056917 0.048744 
0.059374 0.034797 0.056527
.All 88 44 132
0.045136 0.040591 0.043621 
0.055202 0.028704 0.047946
Cell Contents —
Human: N 
Mean 
StDev
MTB >
1 3 8
MTB > glm cl3=cl c2 cl*c2
General Linear Model
Factor Levels V alues 
Atopic 2 1 -
GDBA 2 1 2
Analysis of Variance for Mucor
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.002564 0.003303 0.003303 0.33 0.564
GDBA 1 0 040385 0.041370 0.041370 4.19 0.043
Atopic*GDBA i 0.007454 0.007454 0.007454 0.75 0.387
Error 128 1.263922 1.263922 0.009874
Total 131 f. 314326
0.011552 0.340189 3.45R
0.011552 0 642189 6.51R
0.011552 0 263189 2.67R
0.011552 0.220189 2.23R
0.026558 0.282071 2.95R
0.026558 0.292071 3.05R
Unusual Observations for Mucor
Obs Mucor Fit StDev Fit Residual St Resid 
27 0.449000 0.108811 
39 0.751000 0.308811 
51 0.372000 0 .108811 
59 0 329000 0.108811 
79 0.423000 0.140929 
83 0.433000 0.140929
R denotes an observation with a large standardized residual
MTB > table cl c2.
SUBC> stats c 13
Tabulated Statistics
Rows Atopic Coiumns: GDBA 
1 2 All
1 14 32 46
0.14093 0.07622 0 09591 
0.13171 0.04634 0 08601
2 74 12 36
0.10881 0.08267 0 10516 
0.11426 0.04129 0.10731
AJ1 88 44 132
0.11392 0 07798 0 10194 
0.11699 0.04464 0.10016
Cell Contents —
Mucor: N 
Mean 
StDev
MTB >
1 3 9
MTB > glm cl4=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Orchard
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0 005394 0.000093 0.000093 0 01 0.911
GDBA 1 0 009784 0.009953 0.009953 1.35 0.247
Atopic*GDBA 1 0.000938 0.000938 0.000938 0.13 0.722 
Error 128 0.941534 0.941534 0.007356
Total 131 0 957650
Unusual Observ ations for Orchard
Obs Orchard Fit StDev Fit Residual St Resid
3 0.623000 0.093473 0.009970 0.529527 6.22R
54 0.324000 0.093473 0.009970 0.230527 2.71R
89 0.433000 0 117906 0.0151610 315094 3.73R
119 0.348000 0 117906 0.015161 0.230094 2.73R
R denotes an observation with a large standardized residual
MTB > table cl c2;
SUBC> stats cI4
Tabulated Statistics
Rows. Atopic Columns: GDBA 
1 2 All
1 14 32 46
0.08879 0.11791 0.10904 
0.05034 0.09949 0.08794
2 74 12 86
0.09347 0.10892 0.09563 
0.08908 0.04525 0 08431
All 88 44 132
0.09273 0.11545 0.10030 
0.08390 0.08761 0.08550
Cell Contents —
Orchard :N 
Mean 
StDev
MTB >
MTB >glm cl5=cl c 2 c l ,‘c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Timothy
Source DF Seq SS Adj SS Adj MS F P
Atopic I 0.006029 0.000222 0.000222 0.02 0.880
GDBA 1 0.019736 0.019701 0.019701 2.02 0.158
Atopic*GDBA 1 0.000005 0.000005 0.000005 0 00 0.983
Error 128 1 251335 1.251335 0.009776
Total 131 1.277104
Unusual Observations tor Timothy
Obs Timothy Fit SfDev Fit Residual St Resid
3 0.618000 0.115919 0.011494 0.502081 5. HR
8 0.576000 0 115919 0 011494 0.460081 4 68R
48 0.320000 0 .1159T9 0.011494 0.204081 2.08R
89 0.378000 0 143937 0 017479 0.234063 2 41R
101 0 366000 0.143937 0.017479 0.222063 2.28R
104 0.417000 0 143937 0.017479 0.273063 2.81R
R denotes an observation with a large standardized residual
.MTB > table cl c2;
SU BO  stats c l5.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
I 2 All
1 14 32 46
0.11307 0.14394 0.13454 
0.06228 0.10350 0 09330
2 74 12 86
0.11592 0.14775 0.12036 
0.10520 0.07440 0.10171
All 88 44 132
0.11547 0.14498 0.12530 
0.09934 0.09561 0.09874
Cell Contents —
Timothy:N 
Mean 
St Dev
MTB >
1 1* 1
MTB > glm cl6=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Kentucky
Source DF Seq &S Adj SS Adj MS F P
Atopic 1 0.00759 0.00000 0.00000 0.00 0.983
GDBA 1 0.01749 0.01748 0.01748 1.63 0.204
Atopic*GDBA 1 0.00000 0.00000 0 00000 0 00 0.995 
Error 128 1.37223 1.37223 0.01072
Total 131 1.39731
Unusual Observations for Kentucky
Obs Kentucky Fit StDev Fit Residual Sr Resid
3 0.669000 0 103203 0.012036 0.565797 5.50R
8 0.613000 0.103203 0 012036 0.509797 4.96R
89 0.545000 0.132250 0 018303 0.412750 4.05R
104 0.389000 0 132250 0.018303 0.256750 2.52R
R denotes-an observation with a large standardized residual
MTB > table cl c2;
SUBC> stats c 16
Tabulated Statistics
Rows: Atopic Columns: GDBA
i : ah
1 14 32 46
0.10257 0 13225 0.12322 
0 05128 0 11289 0.09864
2 74 12 86
0.10320 0.13258 0.10730 
0.10944 0 07900 0 10583
All 88 44 132
0.10310 0.13234 0.11285 
0.10219 0 10384 0.10328
Cell Contents —
Kentucky :N 
Mean 
StDev
MTB >
1 4  2
M TB>glmcl7=cl c2cl*c2
Genera! Linear Mode!
Factor Levels Values 
Atopic 2 I 2 
GDBA 2 1 2
.Analysis of Variance for Fescue
Source DF Seq SS Adj SS Adj MS F P
Atopic I 0.000885 0.010473 0.010473 1.15 0.286
GDBA 1 0.044518 0.043705 0.043705 4.79 0.030 
Atopic*GDBA I 0.003987 0.003987 0.003987 0 44 0.510
Error 128 1.168541 1.168541 0.009129
Total 131 1.217930
Unusual Observations for Fescue
Obs Fescue Fit StDev Fit Residual St Resid
3 0.682000 0 102041 0.011107 0.579959 6.11R
54 0.460000 0 102041 0.011107 0.357959 3.77R
89 0.435000 0 125875 0.016890 0.309125 3.29R
101 0.325000 0.125875 0 016890 0.199125 2.12R
125 0.418000 0.162833 0.027582 0.255167 2.79R
R denotes an observation with a large standardized residual
.MTB > table c 1 c2;
SUBC> stats c 17
Tabulated Statistics
Rows. Atopic Columns: GDBA 
1 2 All
1 14 32 46
0.09329 0.12588 0.11596 
0.05502 0 09544 0 08591
2 74 12 86
0.10204 0.16283 0 .11052 
0.10029 0 10112 0.10204
All 88 44 132
0.10065 0.13595 0.11242 
0.09436 0 09726 0.09642
Cell Contents -  
Fescue: N 
Mean 
StDev
MTB >
1 4 3
MTB> glm c!8=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis o f Variance for Poplar
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.00334 0.01222 0.01222 0 97 0.328
GDBA 1 0.00625 0.0QS65 0.00565 0.45 0.505
Atopic*GDBA I 0.01694 0.01694 0.01694 1.34 0.249
Error 128 1.61966 1.61966 0.01265
Total 131 1.64619
Unusual Observations for Poplar
Obs Poplar Fit StDev Fit Residual St Resid 
3 0.877000 0.108554 0.013077 0.768446 6.88R
36 0.461000 0 108554 0.013077 0.352446 3.15R
54 0.343000 0.108554 0.013077 0.234446 2.10R
79 0.332000 0.112929 0.030064 0.219071 2.02R
89 0.352000 0.100656 0 019885 0.251344 2.27R
101 0.385000 0.100656 0.019885 0.284344 2.57R
128 0.404000 0.154417 0.032473 0.249583 2.32R
R denotes an observation with a large standardized residual
MTB > table cl c2,
SUBC> stats cl8
Tabulated Statistics
Rows; Atopic Columns: GDBA 
1 2 All
1 14 32 46
0.11293 0.10066 0.10439 
0.09234 0.09484 0.09323
2 74 12 86
0.10855 0.15442 0.11495 
0.12268 0.10925 0.12135
All 88 44 132
0.10925 0.11532 0.11127 
0.11792 0.10062 0.11210
Cell Contents —
Poplar. N 
Mean 
StDev
MTB >
MTB >glm c!9=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 I 2
Analysis of Variance lor Birch
Source DF Seq SS Adj SS Adj MS F P
Atopic i 0.00092 0.00689 0.00689 0.42 0.517
GDBA . 1 0.01356 0.01385 0.01385 0.85 0.359
Atopic*GDBA 1 0.00196 0 00196 0.00196 0.12 0.730
Error 128 2.09110 2.09110 0.01634
Total 131 2.10754
Unusual Observations for Birch
Obs Birch Fit StDev Fit Residual St Resid 
27 0.460000 0 111649 0.014858 0.348351 2.74R
39 0.792000 0 111649 0.014858 0.680351 5 36R
54 0.656000 0.111649 0.014858 0.544351 4.29R
79 0.770000 0.140071 0 034160 0.629929 5 HR
101 0.381000 0 103906 0 022595 0 277094 2.20R
117 0.525000 0.103906 0.022595 0.421094 3.35R
R denotes an observation with a large standardized residual
MTB > table cl c2;
SUBC> stats cl 9
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 14 32 46
0 14007 0.10391 0.11491 
0.19267 0.11163 0.13997
2 74 12 86
0.11165 0.09525 0.10936 
0.12718 0.06143 0.12005
All 88 44 132
011617 0.10155 0.11130 
0.13866 0 09982 0 12684
Cell Contents —
Birch; N 
Mean 
StDev
MTB >
1 U 5
MTB > glm c20=c I c2 c 1 *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
.Analysis of V ariance for Sorrel
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.00790 0.00918 0.00918 0.85 0.359
GDBA 1 0.00278 0.00291 0.00291 0.27 0.605
Atopic*GDBA 1 0.00174 0.00174 0.00174 0.16 0 689
Error 128 1.38662 1.38662 0.01083
Total 131 1.39905
Unusual Observations for Sorrel
Obs Sorrel Fit StDev Fit Residual St Resid
3 0.790000 0.101446 0.012099 0 688554 6.66R
8 0.400000 0.101446 0 012099 0.298554 2.89R
69 0.730000 0 101446 0.012099 0.628554 6.08R
89 0.375000 0.092094 0 018399 0.282906 2.76R
R denotes an observation with a large standardized residual
MTB > table cl c2;
SU B O  stats c20.
Tabulated Statistics
Rows. Atopic Columns: GDBA 
1 2 AH
1 14 32 46
0.07071 0.09209 0.08559 
0.03715 0 07197 0.06376
2 74 12 86
0.10145 0.10417 0.10183 
0.12636 0 06220 0.11922
All 88 44 132
0.09656 0 09539 0.09617 
0.11718 0 06895 0.10334
Cell Contents —
Sorrel :N 
Mean 
StDev
MTB >
1 U 6
MTB > glm c21=cl c2 cl*c2
General Linear Made!
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Plantain
Source DF Seq SS Adj SS Adj MS F P
Atopic I 0.000810 0.000098 0.000098 0.01 0.918
GDBA 1 0.000125 0.000095 0.000095 0.01 0.919
Atopic*GDBA 1 0.002315 0.002315 0.002315 0,25 0.618 
Error 128 1.184646 1.184646 0.009255
Total 131 1.187896
Unusual Observations for Plantain
Obs Plantain Fit StDev Fit Residual St Resid 
10.313000 0.103324 0.011183 0.209676 2.19R
3 0.619000 0.103324 0.011183 0.515676 5.40R
39 0.306000 0.103324 0.011183 0.202676 2.12R
54 0.332000 0.103324 0.011183 0.228676 2.39R
79 0.313000 0.116286 0.0257110.196714 2.12R
101 0.487000 0.107719 0.017006 0.379281 4.01R
104 0 328000 0.107719 0.017006 0.220281 2.33R
R denotes an observation with a large standardized residual
MTB > table c 1 c2;
SUBC> stats c21
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 14 32 46
0.11629 0.10772 0.11033 
0.08262 0.10746 0.09972
2 74 12 86
0.10332 0.11625 0.10513 
0.09522 0.08316 0.09328
All 88 44 132
0.10539 0.11005 0.10694 
0.09301 0.10055 0.09523
Cell Contents —
Pfantain:N
Mean
StDev
MTB >
U  7
MTB > elm c22=ci c2 cJ *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Mugwort
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.00049 0.00055 0.00055 0.03 0.861
GDBA I 0 00102 0.00118 0.00118 0.07 0.796
Atopic*GDBA 1 0.00707 0.00707 0.00707 0.40 0.528
Error 128 2.25906 2.25906 0.01765
Total 131 2.26764
Unusual Observations for Mugwort
Obs Mugwort Fit StDev Fit Residual St Resid
3 0.507000 0.095149 0.015443 0.411851 3.I2R
27 0.433000 0.095149 0.015443 0.337851 2.56R
39 0.601000 0.095149 0.015443 0.505851 3.83R
48 0.381000 0.095149 0.015443 0.285851 2.17R
54 0.582000 0.095149 0.015443 0.486851 3.69R
79 0.706000 0.119143 0.035505 0.586857 4.58R
101 0.464000 0 092688 0 023485 0.371313 2.84R
126 0.372000 0.10625Q 0.038350 0.265750 2.09R
R denotes an observation with a large standardised residual
MTB > table cl c2;
SUBC> stats c22.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
i : All
1 14 32 46
0.11914 0.09269 0.10074
0.18355 0.10380 0.13155
2 74 12 86
0.09515 0.10625 0.09670
013746 0 09893 0.13233
All 88 44 132
0.09897 0.09639 0.09811
0.14480 0 10153 0.13157
Cell Contents — 
Mugwort :N 
Mean 
StDev
MTB >
MTB > glm c23=cl c2 cl *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Dandelio
Source DF Seq SS Adj SS Ad] MS F P
Atopic 1 0.00026 0.01850 0.01850 0.71 0.401
GDBA 1 0.05115 0.05138 0.05138 1.97 0.163
Atopic*GDBA 1 0.00041 0.00041 0.00041 0.02 0.901
Error 128 3.33231 3.33231 0.02603
Total 131 3.38414
Unusual Observations for Dandelio
Obs Dandelio Fit StDev Fit Residual St Resid 
27 0.520000 0.117622 
39 0.681000 0.117622 
44 0.760000 0.117622 
54 0.756000 0.117622 
71 0.713000 0.117622 
79 0.737000 0.152500 
83 0.686000 0.152500 
98 0.500000 0.097375 
101 0.421000 0.097375
0.018757 0.402378 2.51R
0.018757 0.563378 3.52R
0.018757 0.642378 4.01R
0.018757 0.638378 3.98R
0.018757 0.595378 3.72R
0.043122 0.584500 3.76R
0.043122 0.533500 3.43R
0.028523 0.402625 2.54R
0.028523 0.323625 2.04R
R denotes an observation with a large standardized residual
MTB > table c 1 c2; 
SUBO  stats c23.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 14 32 46
0.15250 0.09737 0 .11415 
0.24125 0 10965 0.16048
2 74 12 86
0.11762 0.07150 0.11119 
0.17242 0.05456 0.16179
All 88 44 132
0.12317 0.09032 0.11222 
0.18387 0 09780 0.16073
Cell Contents — 
DandelioN 
Mean 
StDev
MTB >
MTB > glm c24=c 1 c2 c I *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Nettle
Source DF Seq SS Adj SS Adj MS F P
Atopic I 0.00159 0.00098 0.00098 0.08 0.784
GDBA 1 0.01475 0.01490 0.01490 1.14 0.288
Atopic*GDBA 1 0.00057 0 00057 0.00057 0.04 0.836
Error 128 1.67415 1.67415 0.01308
Total 131 1.69105
Unusual Observations for Nettle
Obs Nettle Fit StDev Fit Residual StResid 
1 0.406000 0.108541 0.013295 0.297459 2.62R
3 0.560000 0.108541 0.013295 0.451459 3.97R
36 0.630000 0.108541 0.013295 0.521459 4.59R
39 0 570000 0.108541 0.013295 0.461459 4.06R
79 0 423000 0.120857 0.030565 0 302143 2.74R
83 0.436000 0.120857 0.030565 0 315143 2.86R
101 0.482000 0.088281 0.020217 0.393719 3.50R
R denotes an observation with a large standardized residual
MTB > table c 1 c2;
SUBC> stats c24.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 14 32 46
0 12086 0.08828 0.09820 
0.13590 0.08989 0.10551
2 74 12 86
0.10854 0.08658 0.10548 
0.12611 0.04538 0.11825
All 88 44 132
0.11050 0.08782 0.10294 
0.12698 0.07971 0.11362
Cell Contents —
Nettle:N
Mean
StDev
MTB >
1 5  0
Appendix 12
Statisitical analysis of ELISA results for atopic and non-atopic 
dogs (non-GDBA/non-atopic =beagles).
1 5  1
MTB > glm c3=c I c2 c I *c2
General Linear Model
Factor Levels Values 
Atopic 2 I 2 
GDBA 2 1 2
.Analysis of Variance for Flea
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.000015 0.000020 0.000020 0 00 0.957
GDBA 1 0.000405 0.000105 0.000105 0.02 0.901
Atopic*GDBA 1 0 004232 0.004232 0.QQ4232 0.63 0.429 
Error 124 0 834982 0.834982 0.006734
Total 127 0.839634
Unusuai Observations for Flea
Obs Flea Fit StDev Fit Residual St Resid
19 0 317000 0.072959 0.009539 0.244041 2.99R
39 0 474000 0.072959 0 009539 0.401041 4 92R
64 0 656000 0.072959 0.009539 0.583041 7.15R
116 0 298000 0.076563 0.014506 0.221438 2.74R
121 0 064000 0.059500 0.029012 0.004500 0.06 X
122 0.065000 0.059500 0.029012 0.005500 0.07 X
123 0 052000 0 059500 0 029012 -0.007500 -0.10 X
124 0 041000 0.059500 0.029012 -0.018500 -0.24 X
125 0.037000 0.059500 0 029012 -0 022500 -0.29 X
126 0 035000 0.059500 0.029012 -0 024500 -0.32 X
127 0.125000 0059500 0 029012 0 065500 0.85 X
128 0057000 0.059500 0 029012 -0.002500 -0.03 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence
MTB > table cl c2;
SUBC> stats c3.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 .All
1 14 32 46
0.05807 0.07656 0.07093 
0 04482 0.06152 0.05711
2 74 8 82
0.072% 0.05950 0.07165 
0.09692 0.02891 0.09249
All 88 40 128
1 5 2
0.0/059 0.07315 0.07139 
0 09062 0.05662 0.08131
Cell Contents —
Flea:N
Mean
StDev
MTB > gim c4=cl c2 cl*c2
Genera} Linear Moaei
Factor Levels values 
Atopic 2 1 2
GDBA 2 l 2
Analysis of Vanance tor Mites
Source DF Seq SS Adj SS Adj MS F P
Atopic I 0.001621 0.000173 0.000173 0 05 0.832
GDBA 1 0.002890 0 003478 0.003478 0.9 i 0 343
Atopic*GDBA 1 0.001532 0.001532 0.001532 0.40 0 528 
Error 124 0.475287 0 475287 0 003833
Total 127 0.481331
Unusual Observations for Mites
Obs Mites Fit StDev Fit Residual St Resid
16 0.287000 0 116905 0.007197 0.170095 2.77R
27 0 276000 0.116905 0.007197 0.159095 2.59R
39 0.303000 0.116905 0.007197 0.186095 3 03 R
46 0.276000 0 116905 0 007197 0 159095 2 59R
48 0.275000 0 116905 0 007197 0.158095 2.57R
94 0 275000 0.128156 0 010944 0.146844 2.41 R
97 0 000000 0.128156 0.010944--0.128156 -2.10R
1J7 0.263000 0 128156 0 010944 0.134844 2.21R
121 0 163000 0.141000 0 021889 0 022000 0.38 X
122 0 250000 0 141000 0 021889 0.109000 1.88 X
123 0.147000 0.141000 0.021889 0.006000 0.10 X
124 0 098000 0.141000 0.021889 4)043000 -0.74 X
125 0 199000 0 141000 0 021889 0.058000 1.00 X
126 0 063000 0.141000 0.021889 -0.078000 -1.35 X
127 0.121000 0.141000 0 021889 -0.020000 -0.35 X
128 0 087000 0.141000 0.021889 -0.054000 -0.93 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table c I c2;
SUBC> stats c4.
Tabulated Statistics
Rows: Atopic Columns: GDBA
1 5 3
I 2 Ail
1 i 4 32 46
0.12329 0.12816 0.12667 
0 05247 u.06425 0.06037
2 74 8 82
0.11691 0.14100 0.11926 
0.06243 0.06212 0.06243
All 88 40 128
0.11792 0.13073 0.12192 
0.06072 0.06325 0.06156
Cell Contents —
Mites: N 
Mean 
StDev
MTB > glm c5=cl c2 cl *c2
Genera} Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Vanance tor Feathers
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.001333 0.000316 0.000316 0.11 0.740 
GDBA 1 0.008199 0.007282 0.007282 2.55 0 113 
Atopic*GDBA 1 0000804 0.000804 0.000804 0 28 0.597
brror 124 0 354525 0.354525 0 002859
Total 127 0.364861
Unusual Observations for Feathers
Obs Feathers Fit StDev Fit Residual St Resid
3 0.180000 0.071257 
12 0.213000 0 071257 
51 0.291000 0.071257 
94 0.208000 0.087844 
110 0.388000 0.087844
121 0 .110000 0.085250
122 0.091000 0.085250
123 0 066000 0.085250
124 0.079000 0.085250
125 0.123000 0.085250
126 0.060000 0.085250
127 0.081000 0.085250
128 0.072000 0.085250
0.006216 0.108743 2.05R
0.006216 0.141743 2.67R
0.006216 0.219743 4 14R
0.009452 0.120156 2.28R
0 009452 0.300156 5.70R
0.018905 0.024750 0.49 X
0.018905 0.005750 0.11 X
0.018905 -0.019250 -0 38 X
0.018905 -0.006250 -0 12 X
0.018905 0.037750 0.75 X
0.018905 -0.025250 -0 50 X
0.018905 -0.004250 -0.08 X
0.018905 -0 013250 -0.26 X
R denotes an observation with a large standardized residual
1 5 4
X denores an observation whose X value gives it large intiuence.
iVHB > labie ci c2;
SUBC> stats c5
Tabulated Statistics
Kows: Atopic Columns: CUBA 
i 2 Ali
1 i4 51 40
0.05993 0.08784 0.07935 
0.03138 0.07091 0.06262
2 74 8 82
0.07126 0.08525 0.07262 
0.04998 0.02175. 0.04806
All 88 40 128
0.06945 0.08733 0.07504 
0 04 756 0.06390 0.05360
Cell Contents —
Feathers:N
Mean
StDev
MTB > glm c6=c 1 c2 c I *c2
General Linear fwoaei
Factor Leveis Values 
Atopic 2 ! 2
UDBA 2 J
Analysis ot Variance tor AJtemar
Source DF Seq SS Acij SS Aaj MS F P
Atopic 1 0.012789 0 011218 0.011218 3.04 0.084
GDBA ~ I 0.000669 0 000811 0.000811 0.22 0.640
Atopic*GDBA I 0.000383 0 000383 0.000383 0.10 0.748 
Error 124 0.457249 0.457249 0.003687
Total 127 0.471089
Unusual Observations tor Altemar
Obs .Altemar Fit StDev Fit Residual 
7 0.225000 0.087797 
17 0.268000 0.087797 
24 0.209000 0.087797 
69 0.233000 0.087797 
83 0 353000 0.109000 
121 0.118000 0.076000
St Resid
0.007059 0.137203 2.27R
0.007059 0.180203 2.99R
0.007059 0.121203 2 01R
0.007059 0.145203 2.41R
0.016229 0.244000 4 17R
0.021469 0042000 0.74 X
15 5
i 22 u. 154000 O.G 7oOGO 0.02 1469 0.038000 1.02 X
123 0 040000 0.076000 0.021469-0.036000 -0.63 X
124 0 090000 0.076000 0.021469 0.0i4000 0.25 X
125 0 104000 0.076000 0.021469 0.028000 0.49 X
126 0.036000 0.076000 0.021469-0.040000 -0.70 X
127 0.036000 0.076000 0.021469-0.040000 -0.70 X
128 0.050000 0.076000 0.021469-0.026000 -0.46 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table c 1 c2;
SUBC> stats c6
Tabulated Statistics
Rows: Atopic Columns: GDBA 
J 2 All
1 14 32 46
0.10900 0.10681 0.10748 
0 07756 0.06226 0.06641
2 74 8 82
0.08780 0.07600 0.08665 
0 05824 0.04014 0.05664
r
All 88 40 128
0.09117 0.10065 0.09413 
0.06169 0 05938 0.06090
Cell Contents —
AJtemanN
Mean
StDev
MTB > elm c7=cl c2 cl *c2 
General Linear fooaet
t'actor Levels Values 
Atopic 2 1 2
uuBn z i
Analysis or variance ror Aspergn
source L>f 6eq 66 Adj 66 Adj \16 r k
Atopic 1 0 015816 0.016926 0.016926 635  0.013 
ui7on  i u.u00o3o 0.00i254 0.00i254 0.47 0 4V4
Atopic*GDBA I 0 004966 0 004966 0 004966 1.86 0 175
1 5  6
hiior
Total
124 0.330400 0.33G4o0 0.002665 
127 0.351878
Unusual Observations ior Aspergu
uos Aspergu 
64 0.226000 
93 0.232000 
98 0.001000 
i i 2 0 226000 
118 0 333000
121 0 148000
122 0.078000
123 0.051000
124 0 044000
125 0.043000
126 0.043000
127 0.047000
128 0 070000
Nt ML>ev t-it Kesiduai 
0.091500
0.114750 
0.114750 
0 .114750 
0.114750 
0.065500 
0.065500 
0.065500 
0.065500 
0.065500 
0.065500 
0.065500 
0.065500
M Kesid
0.006001 0 134500 2.62R
0.009126 0. i 17250 2.31R
0 009126■-0.113750 -2.24R
0.009126 0.111250 2.I9R
0.009126 0.218250 4.30R
0.018252 0.082500 1.71 X
0.018252 0.012500 0.26 X
0.018252 -0.014500 -0.30 X
0.018252 -0.021500 -0.45 X
0.018252 -0.022500 -0.47 X
0.018252 -0.022500 -0.47 X
0.018252 -0.018500 -0.38 X
0.018252 0.004500 0.09 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table cl c2;
SUBO  stats c7.
Tabulated Statistics
Rows Atopic Columns: UUUA 
1 2 All
i 14 32 40
0.10614 0.11475 0.11213 
0 052oo 0.070o7 O uo525
1 ;4 8 82
0.09150 0.06550 0.08896 
0 04229 0.03588 0.04223
Aii 88 40 i28
0.09383 0.10490 0 09729 
0.04409 0.06781 0.05264
Cell Contents —
Aspergil:N
Mean
StDev
MTB > glm c8=cl c2 ci *c2
General Linear Model
15 7
ra c to i l c v c i s  values 
Atopic 2 1 2
yjuda 2 i
Analysis oi variance for Rhizopus
source ut* seq s s  Adj s s  Aaj m s  h p
Atopic I 0.016523 0.000660 0 000660 0.07 0 794
vjDd A i u.u2/2oy u.uit>ft55 e.uJGS53 5.20 0.o7o
Atopic*GDBA 1 0.006844 0.006844 0.006844 0.71 0.401 
Error 124 i. 196465 1.196465 0.009649
Total 127 1.247101
Unusual Observations tor Rhizopus
Obs Rhizopus Fit StDev Fit Residua} si Resiti 
3 0.406000 0.099932 
27 0 588000 0.099932 
39 0.396000 0.099932 
54 0 615000 0.099932 
83 0.3 33000 0.085929 
101 u 518000 0.063123
121 0 041000 0.036500
122 UO65GG0 0.036500
123 0 048000 0.036500
124 u '.>44000 0 036500
125 0 045000 0.036500
126 0.012000 0.036500
127 0 017000 0.036500
128 U.'.CUVUU U U3b5UV
0.011419 0.306068 3.14R
0.011419 0.488068 5.00R
0.011419 0.296068 3.03R
0.011419 0 515068 5 28R
0.026253 0.227071 2.40R
U.Ol /365 0.254ft/J *i.o4i<
0.034729 0.004500 0 05 X
0.034729 0.028500 0 Si A
0.034729 0.011500 0.13 X
0.03472y U.00/500 U.Uft A
0.034729 0.008500 0.09 X
0 034729 -0.024500 -0.27 X
0 034729-0.019500 -0.21 X
U U34/2y -0.UI6S6U -v. 18 A
K. ueiiincs an uu>ci vation wttn a large standardized residual 
X denoies an observation whose X value gives it large influence
Vi11) -  laDie ci cz; 
SUBC> stats c8.
iduuiaieu otatistics
Rows Aiopic Cuiunins. uUtiA  
i 2 Ail
1 W 40
0.08593 0.06313 0.07007 
0.u75u3 0.06/24 u.uo9o7
2 -+ 8 82 
0.09993 0.03650 0.09374 
U. 1 i59i U.UI831 o il I /is
15 8
All 88 40 128
0.09770 0.05780 0.08523 
0.11019 0.06141 0.09909
Cell Contents -- 
Rhizopus: N 
Mean 
StDev
MTB > glm c9=c 1 c2 c 1 *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Kapok
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.000314 0.003142 0.003142 0.48 0 492
GDBA 1 0.010723 0.011337 0 011337 1.72 0.193
Atopic*GDBA 1 0.000752 0 000752 0.000752 0.11 0.7 
Error 124 0.819568 0.819568 0 006609
Total 127 0.831358
Unusual Observations for Kapok
Obs Kapok Fit StDev Fit Residual St Resid
3 I0 319000 <0 077257 0.009451 l0.241743 2.99R
27 0 383000 0.077257 0 009451 0.305743 3.79R
39 0 320000 0.077257 0.009451 0 242743 3.01R
54 0 410000 0.077257 0.009451 0.332743 4.12R
79 0.479000 0 084286 0.021728 0.394714 5.04R
10! 0 308000 0.064875 0.014372 0.243125 3.04R
121 0076000 0.044375 0.028743 0.031625 0.42 X
122 0 081000 0.044375 0.028743 0.036625 0.48 X
123 0 049000 0.044375 0 028743 0.004625 0.06 X
124 0 034000 0 044375 0.028743 -0.010375 -0.I4X
125 0 032000 0.044375 0.028743 -0.012375 -0.16 X
126 0.028000 0.044375 0.028743 -0.016375 -0.22 X
127 0037000 0.044375 0.028743 -0.007375 -0.10X
128 0.018000 0.044375 0.028743 -0.026375 -0.35 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table cl c2;
SUBC> stats c9.
Tabulated Statistics
Rows: Atopic Columns: GDBA
1 2 All
1 ]4 32 46
0.08429 0.06487 0.07078 
0.12341 0.06438 0.08565
2 74 8 82
0.07726 0.04438 0.07405 
0.08188 0.02281 0.07864
.Ail 88 4Q 128
0.07837 0.06078 0.07288 
0.08893 0.05879 0.08091
Cell Contents -- 
Kapok. N 
Mean 
StDev
MTB > glm c 10=c 1 c2 c 1 *c2
Genera! Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Dust
Source DF Seq SS Adj SS Adj MS F P
Atopic ) 0.001846 0.001771 0 001771 I 58 0.212 
GDBA ! 0 000051 0.000098 0 000098 0 09 0.768
Atopic*GDBA 1 0.000361 0.000361 0 000361 0 32 0 572
Error 124 0.139392 0.139392 0.001124
Total 127 0.141650
Unusual Observations for Dust
Obs Dust Fit StDev Fit Residual St Resid
1 10.123000 0.050027 0.003898 I3.072973 2.19R
12 0.136000 0.050027 0.003898 0.085973 2 58R
73 0.160000 0.050027 0.003898 0.109973 3.30R
79 0.155000 0044357 0.008961 0.110643 3.42R
121 0.123000 0.057125 0.011854 0.065875 2.I0RX
122 0.039000 0.057125 0.011854-0.018125 -0.58 X
123 0.123000 0.057125 0.011854 0.065875 2.10RX
124 0.026000 0.057125 0.011854 -0.031125 -0.99X
125 0.032000 0.057125 0.0II854 -0.025125 -0 80 X
126 0.022000 0.057125 0.011854 -0.035125 -1.12 X
127 0.046000 0.057125 0.011854 -0.011125 -0.35 X
128 0.046000 0.057125 0.011854 -0 011125 -0.35 X
1 6  0
\
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > tabled c2;
SUBC> stats clO.
Tabulated Statistics
Rows: Atopic Columns; GDBA 
1 2 All
1 14 32 46
0.044357 0.042125 0.042804 
0.040636 0.026655 0.031106
2 74 8 82
0.050027 0.057125 0.050720 
0.033883 0.041557 0.034474
All 88 40 128
0.049125 0.045125 0.047875 
0.034849 0.030194 0.033397
Cell Contents —
Dust:N
Mean
StDev
MTB > glm cl !=cl c2 c 1 *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 I 2
.Analysis of Variance for Cat
Source DF Seq SS Adj SS Adj MS F P 
Atopic 1 0.0001829 0.0001057 0.0001057 0.15 0 700 
GDBA 1 0.0000133 0.0000067 0.0000067 0.01 0.923 
Atopic*GDBA 1 0 0000468 0.0000468 0.0000468 0.07 0.798
Error 124 0.0880762 0.0880762 0.0007103
Total 127 0.0883192
Unusual Observations for Cat
Obs Cat Fit StDev Fit Residual St Resid
l 0.115000 0.037919 0.003098 0.077081 2.91R
3 i0.091000 0.037919 0.003098 ■0.053081 2.01R
17 0.103000 0.037919 0.003098 0.065081 2.46R
60 0.101000 0.037919 0 003098 0.063081 2.38R
62 0:091000 0.037919 0.003098 0.053081 2.01R
121 0.095000 0.036875 0.009423 0.058125 2.33RX
122 0.031000 0.036875 0.009423 -0.005875 -0.24 X
123 0 043000 0.036875 0.009423 0.006125 0.25 X
124 0.042000 0.036875 0.009423 0.005125 0.21 X
125 0.021000 0.036875 0.009423 -0.015875 -0.64 X
126 0.019000 0.036875 0.009423 -0.017875 -0.72 X
127 0 017000 0.036875 0.009423 -0.019875 -0.80 X
128 0.027000 0.036875 0.009423 -0.009875 -0.40 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table cl c2;
SUBC> stats c l 1.
Tabulated Statistics
Rows: Aropic Columns: GDBA 
1 2 All
1 14 32 46
0.033714 0.036031 0 035326 
0.019201 0.024843 0.023083
2 74 8 82
0 037919 0.036875 0.037817 
0.028576 0.025470 0.028144
All 88 40 128
0 037250 0.036200 0.036922 
0.027252 0.024640 0.026371
Ceil Contents -- 
Cat.N 
Mean 
StDev
MTB > gJm cl2=cl c2 cl*c2
Genera) Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
1 6  2
Analysis of Variance for Human
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.003689 0.000099 0.000099 0.04 0.835 
GDBA 1 0.001296 0.001832 0.001832 0.81 0.370
Atopic*GDBA 1 0.002352 0.002352 0.002352 1 04 0 310 
Error 124 0.280819 0280819 0.002265
Total 127 0.288155
Unusual Observations for Human
Obs Human Fit StDev Fit Residual St Resid 
8 0.197000 0.047419 0.005532 
39 0.226000 0.047419 0.005532 
48 0.434000 0.047419 0.005532
121 0.036000 0.025000 0.016825
122 0.024000 0.025000 0.016825
123 0.034000 0.025000 0.016825
124 0.023000 0.025000 0.016825
125 0.030000 0.025000 0.016825
126 0.019000 0.025000 0.016825
127 0.020000 0.025000 0.016825
128 0.014000 0 025000 0.016825
0.149581 3.16R
0.178581 3.78R
0.386581 8.18R
0.011000 0.25 X
-0.001000 -0.02 X
i 0.009000 0.20 X
i -0.002000 -0.04 X
0.005000 0.11 X
; -0.006000 -0.13 X
i -0.005000 -0.11 X
-0 011000 -0.25 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table cl c2;
SUBC> stats c l2.
Tabulated Statistics
Rows Atopic Columns: GDBA 
1 2 AJ1
! (4 32 46
0.033071 0 034469 0 034043 
0.020281 0.023903 0.022646
2 74 8 82
0.047419 0.025000 0 045232 
0.059374 0.007690 0.056807
All 88 40 128
0.045136 0.032575 0.041211 
0.055202 0.021897 0.047633
Cell Contents —
Human: N 
Mean 
StDev
1 6  3
MTB > glm cl3=tl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Mucor
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.00127 0.01723 0.01723 1.71 0.193
GDBA 1 0.07122 0.06969 0.06969 6.92 0.010
Atopic*GDBA 1 0.00000 0.00000 0.00000 0.00 0.996
Error 124 1.24804 1.24804 0.01006
Total 127 1.32054
Unusual Observations for Mucor
Obs Mucor Fit StDev Fit Residual St Resid
27 0.449000 0.108811 0.011662 0.340189 3.41R
39 0.751000 0.1088! 1 0.011662 0.642)89 6 44R
51 0.372000 0.108811 0.011662 0.263189 2.64R
59 0.329000 0.108811 0.011662 0.220189 2.21R
79 0.423000 0.140929 0.026813 0.282071 2.92R
83 0433000 0.140929 0.026813 0.292071 3.02R
121 0.038000 0.043875 0.035470-0.005875 -0.06 X
122 0.077000 0.043875 0.035470 0.033125 0.35 X
123 0.043000 0.043875 0.035470 -0.000875 -0.01 X
124 0.070000 0 043875 0.035470 0.026125 0 28 X
125 0.045000 0 043875 0.035470 0.001125 0.01 X
126 0.023000 0.043875 0.035470 -0.020875 -0.22 X
127 0.034000 0043875 0.035470 -0.009875 -0 11 X
128 0 021000 0.043875 0.035470 -0.022875 -0.24 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence
MTB > table cl c2:
SUBC> stats c 13
Tabulated Statistics
Rows: Atopic Columns GDBA
1 2 .All
I M 32 46
0.14093 0.07622 0.09591 
0.13171 0.04634 0.08601
1 6  k
2 74 8 82
0.10881 0.04388 0.10248 
0.11426 0.02026 0.11035
All 88 40 128
0.11392 0.06975 0.10012 
0.11699 0.04419 0.10197
Cell Contents -- 
Mucor: N 
Mean 
StDev
MTB > gim cl4=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
.Analysis of Variance for Orchard
Source DF Seq SS Adj SS Adj MS F P
Atopic I 0 010307 0.0I I 144 0.011144 1 50 0.223
GDBA I 0.000159 0.000037 0.000037 0.00 0.944
Atopic*GDBA 1 0.015538 0.015538 0.015538 2.09 0.151
Error 124 0.921703 0.921703 0.007433
Total 127 0 947708
Unusual Observations for Orchard
Obs Orchard Fit StDev Fit Residual St Resid
3 0 623000 0.093473 
54 0.324000 0.093473 
89 0.433000 0.117906 
119 0 548000 0.117906
121 0 062000 0.061375
122 0.068000 0.061375
123 0 092000 0.061375
124 0.030000 0.061375
125 0.051000 0 061375
126 0.058000 0.061375
127 0.048000 0.061375
128 0.082000 0.061375
0.010022 0.529527 6 18R
0.010022 0.230527 2.69R
0.015241 0.315094 J71R
0.015241 0.230094 2.71 R
0.030482 0.000625 0.01 X
0.030482 0.006625 0 08 X
0.030482 0.030625 0.38 X
0.030482-0.031375 -0.39 X
0.030482-0.010375 -0.13 X
0.030482 -0.003375 -0.04 X
0.030482-0.013375 -0.17 X
0.030482 0.020625 0.26 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table cl c2,
SUBC> stats cl 4.
Tabulated Statistics
16 5
Rows: Atopic Columns: GDBA 
1 2 All
1 14 32 46
0.08879 0.11791 0.10904 
0.05034 0.09949 0.08794
2 74 8 82
0.09347 0.06137 0.09034 
0.08908 0.01960 0.08530
All 88 40 128
0.09273 0.10660 0.09706 
0.08390 0.09198 0.08638
Cell Contents —
Orchard. N 
Mean 
StDev
MTB > gim cl5=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Timothy
Source DF Seq SS Adj SS Adj MS F P
Atopic I 0.013004 0.010196 0 010196 1 04 0.309
GDBA 1 0.000911 0.000172 0.000172 0.02 0.895
Atopic*GDBA 1 0.012672 0.012672 0.012672 1.30 0.257 
Error 124 1.211246 1.211246 0.009768
Total 127 1.237834
Unusual Observations for Timothv
Obs Timothy Fit StDev Fit Residual St Resid
3 0.618000 0.115919 
8 0 576000 0.115919 
48 0.320000 0 .115919 
89 0.378000 0.143937 
101 0.366000 0.143937 
104 0.417000 0 143937
121 0.161000 0.091500
122 0.173000 0.091500
123 0.106000 0.091500
0.011489 0.502081 5.11R
0.011489 0.460081 4.69R
0.011489 0.204081 2.08R
0.017472 0.234063 2.41R
0 017472 0.222063 2.28R
0.017472 0.273063 2.81R
0.034943 0.069500 0.75 X
0.034943 0.081500 0.88 X
0.034943 0.014500 0.16X
1 6  6
124 0.032000 0.091500 0.034943 -0.059500 -0.64 X
125 0.056000 0.091500 0.034943 -0.035500 -0.38 X
126 0.026000 0.091500 0.034943-0.065500 -0.71 X
127 0.091000 0.091500 0.034943-0.000500 -0.01 X
128 0.087000 0.091500 0.034943-0.004500 -0.05 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table cl c2;
SU BO  stats cl 5.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 14 32 46
0.11307 0.14394 0.13454 
0.06228 0.10350 0.09330
2 74 8 82
0.11592 0.09150 0.11354 
0.10520 0.05450 0.10141
AJ1 88 40 128
0.11547 0.13345 0.12109 
0.09934 0.09746 0.09873
Cell Contents —
Timothy:N
Mean
StDev
MTB > dm c 16=c I c2 c 1 *c2 
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Kentucky
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.01246 0.00479 0.00479 0.45 0.503
GDBA 1 0.00365 0.00241 0.00241 0.23 0.635
Atopic*GDBA 1 0.00515 0.00515 0.00515 0 49 0 487
Error 124 1.31628 1.31628 001062
Total 127 1.33754
1 6  7
Unusual Observations for Kentucky
Obs Kentucky Fit StDev Fit Residual St Resid
3 0.669000 0.103203 
8 0.613000 0.103203 
89 0.545000 0 132250 
104 0.389000 0.132250
121 0 097000 0.097625
122 0.123000 0.097625
123 0.070000 0.097625
124 0.038000 0.097625
125 0.115000 0.097625
126 0.175000 0.097625
127 0.103000 0.097625
128 0.060000 0.097625
0.011977 0 565797 5.53R
0.011977 0 509797 4 98R
0.018213 0.412750 4.07R
0.018213 0.256750 2.53R
0.036427-0.000625 -0.01 X
0.036427 0.025375 0.26 X
0.036427 -0.027625 -0.29 X
0.036427 -0.059625 -0.62 X
0.036427 0.017375 0.18 X
0.036427 0.077375 0.80 X
0.036427 0.005375 0.06 X
0.036427 -0.037625 -0.39 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table cl c2;
SU BO  stats c l6.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 14 32 46
0.10257 0.13225 0.12322 
0.05128 0.11289 0.09864
2 74 8 82
0.10320 0.09762 0.10266 
0.10944 0.04259 0.10466
All 88 40 128
0.10310 0.12532 0.11005 
0.10219 0.10321 0.10262
Ceil Contents —
Kentucky :N 
Mean 
StDev
MTB >glm c!7=cl c2cl*c2
General Linear Model
Factor Levels Values
1 6 8
Atopic 2 i 2 
GDBA 2 1 2
Analysis of Variance tor Fescue
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.007208 0.004446 0.004446 0.52 0.474 
GDBA 1 0.002125 0.000923 0.000923 0.11 0 744
Atopic*GDBA 1 0.010471 0.010471 0.010471 1.22 0.272
Error 124 1.067461 1.067461 0.008609
Total 127 1.087266
Unusual Observations for Fescue
Obs Fescue Fit StDev Fit Residual St Resid
3 0.682000 I0.102041 0.010786 '0.579959 6 29R
54 0.460000 0.102041 0.010786 0.357959 3 88R
89 0.435000 0.125875 0.016402 0.309125 3.39R
101 0.325000 0.125875 0.016402 0.199125 2.I8R
121 0.111000 0.084375 0.032804 0.026625 0 31 X
122 0.169000 0.084375 0.032804 0.084625 0.98 X
123 0.083000 0.084375 0.032804 -0.001375 -0.02 X
124 0 055000 0.084375 0.032804 -0.029375 -0.34 X
125 0.087000 0.084375 0.032804 0.002625 0.03 X
126 0.042000 0.084375 0.032804 -0.042375 -0.49 X
127 0.068000 0.084375 0032804 -0.016375 -0.19 X
128 0.060000 0.084375 0.032804 -0.024375 -0.28 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence
MTB > table c 1 c2;
SU BO  stats c l7.
Tabulated Statistics
Rows. Atopic Columns: GDBA 
1 2 All
1 14 32 46
0.09329 0.12588 0.11596 
0.05502 0.09544 0.0859!
2 74 8 82
0.10204 0.08438 0.10032 
0.10029 0.04036 0.09609
AJJ 88 40 128
0.10065 0.11758 0.10594 
0.09436 0.08841 0.09253
Cell Contents —
Fescue:N
Me&n
StDev
MTB >glm cl8==cl c2 cl*c2
Genera) Linear Mode)
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Poplar
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.00005 0.00262 0.00262 0.22 0.642
GDBA 1 0.00629 0.00695 0.00695 0.58 0.449
Atopic*GDBA I 0.00112 0.00112 0.00112 0.09 0.761 
Error 124 1.49357 1.49357 0.01204
Total 127 1.50102
Unusual Observations for Poplar
Obs Poplar Fit StDev Fit Residual St Resid
3 13.877000 (3.108554 0.012758 13.768446 7.05R
36 0.461000 0.108554 0.012758 0.352446 3.23R
54 0.343000 0.108554 0.012758 0.234446 2.15R
79 0.332000 0.112929 0.029332 0.219071 2.07R
89 0.352000 0.100656 0.019401 0.251344 2.33R
101 0.385000 0.100656 0.019401 0.284344 2.63R
121 0.094000 0.079875 0.038802 0.014125 0.14 X
122 0.097000 0.079875 0.038802 0.017125 0.17 X
123 0.088000 0.079875 0.038802 0.008125 0.08 X
124 0.101000 0.079875 0.038802 0.021125 0 21 X
125 0.109000 0.079875 0.038802 0.029125 0.28 X
126 0.038000 0.079875 0 038802 -0.041875 -0.41 X
127 0.071000 0.079875 0.038802 -0.008875 -0.09 X
128 0.041000 0.079875 0.038802 -0.038875 -0.38 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table c I c2.
SUBC> stats c l8.
Tabulated Statistics
Rows: Atopic Columns: GDBA
I 2 All
1 14 32 46
0.11293 0.10066 0.10439 
0.09234 0.09484 0.09323
2 74 8 82
0.10855 0.07988 0.10576 
0.12268 0.02725 0.11705
All 88 40 128
0.10925 0.09650 0.10527 
0.11792 0.08575 0.10872
Cell Contents —
PoplarN
Mean
StDev
MTB> gimclO^cl c2cl*c2
Genera) Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 I 2
Analysis of Variance for Birch
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.00218 0.02353 0.02353 1.42 0.235
GDBA 1 0.03288 0.034-19 0.03419 2.07 0 153
Atopic*GDBA 1 0.00142 0.00142 0.00142 0 09 0.770
Error 124 2.05282 2.05282 0.01656
Total 127 2.08930
Unusual Observations for Birch
Obs Birch Fit StDev Fit Residual St Resid
27 0.460000 0.111649 0.014957 0 348351 2.73R
39 0.792000 0.111649 0.014957 0.680331 5 32R
54 0.656000 0.111649 0.014957 0.544351 426R
79 0.770000 0.140071 0034388 0.629929 5 08R
101 0.381000 0.103906 0.022745 0.277094 2.19R
117 0.525000 0.103906 0.022745 0.421094 3 33R
121 0.053000 0.057000 0.045490 -0.004000 -0.03 X
122 0.093000 0.057000 0.045490 0.036000 0.30 X
123 0.089000 0.057000 0.045490 0.032000 0.27 X
124 0.040000 0.057000 0.045490 -0.017000 -0 14 X
125 0.040000 0.057000 0.045490 -0.017000 -0.14 X
126 0.047000 0.057000 0.045490 -0.010000 -0 08 X
127 0.045000 0.057000 0 045490 -0.012000 -0.10 X
128 0.049000 0.057000 0.045490 -0.008000 -0 07 X
R denotes an observation with a large standardized residual
1 7  1
X denotes an observation whose X value gives it large influence.
MTB > table cl c2;
SUBC> stats c l9.
Tabulated Statistics
Rows: Atopic Columns: GDBA
1 2 .Ml
1 14 32 46
0.14007 0.10391 0.1I49I 
0.19267 0.31163 0.13997
2 74 8 82
0.11165 0.05700 0.10632 
0.12718 0.02145 0.12199
All 88 40 128
0.11617 0.09452 0.10941 
0.13866 0 10173 0.12826
Cell Contents —
Birch:N
Mean
StDev
MTB > gJm c20=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 I 2 
GDBA 2 I 2
Analysis of Variance for Sorrel
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.00547 0.00122 0.00122 0.11 0.740
GDBA 1 0.00011 0.00001 0.00001 0.00 0 976
Atopic*GDBA 1 0.00815 0.00815 0.00815 0.74 0.391
Error 124 1.36396 1.36396 0.03 300
Total 127 1.37768
Unusual Observations for Sorrel
Obs Sorrel Fit StDev Fir Residual St Resid 
3 0.790000 0.101446 0.012192 0.688554 661R
8 0.400000 0.101446 0.012192 0.298554 2.87R
1 7  2
69 0.730000 
89 0.375000 
12] 0.076000
122 0 167000
123 0.156000
124 0 065000
125 0.030000
126 0.052000
127 0.039000
128 0 043000
0.101446 
0.092094 
0.078500 
0 078500 
0.078500 
0.078500 
0.078500 
0.078500 
0.078500 
0.078500
0.012192
0.018540
0.037080
0.037080
0.037080
0.037080
0.037080
0.037080
0.037080
0.037080
0.628554
0.282906
-0.002500
0.088500
0.077500
-0.013500
-0.048500
-0 026500
-0.039500
-0.035500
6.03R 
2.74R 
-0.03 X 
0.90 X 
0.79 X 
-0.14 X 
-0.49 X 
-0.27 X 
-0.40 X 
-0.36 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > tabled c2;
SUBC> stats c20.
Tabulated Statistics
Rows Atopic Columns: GDBA 
] 2 All
1 14 32 46
0.07071 0.09209 0.08559 
0.03715 0.07197 0.06376
2 74 8 82
0 10145 0.07850 0.09921 
0.1263 6 0.05332 0.12117
.AH 88 40 128
0 09656 0.08938 0.09431 
0.11718 0.06825 0.10415
Cell Contents-- 
Sorrel. N 
Mean 
StDev
MTB > glm c21 =c 1 c2 c 1 *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Plantain
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.002411 0 006083 0.006083 0 67 0.413
GDBA 1 0.003248 0.003612 0.003612 0.40 0.528
Atopic*GDBA 1 0.000636 0.000636 0.000636 0.07 0.791 
Error 124 1.118101 1.118101 0.009017
Total 127 1.124396
Unusual Observations for Plantain
Obs Plantain Fit StDev Fit Residual St Resid
1 '0.313000 0.103324 0.011039 0.209676 2.22R
3 i0.619000 0.103324 0.011039 0.515676 5.47R
39 0.306000 0.103324 0.011039 0.202676 2.15R
54 0.332000 0.103324 0.011039 0.228676 2.42R
79 0.313000 0.116286 0.025378 0.196734 2.15R
101 0 487000 0.107719 0.016786 0.379281 4.06R
104 0.328000 0.107719 0.016786 0.220281 2.36R
121 0.081000 0.082375 0.033573 -0.001375 -0.02 X
122 0.132000 0.082375 0.033573 0.049625 0.56 X
123 0.113000 0.082375 0.033573 0.030625 0.34 X
124 0.122000 0.082375 0.033573 0.039625 0.45 X
125 0 048000 0.082375 0.033573 -0.034375 -0.39 X
126 0.052000 0.082375 0.033573 -0.030375 -0.34 X
127 0.033000 0.082375 0.033573 -0.049375 -0.56 X
128 0078000 0.082375 0033573 -0.004375 -0.05 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table cl c2;
SUBC> stats c21.
Tabulated Statistics
Rows. Atopic Columns: GDBA 
1 2 All
1 14 32 46
0.11629 0.10772 0.11033 
0.08262 0.10746 0.09972
2 74 8 82
0.10332 0.08238 0.10128 
0.09522 0.03691 0.09126
All 88 40 128
0.10539 0.10265 0.10453 
0.09301 0.09762 0.09409
Cell Contents —
Plantain :N 
Mean 
StDev
1 7  I*
MTB > gim c22=c I c2 c 1 *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Mugwort
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.00333 0.02220 0.02220 1.28 0.261
GDBA 1 0.02344 0.02529 0.02529 1.45 0.230
Atopic*GDBA 1 0.00263 0.00263 0.00263 0.15 0.698
Error 124 2.15565 2.15565 0.01738
Total 127 2.18505
Unusual Observations for Mugwort
Obs Mugwort Fit StDev Fit Residual St Resid
3 ID.507000 0.095149 0.015327 0.411851 3.14R
27 0.433000 0.095149 0.015327 0.337851 2.58R
39 0.601000 0.095149 0.015327 0.505851 3 86R
48 0.381000 0.095149 0.015327 0.285851 2.18R
54 0.582000 0.095149 0.015327 0.486851 3.72R
79 0 706000 0.119143 0.035238 0.586857 4.62R
101 0 464000 0.092688 0.023308 0.371313 2.86R
121 0.064000 0.043500 0.046616 0.020500 0.17 X
122 0.067000 0.043500 0046616 0.023500 0.19 X
123 0.075000 0.043500 0.046616 0.031500 0.26 X
124 0.000000 0.043500 0.046616 -0.043500 -0.35 X
125 0.041000 0.043500 0.046616 -0.002500 -0.02 X
126 0.028000 0 043500 0.046616 -0.015500 -0.13 X
127 0 032000 0.043500 0.046616 -0 011500 -0.09 X
128 0.041000 0.043500 0.046616 -0.002500 -0.02 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table cl c2;
SUBC> stats c22.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 14 32 46
17 5 -
0.11914 0.09269 0.10074 
0.18355 0.10380 0.13155
2 74 8 82
0.09515 0.04350 0.09011 
0.13746 0.02462 0.13161
All 88 40 128
0.09897 0.08285 0.09393 
0.14480 0.09523 0.13117
Cell Contents —
Mugwort :N 
Mean 
StDev
MTB > glm c23=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
.Analysis of Variance for Dandelio
Source DF Seq SS Adj SS Adj MS F P
Atopic I 0.00045 0.03377 0.03377 1.27 0.262
GDBA 1 0.06914 0.07088 0.07088 2.66 0.105
Atopic*GDBA 1 0.00174 0.00174 0.00174 0.07 0.799
Error 124 3.30400 3.30400 0.02665
Total 127 3.37533
Unusual Observations for Dandelio
Obs Dandelio Fit StDev Fit Residual St Resid
27 0.520000 0.117622 0.018975 0 402378 2.48R
39 0.681000 0 117622 0.018975 0.563378 3.47R
44 0.760000 0.117622 0 018975 0.642378 3 96R
54 0.756000 0 .117622 0.018975 0.638378 3 94R
71 0.713000 0.117622 0.018975 0.595378 3.67R
79 0.737000 0 .152500 0.043626 0.584500 3.72R
83 0.686000 0.152500 0.043626 0.533500 3 39R
98 0.500000 0.097375 0.028856 0.402625 2.51R
101 0.421000 0.097375 0.028856 0.323625 2.01R
121 0.077000 0.042000 0.057712 0.035000 0.23 X
122 0.082000 0.042000 0.057712 0.040000 0.26 X
123 0.031000 0.042000 0.057712 -0.011000 -0.07 X
124 0.028000 0.042000 0.057712 -0.014000 -0.09 X
125 0.047000 0.042000 0.057712 0.005000 0 03 X
126 0.014000 0.042000 0.057712 -0.028000 -0 18 X
127 0.036000 0.042000 0.057712 -0.006000 -0.04 X
128 0.021000 0.042000 0.057712 -0.021000 -0.14 X
R denotes an observation with a large standardized residual
17 6 -
X denotes an observation whose X value gives it large influence.
MTB> tabled c2;
SU B O  stats c23.
Tabulated Statistics
Rows. Atopic Columns: GDBA 
J 2 All
1 14 32 46
0.15250 0.09737 0 .11415 
0.24125 0.10965 0.16048
2 74 8 82
0.11762 0.04200 0.11024 
0.17242 0.02515 0.16540
All 88 40 128
0.12317 0.08630 0.11165 
0.18387 0.10086 0.16303
Cell Contents -  
Dandelio :N 
Mean 
StDev
MTB > glm c24=cl c2 cl *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 J
Analysis of Variance for Nettle
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.00065 0.01041 0.0104 1 0.78 0.379
GDBA 1 0.03197 0.03404 0.03404 2.55 0 113
Atopic*GDBA I 0.00269 0.00269 0.00269 0.20 0.654 
Error 124 1.65327 1.65327 0.01333
Total 127 1.68857
Unusual Observations for Nettle
Obs Nettle Fit StDev Fit Residual St Resid 
1 0.406000 0.108541 0.013423 0 297459 2.59R
3 0.560000 0.108541 0.013423 0.451459 3.94R
17 7
36 0.630000 
39 0.570000 
79 0.423000 
83 0 436000 
301 0.482000 
121 0.081000
122 0,045000
123 0 064000
124 0.041000
125 0.049000
126 0.037000
127 0.0320QQ
128 0.055000
0.108541
0,108541
0.120857
0.120857
0.088281
0.050500
0.050500
0.050500
0.050500
0.050500
0.050500
G.Q5Q50G
0.050500
0.013423 0.521459 4.55R
0.013423 0.461459 4.02R
0.030860 0.302143 2.72R
0.030860 0.315143 2.83R
0.020412 0.393719 3.46R
0.040824 0.030500 0.28 X
0 040824-0.005500 -0.05 X
G.G40824 0.013500 0.12 X
0.040824 -0.009500 -0.09 X
0.040824 -0.001500 -0.01 X
0.040824-0.013500 -0.12 X
0.040824 -0.018500 -0.17 X
0.040824 0.004500 0.04 X
R denotes an observation with a large standardised residual 
X denotes an observation whose X value gives it large influence
MTB > table cl c2;
SUBC> stats c24.
Tabulated Statistics
Rows: .Atopic Columns: GDBA 
1 2 All
1 14 32 46
0.12086 0.08828 0.09820 
0.13590 0.08989 0.10551
2 74 8 82
0.10854 0.05050 0.10288 
0.12611 0.01595 0.12106
Ail 88 40 128
0.11050 0.08073 0 10120 
0.12698 0 08187 0.11531
Cell Contents -- 
\'ettle:N 
Mean 
StDev
WTR>
1 7 8
Appendix 13
Statisitical analysis of ELISA results for atopic and non-atopic 
dogs (non-GDBA/non-atopic =greyhounds & beagles).
MTB > gJm c3=cl c2cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis o f Variance for Flea
Source DF Seq SS Adj SS Adj MS F P
Atopic I 0.000003 0.000065 0.000065 0.01 0.921
GDBA 1 0.000114 0.000661 0 000661 0.10 0.751
Atopic'GDBA 1 0.004226 0.004226 0.004226 0.65 0 422 
Error 136 0.885857 0.885857 0.006514
Total 139 0.890200
Unusual Observations for Flea
Obs Flea Fir StDev Fit Residual St Resid 
19 0 317000 0.072959 0.009382 0.244041 3.04R
39 0 474000 0.072959 0.009382 0.401041 5.00R
64 0 656000 0.072959 0.009382 0.583041 7.27R
116 0.298000 0.076562 0.014267 0.221438 2.79R
R denotes an observation with a large standardized residual
MTB > table cl c2,
SU B O  stats c3.
Tabulated Statistics
Rows: Atopic Columns. GDBA
1 2 All
1 14 32 46
0 05807 0 07656 0.07093 
0.04482 006152 0.05711
2 74 20 94
0.07296 0.06495 0.07126 
0.09692 0.05464 0.08941
AJ1 88 52 140
0.07059 0.07210 0.07115 
0.09062 0.05870 0.08003
Cell Contents —
Flea.N
Mean
StDev
1 8 0
MTB > glm c4=cl c2 cJ*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Mites
Source DF Seq SS Adj SS Adj MS F P
Atopic I 0.000725 0.000183 0.000183 0.05 0.825
GDBA 1 0-006656 0.004723 0.004723 1.26 0.263
Atopic*GDBA 1 0.002009 0.002009 0.002009 0 54 0.465
Error 136 0.508846 0:508846 0:803742
Total 139 0.518236
Unusual Observations for Mites
Obs Mites Fit StDev Fit Residual St Resid
16 0287000 0.116905 0.007111 0.170095 2.80R
27 0.276000 0  116905 0.007111 0.159095 2.62R
39 0.303000 0.116905 0.0071 II 0.186095 3.06R
46 0.276000 0.116905 0.007111 0.159095 2.62R
48 0.275000 0.116905 0.007111 0.158095 2.60R
94 0275000 0.128156 0010813 0.146844 2.44R
97 0.000000 0.128156 0 010813 -0.128156 -2.13R
117 0.263000 0.128156 0.010813 0134844 2.24R
R denotes an observation with- a large-standardized residual
MTB > tabled c2;
SU B O  stats c4.
Tabulated Statistics
Rows: Atopic Columns: GDBA
1 2 .All
1 14 32 46
0.12329 0.12816 0.12667 
0.05247 0.06425 006037
2 74 20 94
0.11691 0.14005 0.12183 
0.06243 0.05646 0.06166
All 88 52 140
0.11792 0.13273 0.12342 
0.06072 006108 0.06106
Cell Contents —
Mites :N 
Mean
18 1
MTB ? glm c5=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis o f Variance for Feathers
Source DF Seq SS Adj SS Adi MS F P
Atopic I 0 001171 0.000088 0.000088 0.03 0.860 
GDBA 1 0006760 0.008241 0.00824 J 2.92 0.090
Atopic*GDBA 1 0.002132 0.002132 0.002132 0.76 0.386 
Error 136 0.383392 0.383392 0.002839
Total 139 0.393454
Unusual Observations for Feathers
Obs Feathers Fit StDev Fit Residual St Resid
3 0 180000 0.071257 0.006172 0.108743 2.06R
12 0.213000 0 07125 7 0.006172 0.141743 2.69R
51 0.291000 0.071257 0.006172 0.219743 4.17R
94 0  208000 0.087844 0.009386 0.120156 2.30R
110 0 388000 0.087844 0.009386 0.300156 5.74R
R denotes an observation with a large" standardized residual:
MTB > table cl c2;
SUBC> stats c5
Tabulated Statistics
Rows: Atopic Cofexcans: GDBA 
i 2 AH
1 14 32 46
0.05993 0.08784 0.07935 
0.03158 0.07091 0.06262
2 74 20 94
0.07126 0.08035 0.07319 
0.04998 0.04115 0.048-17
All 88 52 140
0.06945 0.08496 0.07521 
0 04756 0.06084 0.05320
Cell Contents —
Feathers. N 
Mean
1 8 2
MTB > gjm c6=cl c2 cl *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis o f Variance for Ahefisaer
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.016067 0.018146 0.018146 5.22 0.024 
GDBA 1 0.002506 0.001715 0001715 0 4 9  0483
Atopic*GDBA 1 0.000942 0.000942 0.000942 0.27 0.603 
Error 136 0.472377 0.472377 0003473
Total 139 0491891
Unusual Observations for Alternar
Obs .Alternar Fit StDev Fit Residual SfResid 
7 0 225000 0.087797 0.006851 0.137203 2.34R
17 0268000 0.98779-7 0.006851 0.180203 3.08R
24 0.209000 0.087797 0.006851 0.121203 2.07R
59 0 233000 0 087797 0.006851 0145203 2.48R
83 0.353000 0.109000 0.015751 0.244000 4.30R
94 0.224000 0106813 0010418 0.117188 2.02R
106 0.226000 0.106813 0.010418 0.119188 2.05R
R denotes an observation with a large standardized residual
MTB > table cl c2.
SUBC> stats c6.
Tabulated Statistics
Rows Atopic Columns: GDBA
} 2 Ail
1 14 32 46
0 10900 0.10681 0.10748 
0.07756 0.06226 0.06641
2 74 20 94
0.08780 0.07310 0.08467 
0.05824 0.03728 0.05461
AH 88 52 140
0.09117 0.09385 0.09216 
0.06169 0.05611 0.05949
Cell Contents —
AltemarrN
Mean
StDev
1 8 3
MTB > glm c7=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis o f Variance for Aspergil
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.016147 0.014091 0.014091 5.46 0.021
GDBA 1 0.000261 0.000022 0.000022 0.01 0.927
Atopic*GDBA 1 0.002197 0 002197 0.002197 0.85 0.358 
Error 136 0.351196 0.351196 0.002582
Total 139 0.369800
Unusual Observations for Aspergil
Obs Aspergil Fit StDev Fit Residual St Resid
64 0.226000 0.091500 0.005907 0.134500 2.66R
93 0 232000 0.114750 0.008983 0.117250 2.34R
98 0.001000 0.114750 0.008983-0.113750 -2.27R
112 0.226000 0.114750 0.008983 0.111250 2.22R
118 0 333000 0 114750 0.008983 0.218250 4.36R
R denotes an observation with a large standardized residual
MTB > table cl c2;
SU B O  stats c7
Tabulated Statistics
Rows: Atopic Columns: GDBA 
I 2 All
1 14 32 46
0.10614 0.11475 0.11213 
0.05266 0.07067 0.06525
2 74 20 94
0.09150 0.08100 0.08927 
0.04229 0.03957 0.04174
All 88 52 140
0.09383 0.10177 0.09678 
0.04409 0.06240 0.05158
Cell Contents -  
.Aspergil :N 
Mean 
StDev
1 8 4
MTB > glrr. ck- l * c2 cl *c2
General Linear Model
Factor Levels Values
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Rhizopus
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.014106 0.000712 0.000712 0.08 0.778 
GDBA 1 0.028405 0.023682 0.023682 2.65 0.106
Atopic’GDBA 1 0.001765 0.001765 0.001765 0.20 0.657 
Error 136 1.214785 1.214785 0.008932
Total 139 1.259062
Unusual Observations for Rhizopus
Obs Rhizopus Fit StDev Fit Residual St Resid 
3 0 406000 0.099932 0.010987 0.306068 3.26R
5 0 290000 0.099932 0.010987 0.190068 2.02R
27 0 588000 0.099932 0.010987 0.488068 5.20R
39 0 396000 0.099932 0.010987 0.296068 3.15R
54 0 615000 0.099932 0.010987 0.515068 5.49R
83 0 3)3000 0.085929 0.025259 0.227071 2.49R
101 0.318000 0.063125 0016707 0.254875 2.74R
R denotes an observation with a large standardized residual
MTB > tabled c2,
SUBO  stats c8
Tabulated Statistics
Rows Atopic Columns: GDBA
1 2 All
J :4 32 46
0 08593 0.06313 0.07007 
0.07503 0.06724 0.06967
2 '4 20 94
0 09993 0.06000 0.09144 
0.11591 0.03298 0.10506
All SS 52 140
0.09770 0.06192 0.08441 
0.11019 0.05618 0.09517
Cell Contents —
Rhizopus: N 
Mean 
StDev
1 8 5
MTB > gini c9=ci c2 cl *c2
General Unear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Kapok
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.000000 0.003643 0.003643 0.60 0.441
GDBA I 0.017130 0.014665 0.014665 2.41 0.123
Atopic*GDBA 1 0 000669 0.000669 0.000669 0 11 0.741 
Error 136 0 828399 0.828399 0.006091
Total 139 0.846198
Unusual Observations for Kapok
Obs Kapok Fit StDev Fit Residual St Resid 
3 0.319000 0.077257 0.009073 0.241743 3.12R
27 0.383000 0.077257 0.009073 0.305743 3.94R
39 0.320000 0.077257 0.009073 0.242743 3.13R
54 0.410000 0.077257 0.009073 0J32743 4.29R
79 0 479000 0.084286 0.020859 0.394714 5.25R
101 0.308000 0.064875 0.013797 02.43125 3.16R
R denotes an observation with a large standardized residual
MTB > table cl c2;
SUBC> stats c9.
Tabulated Statistics
Rows: Atopic Columns. GDBA 
1 2 All
1 14 32 46
0.08429 0.06487 0.07078 
0.12341 0.06438 0.08565
2 74 20 94
0 07726 0.04730 0.07088 
0.08388 0.02562 0.07449
.Ail 88 52 140
0.07837 0.05812 0.07085 
0.08893 0.05327 0.07802
Cell Contents —
Kapok :N 
Mean 
StDev
1 8 6
MTB> aim cIO=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance forDtrsf
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.001671 0.001212 0.001212 1.12 0.292
GDBA 1 Q.QQQGG6 0,000016 0000016 frftl 0.905
Atopic*GDBA 1 0.000049 0.000049 0.000049 0.05 0.832 
Error 136 0.147133 0147133 0.001082
Total 139 0.148859
Unusual Observations for Dust
Obs Dnsr Fir SrDevFir Residual SrResid
1 0.123000 0.050027 0.003824 0.072973 2.23R
12 0.136000 0.050027 0.003824 0.085973 2.63R
73 0.160000 0.050027 0.003824 0.109973 3.37R
79 0 155009 0.044357 0.008791 0.110643 3.49R
121 0.123000 0.050650 0.007355 0.072350 2.26R
123 0.123000 0.050650 0007355 0072350 2.26R
R denotes an observation with- a large standardized residual
MTB > table cl c2,
SUBC> stats clO.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 14 32 46
0.044357 0.042125 0.042804 
0040636 0.026655 0.031106
2 ”4 20 94
0.050027 0.050650 0.050160 
0.033883 0.032307 0.033384
Alt 88 52 140
0.049125 0.045404 0.047743 
0034849 0028952 0.032725
Cell Contents —
Dust.N
Mean
StDev
1 8 7
MTB > gJm cl l=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Cat
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.0005491 0.0011332 0.0011332 1.53 0.218
GDBA 1 0.0007992 0.0005955 0 0005955 0.81 0.371
Atopic*GDBA 1 0.0001699 0.0001699 0.0001699 0.23 0.632 
Error 136 0.1004483 0.1004483 0.0007386
Total 139 0.1019665
Unusual Observations for Cat
Obs Cat Fit StDev Fit Residual St Resid 
1 0 115000 0.037919 0.003159 0.077081 2.86R
17 0.103000 0.037919 0.003159 0.065081 2.41R
60 0.101000 0.037919 0.003159 0.063081 2.34R
140 0 100000 0.045550 0.006077 0.054450 2.06R
R denoies an observation with a large standardized residual
MTB > table cl c2;
SUBC> stats cl I.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 14 32 46
0.033714 0.036031 0.035326 
0 019201 0.024843 0.023083
2 74 20 94
0 037919 0.045550 0.039543 
0.028576 0.029835 0.028856
All 88 52 140
0.037250 0.039692 0.038157 
0.027252 0.026993 0.027085
Cell Contents ~
Cat:N
Mean
StDev
1 8 8
MTB > glm cl2=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 J 2
Analysis of Variance for Human
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.004966 0.003474 0.003474 1.58 0.211
GDBA 1 0.000056 0.000021 0.000021 0.01 0.922
Atopic*GDBA 1 0.000131 0.000131 0.000131 0.06 0.808
Error 136 0.299027 0.299027 0.002199
Total 139 0.304181
Unusual Observations for Human
Obs Human Fit StDev Fit Residual St Resid
8 0.197000 0.047419 0.005451 0.149581 3.21R
39 0.226000 0.047419 0.005451 0.178581 3.83R
48 0 434000 0.047419 0.005451 0.386581 8.30R
140 0.140000 0.044150 0.010485 0.095850 2.1 OR
R denotes an observation with a large standardized residual
MTB > tabled c2;
SUBC> stats c l2.
Tabulated Statistics
Rows: Atopic Columns. GDBA
] 2 All
J 14 32 46
0.033071 0.034469 0.034043 
0.020281 0.023903 0.022646
2 74 20 94
0.047419 0.044150 0.046723 
0.059374 0.031307 0.054490
All 88 52 140
0.045136 0.038192 0.042557 
0.055202 0.027112 0.046780
Cell Contents —
Human:N
Mean
StDev
1 8 9
MTB > gJm cJ3=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Mucor
Source DF Seq SS Adj SS Adj MS F P
Atopic I 0.000503 0.010207 0 010207 1.09 0.298
GDBA 1 0.064911 0.068082 0.068082 7.27 0.008
Atopic*GDBA 1 0.003197 0.003197 0.003197 0.34 0.560 
Error 136 1.274018 1.274018 0 009368
Total 139 1342629
Unusual Observations for Mucor
Obs Mucor Fit StDev Fit Residual St Resid 
27 0.449000 0.108811 
39 0.751000 0.108811 
51 0.372000 0.108811 
59 0.329000 0.108811 
79 0.423000 0.140929 
83 0.433000 0.140929
0 011251 0.340189 3.54R
0.011251 0.642189 6.68R
0.011251 0.263189 2.74R
0.011251 0.220189 2.29R
0.025867 0.282071 3.02R
0.025867 0.292071 3.13R
R denotes an observation with a large standardized residual
MTB > table cl c2; 
SUBC> stats c l3.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 14 32 46
0.14093 0.07622 0.09591 
0.13171 0.04634 0.08601
2 74 20 94
0.10881 0.06715 0.09995 
0.11426 0.03897 0.10417
.All 88 52 140
0.11392 0.07273 0.09862 
0.11699 0.04349 0.09828
Cell Contents — 
MucorN 
Mean 
StDev
1 9 0
MTB > gim cI4=cl c2 c\*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Orchard
Source DF Seq SS Adj SS AdjMS F P
Atopic I 0.008237 0.003272 0.003272 0.47 0.496
GDBA I 0.002028 0.003927 0.003927 0.56 0 456
Atopic*GDBA I 0.006432 0.006432 0.006432 0.92 0.340 
Error 136 0.955073 0.955073 0.007023
Total 139 0.971770
Unusual Observations for Orchard
Obs Orchard Fit StDev Fit Residual St Resid 
3 0.623000 0.093473 0.009742 0.529527 6.36R
54 0.324000 0.093473 0.009742 0.230527 2.77R
89 0.433000 0.117906 0.014814 0.315094 3.82R
119 0.348000 0.117906 0.014814 0.230094 2.79R
R denotes an observation with a large standardized residual
MTB > tabled c2;
SUBC> stats c l4.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
i 2 AH
1 14 32 46
0.08879 0.11791 .0.10904 
0 05034 0.09949 0.08794
2 74 20 94
0.09347 0.08990 0.09271 
0 08908 0.04356 0.08135
All 88 52 140
0.09273 0.10713 0.09808 
0.08390 0.08314 0.08361
Cell Contents —
Orchard :N 
Mean 
StDev
1 9 1
MTB > glm cl5=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 I 2
GDBA 2 1 2
Analysis o f Variance for Timothy
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.008551 0.001510 0.001510 0.16 0.690
GDBA 1 0.007859 0.009723 0.009723 1.03 0.313
Atopic*GDBA 1 0.002790 0.002790 0.002790 0.29 0.588 
Error 136 1.287316 1.287316 0.009466
Total 139 1.306517
Unusual Observations for Timothy
Obs Timothy Fit StDev Fit Residual St Resid
3 0.618000 0.115919 0.011310 0.502081 5.20R
8 0.576000 0.115919 0.011310 0.460081 4.76R
48 0.320000 0.115919 0.011310 0.204081 2.11R
89 0 378000 0.143937 0.017199 0.234063 2.44R
101 0 366000 0.143937 0.017199 0.222063 2.32R
104 0 417000 0.143937 0.017199 0.273063 2.85R
R denotes an observation with a large standardized residual
MTB > table cl c2;
SUBC> stats c l5.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 14 32 46
0.11307 0.14394 0.13454 
0.06228 0.10350 0.09330
2 "4 20 94
0.11592 0.12525 0.11790 
0.10520 0.07140 0.09871
All 38 52 140
0.11547 0.13675 0.12337 
0.09934 0.09217 0.09695
Cell Contents -- 
Timothy:N 
Mean 
StDev
19  2 -
MTB > glm c!6=c 1 c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis o f Variance for Kentucky
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.00865 0.00102 0.00102 0.10 0.753
GDBA 1 0 01108 0.01223 0.01223 1.20 0 276
Atopic*GDBA I 0.00123 0.00123 0.00123 0.12 0.730 
Error 136 1.39079 1.39079 0.01023
Total 139 1.41176
Unusual Observations for Kentucky
Obs Kentucky Fit StDev Fit Residual St Resid 
3 0.669000 0 103203 0.011756 0.565797 5.63R
8 0.613000 0 103203 0.011756 0.509797 5.08R
39 0.305000 0 103203 0.011756 0.201797 2.01R
89 0.545000 0.132250 0.017877 0.412750 4.15R
104 0.389000 0.132250 0.017877 0.256750 2.58R
R denotes an observation with a large standardized residual
MTB > table cl c2;
SU B O  stats cl 6
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 14 32 46
0.10257 0.13225 0.12322 
0 05128 0.11289 0.09864
2 74 20 94
0.10320 0.11860 0.10648 
0.10944 0.06775 0.10188
All 88 52 140
0.10310 0.12700 0.11198 
0.10219 0.09747 0.10078
Cell Contents -- 
Kentucky: N 
Mean 
StDev
1 9 3
MTB > glm c!7=cl c2 cl*c2
Genera! Linear Model
Factor Levels Values 
Atopic 2 I 2
GDBA 2 1 2
Analysis of Variance for Fescue
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.001812 0.001236 0.001236 0.14 0.710 
GDBA 1 0.023901 0.023129 0.023129 2.60 0.109
Alopic*GDBA 1 0.000061 0.000061 0.000061 0.01 0934  
Error 136 1.209488 1.209488 0.008893
Total 139 ].235261
Unusual Observations for Fescue
Obs Fescue Fit StDev Fit Residual St Resid
3 0 682000 0.102041 0.010963 0.579959 6.19R
54 0.460000 0.102041 0.010963 0.357959 3.82R
89 0.435000 0.125875 0.016671 0.309125 3.33R
101 0.325000 0.125875 0.016671 0.199125 2.15R
133 0 418000 0 131450 0.021087 0.286550 3.12R
R denotes an observation with a large standardized residual
MTB > table cl c2,
SUBC> stats c l7.
Tabulated Statistics
Rows: Atopic Columns: GDBA
1 2 .Mi
1 14 32 46
0.09329 0.12588 0.11596 
0.05502 0.09544 0.08591
2 74 20 94
0.10204 0.13145 0.10830 
0 10029 0.08986 0.09845
All 88 52 140
0 10065 0.12802 0.11081 
0.09436 0.09248 0.09427
Cell Contents -  
Fescue: N 
Mean 
StDev
1 9 i>
MTB > gJm cl8=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Poplar
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.00177 0.00230 0.00230 0.19 0.664
GDBA 1 0.00070 0.00009 0.00009 0.01 0.933
Atopic*GDBA I 0.00483 0.00483 0-00483 040  0.530 
Error 136 1.65153 1.65153 0.01214
Total 139 1.65882
Unusual Observations for Poplar
Obs Poplar Fit StDev Fit Residual St Resid 
3 0.877000 0.108554 0.012810 0.768446 7.02R
36 0 461000 0.1Q8554 0.012810 0.352446 3.22R
54 0.343000 0.108554 0.012810 0.234446 2.14R
79 0 332000 0.112929 0.029452 0.219071 2.06R
89 0 352000 0 100656 0.019480 0.251344 2.32R
101 0 385000 0.100656 0.019480 0.284344 2.62R
136 0.404000 0.124600 0.024641 0.279400 2.60R
R denotes an observation with a large standardized residual
MTB > table cl c2;
SU BO  stats c 18.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 .All
1 14 32  46
0 11293 0.10066 0 10439 
0.09234 0.09484 0.09323
2 ~4 20 94
0 10855 0.12460 0.11197 
0.12268 0.09267 0.11667
Ail 88 52 140
0.10925 0.10987 0.10948 
0.11792 0.09383 0.10924
Cell Contents -- 
Poplar: N 
Mean 
StDev
19 5
MTB > glm ci9=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 I 2
Analysis o f Variance for Birch
Source DF Seq SS Adj SS .Adj MS F P
Atopic 1 0.00309 0.01651 0.01651 1.07 0.303
GDBA 1 0.02844 0.02771 0.02771 1.79 0.183
Atopic*GDBA 1 0.00012 0.00012 0.00012 0 01 0.930 
Error 136 2.10135 2.10135 0.01545
Total 139 2.13300
Unusual Observations for Birch
Obs Birch Fit StDev Fit Residual St Resid
27 0 460000 0.111649 0.014450 0.348351 2.82R
39 0.792000 0.111649 0.014450 0 680351 5.51R
54 0 656000 0.111649 0.014450 0 544351 4.41 R
79 0 770000 0.140071 0.033221 0.629929 5.26R
101 0 381000 0.103906 0.021974 0.277094 2.26R
117 0 525000 0.103906 0.021974 0 421094 3.44R
R denotes an observation with a large standardized residual
MTB > table cl c2;
SUBC> stats c l9.
Tabulated Statistics
Rows: Atopic Columns. GDBA
1 2 All
1 14 32 46
0 14007 0.10391 0.11491 
:• 19267 0.11163 0.13997
2 74 20 94
0.11165 0.07995 0.10490 
0.12718 0.05219 0.11585
Ail 88 52 140
0.11617 0.09469 0.10819 
0.13866 0.09342 0.12388
Cell Contents —
Birch:N
Mean
StDev
19 6
MTB > glm c20=c 1 c2 c 1 *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis o f Variance for Sorrel
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.00627 0.00637 0.00637 0.61 0.434
GDBA 1 0.00031 0.00115 0.00115 0.11 0.739
Atopic'GDBA 1 0.00503 0.00503 0.00503 0.49 0.487 
Error 136 1.40968 1.40968 0.01037
Total 139 1.42130
Unusual Observations for Sorrel
Obs Sorrel Fit StDev Fit Residual StResid 
3 0 790000 0.101446 0.011835 0.688554 6.81R
8 0.400000 0.101446 0.011835 0.298554 2.95R
69 0 730000 0.101446 0.011835 0 628554 6.22R
89 0.375000 0.092094 0.017998 0.282906 2.82R
R denotes an observation with a large standardized residual
MTB > table cl c2r 
SU BO  stats c20.
Ta bu lated Statistics
Rows: Atopic Columns: GDBA
1 2 AJ1
1 14 32 46
0.07071 0.09209 0 08559 
0.03715 0.07197 0.06376
2 74 20 94
0 10145 0.09390 0.09984 
0.12636 0.05877 0.11510
All 88 52 140
0 09656 0.09279 0.09516 
0.11718 0.06660 0.10112
Cell Contents —
Sorrel.N
Mean
StDev
1 9 7
M TB>glm c2l=ci c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Plantain
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.001572 0.001945 0.001945 0.22 0.639
GDBA 1 0.000341 0.000508 0.000508 0.06 0.811
Atopic*GDBA I 0.000380 0.000380 0.000380 0.04 0.836 
Error 136 1.199688 1.199688 0.008821
Total 139 1.201981
Unusual Observations for Plantain
Obs Plantain Fit StDev Fit Residual St Resid
1 0 313000 0.103324 0.010918 0.209676 2.25R
3 0 619000 0.103324 0.010918 0.515676 5.53R
39 0 306000 0.103324 0.010918 0.202676 2.17R
54 0.332000 0.103324 0.010918 0.228676 2.45R
79 0 313000 0.116286 0.025102 0.196714 2.17R
94 0.294000 0.107719 0.016603 0.186281 202R
101 0.487000 0.107719 0.016603 0.379281 4 10R
104 0.328000 0.107719 0.016603 0.220281 2.38R
R denotes an observation with a large standardized residual
MTB > table cl c2;
SUBC> stats c21
Tabulated Statistics
Rows- Atopic Columns: GDBA
1 2 .All
1 14 32 46
0.11629 0.10772 0.11033 
0.08262 0.10746 0.09972
2 74 20 94
0.10332 0.10270 0.10319 
0.09522 0.06925 0.08998
All 88 52 140
0.10539 0.10579 0.10554 
0.09301 0.09387 0.09299
Cell Contents —
Plantain: N 
Mean 
StDev
1 9 «
MTB > glm c22=cl c2 cl *c2
General Linear Model
Factor Levels Values
Atopic 2 1 2
GDBA 2 I 2
Analysis of Variance for Mugwort
Source DF Seq SS Adj SS Adi MS F P
Atopic 1 0.00227 0.00760 0.00760 0.45 0.502
GDBA 1 0.00897 0.00985 0 00985 0.59 0.445
Atopic*GDBA 1 0.00093 0.00093 0 00093 0.06 0.814
Error 136 2.28221 2.28221 0.01678
Total 139 2.29438
Unusual Observations for Mugwort
Obs Mugwort Fit StDev Fit Residual St Resid 
1 0 356000 0.095149 0.015059 0.260851 2.03R
3 0 507000 0.095149 0.015059 0.411851 3.20R
27 0.433000 0.095149 0.015059 0.337851 2.63R
39 0.601000 0.095149 0.015059 0.505851 3.93R
48 0 381000 0.095149 0.015059 0 285851 2.22R
54 0 582000 0.095149 0.015059 0.486851 3.78R
79 0 706000 0.119143 0.034621 0.586857 4.70R
101 0 464000 0.092688 0.022900 0.371313 2.91 R
134 0 372000 0.081150 0.Q28966 0290850 2.30R
R denotes an observation with a large standardized residual
MTB > table cl c2,
SUBC> stats c22.
Tabulated Statistics
Rows: Atopic Columns: GDBA
1 2 All
1 14 32 46
0 11914 0.09269 0.10074 
0 18355 0.10380 0.13155
2 74 20 94
0.09515 0 08115 0.09217 
0.13746 0.08297 0.12756
All 88 52 140
0.09897 0.08825 0.09499 
0.14480 0 09563 0.12848
Cell Contents —
Mugwort:N
Mean
StDev
1 9 9
MTB > glm c23=cl c2 cl *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Dandeiio
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.00242 0.03167 0.03167 1.29 0.258
GDBA 1 0.08237 0.07690 0.07690 3.13 0.079
Atopic*GDBA 1 0.00005 0.00005 0.00005 0.00 0.965
Error 136 3.34092 3.34092 0.02457
Total 139 3.42576
Unusual Observations for Dandeiio
Obs Dandeiio Fit StDev Fit Residual St Resid 
3 0.430000 0.117622 0.018220 0 312378 2.01R
27 0.520000 0.117622 0.018220 0.402378 2.58R
39 0.681000 0 117622 0.018220 0 563378 3 62R
44 0.760000 0.117622 0.018220 0.642378 4.13R
54 0.756000 0.117622 0.018220 0.638378 4.10R
710.713000 0.117622 0.018220 0 595378 3.82R
79 0.737000 0.152500 0.041889 0.584500 3.87R
83 0 686000 0.152500 0.041889 0.533500 3.53R
98 0.500000 0.097375 0.027707 0.402625 2.61R
101 0.421000 0.097375 0.027707 0.323625 2.10R
R denotes an observation with a large standardized residual
MTB > table cl c2;
SU B O  stats c23.
Tabulated Statistics
Rows Atopic Columns: GDBA
1 2 AH
1 14 32 46
0.15250 0.09737 0.11415 
0.24125 0. J 0965 0.16048
2 74 20 94
0.11762 0 05970 0.10530 
0 17242 0.04665 0.15604
All 88 52 140
0.12317 0.08288 0.10821 
0.18387 0.09198 0.15699
Cell Contents —
Dandeiio :N 
Mean 
StDev
20 0
MTB > glra c24=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis o f Variance for Nettle
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.00021 0.00487 0.00487 0.39 0.531
GDBA 1 0.03110 0.02862 0.02862 2.31 0.131
Atopic*GDBA 1 0.00009 0.00009 0.00009 0.01 0.933 
Error 136 1.68218 1.68218 0.01237
Total 139 1.71357
Unusual Observations for Nettle
Obs Nettle Fit StDev Fit Residual StResid 
1 0.406000 0.108541 0.012929 0.297459 2.69R
3 0.560000 0.108541 0.012929 0.451459 4.09R
36 0 630000 0.108541 0.012929 0.521459 4.72R
39 0.570000 0.108541 0.012929 0.461459 4 18R
79 0.423000 0.120857 0.029724 0.302143 2.82R
83 0.436000 0 120857 0.029724 0.315143 2.94R
101 0.482000 0.088281 0.019660 0.393719 3.60R
R denotes an observation with a large standardized residual
MTB > table cl c2;
SUBC> stats c24
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 .All
1 14 32 46
0 12086 0 08828 0.09820 
0.13590 0 08989 0.10551
2 74 20 94
0.10854 0.07215 0.10080 
0.12611 0.04019 0.1 J418
.All 88 52 140
0.11050 0.08208 0.09994 
0.12698 0.07467 0.11103
Cell Contents —
Nettle:N
Mean
StDev
20 1
Appendix J
Statistical analysis of Immunodot results for atopic and non- 
atopic GDBA and GUVS dogs, greyhounds and beagles
Appendix J1
Statisitical analysis o f Immunodot results for atopic and non-
atopic dogs (non-GDBA/non-atopic =greyhounds).
20 3
MTB > glm c3=cl c2 cl *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 I 2
Analysis of Variance for Dustmite
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0 22265 0 03776 0.03776 2.23 0.140
GDBA 1 0.07148 0.05295 0.05295 3.12 0.081
Atopic*GDBA 1 0.01442 0.01442 0.01442 0.85 0.360
Error 74 L25580 1.25580 0.01697
Total 77 1.56435
Unusual Observations for Dustmite
Obs Dustmite Fit StDev Fit Residual St Resid 
52 0 562000 0.167583 0.026591 0.394417 3.09R
54 0.609000 0.167583 0.026591 0.441417 3.46R
70 0.740000 0.167583 0.026591 0.572417 4.49R
73 0 575000 0.167583 0.026591 0.407417 3.19R
75 0.043000 0.063250 0.065135-0.020250 -0.18X
76 0.054000 0.063250 0.065135-0.009250 -0.08 X
77 0.024000 0.063250 0.065135-0.039250 -0.35 X
78 0.132000 0.063250 0.065135 0 068750 0.61 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table cl c2;
SU BO  stats c3.
Tabulated Statistics
Rows: Atopic Columns: GDBA
1 2 Ail
1 8 24 32
0.05137 0.16758 0.13853 
0.0854! 0.22446 0.20406
2 42 4 46
0.02674 0.06325 0.02991 
0.03091 0.04748 0.03360
All 50 28 78
0.03068 0.15268 0.07447 
0.04387 0.21107 0.14253
Cell Contents -- 
Dustmite:N 
Mean 
StDev
20 U
iMTB > glm c4=cl c2 cl *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 I 2
Analysts of Variance for Storemit
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.008462 0.000056 0.000056 0.01 0.911
GDBA 1 0.014536 0.012607 0.012607 2.81 0.098
Atopic*GDBA I 0.000368 0.000368 0.000368 0.08 0.776 
Error 74 0.332433 0  332433 0.004492
Total 77 0.355799
Unusual Observations for Storemit
Obs Storemit Fit StDev Fit Residual St Resid
52 0.261000 0.081125 0.013681 0.179875 2.74R
54 0.282000 0.081125 0.013681 0.200875 3.06R
70 0.505000 0.081125 0.013681 0.423875 6.46R
75 0067000 0.077250 0.033512 -0.010250 -0.18 X
76 0.086000 0.077250 0.033512 0.008750 0.15 X
77 0.059000 0.077250 0.033512-0.018250 -0.31 X
78 0.097000 0.077250 0.033512 0.019750 0.34 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence
MTB > table cl c2;
SUBC> stats c4.
Tabulated Statistics
Rows: Atopic Columns. GDBA 
! 2 All
1 S 24 3,2
0 03750 0.08113 0.07022
0.01030 0.11578 0.10167
2 42 4 46
0.04636 0.07725 0.04904
0.02342 0.01737 0.02444
Ail 50 28 78
0.04494 0.08057 0.05773
0 .0 2 2 0 2 0.10702 0 06798
Cell Contents — 
StoremitiN 
Mean 
StDev
20  5
MTB > glm c5=cl c2 cl *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Flea
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.0000522 0.0000492 0.0000492 0.16 0.690
GDBA 1 0.0000442 0.0000030 0.0000030 0 .0 1  0.921 
Atopic*GDBA 1 0.0003746 0.0003746 0 0003746 1 .22 0 272
Error 74 0.0226484 0.0226484 0.0003061
Total 77 0.0231193
Unusual Observations for Flea
Obs Flea Fit StDev Fit Residual St Resid
17 0.095000 0.016095 0.002699 0.078905 4.56R
65 0.074000 0.019000 0.003571 0.055000 3.21R
6 6 0.068000 0.019000 0.003571 0.049000 2.86R
75 0.005000 0.010250 0.008747 -0.005250 -0.35 X
76 0.016000 0.010250 0.008747 0.005750 0.38 X
77 0.005000 0.010250 0.008747 -0.005250 -0.35 X
78 0.015000 0.010250 0.008747 0.004750 0.31 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table cl c2;
SUBC> stats c5.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 .AH
1 8 24 32
0.012000 0 019000 0.017250 
0.011136 0.021657 0.019634
2 42 4 46
0.016095 0 010250 0.015587 
0.016291 0.006076 0.015718
All 50 28 78
0.015440 0.017750 0.016269 
0.015559 0.020332 0.017328
Cell Contents —
Flea;N
Mean
StDev
20  6
MTB > glm c6=cl c2 cl *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 I 2
Analysis ofVariance for Human
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.002631 0.001155 0.001155 0.94 0.335
GDBA I 0.000005 0.000000 0.000000 0.00 0.998 
Alopic*GDBA 1 0.000090 0.000090 0.000090 0.07 0.787 
Error 74 0.090866 0 090866 0.001228
Total 77 0.093593
Unusual Observations for Human
Obs Human Fit StDev Fit Residual St Resid
8 0.182000 0.062429 0.005407 0.119571 3 45R
17 0  180000 0.062429 0.005407 0.117571 3.40R.
6 6 0.143000 0.051125 0.007153 0.091875 2.68R
75 0.062000 0.059250 0.017521 0.002750 0.09 X
76 0.055000 0.059250 0.017521 -0.004250 -0 14 X
77 0.057000 0.059250 0.017521 -0.002250 -0.07 X
78 0.063000 0.059250 0.017521 0.003750 0.12 X
R denotes an observation with a large standardized residual
X denotes an observation whose X value gives it large influence.
MTB > table cl c2;
SUBC> stats c6 .
Tabulated Statistics
Rows Atopic Columns: GDBA 
1 2 All
1 8 24 32
0.048000 0.051125 0.050344 
0.013575 0.042766 0.037422
2 42 4 46
0.062429 0.059250 0.062152 
0.034025 0.003862 0.032506
All 50 28 78
0.060120 0.052286 0.057308 
0.031993 0.039598 0.034864
Cell Contents —
Human: N 
Mean 
StDev
20 7
MTB > glm c7=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 i 2
GDBA 2 1 2
Analysis o f Variance for Cat
Source DF Seq SS Adj SS Adj MS F P
Atopic I 0.0063042 0.0002287 0.0002287 0.46 0.502
GDBA 1 0.0058001 0.0045029 0.0045029 8.96 0.004
Atopic*GDBA I 0.0007740 0.0007740 0.0007740 1.54 0.218
Error 74 0.0371753 0.0371753 0.0005024
Total 77 0.0500537
Unusual Observations for Cat
Obs Cat Fit StDev Fit Residual St Resid
31 0.088000 0.038286 0.003458 0.049714 2.24R
37 0.085000 0.038286 0.003458 0.046714 2.11R
38 0.141000 0.038286 0.003458 0.102714 4.64R
75 0  008000 0.025250 0.011207-0.017250 -0.89 X
76 0.060000 0.025250 0.011207 0.034750 1.79 X
77 0.015000 0.025250 0.011207 -0.010250 -0.53 X
78 0.018000 0.025250 0  011207 -0.007250 -0.37 X
R denotes an observation with a large standardized residual
X denotes an observation whose X value gives it large influence.
MTB > table cl c2;
SUBC> stats c7.
Tabulated Statistics
Rows: Atopic Columns; GDBA 
1 2 All
1 8 24 32
0.042500 0.011000 0.018875 
0.017501 0.013863 0.020095
2 42 4 46
0.038286 0.025250 0.037152 
0.026572 0.023543 0.026345
All 50 28 78
0.038960 0.013036 0.029654 
0.025238 0.015845 0.025496
Cell Contents —
Cat.N
Mean
StDev
20 8
M TB>glmc3=cl c2cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Grass
Source DF Seqr SS Adj SS Adj MS F P
Atopic 1 0.0103210 0.000284* 0.000284* 0.50 0.481
GDBA 1 0.0076828 0.0069034 0  0069034 12.13 0.001 
Atopic*GDBA I 0.0003537 0.0003537 0.0003537 0.62 0  433 
Error 78 0.0444076 0.0444076 0.0005693
Total 81 0.0627650
Unusual Observations for Grass
Obs Grass 
16 0.141000 
49 0.125000 
73 0.114000
79 0.046000
80 0.046000
81 0.041000
82 0.042000
Fit StDev 
0.021940 0 
0.021940 
0.055857 
0.043750 
0.043750 
0.043750 
0.043750
Fit Residual St Resid 
003374 0.119060 5.04R
.003374 0.103060 4.36R
005207 0.058143 2.50R
011930 0.002250 0.11 X
.011930 0.002250 0.1 IX
.011930-0.002750 -0 .I3X
.011930-0.001750 -0.08 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table cl c2 ;
SU B O  stats c3.
Tabulated Statistics
Rows. Atopic Columns. GDBA
1 2 All
] 7 21 28
0 021286 0.055857 0.047214 
0.013149 0.022903 0.025678
2 50 4 54
0.021940 0.043750 0.023556 
0.025896 0.002630 0.025566
.All 57 25 82
0.021860 0.053920 0.031634 
0.024604 0.021412 0.027837
Cell Contents — 
Grass.N 
Mean 
StDev
20 9
MTB > glm c4=c 1 c2 c 1 *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Tree
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.0007511 0.0004760 0.0004760 2.12 0.149
GDBA 1 0.0025487 0.0029016 0.0029016 12.94 0 .0 0 1  
Atopic*GDBA 1 0.0005747 0.0005747 0.0005747 2.56 0  113 
Error 78 0.0174915 0.0174915 0.0002242
Total 81 0.0213660
Unusual Observations for Tree
Obs Tree Fit StDev Fit Residual St Resid
49 0.051000 0.018840 0.002118 0.032160 2.17R
67 0.068000 0.029714 0.003268 0.038286 2.62R
77 0.069000 0.029714 0.003268 0.039286 2.69R
79 0  060000 0.045250 0.007487 0.014750 1.14 X
80 0.059000 0.045250 0.007487 0.013750 1.06 X
81 0 .0 2 1 0 0 0 0.045250 0.007487 -0.024250 -1.87 X
82 0.041000 0.045250 0.007487 -0.004250 -0.33 X
R denotes an observation with a large standardized residual
X denotes an observation whose X value gives it large influence.
MTB > table cl c2 ,
SU BO  stats c4.
Tabulated Statistics
Rows. Atopic Columns: GDBA 
1 2 All
1 7 21 28
0.019571 0.029714 0.027179 
0.014022 0.018879 0.018103
2 50 4 54
0.018840 0.045250 0.020796 
0,012913 0.018373 0.014900
All 57 25 82
0.018930 0.032200 0.022976 
0.012924 0.019313 0.016241
Cell Contents —
Tree:N
Mean
StDev
21 0
MTB > glm c5=cJ c2cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis o f Variance for Mugwort
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.0011731 0.0000443 0.0000443 0.07 0.787
GDBA 1 0.0004840 0.0005277 0.0005277 0 .8 8  0.351 
Atopic*GDBA 1 0.0000567 0.0000567 0.0000567 0.09 0.759 
Error 78 0  0468496 0.0468496 0.0006006
Total 81 0.0485635
Unusual Observations for Mugwort
Obs Mugwort Fit StDev Fit Residual StResid 
5 0.100000 0 050900 0.003466 0.049100 2.02R
0 003466 0.066100 2.72R
0.003466 0.075100 3.1OR
0.012254 0.005750 0.27 X
0.012254 0.005750 0.27 X
0.012254 -0.004250 -0.20 X
0.012254 -0.007250 -0.34 X
8  0.117000 0.050900 
38 0.126000 0.050900
79 0.067000 0.061250
80 0.067000 0.061250
81 0.057000 0.061250
82 0.054000 0.061250
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table cl c2; 
SU B O  stats c5.
Tabulated Statistics
Rows: Atopic Columns: GDBA
] 2 All
1 7 21 28
0.055714 0.060952 0 059643 
0.024662 0.019433 0.020500
2 50 4 54
0.050900 0.061250 0 051667 
0.026920 0.006752 0.026078
All 57 25 82
0.051491 0.061000 0.054390 
0.026492 0.017900 0.024486
Cell Contents — 
Mugwort.N 
Mean 
StDev
2 1 1  ^
MTB > glm c6=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 I 2
GDBA 2 1 2
Analysis of Variance for Olive
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.006828 0.000502 0.000502 0.09 0.765
GDBA 1 0.003751 0.003193 0.003193 0.57 0.452
Atopic*GDBA 1 0.000488 0.000488 0  000488 0.09 0.768 
Error 78 0.435578 0.435578 0.005584
Total 81 0.446645
Unusual Observations for Olive
Obs Olive Fit StDev Fit Residual St Resid
34 0.669000 0.082680 0 010568 0.586320 7.93R
79 0.050000 0.071000 0.037364 -0 .0 2 1 0 0 0 -0.32 X
80 0.071000 0.071000 0.037364 0  0 0 0 0 0 0 0.00 X
81 0.093000 0.071000 0.037364 0 .0 2 2 0 0 0 0.34 X
82 0.070000 0.071000 0.037364 -0 .0 0 1 0 0 0 -0.02 X
R denotes an observation with a large standardized residual
X denotes an observation whose X value gives it large influence.
MTB > table c 1 c2;
SUBC> stats c6 .
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 7 21 28
0.08257 0.05590 0 06257 
0.02721 0.03280 0.03316
2 50 4 54
0.08268 0.07100 0.08181 
0.09133 0.0J 757 0.08797
All 57 25 82
0.08267 0.05832 0.07524 
0.08589 0.03110 0.07426
Cell Contents —
01ive:N
Mean
StDev
2 1 2
MTB > glm 03=^1 c2 cl *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 I 2
Analysis of Variance for Outdoor
Source DF Seq SS Adj SS Adj MS F P
Atopic I 0.002411 0.000665 0.000665 0.13 0.726
GDBA 1 0.000470 0 000340 0.000340 0.06 0.802
Alopic*GDBA 1 0.000054 0.000054 0.000054 0.01 0.920 
Error 28 0.149022 0.149022 0.005322
Total 31 0151957
Unusual Observations for Outdoor
Obs Outdoor Fit StDev Fit Residual St Resid
30 0.374000 0.078800 0.018836 0.295200 4.19R
31 0.029000 0.063000 0.051586-0.034000 -0 6 6 X
32 0 097000 0.063000 0.051586 0.034000 0.66 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > tabled c2 ;
SU B O  stats c3.
Tabulated Statistics
Rows. Atopic Columns: GDBA 
] 2 All
1 4 15 19
0.06650 0.07880 0.07621 
0.03797 0 09657 0.08672
2 11 2 13
0.05773 0.06300 0.05854 
0.03437 0.04808 0.03437
All 15 17 32
0.06007 0.07694 0.06903 
0.03419 0.09128 0.07001
Cell Contents —
Outdoor: N 
Mean 
StDev
21 3
MTB > glmc4=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Indoor
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.021015 0.011254 0.011254 1.26 0  271
GDBA 1 0.000724 0.000101 0.000101 0.01 0.916
Atopic*GDBA 1 0.002667 0.002667 0.002667 0.30 0.589 
Error 28 0.249674 0.249674 0.008917
Total 31 0.274080
Unusual Observations for Indoor
Obs Indoor Fit StDev Fit Residual St Resid
19 0 340000 0.155133 0 024382 0.184867 2.03R
29 0.493000 0.155133 0.024382 0.337867 3.70R
31 0.068000 0.080000 0.066772-0.012000 -0.18 X
32 0 092000 0.080000 0.066772 0.012000 0.18X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table cl c2;
SUBC> stats c4.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 4 15 19
0.12575 0.15513 0.14895 
0.05849 0 12088 0.10994
2 ;i 2 13
0 09982 0.08000 0.09677 
0 05879 0.01697 0.05440
.Ail 15 17 32
0.10673 0.14629 0.12775 
0 05781 0.11587 0.09403
Cell Contents ~
Indoor N 
Mean 
StDev
2 1 4
MTB > glm c5=c 1 c2 c 1 *c2
General Linear Mode!
Factor Levels Values 
Atopic 2 1 2
GDBA 2 I 2
Analysis o f Variance for Foods 1
Source DF Seq SS Adj SS Adj MS F P
Atopic I 0.0000121 0.0000282 0 0000282 0.09 0 762
GDBA 1 0.0001280 0.0000327 0.0000327 0 .1 1  0.744 
Atopic'GDBA I 0.0002817 0.0002817 0.0002817 0.93 0.342 
Error 28 0.0084387 0.0084387 0.0003014
Total 31 0.0088605
Unusual Observations for Foods 1
Obs Foods 1 Fit StDev Fit Residual St Resid 
9 0.086000 0.028273 0.005234 0.057727 3.49R
31 0.021000 0.023000 0.012276-0.002000 -0.16X
32 0 025000 0.023000 0.012276 0.002000 0.16 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table cl c2:
SUBC> stats c5.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 4 15 19
0 017750 0.028467 0.026211 
0.010532 0.014851 0.014497
2  11 2  13
0.028273 0.023000 0.027462 
0.022383 0.002828 0.020545
.AH 15 17 32
0.025467 0.027824 0.026719 
0.020121 0.014028 0.016906
Cell Contents —
Foods I :N 
Mean 
StDev
21 5
MTB > glm c6=cl c2 cl*c2
General Linear Model
Factor Levels Values
Atopic 2 1 . 2
GDBA 2  I 2
Analysis o f Variance for Foods 2
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.0007588 0.0002130 0.0002130 0.33 0.572 
GDBA 1 0.0000010 0  0000604 0.0000604 0.09 0.763
Atopic*GDBA 1 0.0005095 0.0005095 0.0005095 0.78 0.384 
Error 28 0.0182039 0.0182039 0.0006501
Total 31 0  0194732
Unusual Observations for Foods 2
Obs Foods 2 Fit StDev Fit Residual St Resid 
6  0.145000 0.039455 0.007688 0.105545 4.34R
31 0 024000 0.025000 0.018030-0.001000 -0.06 X
32 0.026000 0.025000 0.018030 0 .0 0 1 0 0 0  0.06 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table cl c2;
SUBC> stats c6 .
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 4 15 19
0.02175Q 0.028800 0.027316 
0 Q22765 0.012891 0.014978
2 11 2 13
0.039455 0.025000 0.037231 
0.037843 0.001414 0.034972
AJ1 15 17 32
0 034733 0.028353 0.031344 
0.034636 0.012129 0.025063
Cell Contents —
Foods 2.N 
Mean 
StDev
2 1 6
MTB > gim c7=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 I 2
Analysis o f Variance for Moulds
Source DF Seq SS Adj SS Adj MS F P
Atopic I 0.002444 0.005541 0.005541 3.24 0.083
GDBA 1 0.005379 0.003718 0.003718 2.18 0.151
Atopic*GDBA 1 0.000875 0.000875 0.000875 0.51 0.480 
Error 28 0.047857 0.047857 0.001709
Total 31 0.056554
Unusual Observations for Moulds
Obs Moulds Fit StDev Fit Residual St Resid
30 0.167000 0.082133 0.010675 0.084867 2.12R
31 0.070000 0.103500 0.029233-0.033500 -1.15 X
32 0.137000 0.103500 0.029233 0.033500 1.15 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table cl c2;
SUBC> stats cl.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 4 15 19
0.03900 0.08213 0.07305 
0.03601 0.04615 0.04689
2 II 2 13
0.08855 0.10350 0.09085 
0 03451 0.04738 0.03480
All 15 17 32
0 07533 0.08465 0.08028 
0.04053 0.04532 0.04271
Cell Contents —
Moulds: N 
Mean 
StDev
2 1 7
Appendix J2
Statisitical analysis of Immundot results for atopic and non- 
atopic dogs (non-GDBA/non-atopic =beagles),
21 8
MTB > glm c3=cl c2 cl *c2
General Linear Model
Factor Levels Values
Atopic 2 1 2
GDBA 2 1 2
Analysis o f Variance for Dustmile
Source DF SeqSS Adj SS Adj MS F P
Atopic 1 0.24577 0.08388 0.08388 4.97 0.029
GDBA 1 0.03725 0.01817 0.01817 1.08 0.303
Atopic*GDBA 1 0.04639 0.04639 0.04639 2.75 0.102
Error 74 1.24904 1.24904 0.01688
Total 77 1.57844
Unusual Observations for Dust mite
Obs Dustmite Fit StDev Fit Residual S t ,Resid
52 0.562000 0.167583 0 026520 0.394417 3.10R
54 0.609000 0.167583 0.026520 0.441417 3.47R
70 0.740000 0.167583 0.026520 0.572417 4.50R
73 0 575000 0.167583 0.026520 0.407417 3.20R
75 0000000 0.000000 0.064959 0.000000 0.00 X
76 0  000000 0.000000 0.064959 0.000000 0.00 X
77 0.000000 0.000000 0.064959 0.000000 0.00 X
78 0.000000 0.000000 0 064959 0.000000 0.00 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table c I c2;
SUBC> stats c3.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
i 2 Ail
1 8  24 32
0 05137 0.16758 0.13853 
0 08541 0.22446 0.20406
2 42 4 46
0.02674 0.00000 0.02441 
0 03091 0 00000 0.03047
All 50 28 78
0 03068 0.14364 0 07123 
0.04387 0.21560 0.14318
Ceil Contents —
DustmiteiN
Mean
StDev
21 9
MTB > glm c4=c I c2 c 1 *c2
General Linear Model
Factor Levels Values
Atopic 2 1 2
GDBA 2  1 2
Analysis o f Variance for Storemit
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.014682 0.011857 0.011857 2.65 0.108
GDBA 1 0.000885 0.000017 0.000017 0.00 0.951
Atopic*GDBA 1 0.018382 0.018382 0.018382 4.10 0.046 
Error 74 0.331528 0.331528 0.004480
Total 77 0.365478
Unusual Observations for Storemit
Obs Storemit Fit StDev Fit Residual St Resid 
52 0 261000 0.081125 0.013663 0.179875 2.75R
54 0 282000 0.081125 0.013663 0.200875 3.07R
70 0.505000 0.081125 0.013663 0.423875 6  47R
75 0 .0 0 0 0 0 0  0.000000 0.033467-0.000000 -0.00 X
76 0.000000 0.000000 0.033467-0.000000 -0.00 X
77 0.000000 0.000000 0.033467-0.000000 -0.00 X
78 0 000000 0.000000 0.033467 -0.000000 -0.00 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table cl c2 ;
SUBC> stats c4.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 S 24 32
0 03750 0.08113 0.07022 
0.01030 0.11578 0.10167
2 42 4 46
0.04636 0.00000 0.04233 
0.02342 0.00000 0.02596
All 50 28 78
0.04494 0.06954 0.05377 
0.02202 0.11070 0.06889
Cell Contents — 
Storemit :N 
Mean 
StDev
2 2  0
MTB > glm c5=cl c2 cl*c2
General Linear Model
Factor Levels Values
Atopic 2 1 2
GDBA 2 1 2
Analysis o f Variance for Flea
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.0001231 0.0005043 0.0005043 1 .6 6  0.202
GDBA 1 0.0000292 0.0001878 0.0001878 0.62 0.435
Atopic*GDBA 1 0.0012109 0.0012109 0.0012109 3.98 0.050 
Error 74 0.0225376 0.0225376 0.0003046
Total 77 0.0239009
Unusual Observations for Flea
Obs Flea Fit StDev Fit Residual St Resid
17 0.095000 0.016095 0.002693 0.078905 4.58R
65 0.074000 0.019000 0.003562 0.055000 3.22R
6 6 0.068000 0.019000 0.003562 0.049000 2.87R
75 0.000000 0.000000 0.008726 43.000000 -0.00 X
76 0000000 0.000000 0.008726 -0 .0 0 0 0 0 0 -0.00 X
77 ooooooo ooooooo 0.008726 -0.000000 -0.00 X
78 0  0 0 0 0 0 0 ooooooo 0.008726 -0.000000 -0.00 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table cl c2;
SU BO  stats c5.
Tabulated Statistics
Rows. Atopic Columns: GDBA 
1 2 All
1 8 24 32
0 012000 0019000 0.017250 
0.011136 0.021657 0.019634
2 42 4 46
0.016095 0.000000 0.014696 
0.016291 0.000000 0.016212
All 50 28 78
0.015440 0.016286 0.015744 
0.015559 0.021104 0.017618
Cell Contents -- 
Flea.N 
Mean 
StDev
2 2  1
MTB > glm c6=cl c2 cl *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis o f Variance for Human
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.001189 0.001093 0.001093 0.87 0.355
GDBA 1 0.002501 0.004507 0.004507 3.57 0.063
Atopic*GDBA 1 0.005860 0.005860 0.005860 4.64 0.034 
Error 74 0.093432 0.093432 0.001263
Total 77 0.102982
Unusual Observations for Human
Obs Human Fit StDev Fit Residual St Resid 
8  0.182000 0.062429 0.005483 0.119571 3.41R
17 0.180000 0.062429 0.005483 0.11757J 3.35R
6 6  0.143000 0.051125 0.007253 0.091875 2.64R
75 0.000000 0.014750 0.017766-0.014750 -0.48 X
76 0.000000 0.014750 0.017766-0.014750 -0.48 X
77 0.059000 0.014750 0.017766 0.044250 1.44 X
78 0.000000 0.014750 0.017766-0.014750 -0.48 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > tabled c2; 
SUBC> stats c6 .
Tabulated Statistics
Rows Atopic Columns: GDBA
1 2 .All
1 S 24 32
0 048000 0.051125 0.050344 
0.013575 0.042766 0.037422
2 42 4 46
0.062429 0.014750 0.058283 
0.034025 Q.029500 0.036018
All 50 28 78
0.060120 0.045929 0.055026 
0 031993 0.042693 0.036571
Cell Contents -- 
Human: N 
Mean 
StDev
2 2  2
MTB >glm c7=cl c2 cl*c2
General Linear Model
Factor Levels Values
Atopic 2 1 2
GDBA 2 1 2
Analysis o f Variance for Cat
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.0048805 0.0005255 0.0005255 1.10 0.299
GDBA I 0.0112023 0.0110563 0.0110563 23.04 0  000 
Atopic*GDBA 1 0.0001045 0.0001045 0.0001045 0.22 0.642 
Error 74 0.0355126 0.0355126 0.0004799
Total 77 0.0516999
Unusual Observations for Cat
Obs Cat Fit StDev Fit Residual St Resid
31 0.088000 0.038286 0.003380 0.049714 2.30R
37 0.085000 0.038286 0.00338Q 0.046714 2.16R
38 0.141000 0.038286 0.003380 0.102714 4.75R
75 ooooooo -0 .0 0 0 0 0 0 0.010953 0.000000 0.00 X
76 0.000000 - 0.000000 0.010953 0.000000 o o o x
77 0.000000 -ooooooo 0.010953 0.000000 0.00 X
78 0 000000-ooooooo 0.010953 ooooooo O.OOX
R denotes an observation with a large standardized residual.
X denotes an observation whose X value gives it large influence.
MTB > table cl c2;
SUBC> stats c7.
Tabulated Statistics
Row's Atopic Columns. GDBA 
1 2 /Ml
1 8 24 32
0.042500 0.011000 0.018875 
0.017501 0.013863 0.020095
2 42 4 46
0.038286 0.000000 0.034957 
0.026572 0.000000 0.027609
All 50 28 78
0.038960 0.009429 0.028359 
0.025238 0.013382 0.025912
Cell Contents ~
Cat:N
Mean
StDev
2 2  3
MTB > glm c3=c I c2 cl *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 I 2
Analysis o f Variance for Grass
Source DF Seq SS Adj SS Adj MS F P
Atopic I 0.0096460 0.0002411 0 0002411 0.39 0.536
GDBA 1 0.0089787 0.0090U6 0.0090116 14.45 0.000 
Atopic*GDBA 1 00003II8 0.0003118 0.0003118 0.50 0.481 
Error 80 0.0498742 0.0498742 0.0006234
Total 83 0.0688107
Unusual Observations for Grass
Obs Grass Fit StDev Fit Residual St Resid
16 0.141000 0.021940 0.003531 0.119060 4.82R
49 0.125000 0.021940 0.003531 0.103060 4.17R
51 0.019000 0.021286 0009437 -0.002286 -0 .1OX
52 0 009000 0.021286 0.009437 -0.012286 -0.53 X
53 0.047000 0.021286 0.009437 0.025714 1.11 X
54 0.017000 0.021286 0.009437 -0.004286 -0.I9X
5 5 0.023000 0.021286 0.009437 0.001714 0.07 X
56 0.008000 0.021286 0.009437 -0.013286 -0.57 X
57 0.026000 0.021286 0.009437 0.004714 0.20 X
73 0.114000 0.055857 0.005449 0.058143 2.39R
79 0.057000 0.045667 0.010193 0.011333 0.50 X
80 0.079000 0.045667 0.010193 0.033333 1.46 X
81 0.078000 0.045667 0.010193 0.032333 1.42 X
82 0 048000 0.045667 0.010193 0.002333 0 . 1 0 X
83 0 .0 1  loop 0.045667 0.010193 -0.034667 -1.52 X
84 0 0 0 1 0 0 0 0.045667 0.010193 -0.044667 -1.96 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table cl c2;
SUBC> stats c3.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 .All
1 7 21 28
0.021286 0 055857 0.047214 
0.013149 0.022903 0.025678
2 50 6  56
0.021940 0.045667 0.024482 
0.025896 0.033128 0.027423
All 57 27 84
0.021860 0.053593 0 032060
2 2  4
0.024604 0.025163 0.028793
Cell Contents —
Grass:N
Mean
StDev
M TB>glmc43=cl c2cl*c2
General Linear Model
Factor Levels Values
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Tree
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.0015972 0.0010726 0.0010726 4.91 0  030
GDBA 1 0 0000056 0.0000071 0.0000071 0.03 0.857
Atopic*GDBA I 0.0009222 0.0009222 0.0009222 4.22 0.043 
Error 80 0.0I7468I 0.0174681 0.0002184
Total 83 0.0199930
Unusual Observations for Tree
Obs Tree Fit StDev Fit Residual St Resid
49 0.051000 0.01884Q 0.002090 0.032160 2.20R
51 0.013000 0.019571 0.005585 -0.006571 -0 48 X
52 0.003000 0.019571 0.005585 -0.016571 -1.21 X
53 0.040000 0.019571 0.005585 0.020429 1.49 X
54 0.008000 0.019571 0.005585 -0.011571 -0.85 X
55 0.035000 0.019571 0.005585 0.015429 1.13 X
56 0.025000 0.019571 0.005585 0.005429 0.40 X
57 0.013000 0.019571 0.005585 -0.006571 -0.48 X
67 0.068000 0.029714 0.003225 0.038286 2.65R
77 0.069000 0.029714 0.003225 0.039286 2.72R
79 0.035000 0.010333 0.006033 0.024667 1.83 X
80 0.018000 0.010333 0.006033 0.007667 0.57 X
81 ooooooo 0.010333 0.006033 -0.010333 -0.77 X
82 0.009000 0.010333 0.006033 -0.001333 -0 .I0 X
83 ooooooo 0.010333 0.006033 -0.010333 -0.77 X
84 0 .0 0 0 0 0 0 0.010333 0.006033 -0.010333 -0.77 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table cl c2;
SUBC> stats c4.
Tabulated Statistics
Rows: Atopic Columns: GDBA
1 2 All
1 7 21 28
0.019571 0.029714 0.027179 
0.014022 0.018879 0.018103
2 2  5
2 50 6  56
0.018840 0.010333 0.017929 
0.012913 0.014067 0.013176
All 57 27 84
0.018930 0.025407 0.021012 
0.012924 0.019484 0.015520
Cell Contents ~
Tree:N
Mean
StDev
MTB > glm c5=cl c2 cl *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Mugwort
Source DF Seq SS Ad] SS Adj MS F P
Atopic 1 0.0019886 0.0023232 0.0023232 3 80 0.055
GDBA 1 00002494 0.0002391 0.0002391 0.39 0  534
Atopic*GDBA 1 0.0010576 0.0010576 0 0010576 1.73 0.192
Error 80 0.0489537 0.0489537 0.0006119
Total S3 0.0522492
Unusual Observations for Mugwort
Obs Mugwort Fit StDev Fit Residual St Resid
5 0 .1 0 0 0 0 0 0.050900 0.003498 0.049100 2.01R
8 0.117000 0.050900 0.003498 0.066100 2.70R
38 0.126000 0.050900 0 003498 0.075100 3.07R
51 0.064000 0055714 0.009350 0.008286 0.36 X
52 0 .0 2 0 0 0 0 0.055714 0.009350 -0.035714 -1.56 X
53 0.066000 0.055714 . 0.009350 0.010286 0.45 X
54 0 .0 2 2 0 0 0 0.055714 0.009350 -0.033714 -1.47 X
55 0 084000 0.055714 0.009350 0.028286 1.24 X
56 0.069000 0.055714 0.009350 0.013286 0.58 X
57 0.065000 0.055714 0.009350 0.009286 0.41 X
79 0.053000 0.036167 0.010099 0.016833 0.75 X
80 0.056000 0.036167 0.010099 0.019833 0.88 X
81 0.038000 0.036167 0.010099 0.001833 0.08 X
82 0.050000 0.036167 0.010099 0.013833 0.61 X
83 0 .0 1 0 0 0 0 0.036167 0.010099 -0.026167 -1.16X
84 0 .0 1 0 0 0 0 0.036167 ,0.010099 -0.026167 -1.16X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table cl c2;
SUBC> stats c5.
Tabulated Statistics
Rows: Atopic Columns: GDBA
1 2 All
1 7 21 28
0 055714 0.060952 0.059643 
0.024662 0.019433 0.020500
2  50 6  56
0.050900 0.036167 0.049321 
0.026920 0.021170 0.026599
All 57 27 84
0.051491 0.055444 0.052762 
0.026492 0.022067 0.025090
Cell Contents —
Mugwort:N
Mean
StDev
MTB > glm c6 =cl c2 cl *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Olive
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.002672 0 006400 0.006400 118 0.281
GDBA 1 0.028230 0.027955 0.027955 5.14 0.026
Atopic*GDBA 1 0.006457 0.006457 0.006457 1.19 0.279
Error 80 0435004 0.435004 0.005438
Total 83 0.472363
Unusual Observations for Olive
Obs Olive Fit StDev Fit Residual St Resid
34 0.669000 0.082680 0.010428 0.586320 8.03R
51 0.083000 0082571 0.027871 0.000429 0.01 X
52 0.053000 0.082571 0.027871 -0.029571 -0.43 X
53 0.077000 0.082571 0.027871 -0.005571 -0.08 X
54 0.063000 0.082571 0.027871 -0.019571 -0.29 X
55 0.065000 0.082571 0.027871 -0.017571 -0.26 X
56 0.130000 0.082571 0.027871 0.047429 0.69 X
57 0.107000 0.082571 0.027871 0.024429 0.36 X
79 0 .0 2 0 0 0 0 0.006667 0.030104 0.013333 0.20 X
80 0.007000 0.006667 0.030104 0.000333 0.00 X
81 0.013000 0.006667 0.030104 0 006333 0.09 X
82 OOOOOOO 0.006667 0.030104-0.006667 -0.10 X
83 0 .0 0 0 0 0 0 0.006667 0.030104 -0 006667 -0.10 X
84 0 .0 0 0 0 0 0 0.006667 0.030104-0.006667 -0.10 X
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
2 2  7
MTB > table cl c2; 
SU B O  stats c6 .
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 A1J
1 7 21 28
0.08257 0.05590 0.06257
0.02721 0.03280 0.Q3316
2 50 6  56
0 08268 0 00667 0.07454 
0.09133 0,00838 0.08944
All 57 27 84
0.08267 0.04496 0.07055 
0 08589 0.03572 0.07544
CeU Contents —
Olive.N
Mean
StDev
MTB >
2 2  8
MTB > glm c3=c i c2 c I *c2
Genera! Linear Model
Factor Levels Values 
Atopic 2 i 2 
GDBA 2 I 2
Analysis o f Variance for Outdoor
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.002786 0.001339 0.001339 0.31 0.578
GDBA 1 0.000389 0.000481 0 000481 0 .1 1  0.739
Atopic*GDBA I 0.000149 0.000149 0.000149 0.04 0.852 
Error 35 0.148829 0.148829 0.004252
Total 38 0.152154
Unusual Observations for Outdoor
Obs Outdoor Fit StDev Fit Residual St Resid
30 0.374000 0.078800 0.016837 0.295200 4.69R
R denotes an observation with a large standardized residual
MTB > table cl c2;
SUBC> stats c3.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 4 15 19
0.06650 0.07880 0.07621 
0.03797 0.09657 0.08672
2 11 9 20
0.05773 0.06122 0.05930 
0.03437 0.01628 0.02714
.All 15 24 39
0.06007 0.07221 0.06754 
0.03419 0.07645 0.06328
Cell Contents —
Outdoor: N 
Mean 
StDev
2 2  9
MTB > dm c4=c 1 c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 I 2
Analysis of Variance for Indoor
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.053713 0.036220 0.036220 4 86 0.034
GDBA 1 0.004153 0.001347 0.001347 0.18 0.673
Atopic*GDBA 1 0.013996 0.013996 0.013996 1 .8 8  0.179 
Error 35 0 261070 0.261070 0.007459
Total 38 0.332932
Unusual Observations for Indoor
Obs Indoor Fit StDev Fit Residual St Resid
19 0  340000 0.155133 0.022300 0.184867 2.22R
29 0.493000 0.155133 0.022300 0.337867 4.05R
R denotes an observation with a large standardized residual
MTB > table cl c2;
SU B O  stats c4. .
Tabulated Statistics
Rows: Atopic Columns: GDBA 
I 2 All
1 4 15 19
0.12575 0.15513 0.14895 
0.05849 0.12088 0.10994
2 11 9 20
0.09982 0.04400 0.07470 
0.05879 0.03822 0.05697
All 15 24 39
0.10673 0.U346  0.11087 
0.05781 0.11146 0.09360
Cell Contents ~
Indoor: N 
Mean 
StDev
2 3  0
MTB > glm c5=c 1 c2 c I *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis o f Variance for Foods 1
Source DF Seq SS Adj SS Adj MS F P
Atopic I 0.0000077 0.0001150 0.0001150 0.19 0.662 
GDBA 1 0.0000541 0.0001268 0.0001268 0.21 0.647
Atopic*GDBA I 0.0003422 0.0003422 0.0003422 0.58 0.453 
Error 35 0.0207507 0.0207507 0.0005929
Total 38 0.0211547
Unusual Observations for Foods 1
Obs Foods 1 Fit StDev Fit Residual St Resid 
9 0 086000 0.028273 0.007342 0.057727 2.49R
32 0 119000 0.025667 0.008116 0.093333 4.07R
R denotes an observation with a large standardized residual
MTB > table cl c2;
SUBC> stats c5.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 4 15 19
0 017750 0 028467 0.026211 
0.010532 0.014851 0.014497
2 11 9 20
0 028273 0.025667 0.027100 
0.022383 0.039243 0 030231
A1J 15 24 39
0.025467 0.027417 0.026667 
0.020121 0.025919 0.023595
Cell Contents —
Foods 1:N 
Mean 
StDev
2 3  1
MTB > glm c6=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 I 2
Analysis o f Variance for Foods 2
Source DF Seq SS Adj SS Adj MS F P
Atopic I 0.0033652 0.0035123 0.0035123 5.36 0.027
GDBA 1 0 0010705 0.0008807 0.0008807 1.34 0.254
Atopic*GDBA 1 0 .0 0 0 1 0 2 0  0.0001020 0.0001020 0.16 0.696 
Error 35 0.0229314 0  0229314 0.0006552
Total 38 0.0274691
Unusual Observations for Foods 2
Obs Foods 2 Fit StDev Fit Residual St Resid 
6  0.145000 0.039455 0.007718 0.105545 4.32R
R denotes an observation with a large standardized residual
MTB > table cl c2;
SU B O  stats c6 .
Tabulated Statistics
Rows: Atopic Columns: GDBA
1 2 All
1 4 15 19
0.021750 0.028800 0.027316 
0.022765 0.012891 0.014978
2 11 9 20
0.039455 0.053778 0.045900 
0.037843 0.024314 0.032498
All 15 24 39
0.034733 0.038167 0.036846 
0.034636 0.021433 0.026886
Cell Contents —
Foods 2.N 
Mean 
StDev
2 3  2
MTB > glm c7=cl c2 cl *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Moulds
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.087561 0.103940 0.103940 41.54 0.000
GDBA I 0.125457 0.092775 0.092775 37.08 0.000 
Atopic*GDBA I 0.034154 0.034154 0.034154 13.65 0.001 
Error 35 0.087582 0.087582 0.002502
Total 38 0.334755
Unusual Observations for Moulds
Obs Moulds Fit StDev Fit Residual St Resid 
36 0.096000 0.264778 0.016674-0.168778 -3.58R
39 0.367000 0.264778 0.016674 0.102222 2.I7R
R denotes an observation with a large standardized residual
MTB > tabled c2;
SUBC> stats c7.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 .All
1 4 15 19
0 03900 0.08213 0.07305 
0.03601 0.04615 0.04689
2 11 9 20
0.08855 0.26478 0.16785 
0.03451 0.07243 0.10453
All 15 24 39
0.07533 0.15063 0 12167 
0.04053 0.10621 0.09386
Cell Contents —
Moulds.N
Mean
StDev
23  3 -
Appendix J3
Statisitical analysis of Immunodot results for atopic and non- 
atopic dogs (non-GDBA/non-atopic =greyhounds <£ beagles)*
2 3  U
MTB > glm c3=ci c2 ci*c2
General Linear Model
Factor Levels Values 
Atopic 2 t 2
GDBA 2 1 2
Analysis of Variance for Dustmite
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.24046 0.08175 0.08175 5.05 0.028
GDBA 1 0.0419Q 0.04648 0.04648 2.87 0.094
Atopic*GDBA 1 0.03928 0.03928 0.03928 2.42 0.124
Error 78 1.26380 1.26380 0.01620
Total 81 1.58545
Unusual Observations for Dustmite
Obs Dustmite Fit StDev Fit Residual St Resid 
52 0.562000 0.167583 0.025983 0.394417 3.17R
54 0.609000 0.167583 0.025983 0.441417 3.54R
70 0.740000 0.167583 0.025983 0.572417 4.59R
73 0.575000 0.167583 0.025983 0.407417 3.27R
R denotes an observation with a large standardized residual
MTB > tabid cl c2;
SUBC> stats c3.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 8  24 32
0.05137 0.16758 0.13853 
0.08541 0.22446 0.20406
2 42 8  50
0.02674 0.03162 0.02752 
0.03091 0.04593 0.03323
All 50 32 82
0.03068 0.13359 0.07084 
0.04387 0.20355 0.13991
Ceil Contents —
Dustmite: N 
Mean 
StDev
2 3  5
MTB > glm c4=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis o f Variance for Storemit
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.012292 0.003588 0.003588 0.81 0.370
GDBA 1 0.003460 0.004084 0.004084 Q.92 0.339
Atopic*GDBA 1 0.008361 0.008361 0.008361 1.89 0.173 
Error 78 0.344368 0.344368 0.004415
Total 81 0.368480
Unusual Observations for Storemit
Obs Storemit Fit StDev Fit Residual St Resid
52 0.261000 0.081125 0.013563 0.179875 2.77R
54 0.282000 0.081125 0.013563 0.200875 3.09R
70 0.505000 0.081125 0.013563 0.423875 6.52R
R denotes an observation with a large standardized residual
MTB > table cl c2;
SUBC> stats c4.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 8 24 32
0.03750 0.08113 0.07022 
0.01030 0.11578 0.10167
2 42 8  50
0 04636 0.03863 0.04512 
0 02342 0.04283 0.02700
All 50 32 82
0.04494 0.07050 0.05491 
0.02202 0.10348 0.06745
Cell Contents —
Storemh:N
Mean
StDev
2 3  6
MTB > glm c5=cl c2 cl *c2
General Unear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Flea
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.0001652 0.0003032 0.0003032 1.03 0.312 
GDBA 1 0.0000791 0.0000500 0 0000500 0:17 Q.681
Atopic*GDBA 1 0.0010236 0.0010236 0.0010236 3.49 0  065 
Error 78 0.0228585 0.0228585 0.0002931
Total 81 0.0241265
Unusual Observations for Flea
Obs Flea Fit StDev Fir Residual St Resid 
17 0 095000 0.016095 0 002642 0.078905 4.67R
65 0.074000 0.0190QQ 0.003494 0.055000 3.28R
6 6  0.068000 0.019000 0.003494 0.049000 2.92R
R denotes an observation with a large standardized residual
MTB > table cl c2;
S U B O  stats c5.
Tabulated Statistics
Rows: Atopic Columns. GDBA 
1 2 All
1 8  24 32
0 012000 0.019000 0.017250 
0 011136 0.021657 0.019634
2 42 8  50
0.016095 0.005125 0 014340 
0.01629! 0.006770 0.015657
All 50 32 82
0.015440 0.01553 1 0.015476 
0.015559 0.019890 0.017259
Cell Contents —
Flea.N
Mean
StDev
2 3  7 _
MTB > glm c6=cl c2 cl*c2
Genera) Linear Mode)
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Human
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.001254 0.000000 0.000000 0.00 0.988
GDBA 1 0.001819 0,001577 0.001577 1.26 0.265
Atopic*GDBA 1 0.002584 0.002584 0.002584 2.07 0.154 
Error 78 0.097437 0.097437 0.001249
Total 81 0.103095
Unusual Observations for Human
Obs Human Fit StDev Fit Residual St Resid
8  0.182000 0.062429 0.005454 0.119571 3.42R
17 0.180000 0.062429 0.005454 0.117571 3.37R
6 6  0.143000 0.051125 0.007215 0.091875 2.66R
R denotes an observation with a large standardized residual
MTB > table cl c2;
SU B O  stats c6 .
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 8 24 32
0.048000 0.051125 0.050344 
0.013575 0.042766 0.037422
2 42 8  50
0.062429 0.037000 0.058360 
0.034025 0.030743 0.034531
All 50 32 82
0.060120 0.047594 0.055232 
0.031993 0.040112 0.035676
Cell Contents —
Human:N
Mean
StDev
2 3  8
MTB > glm c7=cl c2 cl *92
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis o f Variance for Cat
Source DF Seq SS Adj SS Adj MS F P
Atopic I 0.0045706 0.0000213 0.0000213 0.04 0.836
GDBA 1 0.0102704 0.0103569 0.0103569 21.01 0.000 
Atopic*GDBA I 0.0001081 0.0001081 0.0001081 0.22 0  641
Error 78 0.0384504 0.0384504 0  0004930
Total 81 0.0533995
Unusual Observations for Cat
Obs Cat Fit StDev Fit Residual St Resid 
31 0 088000 0.038286 0.003426 0.049714 2.27R
37 0.085000 0.038286 0.003426 0.046714 2.13R
38 0 141000 0.038286 0.003426 0.102714 4.68R
76 0.060000 0.012625 0.007850 0.047375 2.28R
R denotes an observation with a large standardized residual
MTB > table c 1 c2 ;
SUBC> stats c7.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 8 24 32
0 042500 0.011000 0.018875 
0 017501 0 013863 0.020095
2 42 8  50
0.038286 0.012625 0.034180 
0.026572 Q.020486 0.027222
All 50 32 82
0.038960 0.011406 0.028207 
0.025238 0.015423 0.025676
Cell Contents —
Cat:N
Mean
StDev
2 3  9
MTB > glm c3=cl c2 cl*c2
General Linear Model
Factor Levels Values
Atopic .2 1 2
GDBA 2 I 2
Analysis o f Variance for Grass
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.0087818 0.0003419 0.0003419 0.58 0 450
GDBA 1 0.0102335 0.0106606 0.0106606 17.94 0.000 
Atopic*GDBA 1 0.0004343 0.0004343 0.0004343 0.73 0.395 
Error 84 0.0499037 0.0499037 0  0005941
Total 87 0.0693533
Unusual Observations for Grass
Obs Grass Fit StDev Fit Residual StResid
16 0.141000 0.021940 0.003447 0.119060 4.93R
49 0.125000 0.021940 0.003447 0.103060 4.27R
51 0.019000 0.021286 0.009213 -0.002286 -0 . 1 0 X
52 0.009000 0.021286 0.009213 -0.012286 -0.54 X
53 0.047000 0.021286 0.009213 0.025714 1.14 X
54 0.017000 0.021286 0.009213 -0.004286 -0.19X
55 0.023000 0.021286 0.009213 0.001714 0.08 X
56 0  008000 0.021286 0.009213 -0.013286 -0.59 X
57 0.026000 0  021286 0.009213 0.004714 0.21 X
73 0 114000 0.055857 0.005319 0.058143 2.44R
R denotes an observation with a large standardized residual 
X denotes an observation whose X value gives it large influence.
MTB > table cl c2;
SUBC> stats c3.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
] 2 All
1 7 21 28
0.021286 0.055857 0.047214 
0.013149 0.022903 0.025678
2 50 10 60
0 021940 0.044900 0.025767 
0.025896 0.024759 0.026924
All 57 31 8 8
0.021860 0.052323 0.032591 
0.024604 0.023679 0.028234
Cell Contents —
Grass: N 
Mean 
StDev
24  0
MTB > gim c4=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis o f Variance for Tree
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.0010535 0.0001217 0.0001217 0.48 0.492
GDBA 1 0.0007179 0.0007841 0.0007841 3.08 0.083
Atopic*GDBA 1 0.0000706 0.0000706 0.0000706 0.28 0.600 
Error 84 0.0214068 0.0214068 0.0002548
Total 87 0.0232489
Unusual Observations for Tree
Obs Tree Fit StDev Fit Residual St Resid
49 0.051000 0.018840 0.002258 0.032160 2.04R
51 0.013000 0.019571 0.006034 -0.006571 -0.44 X
52 0.003000 0.019571 0.006034 -0.016571 -1.12 X
53 0.040000 0.019571 0.006034 0.020429 1.38 X
54 0  008000 0.019571 0.006034 -0.011571 -0.78 X
55 0 035000 0.019571 0.006034 0.015429 1.04 X
56 0.025000 0.019571 0.006034 0.005429 0.37 X
57 0.013000 0.019571 0.006034-0.006571 -0.44 X
67 0.068000 0.029714 0 003484 0.038286 2.46R
77 0 069000 0.029714 0.003484 0.039286 2.52R
79 0.060000 0.024300 0.005048 0.035700 2.36R
80 0.059000 0.024300 0.005048 0.034700 2.29R
R denotes an observation with a large standardized residual
X denotes an observation whose X value gives it large influence.
MTB > table cl c2;
SU B O  stats c4
Tabulated Statistics
Rows. Atopic Columns: GDBA 
1 2 All
1 7 21 28
0.019571 0.029714 0.027179 
0.014022 0.018879 0.018103
2 50 10 60
0.018840 0.024300 0.019750 
0 012913 0.023400 0.015041
All 57 31 8 8
0.018930 0.027968 0.022114 
0.012924 0.020211 0.016347
Cell Contents -- 
Tree:N
24  1
MTB > glm c5=cl c2 cl*c2
General Linear Model
Factor Levels Values
Atopic 2 1 2
GDBA 2 1 2
Analysis o f Variance for Mugwort
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.0017325 0.0012331 0.0012331 2.05 0.156
GDBA 1 0  0000100 0.0000009 0.0000009 0.00 0.969
Atopic*GDBA 1 0.0003181 0.0003181 0.0003181 0.53 0.469
Error 84 0.0506005 0.0506005 0.0006024
Total 87 0.0526611
Unusual Observations for Mugwort
Obs Mugwort Fit StDev Fit Residual St Resid
5 0 .1 0 0 0 0 0 0.050900 0.003471 0 049100 2.02R
8 0 117000 0.050900 0.003471 0.066100 2.72R
38 0.126000 0.050900 0.003471 0.075100 3 09R
51 0.064000 0.055714 0.009277 0.008286 0.36 X
52 0 0 2 0 0 0 0 0.055714 0 009277 -0.035714 -1.57 X
53 0.066000 0.055714 0.009277 0.010286 0.45 X
54 0  0 2 2 0 0 0 0.055714 0.009277 -0.033714 -1.48 X
55 0.084000 0.055714 0.009277 0.028286 1.24 X
56 0 069000 0.055714 0.009277 0.013286 0.58 X
57 0.065000 0.055714 0.009277 0.009286 0.41 X
R denotes an observation with a large standardized residual
X denotes an observation whose X value gives it large influence.
MTB > table cl c2;
SUBC> stats c5.
Tabulated Statistics
Rows: Atopic Columns. GDBA 
1 2 All
1 7 21 28
0.055714 0.060952 0.059643 
0.024662 0.019433 0.020500
2 50 10 60
0.050900 0.046200 0.050117 
0.026920 0.020784 0.025901
All 57 31 8 8
0.051491 0.056194 0.053148 
0.026492 0.020748 0.024603
Cell Contents —
Mugwort :N 
Mean 
StDev
2 U 2
MTB > aim c6=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 I 2
Analysis of Variance for Olive
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.002626 0.001763 0.001763 0.33 0.566
GDBA 1 0.023005 0.019070 0.019070 3.59 0.061 
Atopic*GDBA 1 0.001796 0.001796 0.001796 0  34 0.562 
Error 84 0.445863 0.445863 0.005308
Total 87 0.473290
Unusual Observations for Olive
Obs Olive Fit StDev Fit Residual St Resid
34 0.669000 0.082680 0.010303 0.586320 8.13R
51 0.083000 0.082571 0.027537 0.000429 0.01 X
52 0.053000 0.082571 0.027537 -0.029571 -0.44 X
53 0.077000 0.082571 0.027537 -0.005571 -0.08 X
54 0.063000 0.082571 0.027537-0.019571 -0 29 X
55 0.065000 0.08257! 0.027537-0.017571 -0.26 X
56 0.130000 0.082571 0.027537 0.047429 0.70 X
57 0.107000 0.082571 0.027537 0.024429 0.36 X
R denotes an observation with a large standardized residual
X denotes an observation whose X value gives it large influence.
MTB > table cl c2;
SU BO  stats c6 . •
Tabulated Statistics
Rows: Atopic Columns: GDBA 
I 2 Ail
1 7 21 28
0.08257 0.05590 0.06257 
0.02721 0.03280 0 03316
2 50 10 60
0.08268 0.03240 0.07430 
0.09133 0.03529 0.08645
All 57 31 8 8
0.08267 0.04832.0.07057 
0.08589 0.03487 0.07376
Cell Contents —
Olive: N 
Mean 
StDev
2L 3
MTB > glm c3=c 1 c2 cl *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2  1 2
Analysis o f Variance for Outdoor
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.002801 0.001359 0.001359 0.33 0.568
GDBA 1 0.000414 0.000521 0.000521 0.13 0.723
Atopic*GDBA 1 0.000144 0.000144 0.000144 0.04 0.852 
Error 37 0.151146 0.151146 0.004085
Total 40 0.154505
Unusual Observations for Outdoor
Obs Outdoor Fit StDev Fit Residual St Resid
30 0.374000 0.078800 0.016503 0.295200 4.78R
R denotes an observation with a large standardized residual
MTB > table cl c2;
SUBC> stats c3
Tabulated Statistics
Rows: Atopic Columns: GDBA
1 2 .All
1 4 15 19
0.06650 0.07880 0.07621 
0.03797 0.09657 0.08672
2 11 11 22
0.05773 0.06155 0.05964 
0.03437 0.02106 0 02789
All 15 26 41
0.06007 0.07150 0.06732 
0.03419 0.07400 0.06215
Cell Contents —
Outdoor: N 
Mean 
StDev
2 A A
MTB > glm c4=cl c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 I 2
Analysis of Variance for Indoor
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.055475 0.034174 0.034174 4.80 0.035
GDBA I 0.003668 0.000794 0  000794 0.11 0.740
Atopic*GDBA 1 0.012411 0.012411 0.012411 1.74 0.195 
Error 37 0.263479 0.263479 0.007121
Total 40 0.335034
Unusual Observations for Indoor
Obs Indoor Fit StDev Fit Residual St Resid
19 0.340000 0.155133 0.021788 0.184867 2.27R
29 0.493000 0 155133 0.021788 0.337867 4.14R
R denotes an observation with a Jarge standardized residual
MTB > table cl c2,
SUBC> stats c4.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 4 15 19
0.12575 0.15513 0.14895 
0.05849 0.12088 0.10994
2 II 11 22
0.09982 0.05055 0 07518 
0.05879 0.03754 0.05434
All 15 26 41
0.10673 0.11088 0.10937 
0.05781 0  10735 0.09152
Cell Contents —
Indoor: N 
Mean 
StDev
2 A 5
MTB > glm c5=cl c.2 c \*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Foods 1
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.0000027 0.0001051 0.0001051 0.19 0 6 6 8
GDBA 1 0.0000328 0.0001167 0.0001167 0.21 0.651 
Atopic*GDBA 1 0.0003825 0.0003825 0.0003825 0 .6 8  0.414 
Error 37 0.0207703 0.0207703 0.0005614
Total 40 0  0211882
Unusual Observations for Foods 1
Obs Foods I Fit StDev Fit Residual St Resid 
9 0.086000 0.028273 0.007144 0.057727 2.56R
34 0.119000 0.025182 0.007144 0.093818 4.15R
R denotes an observation with a large standardized residual
MTB > table cl c2;
SUBC> stats c5.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 4 15 19
0.017750 0.028467 0.026211 
0.010532 0.014851 0.014497
2 II II 22
0.028273 0.025182 0.026727 
0.022383 0.035128 0.028787
AJJ 15 26 41
0.025467 0.027077 0.026488 
0.020121 0.024896 0.023015
Cell Contents —
Foods 1 :N 
Mean 
StDev
2 A 6
MTB > glm c6=cl c2 cl *c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 I 2
Analysis of Variance for Foods 2
Source DF Seq SS Adj SS Adj MS F P
Atopic I 0.0028379 0.0028135 0.0028135 4.29 0 045
GDBA 1 0.0006031 0.0005226 0 0005226 0.80 0.378
Atopic’GDBA 1 0.0000084 0.0000084 0.0000084 0.01 0.911 
Error 37 0.0242886 0.0242886 0.0006564
Total 40 0.0277380
Unusual Observations for Foods 2
Obs Foods 2 Fit StDev Fit Residual StResid 
6 0.145000 0.039455 0.007725 0.105545 4.32R
R denotes an observation with a large standardized residual
MTB > table cl c2;
SUBC> stats c6.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 .All
1 4 15 19
0.021750 0.028800 0.027316 
0.022765 0.012891 0.014978
2 11 11 22
0.039455 0.048545 0.044000 
0.037843 0.024671 0.031519
.All 15 26 41
0.034733 0.037154 0.036268 
0.034636 0.020869 0.026333
Cell Contents —
Foods 2:N 
Mean 
StDev
2 A 7
MTB > glm c7=c! c2 cl*c2
General Linear Model
Factor Levels Values 
Atopic 2 1 2
GDBA 2 1 2
Analysis of Variance for Moulds
Source DF Seq SS Adj SS Adj MS F P
Atopic 1 0.080660 0.082560 0.082560 23.07 0.000
GDBA 1 0.102973 0.072452 0.072452 20.25 0.000
Atopic*GDBA I 0.021604 0.021604 0.021604 6.04 0.019 
Error 37 0.132389 0.132389 0.003578
Total 40 0.337627
Unusual Observations for Moulds
Obs Moulds Fit StDev Fit Residual StResid
31 0 070000 0 235455 0.018036-0.165455 -2.90R
38 0 096000 0.235455 0.018036-0.139455 -2.45R
41 0.367000 0.235455 0.018036 0.131545 2.31R
R denotes an observation with a large standardized residual
MTB > table cl c2;
SUBC> stats c7.
Tabulated Statistics
Rows: Atopic Columns: GDBA 
1 2 All
1 4 15 19
0.03900 0.08213 0.07305 
0.03601 0.04615 0.04689
2 11 11 22
0 08855 0.23545 0.16200 
0.03451 0.09315 0.10174
AJJ 15 26 41
0 07533 0.14700 0.12078 
0.04053 0.10311 0.09187
Cell Contents -- 
Moulds: N 
Mean 
StDev
2 A 8
Appendix K
Correlation ofpositive ELISA results for mould allergens with 
serum total IgE concentrations as assessed by Immunodot
2k 9
Correlations (Pearson)
Correlation of Aitemana and IgE -  -0.031
Correlations (Pearson)
Correlation of Aspergillus and IgE ~ -0.284
MTB > prim cl-c3 
Data Display
Row Aitemana Aspergillus IgE
1 0.095 0.078 0.293
2 0 090 0062 0250
3 0 089 0.050 0.060
4 0.117 0.183 0.012
s 0.091 0.143 0.183
6 0.070 0.045 *
7 0.044 0.077 *
8 0.060 0.079 0.247
9 0.228 0.135 *
10 0.353 0.186 0.142
11 0.104 0 146 0.112
12 0.131 0.132 0.191
13 0 041 0.106 0.106
14 0 164 0.166 0.467
15 0.077 0.033 0.425
16 0.144 0.095 *
MTB >
25 0
Appendix L
Intradermal skin test and serological results for atopic and skin
test negative dogs.
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Appendix M
Sensitivity, specificity, efficacy and correlation of serological results compared
with IDST results
Appendix M l
Sensitivity, specificity and efficacy of serological tests in relation to each
other and IDST
2 6  6
HOUSE DUST MITES
IDST +ve IDST -ve
ELISA +ve 13 7
ELISA -ve 27 5 Sensitivity = 32.5%
Specificity =41.7%
Efficacy = 34.6%
IDST +ve IDST -ve
Immdot +ve 16 0
Immdot -ve 14 11
Sensitivity = 53.3%
Specificity = 100%
Efficacy = 65.9%
ELISA +ve ELISA-ve
Immdot +ve 7 8
Immdot -ve 8 14
Sensitivity = 46.7%
Specificity = 63.6%
Efficacy = 56.8%
Topscreen
+ve
Topscreen - 
ve
Immdot +ve 9 1
Immdot -ve 2 8
Sensitivity =81.8%
Specificity = 88.9%
Efficacy = 77.3%
2 6  7
STORAGE MITE
IDST +ve IDST -ve
Immdot +ve 5 0
Immdot -ve 19 17
Sensitivity
Specificity
Efficacy
Topscreen
+ve
Topscreen - 
ve
Immdot +ve 3 0
Immdot -ve 8 11
Sensitivity
Specificity
Efficacy
26  8
=  20 . 8%  
=  100%  
= 53.7%
= 27.3% 
=  100%  
= 63.6%
CAT FLEA
IDST +ve IDST rve
ELISA +ve 0 6
ELISA -ve 3 43
Sensitivity = 0%
Specificity = 87.8%
Efficacy = 82.7%
IDST +ve IDST -ve
Immdot +ve 0 0
Immdot -ve 1 40
Sensitivity = 0%
Specificity = 100%
Efficacy = 97.6%
ELISA +ve ELISA -ve
Immdot +ve 0 0
Immdot -ve 6 32
Sensitivity = 0%
Specificity = 100%
Efficacy = 84.2%
Topscreen
+ve
Topscreen - 
ve
Immdot +ve 0 0
Immdot -ve 11 11
Sensitivity = 0%
Specificity = 100%
Efficacy = 50%
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CAT EPITHELIA
ELISA +ve ELISA -ve
Immdot +ve 0 0
Immdot -ve 0 38
Topscreen
+ve
Topscreen -  
ve
Immdot +ve 0 0
Immdot -ve 11 11
IDST +ve IDST -ve
Immdot +ve 0 0
Immdot -ve 4 37
IDST +ve IDST rve
ELISA +ve 0 0
ELISA -ve 4 48
Sensitivity = 0%
Specificity = 100%
Efficacy = 92.3%
Sensitivity = 0%
Specificity = 100%
Efficacy = 90.2%
Sensitivity = 0%
Specificity = 100%
Efficacy = 100%
Sensitivity = 0%
Specificity = 100%
Efficacy = 50%
2 7 0
HUMAN EPITHELIA
IDST +ve IDST -ve
ELISA +ve 0 0
ELISA -ve 2 50
Sensitivity = 0%
Specificity = 100%
Efficacy = 96.2%
IDST +ve IDST -ve
Immdot +ve 0 0
Immdot -ve 1 40
Sensitivity = 0% 
Specificity = 100%
Efficacy = 97.6%
ELISA +ve ELISA-ve
Immdot +ve 0 0
Immdot -ve 0 38
Sensitivity = 0%
Specificity = 100%
Efficacy = 100%
Topscreen
+ve
Topscreen - 
ve
Immdot +ve 0 0
Immdot -ve 11 11
Sensitivity = 0%
Specificity = 100%
Efficacy =50%
2 7  1
TREES
IDST +ve IDST -ve
ELISA +ve 2 12
ELISA -ve 3 35
Sensitivity = 40%
Specificity = 74.5%
Efficacy =71.2%
IDST +ve IDST -ve
Immdot +ve 0 0
Immdot -ve 3 34
Sensitivity = 0%
Specificity = 100%
Efficacy =91.9%
ELISA +ve ELISA -ve
Immdot +ve 0 0
Immdot -ve 10 24
Sensitivity = 0%
Specificity = 100%
Efficacy = 70.6%
Topscreen
+ve
Topscreen - 
ve
Immdot +ve 0 0
Immdot -ve 1 18
Sensitivity = 0%
Specificity = 100%
Efficacy = 94.7%
2 7  2
GRASSES
Topscreen
+ve
Topscreen - 
ve
Immdot +ve 0 0
Immdot -ve 0 19
ELISA +ve ELISA -ve
Immdot +ve 0 0
Immdot -ve 13 21
IDST +ve IDST -ve
Immdot +ve 0 0
Immdot -ve 9 28
IDST +ve IDST -ve
ELISA +ve 3 21
ELISA -ve 5 23
Sensitivity = 37.5%
Specificity = 52.3%
Efficacy = 59.6%
Sensitivity = 0%
Specificity = 100%
Efficacy = 75.7%
Sensitivity = 0%
Specificity = 100%
Efficacy =61.8%
Sensitivity = 0%
Specificity = 100%
Efficacy = 100%
2 7  3
MUGWORT
IDST +ve IDST -ve
ELISA +ve 1 8
ELISA -ve 2 41
ELISA +ve ELISA-ve
Immdot +ve 0 0
Immdot -ve 8 26
IDST +ve IDST -ve
Immdot +ve 0 0
Immdot -ve 1 36
Topscreen
+ve
Topscreen - 
ve
Immdot +ve 0 0
Immdot -ve 0 19
Sensitivity =33.3%
Specificity = 83.7%
Efficacy = 80.8%
Sensitivity = 0%
Specificity = 100%
Efficacy = 97.3%
Sensitivity = 0%
Specificity = 100%
Efficacy = 76.5%
Sensitivity = 0%
Specificity = 100%
Efficacy = 100%
2 7  k
SORREL
IDST +ve EDST -ve
ELISA +ve 0 6
ELISA -ve 1 45
Sensitivity = 0%
Specificity = 88.2%
Efficacy = 86.5%
PLANTAIN
IDST +ve IDST -ve
ELISA +ve 0 10
ELISA -ve 3 39
Sensitivity = 0%
Specificity = 79.6%
Efficacy = 75%
DANDELION
IDST +ve IDST -ve
ELISA +ve 0 10
ELISA -ve 3 39
Sensitivity = 0%
Specificity = 79.6%
Efficacy = 75%
NETTLE
IDST +ve IDST -ve
ELISA +ve 0 6
ELISA -ve 2 44
Sensitivity = 0%
Specificity = 88%
Efficacy =84.6%
2 7  5
MOULDS
IDST +ve IDST -ve
ELISA +ve 0 18
ELISA -ve 0 34
Sensitivity = 0%
Specificity = 65.4%
Efficacy = 65.4%
IDST +ve IDST -ve
Immdot +ve 0 1
Immdot -ve 0 28
Sensitivity = 0%
Specificity = 96.6%
Efficacy = 96.6%
ELISA +ve ELISA -ve
Immdot +ve 0 1
Immdot -ve 13 15
Sensitivity = 0%
Specificity =93.8%
Efficacy =51.7%
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Appendix M2 
Correlation of serological results with IDST results
Correlations (Pearson)
Correlation of House dust mites - IDST and House dust mites - ELISA = -0.171
Correlations (Pearson)
Correlation of House dust mites - IDST and Immunodot Indoor - HDM = 0.454
Correlations (Pearson)
Correlation of House dust mites - ELISA and Immunodot Indoor - HDM = 0.075
Correlations (Pearson)
Correlation of Storage mites - IDST and Storage mites - Immunodot -  0.330
Correlations (Pearson)
Correlation of cat flea IDST and Cat flea ELISA = -0 089 
Correlation 'cat flea IDST 'Cat flea Immunodot'.
* NOTE * All values in column are identical.
* ERROR * Completion of computation impossible.
Correlation Cat flea ELISA’ 'Cat flea Immunodot'
* NOTE ¥ All values in column are identical.
* ERROR * Completion of computation impossible.
Correlations (Pearson)
Correlation of Trees - IDST and Trees - ELISA = 0.135 
Correlation Trees - IDST' 'Trees - Immunodot'
* NOTE * Ail values in column are identical.
* ERROR * Completion of computation impossible.
Correlation Trees - ELISA' 'Trees - Immunodor'.
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* NOTE * All values in column are identical.
* ERROR * Completion o f computation impossible
Correlations (Pearson)
Correlation o f Grasses - IDST and grasses - ELISA = 0.033 
Correlation 'Grasses - IDST' 'Grass - Immunodot'.
* NOTE * All values in column are identical.
* ERROR * Completion of computation impossible.
Correlation 'grasses - ELISA' 'Grass - Immunodot'.
* NOTE * All values in column are identical.
* ERROR * Completion o f computation impossible
Correlations (Pearson)
Correlation o f Mugwort - IDST and Mugwon - ELISA = 0.105 
Correlation Mugwort - IDST' 'Mugwort - Immdot'.
* NOTE * All values in column are identical.
* ERROR * Completion o f computation impossible.
Correlation 'Mugwort - ELISA’ 'Mugwort - Immdot'.
* NOTE * All values in column are identical
* ERROR * Completion of computation impossible.
Correlations (Pearson)
Correlation of Sorrel - IDST and Sorrel - ELISA = -0.051
Correlations (Pearson)
Correlation of Plantain - IDST and Plantain - ELISA = -0 . 1 2 1
2 7  9
Correlations (Pearson)
Correlation of Dandelion - IDST and Dandelion - ELISA = -0 .12 1
Correlations (Pearson)
Correlation o f nettle - IDST and nettle - ELISA = -0.072
Correlations (Pearson)
Correlation of mould - IDST and mould - ELISA = - 0  1 0 2
Correlations (Pearson)
Correlation of mould - IDST and Immunodot - moulds = -0 036
Correlations (Pearson)
Correlation of mould - ELISA and Immunodot - moulds = -0.170
28 0
Appendix M3
Correlation of Topscreen Immunodot with individual Indoor 
and Outdoor Immunodot panels
2 8  1
Worksheet size: 100000 cells
Correlations (Pearson)
Correlation of Indoor and Topscreen Indoor = 0 730 
Correlation 'Outdoor1 'Topscreen Outdoor'.
* NOTE * All values in column are identical.
* ERROR * Completion o f computation impossible.
* ERROR * Unknown MINITAB command:
MTB > print cl-c4
Data Display
Row Indoor Outdoor Topscreen Indoor Topscreen Outdoor
1 0 0 0 0
*> I 1 1 0
3 0 0 I 0
4 1 0 1 0
5 I 0 1 0
6 0 0 0 0
7 0 0 1 0
8 0 0 0 0
9 0 0 0 0
10 0 0 0 0
i 1 1 0 1 0
12 0 0 0 0
13 I 0 0 0
14 0 0 0 0
15 ] * 1 *
16 I * 1 *
17 1 * 1 *
18 0 0 0 0
19 0 0 0 0
20 1 0 1 0
21 0 0 0 0
22 1 0 1 0
MTB >
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Appendix N
Serum total IgGj concentrations in atopic and non-atopic dogs
&
statistical evaluation of this data.
28 3
Appendix N1 Serum total IgGi concentrations in non-atopic GDBA
dogs with and without skin disease at the time of sampling.
Name Breed Age at Serum IgGi
sampling conc.
(days) (mg/dl)
Non-atopic GDBA
Angus LabradorxGolden Retriever 261 25
Cherie Labrador 615 20
Daniel Labrador 684 10
Emily Labrador 1005 130
Eva Golden RetrieverxLabrador 1833 10
Glen Labrador 634 10
Grace Golden Retriever 457 10
Henry Golden Retriever 465 10
Melody Golden RetrieverxLabrador 1500 10
Paddy LabradorxGolden Retriever 691 35
Pascoe Golden RetrieverxLabrador 280 20
Perry Golden RetrieverxLabrador 793 20
Rigsby Labrador 251 10
Skin disease
non-atopic GDBA
Lucy Labrador 554 10
Henry Golden Retriever 284 10
Mary Golden Retriever 215 10
Sherry Golden RetrieverxLabrador 472 10
Curtis Labrador 644 10
Norma Golden RetrieverxLabrador 423 10
Duncan Golden Retriever 507 10
Ria Labrador 401 10
Illis Golden RetrieverxLabrador 276 10
Onyx LabradorxGolden Retriever 1708 30
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Appendix N2 Serum total IgGi concentration in atopic GDBA dogs
Dog number Breed Age at sampling Serum IgGi
(days) conc.
(mg/dl)
Abel German Shepherd Dog 2689 1550
Alana German Shepherd Dog 1709 25
Andrea German Shepherd Dog 1325 135
Carlo Golden RetrieverxLabrador 429 10
Cedar Golden RetrieverxLabrador 565 10
Chris Labrador 2687 50
Clare Labrador 2892 520
Dusty Golden RetrieverxLabrador 1830 220
Griff Golden Retriever 1820 345
Harris LabradorxGolden Retriever 630 60
Herbie Golden RetrieverxLabrador 125 10
Kai Golden RetrieverxLabrador 784 40
Keaton Labrador 413 100
Opal Labrador 1473 60
Palmer Golden RetrieverxLabrador 916 30
Paul Golden RetrieverxLabrador 908 35
Pedro Golden RetrieverxLabrador 796 10
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Appendix N3 Serum total IgGi concentrations in non-atopic
greyhounds
Dog number Age (yrs) Serum IgGi cone, (mg/di)
334 3 425
338 3 325
342 3 925
344 6 215
345 6 430
346 6 10
347 6 10
348 6 205
349 6 10
350 3 760
371 3 300
372 5 10
373 12 80
374 5 165
2 8  6
Appendix N4 Serum total IgGi concentrations in atopic GUVS dogs.
Atopic GUVS Breed Age at sampling IgGi cone,
(days) (mg/dl)
Alfred German Shorthaired Pointer 1266 240
Brandy Dalmatian 750 25
Budd Labrador 915 240
Holly Yorkshire Terrier 820 100
Islay Staffordshire Bull Terrier 2770 1520
Jess Cross breed 1440 520
Kassie German Shepherd Dog 468 10
Kayla Boxer 550 475
Kerry Terrier 545 200
Kerry II German Shepherd DogxLabrador 2187 35
Kim Labrador 1865 360
Libby Bulldog 607 475
Luke Great Dane 388 970
Macauly German Shepherd Dog 305 165
Megan Labrador 2521 1350
Olwen Irish Wolfhound 498 10
Raver Staffordshire Bull Terrier 1454 80
Rhuri German Shepherd Dog 719 365
Sally Labrador 1092 960
Sammie Golden Retriever 2166 280
Shannon Cairn Terrier 730 10
Shogun German Shepherd Dog 1640 640
Skerry Staffordshire Bull Terrier 1939 330
Tyson Boxer 288 685
2 8  7
Appendix N5
One Way ANOVA and Newman Keuls multiple range test of the 
loge of serum total IgGi concentrations in atopic and non-atopic
dQgs
Worksheet  s ize: ! 00000 cells
TB print c 1- c3
a t a fu / i o p i a v
1GW G r q Li p Se r u m !gG ! Log e ser
j 11 ■> ci .  j 3 . 2 ) 8 8 3
iL 1 2 0 2 . 9 9 5 7 3
3 ! 0 2 . 3 0 2 5 9
n f i 30 4 . 8 6 7 5  3
i 10 -> : j m c ai_ . ^  J
6 i 10
! q
10
2 . 3 0 2 5 9
2 . 3 0 2 5 9
2 . 3 0 2 5 9
t i 11 j n1 W 2 . 3 0 2 5 9
1 0 • 35
2Q
3 . 5 5 5 3 5
2 . 9 9 5 7 3
: o 2 . 9 9 5 7 3
! r J 1 n1 V»
i 4 2 10
* i
2 . 3 0 2 5 9
2 . 3 0 2 5 9
: ! Q 2 . 3 0 2 5 9
i t 2 i n1 w -> ^O^CCl^ O’ -/ J
i 3 i2 10 2 . 3 0 2 5 9
- J. 1 0 2 . 3 0 2 5 9
> “ : n 2 . 3 0 2 5 9
"5 2 i n1 V/  ^ j m c n_✓ O’ 4_ -/ w»
__ 10 2 . 3 0 2 5 9
‘^ i 3 4 0  ! 2 0
T
: r  r ;'j ' . 3 4 6 0 1
1 £ ? 1 1 Q9R_/ . i u u O
- TT > -i r-i 0 D 4 . 9 0 5 2 7
: j- 02 5 9
k_ . j 0 l  j  ^
i c n 2 o n r nj ,  ^
1'J If I-----\ ADZU 6 . 2 5 3 S 3
j - _ z 0 5 . 3 9 3 6 3
_ j ; 4 5 5 . S 4 3 5 4
2, 60 A no A 2/1I.V-» T T
34 2f 10 2 . 3 0 2 5 9
: ^ j 40 3 . 6 8 8 8 8
. o j ! 00 4 . 6 0 5 1 7
if 3 CC\\j 4 . 0 9 4  34
38 3 30 3 . 4 0 1 2 0
35 3 . 5 5 5 3 5
j  0 -> ■ n-. Vw' 2 . 3 0 2 5 9
1 ! AT /I “) cT .£- -/ 6 . 0 5 2 0 9
*•+ il 4 325 5 . 7 8 3 8 3
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4 3 .1 925 6 . 8 2 9 7 9
44 4 2 I 5 5 .3 7 0 6 4
45 4 4 3 0 6 . 0 6 3 7 9
46 -1T 1 0 2 . 3 0 2 5 9
. 1 7 4 ! 0 2 . 3 0 2 5 9
; s 4 205 5 . 3 2 3 0 1
49 4 ! 0 2 . 3 0 2 5 9
50 4 760 6 .6 3 3 3 2
5 i 4 300 5 .7 0 3 7 8
I 1 0 2 . 3 0 2 5 9
53 4 SO 4 . 3 8 2 0 3
54 4 165 5 . 105 9 5
s 5 5 2 4 0 5 .4 8064
56 c 25 3.2 I 8 8 8
57 5 2 4 0 5 .4 8064
53 r. SOO 4 .6 0 5  I 7
59 5 i 520 7 .3 2 6 4 7
60 r- 520 6 .2 5 3 8 3
6  ! 5 I 0 2 . 3 0 2 5 9
/—i 5 4 7 5 6 . 1 6 3 3  I
6 3 c 2 0 0 5 2 9 8 3 2
4 T 35 3 .5 5535
6  5 5 360 5 .8 8 6 !  0
6 6 5 4 75 6 . 1 6 3 3 !
■J ; 3 9 70 6 . S 7 7 3 0
■:o 5 I 65 5. 10595
69 5 ! 350 7 .2 0 7 8 6
70 5 1 0 2 . 3 0 2 5 9
7 ! s. 30 4 . 3 8 2 0 3
— -j c 365 5 . 8 9 9 9 0
— o> 5 9 6 0 6 . 8 6 6 9 3
74 5 2 8 0 5 .6 3 4 7 9
"5 5 ; n 2 . 3 0 2 5 9
- 6 4 0 6 .46 147
7 ~ 5 330 5 .7 9 9 0 9
"S n 6S5 6 .5 2 9 4 2
One-W av A nalysis o f Variance
Analysis o f  Variance for Log e se  
Source D F  SS MS F
‘- j ' ou p 
£: roi 
T otas
._evei
4 3 9 .53
73 136.40
77 2 2 5 .9 3
Mean
~> O") 7
2 .4 12  
,i non
10
22.33
1.37
» I o s  n nnn
Individual 95% Cis For Mean 
Based on Pooled StDev
StDev .....................
0 . 7 5 6  ( )
0 .3 4 7  ( }
1.439
2 9  0
4 i .i 4 74 7 I 7! 4
5 24 5 . 2 9 6  1 . 543
Pooled StDev -  1 .3 6 7  2 .4 3.6 4 .8
VI TR
Execut ing from file: C. MTBWIN-MACROS nk.MAC 
N ew m an -K eu ls  Multiple Range  Test
Please enter  the tol lowmq into at the DATA> prompt  :
Number  of  g r o u p s
DATA 5
VI C /a  f f Q f I
r '  \  T (  i <3 " 7.J  -a i -a ; . O  /
Df(error)
DATA 73
m e a n s  of  each gr ou p  
DATA 2 . 3 2 7  
. 2 .4  I 2 
DATA 4 . 0 9 0  
DATA - '1.74 7 
DATA 5 . 2 9 6
number  of obse rvat ion s  in each group-A * -r \ . -7I 1 !■
DATA : 0  
DATA ! 7
..»^>..hc .at uan Keuis multiple iaucie test
Data D isplay
\t5 error  \ . S ,  d f  error:
Group Mean Count
w d  c q  u i 4 > M i a y
2 , . 8 2 7 1 3
2 . 412 1 0
L . 0 9 0 j 7
2 9  1
•i 4 . 7 4  7 
5 5 . 2 9 6
14
24
Data D isplay
L f i C u p  j  S I Cf MS  ficaritly di fferent  to  group  
Data D isplay
G io up  4 significantly d i f ferent  to group  
Data D isplay
Croup 5 s ignif icant ly di f ferent  to group  
Data D isplay
Giou p i  significantly dif ferent  to qroup  
Data D isplay
Croup \ signif icantly di fferent  to group  
Data D isplay
' i iuni ficant iv di fferent  to. g i o u p
U T D
1 «t f LS
